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1 Introduction 
 
1.1 Gallium 
 
Gallium’s existence was first predicted in 1869 by Dmitri Mendeleev before Paul Émile 
Lecoq de Boisbaudran actually discovered the element in 1875.[1,2] With the atomic number 
31 it is the heavier homologue of aluminium in the boron group. Gallium is a silvery white 
and brittle element with a melting point at 29.78 °C and a boiling point at 2403 °C. Despite 
its rather high electric conductivity (5.77 × 104 Ω−1 cm−1), gallium is still referred to as a 
metalloid. This is mostly due to its melting behaviour as well as characteristics found in 
structures of solid gallium. The melting of gallium causes a volume contraction, a property 
shared with elements such as silicon, germanium, antimony and bismuth. Furthermore, 
the metalloid has a strong tendency to supercool below its melting point enabling it to stay 
liquid at room temperature and below for an extended period of time.[2]  
There are only two naturally occurring isotopes of gallium—69Ga and 71Ga. The element 
can be found in trace concentrations associated with aluminium, and zinc or germanium.[2] 
Thus there are only very few known minerals in which gallium is a major component[3-5] 
and it is mainly produced as a byproduct of zinc and aluminium[2]. The overall abundance 
of gallium in the upper continental crust is estimated to be 17–18 µg/g[6,7], therefore it can 
be considered a rare element[1]. According to the current state of research, gallium is not 
an essential element[2]. 
 
1.2 Chemistry of gallium 
 
Gallium and aluminium share similarities concerning their chemical nature. Just as 
aluminium, gallium is stable in dry air and water due to the formation of a passive, 
protective oxide/hydroxide layer. The metalloid is soluble in non-oxidising acids (formation 
of Ga3+ salts) and bases (formation of gallates). In general, the chemistry of gallium is 
dominated by the stability of its oxidation states 0 and III. Even though gallium(I) 
compounds exist, these are considered to be highly unstable and get easily oxidised, 
thereby forming stable gallium(III) compounds.[2]  
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In acidic aqueous solution (pH < 3), gallium(III)—just like its lighter homologue 
aluminium(III)—forms mononuclear species like [Ga(OH)(H2O)x]2+ and [Ga(OH)2(H2O)x]+ 
aside from the hexaquagallium(III) complex.[8-10] With rising pH value of the solution, aqua 
ligands get deprotonated leading to the formation of hydroxido ligands which can get 
further deprotonated to oxido ligands. Both can function as bridging ligands to form various 
polynuclear species.[8,11] In weakly acidic, neutral and weakly basic aqueous solutions 
precipitation of hydroxidooxido species occurs. Ga(OH)3 is the main component of these 
precipitates. It is stable across a wide range of pH values while occurring predominantly 
between pH 4.5 and 8.5[11] and displays a very low solubility in water (Ks = 1.585 × 10−37).[12] 
At around pH 8, tetrahydroxidogallate(III) begins to form, which is the only species in 
strongly basic solutions.[8,13,14] On a side note, the formation of precipitates often hinders 
reliable potentiometric solution studies.[10,11]  
Gallium shows different coordination modes ranging from one to six ligands with the 
coordination numbers four and six dominating.[2] Various complexes of gallium(III) are 
formed with carbon-, nitrogen-, phosphorus- and oxygen-bearing ligands. A difference in 
the chemical behaviour between aluminium and gallium can be found in the tendency to 
bind oxygen ligands. The thermodynamic driving force behind much of the chemistry of 
aluminium is the Al–O bond formation.[1] While gallium(III) does readily form complexes 
with oxygen ligands, it also has a tendency to bind nitrogen ligands. Hence it follows the 
trend of an increased affinity to nitrogen ligands with higher period in the 13th group of the 
periodic table. This was demonstrated by Hegetschweiler et al.[15] by using 1,3,5-triamino-
1,3,5-trideoxy-cis-inositol (taci) as a ligand for 13th group elements. The ligand is capable 
of forming two isoenergetic chair conformations with either three amine groups or three 
hydroxide groups in axial positions for facial coordination. Therefore, when two of these 
ligands are used for the formation of an octahedral complex with a metal centre, three 
different arrangements around the centre are possible: two metal centres surrounded with 
either all oxygen (MO6) or nitrogen (MN6), and one with mixed oxygen and nitrogen 
surrounding, MO3N3. Aluminium(III) does form the complex with only oxygen surrounding 
the metal centre, whereas the gallium(III) complex has the mixed adjacency GaO3N3 
(Figure 1.1) and thallium(III) is surrounded only by nitrogen.[15] As indicated before, 
examples of gallium(III) complexes with all oxygen[1,16] and all nitrogen[1,17] ligands are 
existent, though mixed N/O-surroundings seem to be preferred when there is opportunity 
(and no hindrance) to form these as shown by Hegetschweiler et al.[15].  
It should be noted that the [Ga(taci)2]3+ complex hydrolyses in aqueous solution, and the 
hydrolytic polymerisation reaches significant levels after a few hours.[15] Of course, in the 
investigation with taci as ligands no other mixed N/O surroundings of gallium(III) other than 
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GaO3N3 can potentially be formed. Hence, no assertion concerning the best ratio of 
oxygen-to-nitrogen ligands is possible with this ligand.  
 
Figure 1.1: Aluminium(III) and gallium(III) complexes with chelating taci ligands.[15] Charges on ammonium 
functions are omitted. 
 
1.3 Applications of gallium compounds 
 
Gallium compounds are applied predominantly in the field of solid state chemistry, for 
example in semiconductors (GaAs)[18] or superconductors (V3Ga)[19]. However, in recent 
years, gallium(III) compounds have raised attention to their potential pharmaceutical 
applications. For example, gallium(III) used in the form of gallium(III) nitrate or gallium(III) 
citrate displays antimicrobial activity.[20,21] 68Ga radiolabelled complexes formed with 
chelating aminopolycarboxylic acids such as 1,4,7-triazacyclononane-1,4,7-triacetic acid 
(NOTA, Figure 1.2) or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA, 
Figure 1.2) as well as derivatives of those compounds are used and/or tested for their 
applicability in PET imaging.[22,23] Furthermore, the antineoplastic activity of gallium(III) 
nitrate, tris(maltolato)gallium(III) and tris(8-hydroxyquinolinato)gallium(III) (Figure 1.3) was 
studied in clinical trials.[24] 
 
Figure 1.2: Chelating ligands NOTA (a) and DOTA (b).[22] 
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Figure 1.3: Tris(maltolato)gallium(III) (a) and tris(8-hydroxyquinolinato)gallium(III) (b).[24] 
While complexes of gallium(III) need to be very stable and fast in formation for imaging 
applications—which is assured by the use of hexa- or octadentate chelators like NOTA 
and DOTA[22]—therapeutic agents are based on the release of gallium(III) in cells. The 
therapeutic effect seems to be due to similar chemical properties—for example the ion 
radius, coordination chemistry and ionisation potential—of gallium(III) and iron(III), which 
renders them indistinguishable for many biological systems.[20,25] The presence of 
gallium(III) affects cellular uptake of iron as it competes by binding to iron transport proteins 
like transferrin, lactoferrin and ferritin.[20,24,25] The gallium–transferrin complex inhibits the 
binding of the iron–transferrin complex to transferrin receptors competitively, leading to 
lower iron concentrations in the cells. Cellular deprivation of iron seems to play an 
important role in the therapeutic effect of gallium, as does the replacement of iron with 
gallium(III) in several enzymes.[24] Gallium(III), unlike iron(III), is not redox-active at 
physiological conditions, therefore gallium(III)-containing enzymes lose their activity.[20] A 
vulnerable target of gallium(III) might be ribonucleotide reductase, an iron(III)-containing 
enzyme essential for deoxyribonucleotide synthesis.[20,25] The replacement of iron(III) with 
gallium(III) in this enzyme impairs DNA synthesis, which causes death in rapidly 
proliferating cells (for example tumour cells or bacteria).[20] Another potential effect of 
gallium(III) on iron-containing enzymes might be located in the mitochondria, which could 
lead to apoptosis.[24]  
As the pharmacological properties of gallium(III) compounds are different from those of 
other antibiotics, gallium-based therapies might be possible for antibiotic-resistant 
bacterial pathogens.[20] One important property of gallium-based therapeutic agents is their 
bioavailability, especially allowing for oral supplementation. However, this is not true for 
gallium(III) nitrate which shows very low bioavailability when administered orally[24] and is 
poorly soluble at physiological conditions due to the formation of gallium(III) hydroxide[8,21]. 
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When compared to gallium(III) nitrate, the use of tris(maltolato)gallium(III) and tris(8-
hydroxyquinolinato)gallium(III) increases the bioavailability of gallium(III). This was an 
important advance in gallium-based therapeutics research.[24] 
 
1.4 Aminecarboxylatogallium(III) complexes 
 
While complexes with NOTA- and DOTA-based ligands have been studied extensively[23], 
ligands with lesser denticity have not raised such attention. Although proteinogenic amino 
acids (AAs) have been used as proteinogenic aminecarboxylato (aa) ligands for the 
formation of gallium(III) complexes, earlier investigations were mainly done by IR 
spectroscopy and products were not studied by X-ray diffraction or 13C{1H} NMR and 
1H NMR spectroscopy. These studies implied the existence of Ga(aa) complexes with aa 
ligands bound to gallium(III) as chelating ligands and/or with just one functional group. 
Among others, complexes with up to three aa ligands in an octahedral gallium(III) complex 
[Ga(aa)3] were discussed. In this kind of complex the aa ligand binds via the amine function 
and the deprotonated carboxylic function in a bidentate fashion (Figure 1.4).[26-33] The 
formation of such complexes with the ligands L-histidinato, L-methioninato, L-prolinato and 
L-tryptophanato were also described in the most recent publication[34] on this topic, though 
still no X-ray diffraction experiments were done to confirm the structure of these 
complexes. As a side note, the products described in this particular work did always 
contain residual sodium nitrate due to the use of gallium(III) nitrate and sodium carbonate 
in the course of synthesis.  
Among all aforementioned studies, only the AAs L-asparagine, L-arginine, L-glutamine and 
L-tyrosine were not used as ligands for gallium(III) complexes.[26-35] While molecular 
structures of gallium(III) complexes which incorporate glycinato and L-prolinato ligands as 
bidentate ligands in combination with methyl ligands (Figure 1.5) are known, those 
complexes were prepared under strictly inert conditions.[36,37] 
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Figure 1.4: General structure of [Ga(aa)3] complexes. R is the side chain of the respective aa ligand. 
 
 
Figure 1.5: Glycinatodimethylgallium(III) (a) and dimethyl-L-prolinatogallium(III) (b).[36,37] 
 
Complexes with the tridentate iminodiacetato (ida) ligand or the tetradentate nitrilo-
triacetato (nta) ligand are more thoroughly documented via crystallographic data.[38-40] For 
example, nta forms a dinuclear complex [{Ga(nta)(µ-OH)}2]2− (Figure 1.6) with two bridging 
hydroxido ligands and two capping nta ligands. The anionic complex was crystallised in 
water with sodium and caesium cations at pH 6.[39,40] Furthermore, two molecular 
structures of mononuclear nitrilotriacetatogallate(III) complexes, NH4/Cs[Ga(nta)(SCN)2] 
and NMe4[Ga(nta)F2] have been reported.[39,40] The synthesis and crystallisation of the 
monoanionic octahedral [Ga(ida)2]− complex (Figure 1.6) was accomplished in aqueous 
solution at pH 3 as the respective potassium salt.[38] 
Overall, it was shown that aminecarboxylato ligands are suitable ligands for gallium(III) 
complexes and yet structural information of those gallium(III) complexes and details of 
their behaviour in aqueous solution are scarce, especially when it comes to Ga(aa) 
complexes. 
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Figure 1.6: The complexes [{Ga(nta)(µ-OH)}2]2− (a) and [Ga(ida)2]− (b).[38-40] 
 
1.5 Aim of this work 
 
The overall goal was to synthesise and characterise gallium(III) complexes suitable for 
pharmacological applications, specifically as antibiotic or antineoplastic agents.  
As described before, gallium(III) compounds need to release gallium(III) in cells to achieve 
pharmacological effects (Section 1.3). Consequently, at least two properties concerning 
the stability of the complexes are key for their applicability as therapeutic agents. On the 
one hand, the complexes need to be stable enough to allow for transport to the targeted 
cells. Hence, the complexes should not precipitate gallium(III) hydroxide in aqueous 
solution at physiological pH levels. On the other hand, the complexes need to release 
gallium(III) in cells. Thus, the composition of the complexes must still allow for ligand 
exchange reactions, for which gallium(III) complexes with hexa- or octadentate ligands are 
not suitable.  
As previous studies have shown (Section 1.3), tris(maltolato)gallium(III) and tris(8-
hydroxyquinolinato)gallium(III) are potential therapeutic agents. The ligands of these 
complexes are bidentate, just as in a further publication[34] with the subject of potential 
gallium-based pharmaceuticals. Among others, the formation of [Ga(aa)3] complexes with 
proteinogenic aminecarboxylato (aa) ligands is described in that work. 
Since no structural information about these [Ga(aa)3] complexes—or overall gallium(III) 
complexes with aa ligands at non-inert conditions—was yet available, the synthesis and 
structural characterisation of such complexes was chosen as a first goal. Previous 
investigations have also shown that the combination of nitrogen- and oxygen-bearing 
ligands is favourable for the formation of gallium(III) complexes. Although some 
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aminecarboxylatogallium(III) complexes are known and characterised, this type of 
complex has not been thoroughly investigated yet, especially if the ligands are not of high 
denticity. Hence, the examination of further complexes with a combination of ligands that 
feature amine and carboxylic groups was another point of interest.  
Elemental analysis was used as a first glance on the composition and the overall purity of 
every product. Since structural investigations of the target complexes were sought for, X-
ray diffraction experiments with crystalline compounds were utilised as a major analytical 
method. Since the behaviour of gallium(III) compounds at physiological pH levels in 
aqueous solution is crucial when it comes to pharmaceutical applications and some 
characteristics of the examined compounds called for it, extensive studies by 13C{1H} NMR 
and 1H NMR spectroscopy in combination with 2D NMR techniques were done.  
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2 Results  
 
2.1 Glycinatogallium(III) complexes 
 
As mentioned in section 1.4, several studies on the topic of gallium(III) complexes with aa 
ligands have been published, yet no structural investigation has confirmed the existence 
of such complexes. In general, past investigations stated that gallium(III) can form 
octahedral, mononuclear and neutral [Ga(aa)3] complexes with bidentate monoanionic aa 
ligands. To assess this hypothesis and obtain crystalline compounds for structural 
investigations, the most simple amino acid, glycine, was used to synthesise [Ga(gly)3]. 
Glycine, unlike every other proteinogenic amino acid, is not chiral and does not feature a 
side chain at the C2 atom. Therefore, the crystallisation of the target complex should not 
be hindered by steric effects or disordered side chains of the ligand.  
One issue that was encountered in the latest publication on the topic of [Ga(aa)3] 
complexes is the contamination of products with sodium nitrate. This was due to the use 
of sodium carbonate as a basic compound and gallium(III) nitrate as a starting material.[34] 
The solubility of sodium nitrate and the solubilities of the target complexes are too similar 
to allow for full separation of product and byproduct, hence the implementation of different 
bases in the synthesis is advised. Triethylamine (NEt3), when used as a base in reactions 
with gallium(III) salts, should form the corresponding triethylammonium salts. For example, 
triethylammonium chloride is more soluble in organic solvents like ethanol when compared 
to the respective alkali salts[41] and should enable the separation of the [Ga(aa)3] complex 
and the byproduct.  
 
Figure 2.1: Attempted synthesis of [Ga(gly)3]. 
 
The attempt to synthesise [Ga(gly)3] was done by letting gallium(III) chloride react with 
glycine and triethylamine in a molar ratio of 1:3:5 in water at room temperature (Figure 
2.1). An excess of base was needed to yield a solution (pH 10.0) and, therefore, ensure 
that every reactant was available for the reaction. This was important to guarantee that no 
gallium(III) was withdrawn from the reaction mixture by the potential formation of 
gallium(III) hydroxide. After 16 hours, a slurry had formed which was treated with 2 mL of 
ethanol. This was done to ensure that the target complex was precipitated and 
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triethylammonium chloride was still kept in solution. The choice of solvents was also 
loosely based on the reaction conditions used by Thottathil et al.[34] The solid was 
separated by filtration, washed with ethanol, dried and first examined by elemental 
analysis. This was done to ensure the removal of the side product triethylammonium 
chloride and to get information about the obtained gallium(III) complex. Contrary to 
expectation, the elemental analysis did not show the formation of [Ga(gly)3]. Rather, a 
mixture of [{Ga(gly)2(µ-OH)}2] and unreacted glycine seems to be present in the product. 
This implies that one equivalent of glycine did not bind to gallium(III) (Figure 2.2).  
 
Figure 2.2: Chemical equation for the synthesis of [{Ga(gly)2(µ-OH)}2]. 
 
To confirm the result of the elemental analysis, several crystallisation experiments were 
done. After six weeks, a solution of the raw product in water and triethylamine (pH 10.0), 
which was stored over 1,4-dioxane, yielded crystals of [{Ga(gly)2(µ-OH)}2] (Figure 2.3).  
 
Figure 2.3: Plot of [{Ga(gly)2(µ-OH)}2] in crystals of 1a. Space group: P21/n. CShMOC-6: 0.738. The thermal 
ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard deviation 
of the last digit in parentheses: Ga1–N1 2.0547(15), Ga1–N2 2.0692(15), Ga1–O1 1.9898(12), Ga1–O3 
1.9836(12), Ga1–O5 1.9620(12), O3–Ga1–O5 170.35(5), N1–Ga1–O5 169.75(5), N2–Ga1–O1 172.89(6), 
N1–Ga1–N2 93.81(6), N1–Ga1–O1 82.35(6), N1–Ga1–O3 92.77(6), N1–Ga1–O5 95.09(6), N2–Ga1–O5′ 
95.77(6), O5–Ga1–O5′ 81.09(5). 
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The octahedral GaN2O4 coordination of gallium(III) is slightly distorted and was quantified 
with a CShMOC-6 (continuous shape measure, as established by Alvarez et al.[42]) value of 
0.738. The distortion is expected, as five-membered chelate rings should lead to angles 
of less than 90° in the complex. In addition, the Ga–N and Ga–O distances should differ 
and, indeed, the Ga–N distances are slightly longer than the Ga–O distances. 
The molecular structure is the first structure of a glycinatogallium(III) complex that was 
obtained by growing crystals in aqueous solution. While this is a positive result, there were 
negative aspects to that outcome. Obviously, the formation of the expected [Ga(gly)3] 
complex was not achieved. Despite the supply of three equivalents of glycine for the 
reaction, only two equivalents reacted with gallium(III). The octahedral coordination of 
gallium(III) is completed by bridging hydroxido ligands, thereby forming a binuclear instead 
of the targeted mononuclear complex. Furthermore, the synthesis and the crystallisation 
experiments had to be done at basic conditions due to the extremely low solubility of the 
product at pH levels that resemble physiological conditions.  
The main question is, of course, why no [Ga(gly)3] was obtained. Common reasons for the 
formation of one complex instead of another can be issues with its charge, coordination 
and thermodynamic effects. As [{Ga(gly)2(µ-OH)}2] and [Ga(gly)3] are both neutral 
complexes, the charge of these complexes can be ruled out as a factor for the formation 
of one complex instead of the other. Also, the formation of [Ga(gly)3] instead of 
[{Ga(gly)2(µ-OH)}2] should be slightly favoured when it comes to entropy as two complexes 
are formed instead of one while the same number of ligands is contained (Figure 2.4). 
Entropic effects would, therefore, suggest the opposite result.  
 
 
Figure 2.4: Potential equilibrium reaction between [Ga(gly)3] and [{Ga(gly)2(µ-OH)}2]. 
 
One possible restriction to bonding the third glycinato ligand may be found in a heavier 
distortion of the octahedral coordination sphere in the complex. However, the angle 
between the two bridging hydroxido ligands is the smallest and, therefore, farthest away 
of an ideal octahedral coordination. A [Ga(gly)3] complex should therefore be more 
symmetrical. This assumption was confirmed later, as, in a later experiment, crystals of 
[Ga(gly)3] (Figure 2.5) were obtained from an unexpected source. In that experiment 
glycylglycylglycine and glycine were used in combination with gallium(III) chloride to form 
a heteroleptic, mononuclear complex. Instead, crystals of [Ga(gly)3] were obtained by 
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storing an aqueous solution of this reaction′s product for one year. Hence, a structural 
investigation of [Ga(gly)3] was possible, yet the reproduction of crystals was not feasible. 
 
Figure 2.5: Plot of [Ga(gly)3] in crystals of 1b·H2O. Space group: P21/c. CShMOC-6: 0.642. The thermal 
ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard deviation 
of the last digit in parentheses: Ga1–N1 2.0498(14), Ga1–N2 2.0577(14), Ga1–N3 2.0437(14), Ga1–O1 
1.9732(12), Ga1–O3 1.9823(11), Ga1–O5 1.9857(12), N1–Ga1–O3 173.35(5), N2–Ga1–O5 171.80(5), N3–
Ga1–O1 170.70(5), N1–Ga1–N2 96.39(6), N1–Ga1–N3 97.21(6), N1–Ga1–O1 82.55(5), N1–Ga1–O5 
91.63(5), N2–Ga1–O3 81.92(5). 
Each of the glycinato ligands in [Ga(gly)3] is bound in a bidentate fashion and with the 
oxygen atom of the carboxylato function opposing a nitrogen atom of another glycinato 
ligand. Therefore, the nitrogen and the oxygen atoms form a facial pattern. The interatomic 
distances are in the expected range, with Ga–N slightly longer than Ga–O. Also, as 
expected, the angles of the five-membered chelate rings are smaller than 90°. Once again, 
the distortion of the octahedral coordination sphere was quantified with a CShMOC-6 value 
of 0.642. Therefore, [Ga(gly)3] features a slightly smaller deviation from the perfect 
octahedral shape than [{Ga(gly)2(µ-OH)}2]. 
As possible comparisons in literature are not available and both complexes were 
obtained—though not in the same experiment—it is difficult to explain why 
[{Ga(gly)2(µ-OH)}2] instead of [Ga(gly)3] was formed despite the use of stoichiometric 
ratios. It may be assumed that to some extent gallium(III) has a disposition to form 
complexes with hydroxido ligands which would imply a thermodynamic cause for the 
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formation of [{Ga(gly)2(µ-OH)}2]. However, more experimental data is needed to reach a 
satisfactory level of evidence. This issue will be discussed further in section 3.3. 
At this point it was obvious that the synthesis of gallium(III) complexes with aa ligands is 
not as straightforward as expected and several problems can be specified. The formation 
of two different complexes was observed, and their synthesis was not achieved by the 
stoichiometric use of ligands. Further problems arose when the synthesis of the complexes 
should have been repeated. In the case of [{Ga(gly)2(µ-OH)}2], uncoordinated glycine was 
still present in solution and, to some extent, in the raw products if three equivalents of 
glycine were used. Hence, the circumstances must be ideal to precipitate 
[{Ga(gly)2(µ-OH)}2] with as little contamination with uncoordinated glycine as possible. 
Unfortunately, the attempt to synthesise [{Ga(gly)2(µ-OH)}2] with stoichiometric ratios of 
starting materials at basic pH levels was not successful. Also, crystals of both molecular 
structures were obtained only once and in very small yields. When it came to [Ga(gly)3], 
only few crystals were obtained and, as mentioned, the exact conditions were dubious. 
Thus, the results remain generally irreproducible.  
To conclude, instead of gathering information to consolidate previous findings reported in 
literature, these experiments raised many questions about the chemistry of gallium(III) 
complexes with aa ligands in aqueous solution. As the most simple AA glycine already 
caused these issues, it was obvious that the use of only aa ligands in experiments was not 
reasonable. Therefore, to get more conclusive data and controllable experiments, the use 
of co-ligands in combination with aa ligands was inevitable.  
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2.2 Nitrilotriacetatogallium(III) complexes 
 
A suitable co-ligand for gallium(III) complexes in combination with aa ligands had to meet 
a few requirements. The ligand should be tetradentate and allow the bonding of the aa 
ligands to gallium(III) in cis configuration as bidentate ligands. The resulting charge of the 
complex should ideally be close to neutral and last, but not least, the ligand should not 
allow the formation of too many different complex isomers in combination with aa ligands 
to keep the experiments as simple as possible.  
Nitrilotriacetic acid (H3nta) was chosen as a co-ligand since it is known to form gallium(III) 
complexes in the form of dinuclear M2[{Ga(nta)(µ-OH)}2] complexes with monovalent 
cations like Na+ and Cs+.[19,20] In this complex, the two binding sites of the hydroxido ligands 
are located in cis configuration to one another. Therefore, it was expected that 
mononuclear octahedral complexes could be formed with a combination of nta and aa 
ligands. At neutral or slightly basic pH levels the carboxylic functions of both ligands should 
be deprotonated, while the amine group of the ligand is uncharged. Hence, complexes of 
the composition [Ga(aa)(nta)]− should be monoanionic when polar or nonpolar 
proteinogenic amino acids are used as ligands. In addition, only two different isomers of 
this kind of complex can be formed provided the side chains of the aa ligands are not 
involved in the complex formation (Figure 2.6).  
Due to the fact that both the synthesis of [Ga(aa)(nta)]− and [{Ga(nta)(µ-OH)}2]2− involve 
basic compounds in the reaction, it can be assumed that an optimal pH range for the 
formation of one or the other exists.  
 
 
Figure 2.6: The two possible isomers of [Ga(aa)(nta)]−. R is the side chain of the respective aa ligand. 
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2.2.1 Triethylamine and -ammonium compounds 
 
To synthesise the target complexes, equal conditions as described for the synthesis of 
glycinatogallium(III) complexes (Section 2.1) were chosen. Water was used as a solvent 
and gallium(III) chloride, nitrilotriacetic acid and the respective proteinogenic amino acid 
were used as starting materials in a molar ratio of 1:1:1. The reaction would result in the 
formation of the complex salt and the chloride of the respective base, hence triethylamine 
(NEt3) was chosen as the basic compound because triethylammonium chloride is easy to 
remove from the products due to its solubility in organic solvents. Triethylamine was used 
in excess to guarantee the full deprotonation of the AA over the length of the reaction 
(Figure 2.7) which led to a pH of around 8.0–8.5 in every reaction mixture. The complex 
salts were precipitated by the addition of organic solvents to the aqueous reaction 
solutions. On occasion, the removal of water before the addition of organic solvents was 
necessary to reach satisfying product yields. 
 
 
Figure 2.7: Reaction scheme for the synthesis of compounds containing Ga(nta) fragments and aa ligands by 
use of NEt3 as base. Water is used as a solvent and, depending on the AA used in the reaction, n is either 4.5 
or 5.5.  
 
The abbreviations used in Figure 2.7 and throughout this work are based on the definitions 
of aa ligands by IUPAC. Amino functions are uncharged and carboxylato groups are 
negatively charged when proteinogenic amino acids are bound as ligands. Hence, polar, 
nonpolar and basic aa ligands are defined as monoanionic ligands, while acidic aa ligands 
bear a double negative charge. The zwitterionic forms of those compounds are, therefore, 
Haa in the case of polar, nonpolar and basic proteinogenic amino acids and H2aa in the 
case of acidic proteinogenic acids. 
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Every product was characterised by elemental analysis. In contrast to section 2.1, the 
elemental analyses indicate the successful formation of the target complexes in most 
cases. However, the formation of well-defined target complexes is dependent on the 
respective amino acid in use. In particular, the main differences can be seen when 
products with polar and nonpolar amino acids (Table 2.2) are compared to products 
obtained with acidic and basic amino acids (Table 2.1). Since the basic and acidic aa 
ligands are potential tridentate ligands, nta is not a well-suited co-ligand in combination 
with those. This is clearly visible in the compositions of the raw products listed in Table 2.1 
which have to be explained in detail.  
Table 2.1: Interpretation of elemental analyses: nitrilotriacetatogallium(III) compounds with acidic or basic aa 
ligands and NEt3. The maximum difference (max. diff.) is given between the found and calculated percentages 
of the listed compositions.  
complex/complex salt contamination max. diff. 
[Ga(Harg)(nta)]·0.10NEt3 1.55 H2O + 0.10 EtOH  0.07 
HNEt3[Ga(Hasp)(nta)]·0.30NEt3 1.40 H2O  0.22 
HNEt3[Ga(Hglu)(nta)]·0.10NEt3 0.55 H2O 0.05 
[Ga(Hhis)(nta)]·0.30NEt3 1.60 H2O 0.11 
[Ga(Hlys)(nta)]·0.10NEt3 2.15 H2O 0.20 
 
The amount of triethylamine displayed after the complexes and complex salts might also 
be interpreted as a non-integer amount of triethylammonium ions present in the product. 
HNEt3[Ga(Hasp)(nta)]·0.30NEt3 might therefore also be described in a different way, for 
example, that 70% HNEt3[Ga(Hasp)(nta)] and 30% (HNEt3)2[Ga(asp)(nta)] are present. 
The style of displaying the compositions of the crude products in Table 2.1 may seem 
awkward, but was chosen for two reasons. First of all it is a more concise visual display, 
but the more significant reason is found in the properties of the products. To explain this, 
HNEt3[Ga(Hasp)(nta)]·0.30NEt3 is used as an example. Regardless of the interpretation, 
the result of the elemental analysis of this product states that the aa ligand is protonated 
once to at least about 70%. This is not due to a lack of triethylamine in the reaction, as an 
excess of this compound was used. The synthesis was done at basic conditions which 
should result in full deprotonation of H2asp if the ligand is bound to gallium(III) with the 
amino group and one carboxylato function. This is likely, since the same results were 
obtained when L-glutamato was used as a ligand instead of L-aspartato. L-glutamato 
should not be bound to gallium(III) with both carboxylato groups, since this requires the 
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formation of a seven-membered chelate ring. Hence, the acidic aa ligands should be 
bound to gallium(III) with the amino function and one carboxylato group. 
The reaction was, therefore, not the reason for the protonated state of the aa ligand. 
Instead, this was caused by the instability of the complex salt. At room temperature, the 
solid releases triethylamine, which can be proven both by the compound’s strong odour of 
amines and the declining amount of triethylammonium cations which was observed in 
subsequent analyses. Because of the instability of the complex salt, the non-integer 
amount of triethylammonium ions is shown in the form of a triethylamine adduct. The same 
reasoning is applicable for the glutamatogallium(III) complex.  
A closer look at the elemental analyses of the products with basic aa ligands reveals a 
similar issue. The side chains of the basic aa ligands are at least partially protonated which 
is due to the basic function of the ligand competing with triethylamine in the reaction 
mixture. This led to a non-integer amount of triethylamine/triethylammonium ions in the 
products. In addition, the products were not entirely stable and emitted a slight odour of 
amines which was due to the loss of triethylamine. The instability of the product was not 
as significant as found for [Ga(Haa)(nta)]− compounds with acidic aa ligands, but was still 
recognisable. Therefore, the products are also displayed in the form of triethylamine 
adducts with fully protonated side chains of the aa ligands. 
In general, the synthesis of the target complexes was successful with every acidic and 
basic amino acid, though the acidic and basic functions of the side chains did prevent the 
formation of stable well-defined products. These results were backed with elemental 
analysis as well as NMR spectroscopy. 
In contrast, the products with polar and nonpolar aa ligands were better defined in general. 
With one exception, L-tyrosine, the synthesis of the target complexes was successful with 
every polar and nonpolar amino acid (Table 2.2).  
L-tyrosine, which is almost insoluble in water, did not seem to react with gallium(III). 
Instead of the target complex, the attempt of synthesis resulted in a mixture of L-tyrosine 
and (HNEt3)2[{Ga(nta)(µ-OH)}2], according to elemental analysis. This peculiarity will be 
further addressed in section 3.3.1.  
Two of the synthesised target complexes—HNEt3[Ga(cys)(nta)] and HNEt3[Ga(nta)(trp)]—
are special. HNEt3[Ga(cys)(nta)] was not obtained without free L-cysteine still present in 
the crude product and the elemental analysis of HNEt3[Ga(nta)(trp)] indicate that a non-
integer amount of triethylammonium-cations is present. A small amount of complex salt 
seems to be protonated in this case, most likely due to the nitrogen atom in the side chain.  
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Table 2.2: Interpretation of elemental analyses: HNEt3[Ga(aa)(nta)] compounds with polar or nonpolar aa 
ligands. The maximum difference (max. diff.) is given between the found and calculated percentages of the 
listed compositions.  
complex salt contamination max. diff. 
HNEt3[Ga(ala)(nta)] 0.60 H2O 0.09 
HNEt3[Ga(asn)(nta)] 0.20 Ga(OH)3 + 0.10 EtOAc 0.13 
HNEt3[Ga(cys)(nta)] 1.25 H2O + 0.10 Hcys 0.05 
HNEt3[Ga(gln)(nta)] 0.75 H2O 0.09 
HNEt3[Ga(gly)(nta)] 0.20 H2O 0.08 
HNEt3[Ga(ile)(nta)] - 0.07 
HNEt3[Ga(leu)(nta)] 0.05 Ga(OH)3 0.14 
HNEt3[Ga(met)(nta)] 0.70 H2O 0.13 
HNEt3[Ga(nta)(phe)] 1.10 H2O 0.07 
HNEt3[Ga(nta)(pro)] 0.75 H2O 0.13 
HNEt3[Ga(nta)(ser)] 0.15 Ga(OH)3 + 0.10 H2O 0.06 
HNEt3[Ga(nta)(thr)] 0.15 H2O 0.08 
HNEt3[Ga(nta)(trp)] + 0.10 [Ga(nta)(Htrp)] 1.65 H2O 0.04 
- 
Htyr + 0.35 (HNEt3)2[{Ga(nta)(µ-OH)}2] 
+ 1.15 H2O 
0.16 
HNEt3[Ga(nta)(val)] 0.15 H2O 0.06 
 
Overall, the formation of 19 target complexes was achieved according to elemental 
analyses. These products were not pure, solvent residue—most often water—and 
sometimes gallium(III) hydroxide were found in the crude products along with the 
aforementioned impurities. Water was an expected contaminant as the complex salts 
proved to be hygroscopic. The existence of gallium(III) hydroxide might indicate that the 
respective ligand combination was not optimal to form the target [Ga(aa)(nta)]− complexes. 
However, gallium(III) hydroxide may have been present because of unfavourable reaction 
conditions or imprecise amounts of the starting materials. In any case, the contaminants 
which were present in the crude products did not interfere with any subsequent analyses 
or experiments and were, therefore, not regarded as problematic. 
Of course, elemental analysis is only a first glance at a product composition and is not 
sufficient on its own. Hence, crystallisation experiments with the obtained crude products 
were necessary. 
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2.2.2 Structural investigations of HNEt3[Ga(aa)(nta)] salts 
 
The crystallisation method of choice was to slowly add anti-solvent to aqueous or 
methanolic solutions of the compounds by vapour diffusion. Crystallisation experiments 
with the crude products shown in subsection 2.2.1 were successful in a few cases. X-ray 
diffraction experiments with these crystals show the formation of HNEt3[Ga(aa)(nta)] salts 
and support the results that were derived from elemental analyses. Unfortunately, only 
four data sets obtained by single crystal X-ray diffraction were of high enough quality to 
allow for presentation. The molecular structures of these complex salts—
HNEt3[Ga(gly)(nta)], HNEt3[Ga(met)(nta)], HNEt3[Ga(nta)(pro)] and HNEt3[Ga(nta)(ser)]—
are shown in Figure 2.8–Figure 2.11.  
 
Figure 2.8: Plot of HNEt3[Ga(gly)(nta)] in crystals of (HNEt3)2c. Space group: P21/c. CShMOC-6: 0.569. The 
thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.0627(18), Ga1–N2 2.0052(18), Ga1–O1 1.9414(16), Ga1–
O3 1.9571(15), Ga1–O5 1.9975(15), Ga1–O7 1.9995(16), N1–Ga1–N2 175.62(7), O1–Ga1–O7 178.23(7), 
O3–Ga1–O5 164.66(6), N1–Ga1–O5 81.53(7), N2–Ga1–O1 95.74(7), N2–Ga1–O3 99.97(7), N2–Ga1–O5 
94.98(7), N2–Ga1–O7 83.24(7), N3–O8 2.732(3). 
As illustrated, the gallium(III) ions in these complexes have a slightly distorted octahedral 
GaN2O4 coordination. The distortion of the octahedral geometry is expected due to the 
formation of five-membered chelate rings between the chelating ligands and the 
gallium(III) centre and was interpreted in greater depth with the CShMOC-6 values. The 
interatomic distances and angles between gallium(III) and the nitrogen and oxygen atoms 
of the ligands are consistent with the observation of a distorted octahedral geometry and 
are in the anticipated range. As expected, the Ga–N distances are slightly longer than the 
Ga–O distances.  
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Figure 2.9: Plot of the two symmetrically independent [Ga(met)(nta)]− ions in crystals of (HNEt3)2f. Space 
group: P21. CShMOC-6: Ga1 1.322, Ga2 1.298. To avoid overlap in the picture the HNEt3+ ions are not 
displayed. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) 
with standard deviation of the last digit in parentheses: Ga1–N1 2.099(8), Ga1–N2 2.039(8), Ga1–O1 1.943(8), 
Ga1–O3 1.992(5), Ga1–O5 2.010(5), Ga1–O7 1.905(6), Ga2–N3 2.098(8), Ga2–N4 2.044(8), Ga2–O9 
1.963(7), Ga2–O11 1.978(6), Ga2–O13 2.025(5), Ga2–O15 1.917(6), N1–Ga1–O7 173.4(3), N2–Ga1–O1 
170.5(3), O3–Ga1–O5 160.9(2), N1–Ga1–N2 102.8(3), N1–Ga1–O3 80.4(2), N2–Ga1–O3 91.6(3), N2–Ga1–
O5 90.3(3), N2–Ga1–O7 83.7(3), O5–Ga1–O7 100.8(2), N3–Ga2–O15 173.3(3), N4–Ga2–O9 169.8(3), O11–
Ga2–O13 161.4(3), N3–Ga2–N4 102.8(3), N3–Ga2–O13 80.1(3), N4–Ga2–O11 93.5(3), N4–Ga2–O13 
88.6(3), N4–Ga2–O15 83.9(3), O11–Ga2–O15 97.8(2). 
 
The nitrogen atoms of nta and the respective proteinogenic amino acid are – with the 
exception of HNEt3[Ga(met)(nta)] (isomer II, Figure 2.6) – always coordinated trans to one 
another (isomer I, Figure 2.6). This observation will be discussed in greater detail in section 
3.7. 
HNEt3[Ga(gly)(nta)] and HNEt3[Ga(met)(nta)] were crystallised from aqueous solutions at 
neutral pH levels, while HNEt3[Ga(nta)(pro)] and HNEt3[Ga(nta)(ser)] were crystallised 
from methanolic solutions. Only HNEt3[Ga(gly)(nta)] was obtained in significant amounts 
and reasonable time, while only a few small crystals of the other compounds were 
obtained. In the case of HNEt3[Ga(nta)(pro)] the crystallisation did almost take one year.  
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Figure 2.10: Plot of HNEt3[Ga(nta)(pro)] in crystals of (HNEt3)2g·H2O. Space group: P212121. CShMOC-6: 
0.889. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.108(2), Ga1–N2 2.004(2), Ga1–O1 1.955(2), 
Ga1–O3 1.977(2), Ga1–O5 1.971(2), Ga1–O7 1.978(2), N1–Ga1–N2 176.92(10), O1–Ga1–O7 175.33(10), 
O3–Ga1–O5 162.27(9), N1–Ga1–O3 81.04(9), N2–Ga1–O1 91.22(9), N2–Ga1–O3 98.21(9), N2–Ga1–O5 
99.03(9), N2–Ga1–O7 84.13(10).  
 
The crystalline compounds resemble the target complexes, therefore the use of nta as a 
co-ligand proved to be successful for a controlled and straightforward synthesis of 
gallium(III) complexes with aa ligands. Unfortunately, in many cases the triethylammonium 
cation was heavily disordered in crystal structures, which prevented a reasonable structure 
solution of further HNEt3[Ga(aa)(nta)] salts. The structure solution of HNEt3[Ga(met)(nta)] 
already required the use of partial isotropic refinement for some atoms. As a result, the 
crystal structure is presentable but of mediocre quality. Therefore, better suited cations 
needed to be found for further structural investigations of [Ga(aa)(nta)]− complexes.  
Additionally, in some crystallisation experiments crystals of the respective AA in use were 
obtained. At this stage of the work the cause of this was not determined and two possible 
explanation were considered. The complexes might either be unstable which leads to their 
decomposition in solution or the interpretation of the elemental analyses of the particular 
raw products was flawed. This issue will be further addressed in subsection 2.2.6.  
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Figure 2.11: Plot of the two symmetrically independent [Ga(nta)(ser)]− ions in crystals of (HNEt3)2h·0.14H2O. 
Space group: P1. CShMOC-6: Ga1 0.537, Ga2 0.787. To avoid overlap in the picture the HNEt3+ ions are not 
displayed. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) 
with standard deviation of the last digit in parentheses: Ga1–N1 2.079(3), Ga1–N2 1.994(3), Ga1–O1 1.976(3), 
Ga1–O3 1.996(3), Ga1–O5 1.961(3), Ga1–O7 1.958(3), Ga2–N3 2.086(3), Ga2–N4 2.002(3), Ga2–O10 
1.942(3), Ga2–O12 1.985(3), Ga2–O14 1.962(3), N1–Ga1–N2 178.97(15), O1–Ga1–O7 177.41(14), O3–
Ga1–O5 164.01(12), N1–Ga1–O3 81.59(14), N2–Ga1–O1 94.43(13), N2–Ga1–O3 97.44(15), N2–Ga1–O5 
98.53(13), N2–Ga1–O7 85.65(13), N3–Ga2–N4 171.96(13), O10–Ga2–O16 179.15(15), O12–Ga2–O14 
163.44(11), N3–Ga2–O14 81.34(13), N4–Ga2–O10 98.70(12), N4–Ga2–O12 91.53(12), N4–Ga2–O14 
104.84(13), N4–Ga2–O16 81.91(12).  
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2.2.3 N,N-diisopropylethylamine and -ammonium compounds 
 
During the search for suitable cations to enhance the crystallisation of [Ga(aa)(nta)]− 
complexes, N,N-diisopropylethylamine (DIPEA) was identified as an adequate substitution 
for triethylamine. The same synthesis and purification procedures as described for the 
triethylamine and -ammonium compounds (Subsection 2.2.1) were applicable for the 
synthesis of HDIPEA[Ga(aa)(nta)] salts. Hence, the stoichiometric ratios were left 
unchanged (Figure 2.12). A welcome effect of DIPEA usage was the better separability of 
the targeted product and N,N-diisopropylethylammonium chloride, as the latter proved to 
be soluble even in ethyl acetate.  
 
 
Figure 2.12: Reaction scheme for the synthesis of compounds containing Ga(nta) fragments and aa ligands 
by use of DIPEA as base. Water is used as a solvent and, depending on the AA used in the reaction, n is 
either 4.5 or 5.5.  
 
The obtained crude products were examined by elemental analysis (Table 2.3 and Table 
2.4). According to these, the synthesis of HDIPEA[Ga(aa)(nta)] salts was successful in 
most cases and the results were very similar to those of the HNEt3[Ga(aa)(nta)] salts 
(Subsection 2.2.1). Due to this fact, the discussion of the product compositions is not that 
detailed. An elaborate description can be found in subsection 2.2.1. 
As expected, the formation of the target complexes depends on the amino acid. In 
particular, the main differences are found when products containing polar and nonpolar 
amino acids (Table 2.4) are compared to products with acidic and basic amino acids (Table 
2.3). 
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Table 2.3: Interpretation of elemental analyses: nitrilotriacetatogallium(III) compounds with acidic or basic aa 
ligands and DIPEA. The maximum difference (max. diff.) is given between the found and calculated 
percentages of the listed compositions. 
 
 
 
 
 
 
According to the elemental analyses, the side chains of the acidic as well as the basic aa 
ligands are protonated once and adducts with N,N-diisopropylethylamine are formed. 
Those compounds were not stable at room temperature and released N,N-
diisopropylethylamine.  
Table 2.4: Interpretation of elemental analyses: HDIPEA[Ga(aa)(nta)] compounds with polar or nonpolar aa 
ligands. The maximum difference (max. diff.) is given between the found and calculated percentages of the 
listed compositions.  
complex-salt contamination max. diff. 
HDIPEA[Ga(ala)(nta)] 0.85 H2O 0.03 
HDIPEA[Ga(asn)(nta)] 0.20 Ga(OH)3 + 0.05 EtOH 0.11 
HDIPEA[Ga(cys)(nta)] 0.10 Ga(OH)3 + 0.10 H2O + 0.05 EtOH  0.07 
HDIPEA[Ga(gln)(nta)] 0.20 H2O + 0.05 EtOH 0.06 
HDIPEA[Ga(gly)(nta)] 0.95 H2O 0.13 
HDIPEA[Ga(ile)(nta)] 0.20 H2O 0.07 
HDIPEA[Ga(leu)(nta)] 0.15 H2O + 0.05 EtOAc 0.04 
HDIPEA[Ga(met)(nta)] 0.05 H2O 0.11 
HDIPEA[Ga(nta)(phe)] 0.90 H2O 0.10 
HDIPEA[Ga(nta)(pro)] 0.05 Ga(OH)3 + 0.05 H2O 0.09 
HDIPEA[Ga(nta)(ser)] 0.80 H2O 0.09 
HDIPEA[Ga(nta)(thr)] 0.50 H2O 0.18 
HDIPEA[Ga(nta)(trp)]  0.25 H2O + 0.20 Ga(OH)3 0.02 
0.05 HDIPEA[Ga(nta)(tyr)] tyrH + 0.05 Ga(OH)3 0.19 
HDIPEA[Ga(nta)(val)] 0.15 H2O 0.08 
 
complex/complex-salt contamination max. diff. 
[Ga(Harg)(nta)]·0.05DIPEA 2.45 H2O  0.10 
HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA 0.10 Ga(OH)3 0.22 
HDIPEA[Ga(Hglu)(nta)]·0.05DIPEA 0.30 H2O + 0.05 Ga(OH)3  0.21 
[Ga(Hhis)(nta)]·0.25DIPEA 2.10 H2O + 0.05 EtOH 0.17 
[Ga(Hlys)(nta)]·0.05DIPEA 2.25 H2O + 0.15 EtOH 0.17 
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Hence, the resulting compositions are similar to those obtained with triethylamine 
(Subsection 2.2.1) and the synthesis of the target complexes was successful with every 
acidic and basic amino acid. 
Consistently, products with polar and nonpolar amino acid ligands were better defined in 
general. The synthesis of the target complexes was successful with every polar and 
nonpolar amino acid. When compared to the use of triethylamine, an almost insignificant 
difference was found when L-tyrosine was used as a ligand. A very small amount of the 
actual target complex was synthesised according to elemental analysis. Still, the major 
component of the product is unreacted L-tyrosine, therefore the synthesis of [Ga(nta)(tyr)]− 
was once again not achieved. This peculiarity will be addressed further in subsection 3.3.1.  
Overall, the formation of 19 target complexes was successful according to elemental 
analyses. The products were not pure since solvent residue and sometimes gallium(III) 
hydroxide were present in those. As described in subsection 2.2.1, these particular 
contaminations could be ignored. It should be noted, that the HDIPEA[Ga(aa)(nta)] salts 
were obtained in overall higher grades of purity when compared to HNEt3[Ga(aa)(nta)] 
salts.  
In general, triethylamine and N,N-diisopropylethylamine are both adequate bases for the 
synthesis of the target complexes. The product compositions are very similar, albeit a very 
impactful difference between HNEt3[Ga(aa)(nta)] and HDIPEA[Ga(aa)(nta)] salts is found 
when the results of crystallisation experiments are compared. 
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2.2.4 Structural investigations of HDIPEA[Ga(aa)(nta)] salts 
 
In some cases crystallisation experiments in methanolic and aqueous solutions or mixtures 
of water and methanol with the crude products of subsection 2.2.3 yielded crystals of 
suitable quality for X-ray diffraction experiments. The resulting molecular structures 
showed that the disorder of the N,N-diisopropylethylammonium cations was significantly 
reduced when compared to the triethylammonium cations in HNEt3[Ga(aa)(nta)] salts. On 
average, this resulted in an improvement of crystal quality. Altogether, the molecular 
structures of the following seven different complex salts with two different modifications of 
HDIPEA[Ga(gly)(nta)] (Figure 2.13–Figure 2.20) were obtained. 
 
Figure 2.13: Plot of HDIPEA[Ga(ala)(nta)] in crystals of (HDIPEA)2a·2H2O. Space group: P21. CShMOC-6: 
0.686. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.089(4), Ga1–N2 1.982(4), Ga1–O1 1.943(3), 
Ga1–O3 1.989(3), Ga1–O5 1.973(3), Ga1–O7 2.010(3), N1–Ga1–N2 177.56(16), O1–Ga1–O7 176.95(14), 
O3–Ga1–O5 162.71(12), N1–Ga1–O3 80.91(13), N2–Ga1–O1 94.53(14), N2–Ga1–O3 97.03(13), N2–Ga1–
O5 99.58(14), N2–Ga1–O7 83.38(14), N3–O8 2.791(5). 
The molecular structures of the complex salts display octahedral coordination of the 
gallium(III) centre with GaN2O4 environments. As expected, the CShMOC-6 values illustrate 
slight distortions of the octahedral coordination spheres which resemble the distortions 
found in HNEt3[Ga(aa)(nta)] salts. The interatomic distances and angles between 
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gallium(III) and the nitrogen and oxygen atoms are also in the expected range, with Ga–N 
slightly longer than Ga–O.  
 
Figure 2.14: Plot of HDIPEA[Ga(asn)(nta)] in crystals of (HDIPEA)2b. Space group: P21. CShMOC-6: 0.613. 
The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.072(2), Ga1–N2 1.987(2), Ga1–O1 1.949(2), Ga1–O3 
1.975(2), Ga1–O5 1.964(2), Ga1–O7 1.994(2), N1–Ga1–N2 175.70(9), O1–Ga1–O7 177.25(11), O3–Ga1–
O5 164.91(8), N1–Ga1–O3 82.51(8), N2–Ga1–O1 96.14(9), N2–Ga1–O3 100.84(9), N2–Ga1–O5 93.62(9), 
N2–Ga1–O7 82.97(10), N4–O8 2.793(3). 
In the molecular structures of HDIPEA[Ga(aa)(nta)] salts the N-atoms of nta and the 
respective proteinogenic amino acid are, without exception, coordinated trans to one 
another (isomer I, Figure 2.6).  
 
It is odd that one isomer seems to be favoured to such an extent. To get an understanding 
of the preferred occurrence of isomer I over isomer II (Figure 2.6), more structural data of 
complexes that resemble isomer II would certainly be beneficial. At least, the molecular 
structures of the constitutional isomers I and II of the same complex anion were obtained. 
Isomer I was found in crystals of HDIPEA[Ga(met)(nta)] and isomer II in crystals of 
HNEt3[Ga(met)(nta)] (Figure 2.9).  
 
To start the comparison of the two isomers, a closer look at the CShMOC-6 values is 
reasonable. The values of both complex anions show a slightly distorted octahedral 
coordination sphere, but, indeed, the distortion of isomer I (CShMOC-6: 0.574) is not as 
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significant as in isomer II (CShMOC-6: Ga1 1.322, Ga2 1.298, mean value 1.310). 
Unfortunately, due to the lack of further data, it is not possible to tell if this is always the 
case and, therefore, causing the preferred occurrence of isomer I. However, the difference 
between the CShMOC-6 values in the two isomers is quite small. Hence, it is at least doubtful 
whether such a significantly higher prevalence of one isomer is caused by such slight 
differences in distortion.  
 
 
Figure 2.15: Plot of HDIPEA[Ga(gly)(nta)] in crystals of (HDIPEA)2c·MeOH. Space group: Pna21. CShMOC-6: 
0.536. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.074(2), Ga1–N2 1.997(2), Ga1–O1 1.947(2), 
Ga1–O3 1.981(2), Ga1–O5 1.962(2), Ga1–O7 2.011(2), N1–Ga1–N2 173.03(9), O1–Ga1–O7 177.73(8), O3–
Ga1–O5 164.58(8), N1–Ga1–O3 81.89(8), N2–Ga1–O1 99.45(8), N2–Ga1–O3 98.93(8), N2–Ga1–O5 
95.82(9), N2–Ga1–O7 82.53(8), N3–O8 2.821(3). 
 
Another possible reason for the preferred formation of isomer I may be found in some kind 
of steric hindrance in isomer II. However, the molecular shape of both isomers of 
[Ga(met)(nta)]− does not reveal any steric hindrances of the aa ligand’s side chain and the 
rest of the complex molecule. Hence, the reason for the preferred occurrence of isomer I 
may not be found in the molecular structures, but in the formation of the complexes in 
solution. If there is a mechanistic reason that leads to the prioritised formation of isomer I, 
the likelihood of crystallising isomer II may be drastically reduced. This will be discussed 
later in more detail (Section 3.7). 
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Figure 2.16: Plot of HDIPEA[Ga(gly)(nta)] in crystals of (HDIPEA)2c·H2O. Space group: P21/n. CShMOC-6: 
0.574. The thermal ellipsoids are drawn at 50% probability (room temperature data collection). Interatomic 
distances (in Å) and angles (in °) with standard deviation of the last digit in parentheses: Ga1–N1 2.0891(13), 
Ga1–N2 1.9812(13), Ga1–O1 1.9386(12), Ga1–O3 1.9775(12), Ga1–O5 1.9728(12), Ga1–O7 2.0065(12), 
N1–Ga1–N2 175.70(5), O1–Ga1–O7 178.65(5), O3–Ga1–O5 162.91(5), N1–Ga1–O3 80.88(5), N2–Ga1–O1 
96.89(5), N2–Ga1–O3 96.79(5), N2–Ga1–O5 99.48(5), N2–Ga1–O7 83.85(5), N3–O8 2.847(2). 
 
Figure 2.17: Plot of HDIPEA[Ga(leu)(nta)] in crystals of (HDIPEA)2d. Space group: P212121. CShMOC-6: 0.585. 
The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.086(4), Ga1–N2 2.001(4), Ga1–O1 1.959(4), Ga1–O3 
1.982(4), Ga1–O5 1.989(4), Ga1–O7 1.961(4), N1–Ga1–N2 175.33(17), O1–Ga1–O7 177.80(18), O3–Ga1–
O5 163.37(17), N1–Ga1–O3 81.46(18), N2–Ga1–O1 98.10(17), N2–Ga1–O3 99.02(18), N2–Ga1–O5 
97.55(18), N2–Ga1–O7 83.97(17), N3–O6 2.779(6). 
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Figure 2.18: Plot of HDIPEA[Ga(met)(nta)] in crystals of (HDIPEA)2e. Space group: P212121. CShMOC-6: 
0.574. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.079(4), Ga1–N2 1.987(4), 1.987(4), Ga1–O1 
1.944(4), Ga1–O3 1.990(4), Ga1–O5 1.951(4), Ga1–O7 2.012(4), N1–Ga1–N2 173.4(2), O1–Ga1–O7 
177.8(2), O3–Ga1–O5 164.6(2), N1–Ga1–O3 81.3(2), N2–Ga1–O1 98.9(2), N2–Ga1–O3 97.4(2), N2–Ga1–
O5 97.5(2), N2–Ga1–O7 82.5(2), N3–O8 2.859(8). 
Overall, the molecular structures prove the successful synthesis of [Ga(aa)(nta)]− 
complexes. It was expected that crystals suitable for X-ray diffraction were not obtained of 
every complex salt. The molecular structures of eight different [Ga(aa)(nta)]− complexes—
regardless if triethylammonium or N,N-diisopropylethylammonium salt—in combination 
with the elemental analyses could be seen as proof of the existence of the other eleven 
[Ga(aa)(nta)]− complexes, though.  
Still, in some crystallisation experiments only crystals of the respective AA were obtained. 
This issue was encountered in crystallisation experiments with HNEt3[Ga(aa)(nta)] salts, 
too (Subsection 2.2.2). As the successful synthesis of 19 target complexes is reasonable 
to assume, this might indicate that the target complexes are not entirely stable in aqueous 
solution. Further information on this topic will be presented in subsections 2.2.6–2.2.9. 
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Figure 2.19: Plot of the two symmetrically independent [Ga(nta)(pro)]− ions in crystals of (HDIPEA)2g. Space 
group: P21. CShMOC-6: Ga1 0.485, Ga2 0.634. To avoid overlap in the picture the HDIPEA+ ions are not 
displayed. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) 
with standard deviation of the last digit in parentheses: Ga1–N1 2.076(4), Ga1–N2 2.006(5), Ga1–O1 1.939(4), 
Ga1–O3 1.989(3), Ga1–O5 1.966(4), Ga1–O7 1.995(4), Ga2–N3 2.076(5), Ga2–N4 2.005(5), Ga2–O9 
1.947(4), Ga2–O11 1.983(4), Ga2–O13 1.944(4), Ga2–O15 1.981(4), N1–Ga1–N2 176.8(2), O1–Ga1–O7 
178.5(2), O3–Ga1–O5 164.6(2), N1–Ga1–O3 82.0(2), N2–Ga1–O1 95.1(2), N2–Ga1–O3 96.1(2), N2–Ga1–
O5 98.3(2), N2–Ga1–O7 84.8 (2), N3–Ga2–N4 175.8(2), O9–Ga2–O15 178.2(2), O11–Ga2–O13 164.1(2), 
N3–Ga2–O11 81.7(2), N4–Ga2–O9 94.0(2), N4–Ga2–O11 94.1(2), N4–Ga2–O13 100.8(2), N4–Ga2–O15 
84.2(2). 
 
Up to this point, only tertiary amines were used as basic compounds to yield the respective 
complex salts. Unfortunately, these amines are toxic.[43,44] Hence, the substitution of the 
ammonium cations with nontoxic materials would be favourable if a pharmacological 
application of the [Ga(aa)(nta)]− complexes is intended, even though the presence of nta 
in such compounds would still be problematic since it is potentially carcinogenic.[45] 
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Figure 2.20: Plot of HDIPEA[Ga(nta)(val)] in crystals of (HDIPEA)2i·H2O. Space group: P212121. CShMOC-6: 
0.737. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.095(3), Ga1–N2 1.999(3), Ga1–O1 1.944(2), 
Ga1–O3 1.997(2), Ga1–O5 1.967(2), Ga1–O7 1.986(2), N1–Ga1–N2 174.73(11), O1–Ga1–O7 177.80(10), 
O3–Ga1–O5 162.13(10), N1–Ga1–O3 80.99(10), N2–Ga1–O1 94.90(10), N2–Ga1–O3 94.10(10), N2-Ga1-
O5 103.62(10), N2–Ga1–O7 83.85(10), N3–O8 2.730(4). 
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2.2.5 Substitution of cations  
 
A simple way of substituting the tertiary ammonium cations is the use of alkali cations. As 
described before, a very advantageous characteristic of those tertiary amines is the simple 
separability of the target complex and the respective ammonium chloride byproduct after 
the reaction due to the different solubilities of those compounds in organic solvents. In 
contrast to the ammonium chlorides, the alkali chlorides are far less soluble in ethanol.[41] 
Moreover, the solubilities of most alkali chlorides are similar to the solubilities of the target 
compounds. As a consequence, the implementation of the procedure which was used to 
obtain [Ga(aa)(nta)]− salts with tertiary ammonium cations is not recommended for yielding 
M[Ga(aa)(nta)] salts in adequate purity. Therefore, an alternative procedure which utilises 
a cation exchange reaction by reacting HNEt3[Ga(aa)(nta)] salts with alkali hydroxides in 
water was thought to be the best route to receive the respective M[Ga(aa)(nta)] salts.  
 
 
Figure 2.21: Cation exchange reaction with CsOH and HNEt3[Ga(aa)(nta)] salts. 
 
Preliminary tests indicated that CsOH is the most suitable alkali hydroxide for this purpose. 
The reactions were done only with the HNEt3[Ga(aa)(nta)] salts of polar and nonpolar aa 
ligands as starting materials since those aa ligands provided the best-defined compounds. 
This is important, as close to equimolar amounts of alkali hydroxide and the complex salt 
are needed to ensure a stoichiometric reaction to the respective Cs[Ga(aa)(nta)] salts 
(Figure 2.21) without contamination of the product with caesium hydroxide. Therefore, only 
stoichiometric amounts or, sometimes, a small excess of caesium hydroxide were used in 
the reactions. Water was used as a solvent and the products were precipitated by the use 
of organic solvent. Afterwards, the crude products were examined by elemental analysis 
(Table 2.5).  
While the target complexes were obtained according to the elemental analyses, the 
contaminations found in the crude products indicated an overall inferior quality when 
compared to the products obtained with tertiary ammonium cations. In particular, the 
formation of Cs[{Ga(nta)(µ-OH)}2] in eleven cases indicates the decomposition of the 
target complexes in the reaction. 
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Table 2.5: Interpretation of elemental analyses: Cs[Ga(aa)(nta)] salts with polar or nonpolar aa ligands. The 
maximum difference (max diff.) is given between the found and calculated percentages of the listed 
compositions.  
Complex-salt contamination max. diff. 
Cs[Ga(ala)(nta)] 0.25 Cs2[{Ga(nta)(µ-OH)}2] + 1.00 H2O + 1.00 MeOH 0.03 
Cs[Ga(asn)(nta)] 2.35 H2O + 0.25 Ga(OH)3 0.03 
Cs[Ga(gln)(nta)] 0.25 Cs2[{Ga(nta)(µ-OH)}2] + 2.80 H2O 0.11 
Cs[Ga(gly)(nta)] 0.35 Cs2[{Ga(nta)(µ-OH)}2] + 5.20 H2O 0.16 
Cs[Ga(ile)(nta)] 0.65 Cs2[{Ga(nta)(µ-OH)}2] + 3.15 H2O 0.18 
Cs[Ga(leu)(nta)] 3.40 H2O + 0.25 EtOH 0.03 
Cs[Ga(met)(nta)] 0.15 Cs2[{Ga(nta)(µ-OH)}2] + 3.05 H2O 0.12 
Cs[Ga(nta)(phe)] 0.05 Cs2[{Ga(nta)(µ-OH)}2] + 3.25 H2O 0.22 
Cs[Ga(nta)(pro)] 0.05 Cs2[{Ga(nta)(µ-OH)}2] + 1.60 H2O 0.11 
Cs[Ga(nta)(ser)] 0.30 Cs2[{Ga(nta)(µ-OH)}2] + 3.10 H2O 0.05 
Cs[Ga(nta)(thr)] 0.15 Cs2[{Ga(nta)(µ-OH)}2] + 3.05 H2O 0.07 
Cs[Ga(nta)(trp)]  1.65 Cs2[{Ga(nta)(µ-OH)}2] + 4.00 H2O 0.24 
Cs[Ga(nta)(val)] 0.35 Cs2[{Ga(nta)(µ-OH)}2] + 3.85 H2O 0.07 
 
This result is surprising as the HNEt3[Ga(aa)(nta)] salts which were used as starting 
materials were synthesised at similar reaction conditions. However, as elemental analysis 
is not conclusive on its own, crystallisation experiments with the raw products were done. 
No crystallisation attempt of these crude products yielded crystals of Cs[Ga(aa)(nta)] salts. 
Instead—whenever crystals were obtained—only the respective AA and/or the already 
known Cs2[{Ga(nta)(µ-OH)}2] complex[40] were crystallised. The crystallisation of 
Cs2[{Ga(nta)(µ-OH)}2] supports the results of the elemental analyses. As further 
experiments with alkali cations did not point to a different outcome, alkali cations were 
discarded as a reasonable replacement for the tertiary ammonium ions. Hence, the 
presence of tertiary ammonium ions seems to be essential for the crystallisation of the 
target [Ga(aa)(nta)]− complexes.  
These findings imply the existence of either an equilibrium between [{Ga(nta)(µ-OH)}2]2− 
and [Ga(aa)(nta)]− complexes or perhaps progressing degradation of [Ga(aa)(nta)]− 
complexes in aqueous solution. In order to obtain more information about this issue it was 
necessary to study the aqueous solutions of [Ga(aa)(nta)]− complexes. 
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2.2.6 Solution studies of [Ga(aa)(nta)]− salts 
 
Established techniques like UV-Vis, IR, and potentiometric titration are not suitable for 
studying the composition of these gallium(III) complexes in solution. The first two 
techniques are not reasonable choices as the starting materials and complexes lack the 
disparity in colour or functional groups to allow for a differentiated analysis. As mixtures of 
the starting materials of [Ga(aa)(nta)]− salts did usually form suspensions over a wide pH 
range, already intricate potentiometric titrations were excluded as a potential approach of 
the issue. Hence, 13C{1H} and 1H NMR spectroscopy in combination with 2D NMR 
techniques were used to examine the aqueous solutions of [Ga(aa)(nta)]− salts. However, 
one problem with this approach is the low coordination-induced shift (CIS) which is 
generated in the ligand by the coordination of gallium(III). Therefore, exact referencing of 
every spectrum against the signals of added methanol is key to detect these slight changes 
in signal shift. Unfortunately, 71Ga and 69Ga NMR spectroscopy was not applicable. This 
issue will be discussed in section 3.2.  
The following experiments were conducted mainly with the HDIPEA[Ga(aa)(nta)] and 
HNEt3[Ga(aa)(nta)] salts, as these are generally of higher quality and are better soluble in 
water and methanol as the corresponding Cs[Ga(aa)(nta)] salt. Since not every complex 
salt was crystallisable, the NMR experiments were done with the isolated crude products 
of the respective compounds (Table 2.1–Table 2.5). 2D NMR techniques were only utilised 
with HDIPEA[Ga(aa)(nta)] solutions due to the superior solubility of these compounds. 
Since fewer overlaps of signals were observed in 1H NMR spectra of HNEt3[Ga(aa)(nta)] 
solutions, the ratios of compounds in solutions (Table 2.15) were derived from those 
spectra.  
It was only possible to combine information from the NMR spectra of HNEt3[Ga(aa)(nta)] 
and HDIPEA[Ga(aa)(nta)] solutions with one specific aa ligand as the spectra of the 
triethylammonium and N,N-diisopropylethylammonium salts of one specific complex were 
almost perfectly identical. Hence, it was feasible to identify the compounds with 2D NMR 
techniques in HDIPEA[Ga(aa)(nta)] solutions and then use the information to assign 
signals in spectra of HNEt3[Ga(aa)(nta)] solutions without difficulty. This was also possible 
because the pH values of the aqueous solutions were similar regardless if the respective 
HDIPEA[Ga(aa)(nta)] or HNEt3[Ga(aa)(nta)] salt was examined (Table 2.6). In general, the 
solutions of HNEt3[Ga(aa)(nta)] were slightly less acidic than the solutions of 
HDIPEA[Ga(aa)(nta)] salts since those were as concentrated as possible to allow for 
2D NMR experiments. There were, however, differences regarding the pH levels 
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depending on the aa ligand present in the complex. To not influence the composition in 
solution, pH levels were not adjusted by addition of acid or base. 
 
Table 2.6: pH values of solutions: [Ga(aa)(nta)]− complexes with polar or nonpolar aa ligands in D2O.  
aa ligand HDIPEA+ HNEt3+ (c = 0.25 mol L−1) 
L-Alaninato 6.0 6.5–7.0 
L-Asparaginato 5.5 6.5–7.0 
L-Cysteinato 4.5–5.0 5.0 
L-Glutaminato 6.5 6.5–7.0 
Glycinato 6.0–6.5 6.5–7.0 
L-Isoleucinato 6.5–7.0 6.5–7.0 
L-Leucinato 6.5 6.5–7.0 
L-Methioninato 6.5 7.0 
L-Phenylalaninato 7.0 6.5–7.0 
L-Prolinato 6.0 7.0 
L-Serinato 6.0–6.5 7.0 
L-Threoninato 6.5 6.5–7.0 
L-Tryptophanato 4.5–5.0 5.0 
L-Tyrosinato - - 
L-Valinato 6.5–7.0 7.0 
 
 
The spectra displayed differences when polar/nonpolar, basic or acidic proteinogenic aa 
ligands were present in the complexes and are therefore discussed separately. This was 
expected, as the elemental analyses already showed distinct differences in product 
composition depending on the functional groups of the aa ligand in use (Subsections 2.2.1 
and 2.2.3).  
First, the spectra of polar/nonpolar amino acids are discussed using NMR spectra of 
HDIPEA[Ga(ala)(nta)] as an example. As shown in Figure 2.22b, the 13C{1H} NMR 
spectrum of an aqueous solution of HDIPEA[Ga(ala)(nta)] + 0.85 H2O shows more signals 
than expected for the mononuclear complex. In fact, exactly two signal sets are found for 
each ligand, while only one signal set of the HDIPEA cation can be seen. Those 
assignments were proven by 2D NMR spectroscopy. 
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Figure 2.22: HDIPEA[Ga(ala)(nta)] + 0.85 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(ala)(nta)] + 0.85 H2O in D2O*, c: 13C{1H} NMR spectrum of HDIPEA[Ga(ala)(nta)] + 
0.85 H2O with 0.5 equ. of L-alanine in D2O*, d: 13C{1H} NMR spectrum of L-alanine in D2O*. Red: L-alanine, 
cyan: L-alaninato in [Ga(ala)(nta)]−, blue: nta in [Ga(ala)(nta)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: 
HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
The 13C{1H} NMR spectrum indicates the existence of at least two different complexes in 
solution, while the cation is unaffected. If these two complex anions are [Ga(ala)(nta)]− and 
[{Ga(nta)(µ-OH)}2]2−, an equilibrium reaction as shown in Figure 2.22a should be present. 
In this equilibrium, free L-alanine and a coordinated L-alaninato ligand as well as two bound 
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nta ligands in slightly different chemical environments should exist. A comparison of the 
signal sets assigned to L-alanine with the signals of a solution of pure L-alanine in D2O 
(Figure 2.22d) shows that one set of signals matches perfectly. The chemical shifts and 
the corresponding coordination-induced shifts are given in Table 2.7. It should be noted 
that the pH of the complex solution and the solution of free amino acid were not adjusted 
to the same level, hence CIS values are derived from the signals of free amino acid in the 
complex solution to achieve the highest possible accuracy.  
Table 2.7: 13C{1H} NMR shifts (δ/ppm, D2O) of L-alanine and the L-alaninato ligand in [Ga(ala)(nta)]−. The 
relative shift is given in Δδ (CIS).  
   C1 C2 C3 
HDIPEA+ [Ga(ala)(nta)]−  δ 179.7 50.3 18.1 
 L-Alanine δ 176.1 51.1 16.8 
  Δδ 3.6 −0.8 1.3 
HNEt3+ [Ga(ala)(nta)]−  δ 180.0 50.3 18.0 
 L-Alanine δ 176.3 51.1 16.8 
  Δδ 3.7 −0.8 1.2 
 
Because of these findings it was safe to assume that the [Ga(ala)(nta)]− complex is not 
stable against hydrolysis in aqueous solution and releases free L-alanine by forming 
[{Ga(nta)(µ-OH)}2]2−. This was further proven by addition of 0.5 equivalents of L-alanine to 
the solution of HDIPEA[Ga(ala)(nta)] + 0.85 H2O in D2O and re-measuring the 13C{1H} 
NMR spectrum (Figure 2.22c). As expected, the intensity of the signals assigned to free 
L-alanine are drastically increased.  
The addition of L-alanine also effects the intensity of the nta-related signals. The intensity 
of one signal set increases significantly, while the other shows a significant decrease in 
intensity. This observation is also consistent with the predicted equilibrium, as the addition 
of free proteinogenic amino acid should shift the equilibrium from the side of the 
[{Ga(nta)(µ-OH)}2]2− complex and L-alanine to the mononuclear [Ga(ala)(nta)]− complex, 
therefore increasing the intensity of the signal set correlated to nta in the [Ga(ala)(nta)]− 
complex and decreasing the intensity of the signal set of nta in the [{Ga(nta)(µ-OH)}2]2− 
complex. To further prove the existence of HDIPEA2[{Ga(nta)(µ-OH)}2], this compound 
was synthesised by the reaction of GaCl3 and nta in a molar ratio of 1:1. Analytical proof 
of HDIPEA2[[{Ga(nta)(µ-OH)}2] was possible only by elemental analysis, as crystallisation 
attempts remained unsuccessful. Nevertheless, the 13C{1H} NMR spectrum of this 
compound displays the same signals as found in the spectrum of HDIPEA[Ga(ala)(nta)] + 
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0.85 H2O. Since [{Ga(nta)(µ-OH)}2]2−readily crystallises with Cs+ and Li+ as cations, the 
existence of [{Ga(nta)(µ-OH)}2]− in the equilibrium can be proven by comparing the NMR 
spectrum of Cs[Ga(ala)(nta)] with the spectra of HDIPEA[Ga(ala)(nta)] and 
HNEt3[Ga(ala)(nta)]. The 13C{1H} NMR spectrum of a solution of Cs[Ga(ala)(nta)] + 
0.25 Cs2[{Ga(nta)(µ-OH)}2] + 1.00 H2O + 1.00 MeOH in D2O (c = 0.25 mol L−1, Figure 
2.23) indeed shows the same signals as the 13C{1H} NMR spectrum of 
HDIPEA[Ga(ala)(nta)] + 0.85 H2O, therefore the equilibrium shown in Figure 2.22a also 
exists in the solution of the Cs[Ga(ala)(nta)] salt. The only difference can be found in the 
position of the equilibrium. With about 75% free L-alanine, the amount of free amino acid 
is roughly 15% higher than in a comparable solution of HNEt3[Ga(ala)(nta)] with the same 
concentration (Table 2.15). 
 
Figure 2.23: 13C{1H} NMR spectrum of Cs[Ga(ala)(nta)] + 0.25 Cs2[{Ga(nta)(µ-OH)}2] + 1.00 H2O + 1.00 
MeOH in D2O (c = 0.25 mol L−1). Red: free L-alanine, cyan: L-alaninato in [Ga(ala)(nta)]−, blue: nta in 
[Ga(ala)(nta)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, orange: MeOH. * One drop of MeOH was added for 
referencing. 
 
Figure 2.24: 13C{1H} NMR spectrum of HDIPEA[Ga(ala)(nta)] in MeOD. Cyan and light green: L-alaninato in 
[Ga(ala)(nta)]−, blue: nta in [Ga(ala)(nta)]−, grey: HDIPEA+, orange: MeOD. 
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The equilibrium between [{Ga(nta)(µ-OH)}2]2− and [Ga(ala)(nta)]− should exist only in 
aqueous solution since water is needed for the formation of [{Ga(nta)(µ-OH)}2]2−. Hence, 
to guarantee that the assumption is correct and the specific equilibrium is present in 
solution, thoroughly dried HDIPEA[Ga(ala)(nta)] was dissolved in dry MeOD. As expected, 
no equilibrium can be seen in this case: only one set of signals of nta ([Ga(ala)(nta)]−) and 
no signal set of free L-alanine is present in the 13C{1H} NMR spectrum (Figure 2.24) of this 
solution. This confirms the conjecture and is one last proof of the equilibrium reaction in 
aqueous solution. In addition, it explains why some complexes were only crystallisable 
from methanolic solution.  
However, on close inspection, two signal sets of L-alanine/L-alaninato are visible in the 
spectrum (Figure 2.24). One set of signals is very prominent while the other is of very low 
intensity. As stated, there is no second signal set of nta, therefore none of these signal 
sets is related to free L-alanine. Also, both signal sets are in very close proximity to one 
another, hence they are assigned to L-alaninato ligands. Since two different isomers of the 
[Ga(ala)(nta)]− complex can be formed, it is reasonable to assume that one set of signals 
has to be assigned to isomer I and one to isomer II (Figure 2.6). Why this preference of 
one isomer over the other should be so striking is not yet explained but this observation 
matches the aforementioned remarkable preference of isomer I over II in crystal structures 
of [Ga(aa)(nta)]− salts. Based on that information, it seems plausible to assign the signal 
set with low intensity to isomer II, while the signal set with high intensity is assigned to 
isomer I. These signals are potentially present in the 13C{1H} NMR spectrum of 
HDIPEA[Ga(ala)(nta)] + 0.85 H2O in D2O as well, but are lacking the intensity to be 
identified with confidence. Though this is true for most other [Ga(aa)(nta)]− complexes, this 
additional signal set of low intensity seems to be present in a few other 13C{1H} NMR 
spectra of aqueous [Ga(aa)(nta)]− solutions. It is certainly present in the spectra of 
[Ga(Harg)(nta)]·0.05DIPEA + 2.45 H2O (Figure 2.28) and [Ga(Hlys)(nta)]·0.05DIPEA + 
2.25 H2O + 0.15 EtOH (Figure 2.29), while the spectra of HDIPEA[Ga(gly)(nta)] + 0.95 
H2O (Figure 6.4), HDIPEA[Ga(nta)(ser)] + 0.80 H2O and HDIPEA[Ga(nta)(thr)] + 0.50 
H2O (Figure 6.10 and Figure 6.11) may feature it, although the signals are too weak to be 
absolutely certain and are therefore not explicitly labelled in those. The spectra of 
compounds containing [Ga(Harg)(nta)] and [Ga(Hlys)(nta)] are interpreted later 
(Subsection 2.2.8), but this particular feature is mentioned here to support the hypothesis. 
The two different isomers of [Ga(aa)(nta)]− and their occurrence are a relevant issue in this 
work. Hence, data about this topic will be summed up and further discussed in section 3.7.  
The equilibrium of [Ga(aa)(nta)]− with its corresponding proteinogenic amino acid and 
[{Ga(nta)(µ-OH)}2]2− is present in every aqueous solution of HDIPEA[Ga(aa)(nta)] and 
RESULTS 
 41   
HNEt3[Ga(aa)(nta)] salts with polar and nonpolar aa ligands. This was tested by addition 
of the free proteinogenic amino acid if the respective AA exhibits good solubility in water 
(glycine, L-proline, L-serine, L-threonine, L-valine). The corresponding spectra as well as 
the chemical shifts and the CIS values are displayed in section 6.1 while the position of 
the respective equilibria is shown and further discussed in subsection 2.2.10. 
The only exceptions were found when the two polar amino acids L-tyrosine and L-cysteine 
were used as ligands. No spectra of the [Ga(nta)(tyr)]− can be shown, as L-tyrosine did not 
form HNEt3[Ga(nta)(tyr)] at all, and HDIPEA[Ga(nta)(tyr)] was formed only as a minor side 
product according to elemental analysis. Instead, the main product was unreacted 
L-tyrosine, which was likely due to the extremely weak solubility of L-tyrosine in water even 
at higher pH levels. An examination of such a complex is therefore not possible. In 
contrast, L-cysteine formed the target complex but features a more complex equilibrium in 
aqueous solution which needs to be discussed in detail (Subsection 2.2.7).  
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2.2.7 Solution study of [Ga(cys)(nta)]−  
 
L-Cysteine—and its respective [Ga(cys)(nta)]− complex—is special in three ways. First, 
L-cysteine decomposed in aqueous solution. This was observed in NMR spectra as well 
as in crystallisation experiments, since, in one case, crystals of S8-sulfur were obtained. 
Hence, no re-measurement of the 13C{1H} NMR spectrum after addition of free amino acid 
was possible to further investigate the equilibrium in solution. In addition, the pH value of 
the solution was significantly more acidic than every other solution of [Ga(aa)(nta)]− 
complexes with polar and nonpolar aa ligands (Table 2.6). Furthermore, as mentioned in 
subsection 2.2.6, the equilibrium in aqueous solution is more complex than it is in solutions 
of other [Ga(aa)(nta)]− complexes.  
In-depth examination of the spectra and comparison with the 13C{1H} NMR and 1H NMR 
spectra of other [Ga(aa)(nta)]− compounds reveals distinct deviations. According to the 
1H NMR spectra of HNEt3- and HDIPEA[Ga(cys)(nta)] salts one difference is the position 
of the equilibrium. In contrast to the other equilibria, the ratio of bound to free L-cysteine in 
a solution of HNEt3[Ga(cys)(nta)] + 1.25 H2O + 0.10 Hcys in D2O (c = 0.25 mol L−1) is 
about 60 : 40 (due to overlap of signals, the amount of bound L-cysteine could be about 
5% higher or lower). Hence, L-cysteine has the highest ratio of [Ga(aa)(nta)]− to free amino 
acid of all examined complexes in solution (Table 2.15). Another difference can be found 
in the 13C{1H} NMR spectra (Figure 2.25b): instead of only two signal sets for each nta and 
L-cysteine, a third signal set of both ligands is visible in the spectrum. These findings 
suggest that at least three different complexes are present in solution. Unfortunately, none 
of these complexes was crystallisable, therefore any assumptions about their 
characteristics is dependent on the information derived from NMR spectroscopy. Hence, 
the following conclusions are not certain, but appear to be the best explanation at the 
current state of research.  
Since the free aa ligand can be identified, an equilibrium as described before is present 
and the [{Ga(nta)(µ-OH)}2]2− complex is one of the compounds in solution (Figure 2.25a). 
This is consistent with the signal shifts in the 13C{1H} NMR spectra. Two further signal sets 
of nta and L-cysteinato ligands indicate the presence of two different [Ga(cys)(nta)]− 
complexes. The signal sets are not as close in proximity as seems to be reasonable if 
those were to be assigned to isomers I and II of [Ga(cys-κO,N)(nta)]− (Figure 2.6).  
The obvious difference between L-cysteine and the other proteinogenic amino acids used 
in this work is the thiol group, which could be bound to gallium(III) by including the amine 
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group to form a five-membered chelate ring or the carboxylato group to form a six-
membered chelate ring. 
 
Figure 2.25: HDIPEA[Ga(cys)(nta)] + 0.10 Ga(OH)3 + 0.10 H2O + 0.05 EtOH in aqueous solution. a: equi-
librium reaction, b: 13C{1H} NMR spectrum of HDIPEA[Ga(cys)(nta)] + 0.10 Ga(OH)3 + 0.10 H2O + 0.05 EtOH 
in D2O*, c: 13C{1H} NMR spectrum of L-cysteine in D2O*. Red: free L-cysteine, cyan: L-cysteinato in [Ga(cys-
κO,N)(nta)]−, light green: L-cysteinato in [Ga(cys-κ2S,X)(nta)]−, blue: nta in [Ga(cys-κO,N)(nta)]−, purple: nta in 
[Ga(cys-κ2S,X)(nta)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH 
was added for referencing. 
 
Figure 2.26: The four possible constitutional isomers of [Ga(cys-κ2S,X)(nta)]−. 
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The four possible isomers of these complexes are shown in Figure 2.26. Two further 
potential isomers are not shown as reasonable options since these would have resembled 
the isomers III and IV, but with deprotonated carboxylic functions and protonated thiol 
groups. With the data at hand it is not possible to identify which isomer is formed in 
aqueous solution, but the sharp signal in the 13C{1H} NMR spectrum indicates that, most 
likely, not all of these—perhaps only one—are present in solution. Interestingly, the 
[Ga(cys-κ2S,X)(nta)]− complex is not only present but seems to be the main [Ga(cys)(nta)]− 
complex in solution. This can be derived from the shifts of the carboxylic C-atoms assigned 
to nta. The well-known shifts of [{Ga(nta)(µ-OH)}2]− and [Ga(cys-κO,N)(nta)]− are present, 
but the most prominent signal is the new signal at 174.5 ppm (Table 2.8). Therefore, the 
equilibrium described in Figure 2.25a should be present in solution, while [Ga(cys-
κ2S,X)(nta)]− is the main compound.  
Table 2.8: 13C{1H} NMR shifts (δ/ppm, D2O) of L-cysteine and the L-cysteinato ligand in [Ga(cys)(nta)]− 
complexes. The relative shift is given in Δδ (CIS). 
   C1 C2 C3 
HDIPEA+ [Ga(cys-κO,N)(nta)]−  δ - 57.8 26.5 
 L-Cysteine δ 172.8 56.4 25.3 
  Δδ - 1.4 1.2 
HDIPEA+ [Ga(cys-κ2S,X)(nta)]−  δ 174.5 56.1 24.6 
 L-Cysteine δ 172.8 56.4 25.3 
  Δδ 1.7 −0.3 −0.7 
HNEt3+ [Ga(cys-κO,N)(nta)]− δ - 57.8 - 
 L-Cysteine δ 172.9 56.4 25.3 
  Δδ - 1.4 - 
HNEt3+ [Ga(cys-κ2S,X)(nta)]− δ 174.5 56.1 24.6 
 L-Cysteine δ 172.9 56.4 25.3 
  Δδ 1.6 −0.3 −0.7 
 
Whether thiolate groups have a higher tendency to bind to gallium(III) than carboxylate 
groups or amine groups cannot be determined with the scarce information at hand. 
However, this might be an interesting topic for future investigations. At the current state of 
research, a comparative study concerning the preference of gallium(III) towards amine, 
carboxylate or thiol groups has not been done yet. However, gallium(III) complexes 
featuring ligands with all of these functional groups coordinated to gallium(III) are known, 
for example, with the ligands 2-carboxy-8-mercaptoquinoline[46] or N,N'-ethylenedi-L-
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cysteine[47,48]. Those complexes are monoanionic due to the fact that both the carboxylate 
groups and the thiol groups are deprotonated. In the case of N,N'-ethylenedi-L-cysteine 
this is true despite the neutral pH level during the crystallisation from aqueous solution.[48]  
Since the [Ga(cys)(nta)]− complexes were not essential for this work due to their rapid 
degradation in solution, a fact which does not fit the aimed-for characteristics of 
compounds, no further efforts to identify the specific complex isomers in solution were 
made.  
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2.2.8 Solution studies: complexes with basic aa ligands  
 
As described in the subsections 2.2.1 and 2.2.3, the elemental analyses of the synthesised 
nitrilotriacetatogallium(III) complexes with basic aa ligands suggested the formation of 
adducts between [Ga(Haa)(nta)] complexes and the respective tertiary amine in use. This 
was expected, since the basic side chain of these aa ligands competes with the tertiary 
amine as a base in use at the pH levels of the syntheses (ca. 8.5–9.0). To some extent, 
the differing basicity of the side chains can be seen even in the composition of the crude 
products, as the compounds with L-argininato and L-lysinato ligands contained significantly 
lower amounts of tertiary amine than the L-histidinato compounds.  
The crystallisation of nitrilotriacetatogallium(III) complexes with basic aa ligands was not 
successful despite several attempts. A structural characterisation of these complexes was 
therefore not possible. However, the conclusions drawn from the elemental analyses were 
backed by the 13C{1H} NMR and 1H NMR spectra of these compounds in aqueous solution, 
as these showed the presence of the same amounts of tertiary amine which were indicated 
in the elemental analyses.  
The 13C{1H} NMR spectrum of an aqueous solution of [Ga(Hhis)(nta)]·0.25DIPEA + 
2.10 H2O + 0.05 EtOH (Figure 2.27b) with neutral pH level (Table 2.9) shows two signal 
sets each for nta and the proteinogenic amino acid. Therefore it is reasonable to assume 
that the same equilibrium as found in solutions of [Ga(aa)(nta)]− complexes with polar and 
nonpolar aa ligands is also present in this solution. However, as the L-histidinato ligand is 
a potential tridentate ligand, there are different possibilities to form a [Ga(Hhis)(nta)] 
complex. The signals of nta are very similar to the signals found in the aforementioned 
spectra of [Ga(aa)(nta)]− complexes, therefore the tetradentate ligand seems to be 
unaffected and should, therefore, be bound to gallium(III) in the familiar manner.  
 
Table 2.9: pH values of solutions: [Ga(Haa)(nta)] complexes with basic aa ligands in D2O. 
aa ligand DIPEA NEt3 (c = 0.25 mol L−1) 
L-Argininato 7.0 7.0 
L-Histidinato 6.5 6.5–7.0 
L-Lysinato 7.0 7.0 
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The L-histidinato ligand can bind to gallium(III) in three different ways: two κO,N-
configurations and one κN,N-configuration. The κN,N-pattern is unlikely to form, as a 
majority of the L-histidinato ligands is protonated in one position. Since the carboxylic 
function is deprotonated at neutral pH levels, one of the amine groups has to be protonated 
which prevents the coordination of gallium(III) in this manner. Therefore, only two κO,N-
configurations are possible. It is reasonable to assume that the formation of a seven-
membered chelate ring with Nδ and the carboxylato function is unlikely to prevail when the 
formation of a five-membered chelate ring with the amine group at C2 and the carboxylato 
function is also possible. Therefore, either isomer I or II of [Ga(Hhis)(nta)] should be 
present. The NMR shifts and CIS values of the compounds in solution are listed in Table 
2.10. 
 
Table 2.10: 13C{1H} NMR shifts (δ/ppm, D2O) of L-histidine and the L-histidinato ligand in [Ga(Hhis)(nta)]. The 
relative shift is given in Δδ (CIS). 
adduct   C1 C2 C3 C4 C5 C6 
DIPEA [Ga(Hhis)(nta)]  δ 176.9 53.7 26.8 129.6 116.5 133.3 
 L-Histidine δ 173.5 54.4 27.7 129.6 118.2 136.2 
  Δδ 3.4 −0.7 −0.9 0.0 −1.7 −2.9 
NEt3 [Ga(Hhis)(nta)]  δ 176.9 53.7 26.9 129.0 116.5 133.2 
 L-Histidine δ 173.5 54.5 27.7 129.0 118.2 136.2 
  Δδ 3.4 −0.8 −0.8 0.0 −1.7 −3.0 
 
A noteworthy feature of the spectrum is the broadening of aromatic signals. The cause of 
this may be found in the protonation of the side chain, which should be dynamic due to the 
reaction with the present tertiary amine. A rapidly changing chemical environment leads 
to broadening of signals. This is, of course, just an assumption based on the most likely 
isomer in solution. The cause may also be found in the existence of isomer I and II, though 
the non-aromatic signals do not suggest this due to the lack of a third signal set. Another 
issue can be found with the spectrum of the free amino acid L-histidine which was 
measured in D2O for comparison (Figure 2.27c). The pH of this solution is basic, which 
leads to significant differences when compared to signals of L-histidine found in solutions 
with neutral pH levels. If pH values of solutions differ too much, the comparability of their 
spectra is practically non-existent. This should be kept in mind for the remainder of this 
work. 
RESULTS 
 48   
 
Figure 2.27: [Ga(Hhis)(nta)]·0.25DIPEA + 2.10 H2O + 0.05 EtOH in aqueous solution. a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of [Ga(Hhis)(nta)]·0.25DIPEA + 2.10 H2O + 0.05 EtOH in D2O*, c: 13C{1H} NMR 
spectrum of L-histidine in D2O*. Red: L-histidine, cyan: L-histidinato in [Ga(Hhis)(nta)], blue: nta in 
[Ga(Hhis)(nta)], green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, yellow: residual EtOH, orange: MeOH. * 
One drop of MeOH was added for referencing. 
 
While the 13C{1H} NMR spectrum of [Ga(Hhis)(nta)]·0.25DIPEA + 2.10 H2O + 0.05 EtOH 
features two signal sets for each ligand and, therefore, shows the equilibrium found in the 
aqueous solutions of most [Ga(aa)(nta)]− complexes with polar and nonpolar aa ligands, 
the 13C{1H} NMR spectra of [Ga(Harg)(nta)]·0.05DIPEA + 2.45 H2O (Figure 2.28) and 
[Ga(Hlys)(nta)]·0.05DIPEA + 2.25 H2O + 0.15 EtOH (Figure 2.29) in aqueous solutions 
contain two signal sets of nta and three signal sets of the proteinogenic amino acid. Just 
as in the spectrum of [Ga(Hhis)(nta)] the two signal sets of nta and two signals sets of the 
amino acid can be attributed to the equilibrium of [Ga(aa)(nta)]− with the the respective AA 
and [{Ga(nta)(µ-OH)}2]2−. This leaves the third set of signals which must be attributed to 
an aa ligand. 
Partial protonation of the basic functions in the side chain of the aa ligand can be ruled out 
as the cause of the third signal set since the signals of the side chain’s carbon atoms are 
almost not affected. Instead, the signal shift of the carbon atoms 1 and 2 is significant 
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when these signals are compared to the signals of the respective atoms in the other signal 
sets of aa ligands. If protonation in the side chain was the cause of the third signals set, 
the most significant signal shift would be expected for the carbon atom C6.  
Therefore, a different mode of complexation seems to be present. Despite L-arginine and 
L-lysine being potential tridentate ligands, only the κO,N-configuration involving the amino 
group at C2 and the carboxylato function should form since every binding pattern involving 
the basic side chain would lead to the formation of at least seven-membered chelate rings 
in case of the L-arginato ligand or eight-membered chelate rings in the case of the 
L-lysinato ligand. 
 
Figure 2.28: [Ga(Harg)(nta)]·0.05DIPEA + 2.45 H2O in aqueous solution. a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(Harg)(nta)]·0.05DIPEA + 2.45 H2O in D2O*, c: 13C{1H} NMR spectrum of 
L-arginine in D2O*. Red: L-arginine, cyan: L-argininato in [Ga(Harg-κO,N)(nta)] (I), light green: L-argininato in 
[Ga(Harg-κO,N)(nta)] (II), blue: nta in [Ga(Harg-κO,N)(nta)] (I and II), green: nta in in [{Ga(nta)(µ-OH)}2]2−, 
grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
As mentioned before, the most significant signal shift is found in the atoms C1 and C2. 
Therefore—and due to the lack of a better explanation—the third signal set is attributed to 
constitutional isomers II (Figure 2.6). The aqueous solutions of [Ga(Harg)(nta)] and 
[Ga(Hlys)(nta)] should therefore be the only solutions which feature prominent signal sets 
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of both isomer I and II. Regrettably, it is not possible to explain why this isomerisation 
should be favoured when L-arginine or L-lysine are used as ligands.  
In conclusion, the most likely interpretation of the two spectra seems to be that signals of 
both isomer I and II are visible. With regard to the other spectra of [Ga(aa)(nta)]− 
complexes, the signal sets with higher intensity are assigned to isomer I and the signal 
sets with lower intensity to isomer II. The signal shifts of the species and the CIS values 
of those complexes are listed in Table 2.11 and Table 2.12. 
 
 
Figure 2.29: [Ga(Hlys)(nta)]·0.05DIPEA + 2.25 H2O + 0.15 EtOH in aqueous solution. a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of [Ga(Hlys)(nta)]·0.05DIPEA + 2.25 H2O + 0.15 EtOH in D2O*, c: 13C{1H} NMR 
spectrum of L-lysine hydrochloride in D2O*. Red: L-lysine, cyan: L-lysinato in [Ga(Hlys-κO,N)(nta)] (I), light 
green: L-lysinato in [Ga(Hlys-κO,N)(nta)] (II), blue: nta in [Ga(Hlys-κO,N)(nta)] (I and II), green: nta in in 
[{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, yellow: residual EtOH, orange: MeOH. * One drop of MeOH was added 
for referencing. 
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Table 2.11: 13C{1H} NMR shifts (δ/ppm, D2O) of L-arginine and the L-argininato ligand in [Ga(Harg)(nta)] 
complexes. The relative shift is given in Δδ (CIS). 
adduct   C1 C2 C3 C4 C5 C6 
DIPEA [Ga(Harg-κO,N)(nta)] (I) δ 178.6 54.1 29.3 25.3 41.2 157.3 
 L-Arginine δ 174.9 54.9 28.2 24.5 41.1 157.3 
  Δδ 3.7 −0.8 1.1 0.8 0.1 0.0 
DIPEA [Ga(Harg-κO,N)(nta)] (II) δ 179.6 53.6 29.7 25.5 41.2 - 
 L-Arginine δ 174.9 54.9 28.2 24.5 41.1 157.3 
  Δδ 4.7 −1.3 1.5 1.0 0.1 - 
NEt3 [Ga(Harg-κO,N)(nta)] (I) δ 178.6 54.1 29.3 25.3 41.2 157.4 
 L-Arginine δ 174.9 54.9 28.2 24.5 41.1 157.4 
  Δδ 3.7 −0.8 1.1 0.8 0.1 0.0 
NEt3 [Ga(Harg-κO,N)(nta)] (II) δ 179.7 53.6 29.7 25.5 41.2 - 
 L-Arginine δ 174.9 54.9 28.2 24.5 41.1 157.3 
  Δδ 4.8 −1.3 1.5 1.0 0.1 - 
 
Table 2.12: 13C{1H} NMR shifts (δ/ppm, D2O) of L-lysine and the L-lysinato ligand in [Ga(Hlys)(nta)] complexes. 
The relative shift is given in Δδ (CIS). 
adduct   C1 C2 C3 C4 C5 C6 
DIPEA [Ga(Hlys-κO,N)(nta)] (I) δ 178.8 54.2 31.6 22.8 26.9 39.7 
 L-Lysine δ 175.1 55.0 30.5 22.0 27.0 39.7 
  Δδ 3.7 −0.8 1.1 0.8 −0.1 0.0 
DIPEA [Ga(Hlys-κO,N)(nta)] (II) δ 179.9 53.7 31.9 22.9 - 39.7 
 L-Lysine δ 175.1 55.0 30.5 22.0 27.0 39.7 
  Δδ 4.8 −1.3 1.4 0.9 - 0.0 
NEt3 [Ga(Hlys-κO,N)(nta)] (I) δ 178.9 54.2 31.6 22.8 26.9 39.7 
 L-Lysine δ 175.1 55.1 30.5 22.0 27.0 39.7 
  Δδ 3.8 −0.9 1.1 0.8 −0.1 0.0 
NEt3 [Ga(Hlys-κO,N)(nta)] (II) δ 180.0 53.7 - 22.9 - - 
 L-Lysine δ 175.1 55.1 30.5 22.0 27.0 39.7 
  Δδ 4.9 −1.4 - 0.9 - - 
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2.2.9 Solution studies: complexes with acidic aa ligands 
 
The elemental analyses of nitrilotriacetatogallium(III) complexes with acidic aa ligands 
suggested the formation of adducts between HDIPEA[Ga(Haa)(nta)]/HNEt3[Ga(Haa)(nta)] 
complexes and non-integer amounts of the respective tertiary amine (Subsections 2.2.1 
and 2.2.3).  
As described before, the salts were not stable and the volatile tertiary amines were evolved 
even from the solid state which led to their description as adducts. This was accompanied 
by the protonation of the aa ligands’ side chain and had to be considered in the analysis 
of NMR spectra. One direct consequence of this protonation was found in the pH level of 
aqueous solutions of these compounds. While almost every other aqueous [Ga(aa)(nta)]− 
complex solution (with exception of [Ga(cys)(nta)]− and [Ga(trp)(nta)]−) was approximately 
neutral, solutions of [Ga(Hasp)(nta)]− and [Ga(Hglu)(nta)]− were acidic (pH 4.0, Table 
2.13). In addition, or because of, the instability of the complex salts, no crystals of these 
compounds were obtained despite extensive efforts. Therefore, only elemental analysis 
and NMR spectroscopy are available for the characterisation of the complexes.  
 
Table 2.13: pH values of solutions: [Ga(Haa)(nta)]− complexes with acidic aa ligands in D2O.  
aa ligand HDIPEA+/DIPEA HNEt3+/NEt3 (c = 0.25 mol L−1) 
L-Aspartato 4.0 4.0 
L-Glutamato 4.0 4.0 
 
 
In the 13C{1H} NMR spectrum of HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA + 0.10 Ga(OH)3 
(Figure 2.30b) two signal sets of nta and of the proteinogenic amino acid are visible. With 
the information gathered before, these signals and their pattern do indicate the existence 
of the known equilibrium reaction (Figure 2.30a) and can be assigned to [Ga(Hasp)(nta)]−, 
[{Ga(nta)(µ-OH)}2]2− and aspartic acid. In the reaction scheme, isomer I but not isomer II 
is shown. Of course, with the data at hand, it is not possible to state if one or the other is 
present, it is just an assumption based on the experience with other [Ga(aa)(nta)]− 
complexes. 
RESULTS 
 53   
 
Figure 2.30: HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA + 0.10 Ga(OH)3 in aqueous solution. a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA + 0.10 Ga(OH)3 in D2O*, c: 13C{1H} NMR 
spectrum of L-aspartic acid in D2O*. Red: L-aspartic acid, cyan: L-aspartato in [Ga(Hasp)(nta)]−, blue: nta in 
[Ga(Hasp)(nta)]−, green: nta in in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, yellow: residual EtOH, orange: MeOH. 
* One drop of MeOH was added for referencing. 
 
Table 2.14: 13C{1H} NMR shifts (δ/ppm, D2O) of L-aspartic acid and the L-aspartato ligand in [Ga(Hasp)(nta)]− 
complexes. The relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 
HDIPEA+ [Ga(Hasp)(nta)]− δ 177.7 51.7 37.3 176.2 
 L-Aspartic acid δ 176.2 51.9 36.5 173.6 
  Δδ 1.5 ˗0.2 0.8 2.6 
HNEt3+ [Ga(Hasp)(nta)]− δ 177.9 51.8 37.5 176.7 
 L-Aspartic acid δ 176.7 52.1 36.7 173.9 
  Δδ 1.2 ˗0.3 0.8 2.8 
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In fact, it is not even possible to rule out the existence of another [Ga(Hasp-κO,N)(nta)]− 
complex which could be formed by creating a six-membered chelate ring with the amine 
function and the carboxylato function of C4. This is an issue only with the potential 
tridentate ligand aspartic acid, though, since glutamic acid would require the unlikely 
formation of a seven-membered chelate ring in such a case. The signals of the aspartato 
ligand are broadened, which might be due to the simultaneous presence of some or even 
all four potentially existent isomers of the [Ga(Hasp)(nta)]− complex, isomer I and II of both 
[Ga(Hasp-κO,N)(nta)]− complexes. In addition, or perhaps instead of this explanation, the 
acidic pH of the solution could have also led to a broadening of the signals by causing fast 
protonation and deprotonation and/or an accelerated equilibrium reaction. To summarise, 
since the spectrum is not very informative, the [Ga(Hasp)(nta)]− complex or complex 
isomers in solution could not be characterised.  
The 13C{1H} NMR spectra of HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA + 0.10 Ga(OH)3 and 
HDIPEA[Ga(Hglu)(nta)]·0.05DIPEA + 0.30 H2O + 0.05 Ga(OH)3 (Section 6.1, Figure 6.3) 
are almost identical. Therefore, the same conclusions are drawn for [Ga(Hglu)(nta)]− with 
just one exception concerning the possible number of different complex isomers. As 
stated, glutamic acid should not allow for two different κO,N-binding modes to gallium(III), 
therefore, only the isomers I and II of [Ga(Hglu)(nta)]− should potentially be formed. The 
signal shifts of the complexes [Ga(Hasp)(nta)]− and [Ga(Hglu)(nta)]− as well as the 
corresponding CIS values are displayed in Table 2.14 and in section 6.1, Table 6.3.  
In conclusion, the NMR spectra of the two compounds did not allow in-depth 
interpretations of the composition in solution. This should be kept in mind when aspartato 
or glutamato ligands are present, and, in general, if aqueous solutions of different 
compounds are acidic. The overall behaviour of these two compounds might also suggest 
that a charge higher than −1 of the gallium(III) complex is avoided, if possible, for example 
when the charge is not directly located at a functional group bound to the metal centre. If 
this is true, the selection of potential ligands is limited to some extent.  
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2.2.10 Equilibria in solution: ratios of components 
 
The ratios of compounds illustrated in Table 2.15 reveal some trends regarding the 
equilibrium reaction of different nitrilotriacetatogallium(III) complexes in aqueous solutions. 
Only the values of compounds containing triethylamine and/or triethylammonium ions are 
given, since fewer signal overlaps are present in 1H NMR spectra of those when compared 
to 1H NMR spectra of compounds containing N,N-diisopropylethylamine and/or N,N-
diisopropylethyl-ammonium ions.  
Table 2.15: Nitrilotriacetatogallium(III) complexes in D2O: ratios of coordinated aa ligand and free AA in 
solutions (0.25 mol L−1). The ratios are derived from the respective 1H NMR spectra and are given in %. * 
Signal overlap, values may differ up to 5%, # Signal overlap, values may differ up to 10%.  
 aa ligand [%] free AA [%] 
L-Alaninato/L-alanine 38 62 
L-Argininato/L-arginine* 45 55 
L-Asparaginato/L-asparagine 48 52 
L-Aspartato/L-aspartic acid 27 73 
L-Cysteinato/L-cysteine* 60 40 
L-Glutaminato/L-glutamine 47 53 
L-Glutamato/L-glutamic acid* 20 80 
Glycinato/glycine 45 55 
L-Histidinato/L-histidine# 50 50 
L-Isoleucinato/L-isoleucine 44 56 
L-Leucinato/L-leucine 49 51 
L-Lysinato/L-lysine* 41 59 
L-Methioninato/L-methionine 49 51 
L-Phenylalaninato/L-phenylalanine 42 58 
L-Prolinato/L-proline 46 54 
L-Serinato/L-serine* 40 60 
L-Threoninato/L-threonine 55 45 
L-Tryptophanato/L-tryptophan* 42 58 
L-Tyrosinato/L-tyrosine 0 100 
L-Valinato/L-valine 44 56 
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While the values must be seen as not perfectly precise due to their derivation from 1H NMR 
spectral data—the signals in 1H NMR spectra are usually in very close proximity and 
signal-overlap is common—the overall magnitude can be used to examine some trends. 
Most of the solutions consisted of about 40–50 percent of [Ga(aa)(nta)]− complex, while 
the remaining amount of those complexes reacted with water by forming the respective 
free amino acid and the [{Ga(nta)(µ-OH)}2] complex. Overall, the kind of aa ligand did not 
lead to a significant impact on the position of the equilibrium in most cases.  
The most outstanding difference was found when the complex featured acidic aa ligands. 
As described before (Subsection 2.2.9), the amorphous solids containing those 
compounds were not stable and the aa ligand’s side chains of these complexes were 
protonated once. This led to the compounds acidic reaction when solved in water (pH 4.0). 
A direct consequence was the substantial difference found in the position of the equilibria, 
with the ratio of [Ga(Haa)(nta)]− complex less than 30%. Since the deprotonation of the 
amino acid—especially of the ammonium group of the zwitterion—is key for the formation 
of [Ga(Haa)(nta)]−, the overall low amount of this complex present in acidic solution was 
expected. In general, to support the formation of complexes with aa ligands, deprotonation 
of the carboxylic function and ammonium group is key.  
Only two [Ga(aa)(nta)] complexes reached ratios of over 50% in 0.25 M solutions, 
HNEt3[Ga(cys)(nta)] and HNEt3[Ga(nta)(thr)]. This peculiarity was already discussed for 
HNEt3[Ga(cys)(nta)] in subsection 2.2.7. Unfortunately, no complex of L-threonine was 
crystallisable, therefore potential intramolecular interactions or other stabilising 
characteristics of this specific complex could not be examined.  
In general, the high amount of free amino acid in solution indicated that acidic 
proteinogenic amino acids—with the exception of L-tyrosin—were the least appropriate 
proteinogenic amino acids to form the target complexes. The differences between the 
other proteinogenic amino acids, with the exception of L-threonine and L-cysteine, were 
not very significant.  
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2.3 Ethylenediamine-N,N′-diacetatogallium(III) complexes  
 
The synthesis of heteroleptic gallium(III)-complexes with nta and aa ligands was 
successful, but did not fulfil every requirement that was set as a goal. The well-defined 
complexes with polar and nonpolar aa ligands are anionic, therefore cations were always 
present in the compounds. This led to the aforementioned problems, especially with 
crystallisation and, therefore, structural investigation of these complexes. Although this 
problem was largely prevented by the use of N,N-diisopropylethylammonium cations 
(HDIPEA+) which did not lead to significant disorder in the crystal structures, the toxicity of 
N,N-diisopropylethylamine is not ideal.[43] In addition, nta is suspected to be 
carcinogenic.[45] None of these properties is desirable for potential pharmaceuticals if 
alternatives are available.  
Concerning these issues, the formation of a neutral complex by replacing nta with a 
different, non-hazardous ligand could potentially solve both the problems with toxicity and 
crystallisation with just one ligand exchange. As the use of aminecarboxylato ligands was 
proven to be reasonable, another ligand of this type was chosen. Ethylenediamine-N,N′-
diacetic acid (H2edda), a tetradentate anionic ligand with two amine and two carboxylate 
functions should—in combination with polar and nonpolar proteinogenic amino acids—
form neutral [Ga(aa)(edda)] complexes. In addition, edda is not classified as hazardous. 
Admittedly, this is due to the lack of toxicological data. 
 
Figure 2.31: Reaction scheme for the synthesis of compounds with Ga(edda)+ fragments and aa ligands. 
Water is used as a solvent and, depending on the AA used in the reaction, n is either 3.1, 3.5 or 4.5. 
To obtain the target complexes, the procedure of synthesis for HNEt3[Ga(aa)(nta)] 
complexes was adopted. Likewise, every AA was used as a potential ligand. This was 
done despite the target of forming neutral complexes for a better understanding of overall 
complex formation with all aa ligands. The starting materials GaCl3, H2edda and the 
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respective AA were used in a stoichiometric ratio of 1:1:1, while a slight excess of 
triethylamine was used to ensure that enough basic compound was present for the 
reaction (Figure 2.31). After precipitation and washing of the products with organic solvent 
the resulting crude products were first tested by elemental analysis.  
According to the results of these analyses (Table 2.16), the target complexes were 
obtained with every polar and nonpolar AA except L-tyrosine. This outcome was consistent 
with the experiences gained with nitrilotriacetatogallium(III) complexes.  
Table 2.16: Interpretation of elemental analyses: [Ga(aa)(edda)] complexes with polar or nonpolar aa ligands. 
The maximum difference (max. diff) is given between the found and calculated percentages of the listed 
compositions.  
complex salt contamination max. diff. 
[Ga(ala)(edda)] 0.20 H2O 0.08 
[Ga(asn)(edda)] 0.15 H2O 0.16 
[Ga(cys)(edda)] 1.05 H2O + 0.10 HNEt3Cl  0.11 
[Ga(edda)(gln)] 0.80 H2O + 0.05 HNEt3Cl 0.19 
[Ga(edda)(gly)] 1.40 H2O + 0.10 Ga(OH)3 0.02 
[Ga(edda)(ile)] 0.80 H2O + 0.05 HNEt3Cl 0.10 
[Ga(edda)(leu)] 1.50 H2O 0.05 
[Ga(edda)(met)] 0.55 H2O + 0.15 Ga(OH)3 0.08 
[Ga(edda)(phe)] 1.05 H2O 0.04 
[Ga(edda)(pro)] 0.10 H2O 0.11 
[Ga(edda)(ser)] 1.55 H2O + 0.10 Ga(OH)3 0.05 
[Ga(edda)(thr)] 1.75 H2O 0.19 
[Ga(edda)(trp)] 1.50 H2O 0.06 
- tyrH + 0.05 H2O 0.10 
[Ga(edda)(val)] 0.50 H2O 0.08 
 
As expected, the main difference was found between the [Ga(aa)(edda)] complexes 
formed with polar and nonpolar aa ligands and the complexes formed with acidic and basic 
aa ligands. The elemental analyses of [Ga(Haa)(edda)] complexes (Table 2.17) with acidic 
aa ligands indicate the formation of triethylamine adducts. This had been the case with the 
respective nitrilotriacetatogallate(III) complexes as well and was therefore expected. Of 
course, nta is a trianionic ligand while edda is dianionic, therefore the resulting complexes 
are neutral.  
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Table 2.17: Interpretation of elemental analyses: ethylenediamine-N,N′-diacetatogallium(III) complexes with 
acidic or basic aa ligands. The maximum difference (max. diff.) is given between the found and calculated 
percentages of the listed compositions.  
complex salt contamination max. diff. 
[Ga(Harg)(edda)]Cl 2.00 H2O + 0.05 HNEt3Cl 0.09 
[Ga(Hasp)(edda)]·0.30NEt3 1.30 H2O 0.07 
[Ga(edda)(Hglu)]·0.15NEt3 1.25 H2O 0.07 
[Ga(edda)(Hhis)]Cl 0.10 H2O + 0.05 HNEt3Cl 0.13 
[Ga(edda)(Hlys)]Cl 0.60 H2O 0.10 
 
According to experiences with nta, the basic aa ligands of edda complexes should feature 
protonated side chains in the isolated amorphous solids. The complexes would therefore 
be cationic which is, indeed, shown by the elemental analyses (Table 2.17). The 
[Ga(Haa)(edda)]Cl complexes feature full protonation of the basic side chain. These 
compounds might also be described as well-defined hydrochlorides, but, as they are stable 
at room temperature and do not release hydrogen chloride, it seems reasonable to not 
label them as hydrochloride adducts.  
The obtained raw products were not pure. Water, sometimes gallium(III) hydroxide or low 
amounts of triethylammonium chloride were present in the crude products. The first two 
compounds were regularly found in raw products of nitrilotriacetato complexes as well. 
Water proved to be difficult to remove due to the hygroscopic nature of the compounds. 
The contamination of some products with Ga(OH)3 may have been due to incomplete 
complex formation or may have originated in flawed stoichiometric amounts of starting 
material. In five cases—due to the similar solubilities of triethylammonium chloride and the 
target complexes—the complete removal of triethylammonium chloride was not possible 
despite several attempts. This could have been avoided by the use of N,N-
diisopropylethylamine instead of triethylamine since N,N-diisopropylethylammonium 
chloride proved to be more soluble in organic solvents than triethylammonium chloride. 
However, none of the contaminants were problematic when it comes to crystallisation 
experiments or further analytical examinations. This statement may seem odd because 
triethylammonium chloride is a readily crystallising compound. Still, with such low amounts 
present and its good solubility in many solvents it should not crystallise before the target 
complex.  
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2.3.1 Structural investigations of [Ga(aa)(edda)] complexes 
 
Crystallisation experiments with the raw products presented in section 2.3 yielded crystals 
which were suitable for X-ray diffraction experiments in a few cases. Six of the thereby 
obtained crystal structures displayed in Figure 2.32–Figure 2.33 and Figure 2.34—Figure 
2.41 are of adequate quality and show the formation of the target complexes 
[Ga(aa)(edda)]. In contrast to the successful crystallisation experiments of [Ga(aa)(nta)]− 
salts, the crystals of [Ga(aa)(edda)] compounds were obtained only from aqueous 
solutions. All crystals were grown from neutral solutions, except the crystals of 
[Ga(edda)(phe)] which were obtained from a basic (pH 9.5) solution. Unfortunately, while 
further crystals of different [Ga(aa)(edda)] complexes were yielded, those did not allow for 
reasonable structure solutions. For example, the L-tryptophanato ligand in crystals of 
[Ga(trp)(edda)] was heavily disordered which prevented a structural solution of sufficient 
quality.  
 
Figure 2.32: Plot of [Ga(asn)(edda)] in crystals of 3a·2H2O. Space group: P21. CShMOC-6: 0.533. The thermal 
ellipsoids are drawn at 50% probability (room temperature data collection). Interatomic distances (in Å) and 
angles (in °) with standard deviation of the last digit in parentheses: Ga1–N1 2.044(4), Ga1–N2 2.084(3), Ga1–
N3 2.030(3), Ga1–O1 2.002(3), Ga1–O3 1.985(3), Ga1–O5 1.938(2), N1–Ga1–N3 174.16(15), N2–Ga1–O5 
175.76(11), O1–Ga1–O3 171.07(13), N2–Ga1–N3 99.34(13), N2–Ga1–O3 82.03(13), N3–Ga1–O1 94.07(12), 
N3–Ga1–O3 91.34(16), N3–Ga1–O5 83.42(12). 
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As shown, the gallium(III) ion in the [Ga(asn)(edda)], [Ga(edda)(gly)], [Ga(edda)(leu)], 
[Ga(edda)(pro)], [Ga(edda)(phe)] and [Ga(edda)(thr)] complexes features an octahedral 
GaN3O3 environment. The octahedral coordination is slightly distorted in every case, which 
is illustrated by the CShMOC-6 values and consistent with the observed interatomic 
distances and angles between gallium(III) and the N/O atoms of the ligands. These 
distortions are due to the formation of five-membered chelate rings and were, therefore, 
anticipated. The interatomic distances of Ga–N bonds are slightly longer as Ga–O bonds 
and are in the expected range.  
 
Figure 2.33: Plot of [Ga(edda)(gly)] in crystals of 3b·2H2O. Space group: P21/c. CShMOC-6: 0.541. The thermal 
ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard deviation 
of the last digit in parentheses: Ga1–N1 2.0621(17), Ga1–N2 2.0854(17), Ga1–N3 2.0142(17), Ga1–O1 
1.9746(14), Ga1–O3 1.9990(14), Ga1–O5 1.9548(14), N1–Ga1–N3 172.53(7), N2–Ga1–O5 173.14(6), O1–
Ga1–O3 170.80(6), N2–Ga1–N3 97.28(7), N2–Ga1–O3 82.47(6), N3–Ga1–O1 90.49(6), N3–Ga1–O3 
96.06(7), N3–Ga1–O5 85.01(6). 
Only crystals of [Ga(aa)(edda)] complexes with polar or nonpolar aa ligands were 
obtained. This was also true for the [Ga(aa)(nta)]− complexes presented in this work and 
thus not surprising. In contrast to [Ga(aa)(nta)]− complexes, an octahedral gallium(III) 
complex with the tetradentate chainlike ligand edda and a bidentate aa ligand enables the 
formation of six different constitutional isomers of [Ga(aa)(edda)] (Figure 2.35) instead of 
only two isomers. Of those six possible [Ga(aa)(edda)] isomers only two (isomer III and V) 
feature a facial coordination of the nitrogen and oxygen atoms. Despite this variety of 
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possible constitutional isomers, only the isomers I and VI are found in crystal structures of 
the [Ga(aa)(edda)] complexes. In crystals of [Ga(asn)(edda)], [Ga(edda)(gly)] and 
[Ga(edda)(pro)] only isomer I is present, while crystals of [Ga(edda)(leu)] and 
[Ga(edda)(phe)] feature both isomers I and VI and crystals of [Ga(edda)(thr)] only contain 
isomer VI. These two isomers are mirror images of each other if the aa ligand is not chiral. 
It is reasonable to assume that their formation and crystallisation is preferred due to less 
strain in the molecule, as in every other isomer one nitrogen atom of edda is forced to bind 
with non-ideal angles to its neighbouring atoms (Figure 2.35, isomers II–IV, axial position).  
 
 
Figure 2.34: Plot of the asymmetric unit of [Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O in crystals of 
3c·3d·3i·6H2O. Space group: P1. The thermal ellipsoids are drawn at 50% probability.  
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Figure 2.35: The six possible [Ga(aa)(edda)] complex isomers. R is the side chain of the respective AA used 
for complex formation. 
 
 
Figure 2.36: Plot of the two isomers of [Ga(edda)(leu)] in crystals of 3c·3d·3i·6H2O. CShMOC-6: Ga1 0.631, 
Ga2 0.677. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) 
with standard deviation of the last digit in parentheses: Ga1–N1 2.091(11), Ga1–N2 2.101(11), Ga1–N3 
1.988(12), Ga1–O1 1.991(8), Ga1–O3 1.957(8), Ga1–O5 1.931(9), Ga2–N4 2.055(11), Ga2–N5 2.099(11), 
Ga2–N6 2.048(10), Ga2–O7 1.972(8), Ga2–O9 1.979(8), Ga2–O11 1.933(9), N1–Ga1–N3 170.6(4), N2–Ga1–
O5 173.9(4), O1–Ga1–O3 170.8(4), N2–Ga1–N3 100.0(4), N1–Ga1–O5 91.2(4), N2–Ga1–O3 81.9(4), N3–
Ga1–O1 89.3(4), N3–Ga1–O3 96.6(4), N3–Ga1–O5 84.5(4), N4–Ga2–N6 169.4(4), N5–Ga2–O11 174.7(4), 
O7–Ga2–O9 170.4(4), N5–Ga2–N6 99.7(4), N4–Ga2–O11 90.9(4), N4–Ga2–O7 81.7(4), N6–Ga2–O7 
88.9(4), N6–Ga2–O9 97.2(4), N6–Ga2–O11 84.8(4). 
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Figure 2.37: Plot of [{Ga(edda)(µ-OH)}2] in crystals of 3c·3d·3i·6H2O. CShMOC-6: Ga3 0.718, Ga4 0.737. The 
thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga3–N7 2.075(10), Ga3–N8 2.087(10), Ga3–O13 1.973(9), Ga3–
O15 1.992(9), Ga3–O21 1.942(9), Ga3–O22 1.961(9), Ga4–N9 2.096(10), Ga4–N10 2.113(10), Ga4–O17 
1.966(9), Ga4–O19 1.972(9), Ga4–O21 1.949(9), Ga4–O22 1.941(9), N7–Ga3–O21 173.6(4), N8–Ga3–O22 
171.5(4), O13–Ga3–O15 172.2(3), N7–Ga3–N8 84.4(4), N8–Ga3–O21 98.7(4), N7–Ga3–O22 96.3(4), N7–
Ga3–O33 82.3(4), N7–Ga3–O15 92.7(4), O21–Ga3–O22 81.4(3), N9–Ga4–O22 173.3(4), N10–Ga4–O21 
170.9(4), O17–Ga4–O19 172.9(3), N9–Ga4–N10 85.1(4), N9–Ga4–N10 85.1(4), N9–Ga4–O21 95.4(4), N10–
Ga4–O17 92.8(4), N10–Ga4–O19 81.3(4), N10–Ga4–O22 98.7(4). 
The structures of [Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O and 2[Ga(edda)(phe)]·3H2O 
are only of mediocre quality. Some of the atoms in those needed to be solved partially 
anisotropic. However, the molecular structures are not shown just to amass more crystal 
structures of edda complexes. Both feature molecular structures which are of interest due 
to their characteristics. 
As illustrated in Figure 2.36 and Figure 2.39, the crystals of [Ga(edda)(leu)]2·[{Ga(edda)(µ-
OH)}2]·6H2O (Figure 2.34) and [Ga(edda)(phe)] each feature two isomers of the respective 
complex. In addition, [Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O contains a third complex, 
[{Ga(edda)(µ-OH)}2] (Figure 2.37). This complex resembles the [{Ga(nta)(µ-OH)}2]2− 
complex which is described in sections 1.4 and 2.2. It seems that gallium(III) has a 
tendency to form amincarboxylatogallium(III) complexes with bridging hydroxido ligands 
at neutral pH levels.  
RESULTS 
 65   
 
Figure 2.38: Plot of [{Ga(edda)(µ-OH)}6] in crystals of 3j·xH2O. Space group: I41/a. CShMOC-6: Ga1 0.443, 
Ga2 0.422, Ga3 0.422. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and 
angles (in °) with standard deviation of the last digit in parentheses: Ga1–N1 2.107(3), Ga1–N2 2.118(3), Ga1–
O3 1.968(3), Ga1–O5 1.946(2), Ga1–O15′ 1.927(2), Ga2–N3 2.117(3), Ga2–N4 2.115(3), Ga2–O5 1.930(2), 
Ga2–O6 1.987(2), Ga2–O8 1.964(2), Ga2–O10 1.945(2), Ga3–N5 2.138(3), Ga3–N6 2.102(3), Ga3–O10 
1.947(2), Ga3–O11 1.973(2), Ga3–O13 1.972(2), Ga3–O15 1.936(2), N1–Ga1–O15′ 169.23(13), N2–Ga1–
O5 170.35(12), O1–Ga1–O3 171.55(10), N1–Ga1–O1 81.57(13), N1–Ga1–O5 91.92(11), O1–Ga1–O5 
95.04(10), O3–Ga1–O5 90.37(10), O3–Ga1–O15′ 96.29(10), O5–Ga1–O15′ 95.13(10), N3–Ga2–O5 
169.35(11), N4–Ga2–O10 169.74(11), O6–Ga2–O8 170.01(9), N3–Ga2–O6 81.21(10), N3–Ga2–O10 
89.28(10), O5–Ga2–O8 97.47(10), O5–Ga2–O10 96.75(10), O6–Ga2–O10 94.58(10), O8–Ga2–O10 
91.67(10), N5–Ga3–O15 170.63(10), N6–Ga3–O10 169.63(11), O11–Ga3–O13 171.47(10), N5–Ga3–O11 
81.84(10), N6–Ga3–O15 91.48(11), O10–Ga3–O11 95.39(10), O10–Ga3–O15 95.20(10), O11–Ga3–O15 
91.69(9), O13–Ga3–O15 94.92(10). 
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This trend was emphasised by the crystal structure of [{Ga(edda)(µ-OH)}6] (Figure 2.38). 
Characteristic tetragonal crystals of this complex were frequently obtained, sometimes 
even in combination with crystals of [Ga(aa)(edda)] complexes or free AA.  
 
 
Figure 2.39: Plot of the two isomers of [Ga(edda)(phe)] in crystals of 3e·3f·3H2O. Space group: P21. 
CShMOC-6: Ga1 0.708, Ga2 0.544. The thermal ellipsoids are drawn at 50% probability. Interatomic distances 
(in Å) and angles (in °) with standard deviation of the last digit in parentheses: Ga1–N1 2.071(7), Ga1–N2 
2.096(8), Ga1–N3 2.019(7), Ga1–O1 1.968(6), Ga1–O3 1.973(6), Ga1–O5 1.975(6), Ga2–N4 2.062(7), Ga2–
N5 2.092(8), Ga2–N6 2.026(7), Ga2–O7 1.962(6), Ga2–O9 1.977(6), Ga2–O11 1.948(6), N1–Ga1–N3 
171.4(3), N2–Ga1–O5 170.0(3), O1–Ga1–O3 173.9(3), N2–Ga1–N3 94.4(3), N1–Ga1–O5 98.3(3), N2–Ga1–
O3 81.8(3), N3–Ga1–O1 87.8(3), N3–Ga1–O3 95.5(3), N3–Ga1–O5 83.8(3), N4–Ga2–N6 173.8(3), N5–Ga2–
O11 171.0(3), O7–Ga2–O9 175.0(3), N5–Ga2–N6 94.8(3), N4–Ga2–O11 96.5(3), N5–Ga2–O9 81.9(3), N6–
Ga2–O7 89.8(3), N6–Ga2–O9 93.5(3), N6–Ga2–O11 84.6(3). 
While the molecular structure of [{Ga(edda)(µ-OH)}6] is easy to determine, the full structure 
solution was prevented by disordered water molecules in combination with the large cell. 
This was the case despite several attempts and data collections. Hence, the compound is 
described as [{Ga(edda)(µ-OH)}6]·xH2O. Since the molecular structure of [{Ga(edda)(µ-
OH)}6] was resolvable, a few characteristics can still be described. The octahedral 
coordination spheres of the GaN2O4 surroundings are slightly distorted, which is illustrated 
by the CShMOC-6 values and consistent with the observed interatomic distances and angles 
between gallium(III) and the nitrogen and oxygen atoms of the ligands. The gallium(III) 
centres are connected by hydroxido ligands, forming the ring-like structure. Those 
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hydroxido-ligands are bound to gallium(III) in neighbouring positions. Also, edda is 
coordinated to gallium(III) in a C2-symmetric fashion, a characteristic found in every 
molecular structure of complexes featuring Ga(edda)+ fragments. Also, the surrounding of 
gallium(III) in [{Ga(edda)(µ-OH)}2] and [{Ga(edda)(µ-OH)}6] is similar. 
The direct synthesis of [{Ga(edda)(µ-OH)}6] was possible, too. However, crystals obtained 
by this method were of poor quality. This complex seems to require a very slow growth 
rate to form well-defined crystals, which seems to be provided more easily when they are 
obtained as a side product. This makes sense if the compound is present only in small 
amounts due to an equilibrium reaction in water or if it evolves slowly over time due to 
degradation of other complexes in solution. 
 
Figure 2.40: Plot of [Ga(edda)(pro)] in crystals of 3g·3H2O. Space group: P212121. CShMOC-6: 0.906. The 
thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.058(2), Ga1–N2 2.101(2), Ga1–N3 2.031(2), Ga1–O1 
1.988(2), Ga1–O3 1.960(2), Ga1–O5 1.956(2), N1–Ga1–N3 167.29(9), N2–Ga1–O5 171.42(8), O1–Ga1–O3 
173.00(8), N2–Ga1–N3 100.72(10), N1–Ga1–O1 82.31(8), N3–Ga1–O1 86.40(9), N3–Ga1–O3 99.05(9), N3–
Ga1–O5 83.13(9). 
In addition, sometimes only crystals of the respective AA were obtained. Again, just as 
with the nitrilotriacetatogallium(III) complexes, these findings imply the presence of an 
equilibrium reaction between different compounds in solution. The molecular structure of 
[Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O even shows three complexes which might be 
components of such an equilibrium. Of course, the complete decomposition of 
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[Ga(aa)(edda)] complexes in aqueous solution could not be ruled out as a potential cause 
for the formation of hydroxido-bridged complexes without performing solution studies. 
 
 
Figure 2.41: Plot of [Ga(edda)(thr)] in the crystals of 3h·2H2O. Space group: P21. CShMOC-6: 0.828. The 
thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.060(2), Ga1–N2 2.096(2), Ga1–N3 2.024(2), Ga1–O1 
2.006(2), Ga1–O3 1.967(2), Ga1–O5 1.950(2), N1–Ga1–N3 167.46(9), N2–Ga1–O5 173.63(7), O1–Ga1–O3 
171.28(7), N2–Ga1–N3 102.66(9), N2–Ga1–O3 82.14(7), N3–Ga1–O1 88.11(7), N3–Ga1–O3 97.75(7), N3–
Ga1–O5 82.61(9). 
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2.3.2 Solution studies of [Ga(aa)(edda)] complexes 
 
As described in subsection 2.3.1, different complexes, complex isomers and sometimes 
only the respective AA were crystallised from solutions containing [Ga(aa)(edda)] 
complexes. Crystals of [Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O even demonstrated 
that two different complexes exist at the same time, potentially in an equilibrium reaction.  
The sheer number of potential [Ga(aa)(edda)] complex isomers (Figure 2.35), hydroxido 
bridged complexes and free AA that might exist in an equilibrium should result in a large 
number of signals in both 13C{1H} NMR and 1H NMR spectra. A first look at the 
13C{1H} NMR spectrum of [Ga(edda)(thr)] + 1.75 H2O in D2O (Figure 2.42b) confirms this 
assumption. Despite the overall chaotic appearance of the spectrum, it was possible to 
assign most of the signals to specific carbon atoms with the help of 2D NMR techniques 
and by comparison with the respective spectra of [Ga(nta)(thr)]− complex solutions. In 
general, the NMR-spectroscopic studies presented in subsections 2.2.6–2.2.10 were an 
important source of information for the interpretation of the spectra of ethylenediamine-
N,N′-diacetatogallium(III) complexes (Subsections 2.3.2–2.3.6). 
First of all, the most uncommon feature of the 13C{1H} NMR spectrum (Figure 2.42b) needs 
to be addressed. The signals of edda resemble clusters of more or less broadened 
individual signals. While these signals are not assignable to a certain carbon atom, 
complex or complex isomer, these signal clusters indicate that the ligand is bound to 
gallium(III) in various ways. This supports the assumed presence of an equilibrium in 
aqueous solution (Figure 2.42a).  
Altogether, up to five different signals sets can be assigned to L-threonine. The signal set 
with the highest intensity has to be assigned to free L-threonine. This can be verified by 
comparison with a 13C{1H} NMR spectrum of L-threonine in D2O (Figure 2.42d) and by 
addition of L-threonine to a solution of [Ga(edda)(thr)] + 1.75 H2O in D2O which leads to a 
more significant increase of the intensity of this particular signal set than any other signal 
set (Figure 2.42c). Every other signal set not assigned at this point has to be assigned to 
L-threoninato ligands which indicates the existence of at least four out of six different 
[Ga(edda)(thr)] complex isomers (Figure 2.35) in solution. Since not every signal of the 
L-threoninato ligands is sharp, even more [Ga(edda)(thr)] complex isomers might exist in 
solution with their signal sets indistinguishable from the other signals. This is a common 
characteristic of the spectra of [Ga(aa)(edda)] complexes. 
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Figure 2.42: [Ga(edda)(thr)] + 1.75 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(edda)(thr)] + 1.75 H2O in D2O*, c: 13C{1H} NMR spectrum of 
[Ga(edda)(thr)]+ 1.75 H2O with 1.0 equ. of L-threonine in D2O*, d: 13C{1H} NMR spectrum of L-threonine in 
D2O*. Red: L-threonine, cyan: L-threoninato in [Ga(edda)(thr)], blue (A and B): edda in [Ga(edda)(thr)] and 
[{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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In addition, the concentration of complex isomers might just have been too low to be 
detected. Unfortunately, increasing the overall concentration of the solution was not 
feasible to deal with this issue. Although almost all [Ga(aa)(edda)] complexes are soluble 
in water, their solubility is generally lower when compared to the respective [Ga(aa)(nta)]− 
complexes. The [Ga(aa)(edda)] solutions used for the measurement of NMR spectra in 
this work were often already saturated. In fact, the concentration of the HNEt3[Ga(aa)(nta)] 
solutions used for NMR spectroscopy was determined by the highest possible 
concentration reachable with [Ga(aa)(edda)] complexes to allow for some comparability. 
The existence of the assumed equilibrium (Figure 2.42a) in solution was proven by the 
aforementioned addition of free L-threonine to the complex solution. This not only had an 
impact on the intensity of the signals of free L-threonine, but also led to an increase of the 
intensity of signals corresponding to L-threoninato ligands. In fact, it was possible to get 
the ratio of L-threoninato ligands to free L-threonine with the information derived from the 
1H NMR spectra. In a 0.25 M solution of [Ga(edda)(thr)] + 1.75 H2O in D2O 48% of 
L-threoninato ligands and 52% free L-threonine are present. After addition of one 
equivalent of free L-threonine, the ratio of bound L-threonine almost doubled. The 
equilibrium had shifted and about 90% of edda is now bound in [Ga(edda)(thr)] complexes 
and only 10% in [{Ga(edda)(µ-OH)}n] complexes. The impact of L-threonine addition on 
the signals of edda in the 13C{1H} NMR spectrum is not as prominent, but the signal 
clusters are less broadened and in general fewer signals of edda are found. This was 
expected, as almost no edda should be bound in [{Ga(edda)(µ-OH)}n] complexes at this 
point, which in turn reduces the variety of possible chemical environments of edda. When 
comparing the “vanished” signals of this solution with an aqueous solution of directly 
synthesised [{Ga(edda)(µ-OH)}n] complexes it was further proven that these signals 
indeed belong to [{Ga(edda)(µ-OH)}n] complexes. Unfortunately, the solubility of dry 
[Ga(aa)(edda)] complexes in dry MeOD is quite poor. Therefore it was not possible to 
conclusively prove this point by preventing the formation of [{Ga(edda)(µ-OH)}n] 
complexes in methanolic solution and then assigning the missing signals to the 
[{Ga(edda)(µ-OH)}n] complexes by NMR spectroscopy.  
In general, the findings supported the assumed existence of an equilibrium reaction 
between the [Ga(thr)(edda)] complexes on the one side and [{Ga(edda)(µ-OH)}n] 
complexes and free L-threonine on the other and were, therefore. consistent with the 
results of solution studies with [Ga(aa)(nta)]− complexes. As stated, an assignment of 
signals to specific complex isomers was not possible. Therefore, in contrast to the nta 
complexes, no CIS values are reported for edda complexes.  
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NMR-spectroscopic analyses of most [Ga(aa)(edda)] complexes with polar and nonpolar 
aa ligands showed similar results and proved the existence of the equilibrium (Figure 6.14, 
Figure 6.15, Figure 6.17, Figure 6.19, Figure 6.20, Figure 6.22—Figure 6.24, Figure 6.26) 
at neutral pH levels (Table 2.18). In two cases the equilibrium was verified by addition of 
free AA and re-measuring the spectra (Figure 6.17 and Figure 6.23). However, there were 
exceptions: the solubility of [Ga(cys)(edda)] in water is too low, hence no NMR-
spectroscopic analysis was feasible. In addition, [Ga(edda)(gln)], [Ga(edda)(phe)] and 
[Ga(edda)(trp)] are only soluble in water at basic pH levels. This posed a problem since 
changes in the pH value have a significant effect on the composition of the solution. Hence, 
the spectra of these compounds are discussed separately (Subsection 2.3.3). 
 
 
Table 2.18: pH values of solutions (c = 0.25 mol L−1): [Ga(aa)(edda)] complexes with polar or nonpolar aa 
ligands in D2O.  
compound pH value 
[Ga(ala)(edda)] 6.0–6.5 
[Ga(asn)(edda)] 7.0 
[Ga(cys)(edda)] - 
[Ga(edda)(gly)] 6.0 
[Ga(edda)(ile)] 6.5 
[Ga(edda)(leu)] 6.0 
[Ga(edda)(met)] 6.5 
[Ga(edda)(pro)] 6.5 
[Ga(edda)(ser)] 6.5–7.0 
[Ga(edda)(thr)] 7.0 
[Ga(edda)(val)] 6.0–6.5 
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2.3.3 Solution studies at basic pH levels  
 
The low solubilities of [Ga(edda)(gln)], [Ga(edda)(phe)] and [Ga(edda)(trp)] did not allow 
NMR-spectroscopic analyses at neutral pH levels. Hence, the solution studies of these 
compounds were done at basic pH levels (Table 2.19) by adding the lowest possible 
amount of triethylamine in order to obtain solutions. [Ga(edda)(gln)] + 0.80 H2O + 
0.05 HNEt3Cl is soluble at pH 8.5–9.0 by addition of one equivalent of triethylamine to 
obtain a 0.25 M solution. The 13C{1H} NMR spectrum of such a solution is displayed in 
Figure 2.43b. A striking difference in comparison to every other 13C{1H} NMR spectrum of 
[Ga(aa)(edda)] complexes with polar and nonpolar aa ligands can be seen in the “tidiness” 
of this spectrum. Unlike before, no chaotic clusters of signals and only few broadened 
signals—those of edda—are visible. Only two sets of signals are found for L-glutamine, 
one of the free amino acid and one of the L-glutaminato ligand. There may be a second 
signal set of another L-glutaminato ligand, but only two very weak signals are visible and 
it is, therefore, disregarded in the subsequent analysis. The signal assignment was proven 
by re-measuring the 13C{1H} NMR spectrum after addition of L-glutamine (Figure 2.43c).  
Table 2.19: pH values of solutions (c = 0.25 mol L−1): [Ga(aa)(edda)] complexes at basic pH levels in D2O. 
Triethylamine was added to solve the compounds. 
compound pH value 
[Ga(edda)(gln)] 8.5–9.0 
[Ga(edda)(phe)] 9.5 
[Ga(edda)(trp)] 10.0 
 
The signals in this spectrum indicate that only one out of six possible complex isomers of 
[Ga(edda)(gln)] is present in solution at the specific pH level. Even more exceptionally, this 
isomer is the main species in solution. Due to signal overlaps in the 1H NMR spectrum, 
the ratios were not quantifiable with certainty, but the 13C{1H} NMR spectrum supported 
this assertion as well. It was also not possible to specify the complex isomer present in 
solution with the information at hand since no crystals of this complex were obtained.  
To summarise, an equilibrium between free L-glutamine and [{Ga(edda)(µ-OH)}n] on the 
one side and one isomer of [Ga(edda)(gln)] seems to be present in solution (Figure 2.43a) 
and the basic pH level seems to shift the equilibrium in favour of the [Ga(edda)(gln)] 
complex. In addition, the higher-than-usual pH value in solution also affects the number of 
different complexes isomers.  
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Figure 2.43: [Ga(edda)(gln)] + 0.80 H2O + 0.05 HNEt3Cl in basic aqueous solution (c = 0.25 mol L−1). 
a: equilibrium reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(gln)] + 0.80 H2O + 0.05 HNEt3Cl in D2O and 
triethylamine*, c: 13C{1H} NMR spectrum of [Ga(edda)(gln)] + 0.80 H2O + 0.05 HNEt3Cl with 0.8 equ. of 
L-glutamine in D2O and triethylamine*. Red: L-glutamine, cyan: L-glutaminato in [Ga(edda)(gln)], blue (A and 
B): edda in [Ga(edda)(gln)] and [{Ga(edda)(µ-OH)}n] complexes, grey: HNEt3+, orange: MeOH. * One drop of 
MeOH was added for referencing. 
 
The 13C{1H} NMR spectrum of [Ga(edda)(phe)] + 1.05 H2O (Figure 2.44b) needs to be 
discussed separately. The solution of this compound had a pH of 9.5, which was 
significantly more basic than the solution of [Ga(edda)(gln)] + 0.80 H2O + 0.05 HNEt3Cl 
and drastically changed the characteristics of the NMR spectra. 
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Figure 2.44: [Ga(edda)(phe)] + 1.05 H2O in basic aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of [Ga(edda)(phe)] + 1.05 H2O in D2O and triethylamine*, c: 13C{1H} NMR spectrum 
of [Ga(edda)(phe)] + 1.05 H2O with 0.8 equ. of L-phenylalanine in D2O and triethylamine*. Red: 
L-phenylalaninate, blue (A and B): edda in [{Ga(edda)(µ-OH)}n] complexes, grey: HNEt3+, orange: MeOH. * 
One drop of MeOH was added for referencing. 
In comparison with the 13C{1H} NMR spectrum of [Ga(edda)(gln)] + 0.80 H2O + 0.05 
HNEt3Cl, the 13C{1H} NMR spectrum of [Ga(edda)(phe)] + 1.05 H2O features even fewer 
signals sets. While the signals of edda are still slightly broadened, implying that different 
chemical surroundings of the carbon atoms exist, only one set of well-defined signals of 
L-phenylalanine can be seen in the spectrum. This is curious, and a feature which was not 
seen in any of the 13C{1H} NMR spectra in this work before. Since crystals of 
[Ga(edda)(phe)] were obtained from such a solution with quite high yields, it seems 
obvious that the signals in this spectrum need to be assigned to the L-phenylalaninato 
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ligand. Therefore, the equilibrium in solution (Figure 2.44a) seems to be shifted entirely to 
the side of [Ga(edda)(phe)].  
This subject was further investigated by re-measuring the solution after the addition of 
L-phenylalanine. Surprisingly, the 13C{1H} NMR spectrum of this solution (Figure 2.44c) 
featured no additional signals. Therefore, it seems that the equilibrium in solution (Figure 
2.44a) is actually shifted entirely to the side of free L-phenylalanine and [{Ga(edda)(µ-
OH)}n]. It should be mentioned that with the amount of triethylamine in solution, any free 
L-phenylalanine should be fully deprotonated and, therefore, feature the same protonation 
state as a L-phenylalaninato ligand in the [Ga(edda)(phe)] complex. Since the 
coordination-induced shift caused by gallium(III) is very low, it might be possible that the 
signals of fully deprotonated L-phenylalanine and L-phenylalaninato are shifted by exactly 
the same amount, but this is highly unlikely. Hence, the signals in the spectrum are 
assigned to the deprotonated L-phenylalaninate and not to a L-phenylalaninato ligand.  
It seems that the crystallisation of the [Ga(edda)(phe)] complex was dependent on the 
addition of organic solvent or the evaporation of triethylamine to shift the equilibrium in 
solution in its favour. An alternative explanation might be that a very small untraceable 
amount of the [Ga(edda)(phe)] complex still existed in solution and this compound just 
happened to be the first to crystallise.  
The pH of the solution (Table 2.19) of [Ga(edda)(trp)] + 1.50 H2O (Figure 6.25) is even 
higher than in the solution of the [Ga(edda)(phe)] complex. Consistently, the 13C{1H} NMR 
spectrum of [Ga(edda)(trp)] is similar to the spectrum of [Ga(edda)(phe)]. The signals in 
this spectrum are therefore also assigned to the deprotonated L-tryptophanate and not to 
a L-tryptophanato ligand. 
In general, the spectra of complexes in basic solutions differ from those in neutral 
solutions. Since it shows how significant the influence of the pH level on the equilibrium is, 
this issue will be discussed further in section 3.2. 
 
 
  
RESULTS 
 77   
2.3.4 Solution studies: complexes with basic aa ligands 
 
The complexes formed with basic aa ligands and the Ga(edda)+ fragment are different 
when compared to the complexes with the Ga(nta) fragment. In the isolated products, the 
basic side chains of the aa ligands are protonated when used in combination with nta. 
Consequently, neutral complexes are formed. Since adducts are formed with a non-
integral amount of the respective tertiary amine in use, the compositions of the compounds 
are ill-defined. With edda, the resulting complex would be neutral if the side chains are not 
protonated. Of course, the side chains feature basic functions, therefore their protonation 
in the isolated product is likely. Indeed, this is the case according to elemental analysis. 
Therefore, a positive charge is present in the complex which is compensated with chloride 
as an anion in the complex salt. As a result, the products are homogeneous and easy to 
characterise by elemental analysis. Formally, these compounds could be described as 
hydrochlorides. Still, as these were stable and did not emit hydrogen chloride, in the course 
of this work the compounds will be referred to as the chlorides with the proton located at 
the aa ligand. This should emphasise the difference to the adducts formed with tertiary 
amines and [Ga(Haa)(nta)] complexes with basic aa ligands.  
Table 2.20: pH values of solutions (c = 0.25 mol L−1): [Ga(Haa)(edda)]Cl complexes with basic aa ligands in 
D2O. 
compound pH value 
[Ga(Harg)(edda)]Cl 7.0 
[Ga(edda)(Hhis)]Cl 7.0 
[Ga(edda)(Hlys)]Cl 6.5–7.0 
 
Aqueous solutions of the [Ga(Haa)(edda)]Cl compounds are neutral (Table 2.20). 
Consequently, 13C{1H} and 1H NMR spectra of aqueous solutions of those compounds 
were quite similar to the spectra obtained when [Ga(aa)(edda)] compounds with polar and 
nonpolar aa ligands are examined. For example, a 13C{1H} NMR spectrum of 
[Ga(Harg)(edda)]Cl + 2.00 H2O + 0.05 HNEt3Cl (Figure 2.45b) in aqueous solution 
features the same signal patterns which are present in the spectrum discussed in 
subsection 2.3.2. The 13C{1H} NMR spectra of [Ga(Harg)(edda)]Cl + 2.00 H2O + 0.05 
HNEt3Cl, [Ga(edda)(Hlys)]Cl + 0.60 H2O (Figure 6.21) and [Ga(edda)(Hhis)]Cl + 0.10 H2O 
+ 0.05 HNEt3Cl (Figure 6.18) are, therefore, not discussed in detail as the same reasoning 
applies and the conclusions drawn are equal to those in subsection 2.3.2.  
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In the 13C{1H} NMR spectra of those three compounds, three signals sets of the respective 
aa ligands are found.  
 
Figure 2.45: [Ga(Harg)(edda)]Cl + 2.00 H2O + 0.05 HNEt3Cl in aqueous solution (c = 0.25 mol L−1). a: equi-
librium reaction, b: 13C{1H} NMR spectrum of [Ga(Harg)(edda)]Cl + 2.00 H2O + 0.05 HNEt3Cl in D2O*, c: 
13C{1H} NMR spectrum of L-arginine in D2O*. Red: L-argininate, cyan: L-argininato in [Ga(Harg)(edda)]+, blue 
(A and B): edda in [Ga(Harg)(edda)]+ and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of 
MeOH was added for referencing.  
 
In contrast to the spectra of the complexes containing the Ga(nta) fragment, the spectra 
of [Ga(Harg)(edda)]+ and [Ga(Hlys)(edda)]+ do not feature more signals than the spectra 
of other [Ga(aa)(edda)] complexes. This implies that the formation of different complex 
isomers is not that dependent on the aa ligand when edda is bound.  
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2.3.5 Solution studies: complexes with acidic aa ligands  
 
As mentioned in section 2.2, nitrilotriacetatogallium(III) complexes with acidic aa ligands 
are special since they form unstable adducts with the tertiary amine used as base. In the 
isolated products, the acidic side chains of the aa ligand are not deprotonated. Aqueous 
solutions of these compounds are, therefore, acidic. [Ga(Haa)(edda)] complexes with 
acidic aa ligands showed the same characteristics (Section 2.3). Of course, this could also 
be seen in the 13C{1H} NMR spectra of those adducts. As expected, the solutions were 
also acidic (Table 2.21) due to the protonated acidic side chain. The similarities of the 
13C{1H} NMR spectrum of [Ga(Hasp)(edda)]·0.30NEt3 + 1.30 H2O (Figure 2.46b) with 
those of [Ga(Haa)(nta)]− complexes are easily spotted. The signals of the L-aspartic acid 
are broadened in all of these spectra, sometimes to such an extent that they are no longer 
visible in the spectrum. 
 
Figure 2.46: [Ga(Hasp)(edda)]·0.30NEt3 + 1.30 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium 
reaction, b: 13C{1H} NMR spectrum of [Ga(Hasp)(edda)]·0.30NEt3 + 1.30 H2O in D2O*, c: 13C{1H} NMR 
spectrum of L-aspartic acid in D2O*. Red: L-aspartic acid, cyan: L-aspartato in [Ga(Hasp)(edda)], blue (A and 
B): edda in [Ga(Hasp)(edda)] and [{Ga(edda)(µ-OH)}n] complexes, grey: HNEt3+, orange: MeOH. * One drop 
of MeOH was added for referencing.  
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Table 2.21: pH values of solutions (c = 0.25 mol L−1): [Ga(Haa)(edda)] complexes with acidic aa ligands in 
D2O. 
compound pH value 
[Ga(Hasp)(edda)] 4.5 
[Ga(edda)(Hglu)] 4.5 
 
This is due to the acidic pH of the compound’s solutions. Still, the signals of free amino 
acid in the spectra of [Ga(Hasp)(edda)] + 1.30 H2O can be identified. The unassigned 
signals with very weak intensity are, therefore, assigned to the aa ligand, which means 
that at least a small amount of the [Ga(Haa)(edda)] complex should be present in solution. 
This indicates that an equilibrium (Figure 2.46a) exists in solution and it is expected to be 
similar to the equilibria of other [Ga(aa)(edda)] complexes. But, in contrast to the spectra 
of most [Ga(aa)(edda)] complexes, no signal sets of different [Ga(Haa)(edda)] complex 
isomers could be identified. This was a recurring problem of complexes with acidic aa 
ligands and a more in-depth discussion of the subject is found in subsection 2.2.9. Of 
course, this prevented the identification of different complex isomers and it was not even 
possible to state whether different complex isomers were formed.  
The 13C{1H} NMR spectrum of [Ga(edda)(Hglu)]·0.15NEt3 + 1.25 H2O (Figure 6.16) is 
similar to the spectrum of [Ga(Hasp)(edda)] + 1.30 H2O and, therefore, not discussed 
separately. In conclusion, the spectra seem to show the existence of the equilibria (Figure 
2.46a and Figure 6.16a) in solution. Other than that, the informative value of the spectra 
is low, which was expected since spectra of [Ga(Haa)(nta)]− complexes with acidic aa 
ligands are very similar in this regard. Since the pH levels of solutions had a huge impact 
on the equilibrium reaction and on the information that can be derived from the spectra, 
this subject is discussed in more detail later (Section 3.2). It would have been possible to 
adjust the pH levels with the addition of basic ligand. This was not done in order to show 
the difficulties caused by the acidic pH levels and the combination of tri- and tetradentate 
ligands. 
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2.3.6 Equilibria in solution: ratios of components 
 
One striking feature found in all spectra of complexes with Ga(edda)+ fragments and aa 
ligands is the dominant species of free proteinogenic amino acid. While the existence of 
free amino acid was expected due to the experiences with complexes containing the 
Ga(nta) fragment and aa ligands, the amount of uncoordinated AA was significantly higher 
in solutions of ethylenediamine-N,N′-diacetatogallium(III) complexes. Unfortunately, the 
overlap of signals in the 1H NMR spectra did not allow for the specification of ratios 
between free and bound ligand in most cases. The values which could be derived with 
some certainty are presented in Table 2.22. 
 
Table 2.22: Ethylenediamine-N,N′-diacetatogallium(III) complexes in D2O: ratios of coordinated aa ligand and 
free AA in solutions (c = 0.25 mol L−1). The ratios are derived from the respective 1H NMR spectra and are 
given in %. *Signal overlap, values may differ up to 5%. #In basic solution. 
 aa ligand [%] free AA [%] 
L-Argininato/L-arginine* 18 82 
L-Glutaminato/L-glutamine*# 75 25 
Glycinato/glycine* 35 65 
L-Histidinato/L-histidine* 40 60 
L-Isoleucinato/L-isoleucine 23 77 
L-Phenylalaninato/L-phenylalanine# 0 100 
L-Prolinato/L-proline* 10 90 
L-Threoninato/L-threonine 48 52 
L-Tryptophanato/L-tryptophan*# 0 100 
L-Valinato/L-valine 20 80 
 
The NMR spectra of basic solutions have already been discussed extensively in 
subsection 2.3.3. In short, if the pH is slightly higher than neutral, the equilibrium is shifted 
to the side of the [Ga(aa)(edda)] complex. This is illustrated by a ratio of approximately 
75% of L-glutaminato bound in [Ga(edda)(gln)] in an aqueous solution with a pH of 8.5–
9.0. If it gets too high—somewhere between 9.0 and 9.5—the equilibrium is drastically 
changed and completely shifted to the side of free AA. This was found when an aqueous 
solution containing [Ga(edda)(phe)] was analysed at pH 9.5.  
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Neutral solutions (c = 0.25 mol L−1) tend to contain 60% or more free AA. Hence, less than 
40% of gallium(III) is coordinated in [Ga(aa)(edda)] complexes. The rest is likely found in 
[{Ga(edda)(µ-OH)}n] complexes, be it [{Ga(edda)(µ-OH)}6] or [{Ga(edda)(µ-OH)}2]—which 
were both found in crystals—or maybe other, unidentified complexes of this kind.  
One exception is the solution of [Ga(edda)(thr)] which features a significantly higher 
amount of bound aa. The difference in regard to other complex solutions is prominent 
enough that it can be seen even in the 13C{1H} NMR spectrum of this complex. Even 
though a molecular structure of one [Ga(edda)(thr)] complex isomer is available for closer 
inspection, no obvious intramolecular interaction or other cause which would explain the 
higher stability of [Ga(edda)(thr)] in comparison to other ethylenediamine-N,N′-
diacetatogallium(III) complexes is apparent. However, [Ga(nta)(thr)]− was also slightly 
more stable than comparable complexes. Hence, gallium(III) complexes with L-threoninato 
ligands seem to be, generally, more stable than complexes with other aa ligands. 
In conclusion, the abundancy of ethylenediamine-N,N′-diacetatogallium(III) complexes 
with aa ligands is significantly lower than the abundancy of the respective nitrilotriacetato 
complexes in solutions with the same concentration. On average, only around 30% of the 
proteinogenic amino acid is bound in the complexes. The formation of the respective 
nitrilotriacetato complexes seems to be favoured. This is most likely due to the lower steric 
demand of the nta ligand when compared to edda. 
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2.4 Gallium(III) complexes with tridentate aminecarboxylato ligands 
 
Since the synthesis of gallium(III) complexes with combinations of tetra- and bidentate 
aminecarboxylato ligands was possible, a logical follow-up was to use combinations of 
tridentate aminecarboxylato ligands. While monovalent complex anions with tetra- and 
bidentate aminecarboxylato ligands were structurally characterised, the cation did effect 
the quality of the crystal structures obtained. In addition, experiments with edda had shown 
that neutral complexes can be formed and crystallised with tetra- and bidentate 
aminecarboxylato ligands. Last but not least, the gallium(III) compounds which were 
described as most promising therapeutic agents in clinical trials (Section 1.3) are neutral 
complexes. Therefore, it seemed appropriate to use ligand combinations which would 
allow the formation of neutral complexes. 
 
2.4.1 Iminodiacetatogallium(III) complexes 
 
As described in section 1.4, [Ga(ida)2]− is an already characterised gallium(III) complex 
with a tridentate aminecarboxylato ligand. Iminodiacetic acid (H2ida) is comparable to 
aspartic acid, but allows the formation of two five-membered chelate rings and is a more 
symmetrical ligand in addition to not being chiral. Therefore, ida is one of the most simple 
tridentate aminecarboxylato ligands and should be a viable starting point for the formation 
of heteroleptic gallium(III) complexes.  
To form a neutral iminodiacetatogallium(III) complex, the second tridentate ligand should 
be monoanionic. Of the proteinogenic amino acids, only the basic amino acids would be 
fitting ligands to form [Ga(aa)(ida)] complexes while still featuring the established Ga-N/O 
environment with carboxylate and amine functions. Of those three—L-arginine, L-histidine 
and L-lysine—only L-histidine should be a suitable tridentate ligand since the two other 
ligands would require the unfavourable formation of seven-, eight- or even nine-membered 
chelate rings.  
The synthesis of [Ga(his)(ida)] was done in aqueous solution and the starting materials 
were used in stoichiometric ratios (Figure 2.47, pH 5.5).  
 
Figure 2.47: Chemical equation for the synthesis of [Ga(his)(ida)]. 
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After the reaction the product was precipitated by addition of ethanol and examined by 
elemental analysis.  
According to this analysis, the target complex was formed with a small amount of residual 
water still present in the product: [Ga(his)(ida)] + 0.40 H2O. The maximum difference 
between the found and calculated percentages of this composition is 0.03. Unfortunately, 
the isolated compound is not soluble in water at neutral pH levels. Hence, crystallisation 
experiments were done with a solution of the crude product in water and triethylamine 
(pH 9.0). Crystals of [Ga(his)(ida)] (Figure 2.48) were obtained by storing an open vessel 
of this solution for one week. 
 
Figure 2.48: Plot of [Ga(his)(ida)] in crystals of 4a. Space group: P212121. CShMOC-6: 0.756. The thermal 
ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard deviation 
of the last digit in parentheses: Ga1–N1 2.094(2), Ga1–N2 2.039(2), Ga1–N3 2.026(2), Ga1–O1 1.946(2), 
Ga1–O3 1.957(2), Ga1–O5 2.010(2), N1–Ga1–N3 169.71(8), N2–Ga1–O3 174.61(8), O1–Ga1–O5 168.95(7), 
N1–Ga1–N2 99.52(8), N2–Ga1–N3 88.56(8), N2–Ga1–O1 94.00(8), N2–Ga1–O5 81.54(8), N3–Ga1–O1 
101.17(8). 
Just as expected, the complex molecule features an octahedral GaN3O3 coordination of 
gallium(III) which was interpreted in greater depth by using continuous shape measures. 
The CShMOC-6 value shows a slight distortion of the octahedral coordination sphere which 
is in the range of the values found for the complexes with tetra- and bidentate ligands. This 
is true for the atomic distances and angles between gallium(III) and the N/O atoms as well.  
The ligands of the crystallised isomer are coordinated facially, while the N- and O-atoms 
of the ligands each have a meridional arrangement. This result was repeatedly obtained, 
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therefore, only one of three different possible constitutional isomers was found in the 
crystal structure. The limited number of potential complex isomers is due to the nature of 
the ligands in use. L-histidinato can be a tridentate ligand only when it binds facially as the 
meridional arrangement is sterically not possible. A difference between this complex and 
every other complex presented until now is the formation of one six-membered chelate 
ring, proving that the formation of such a chelate ring with aa ligands is possible.  
One important characteristic of the crystallisation experiments is the instability of the 
mother liquor over extended periods of time. This can be observed by the progressing 
discolouration of the solution from slightly yellow to a brownish colour. It also leads to the 
formation of a brownish, amorphous solid which coats the crystals if the crystallisation 
experiment is stored for a few weeks. Since the intention of these experiments was to 
obtain crystals of high quality, the process was set up to be slow. Thereby crystals of good 
quality were obtained, but the yield was limited to only a few crystals before contamination 
with the amorphous brown solid occurred. To reach higher yields of the target complex, 
faster crystallisation methods or just the precipitation method which is used to get the crude 
product should be applied.  
As in previous sections of this work, the composition of an aqueous solution of 
[Ga(his)(ida)] is of interest. However, the complex is not soluble at neutral pH levels, hence 
triethylamine was added to obtain a solution with a pH of 8.0–8.5. This affects the 
significance of NMR-spectroscopic studies, as mentioned before (Subsections 2.2.10 and 
2.3.6).  
In contrast to every other spectrum of basic solutions shown up to this point, the signals in 
the 13C{1H} NMR (Figure 2.49) and 1H NMR spectrum of this solution are broadened to 
such an extent that signal assignment was not possible even with 2D NMR experiments. 
To be specific, this means that the signals of the C1 and C2 atom of the two ligands could 
not be distinguished and an overall assignment of signals to different species in solution 
was also not feasible. A detailed interpretation of the spectra was not possible and, with 
the information at hand, it could not be determined which complexes were present in 
solution. There might only be different complex isomers of [Ga(his)(ida)], though the 
existence of homoleptic complexes cannot be ruled out. Due to this fact, no NMR-
spectroscopic data of the 13C{1H} NMR and 1H NMR spectra are listed in the experimental 
part of this work. 
 
RESULTS 
 86   
 
Figure 2.49: 13C{1H} NMR spectrum of [Ga(his)(ida)] + 0.40 H2O in D2O and triethylamine* (c = 0.25 mol L−1). 
Cyan: signals of L-histidinato and iminodiacetato ligands, grey: HNEt3+, orange: MeOH. * One drop of MeOH 
was added for referencing. 
 
Despite the obstacles to an exhaustive analysis of the spectrum, a few assertions can 
nevertheless be made. Since no defined sharp signals are found in the 13C{1H} NMR 
spectrum, different complexes and/or complex isomers might exist in solution. Also, no 
sharp signals of the ligands can be seen. In this work, the signals of free ligands were well-
defined in every 13C{1H} NMR spectrum of neutral or basic solutions. Therefore, it seems 
that no free ligand is present in solution, which indicates that the complexes are stable 
against hydrolysis, at least in basic solution.  
This is an important difference in comparison to the complexes with tetra- and bidentate 
aminecarboxylato ligands and shows that the investigation of further gallium(III) complexes 
with tridentate aminecarboxylato ligands is reasonable.  
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2.4.2 Gallium(III) complexes with tridentate aa ligands 
 
The successful synthesis of [Ga(his)(ida)] showed that L-histidine is a suitable tridentate 
ligand for gallium(III). To form a comparable complex with L-histidine, ida had to be 
substituted with a similar tridentate ligand. As stated in subsection 2.4.1, L-aspartic acid is 
such a ligand. The main difference when comparing L-aspartic acid with iminodiacetic acid 
is the additional CH2-group, which would necessitate the formation of two six-membered 
and four five-membered chelate rings to form the target complex [Ga(asp)(his)]. This 
complex was synthesised in water with stoichiometric amounts of the starting materials 
and triethylamine as base (Figure 2.50, pH 7.5). After the reaction the product was 
precipitated by addition of ethanol and examined by elemental analysis. 
 
Figure 2.50: Chemical equation for the synthesis of [Ga(asp)(his)]. 
 
The elemental analysis (Table 2.23) of this reaction’s crude product indicates that the 
synthesis of [Ga(asp)(his)] was, most likely, successful. The compound shows excellent 
solubility in neutral aqueous solution, which is a striking difference when compared to 
[Ga(his)(ida)]. Unfortunately, crystallisation experiments of this compound failed despite 
several attempts. Therefore, a structural examination of the obtained complex by 
crystallography was not possible.  
To obtain crystals of a [Ga(asp)(his)] complex, D-histidine and L-aspartic acid were used 
as a ligand combination. The reaction was done with an excess of triethylamine as no 
solution was obtained at neutral pH levels. Aside from that, the procedure was identical to 
that of the reaction with L-histidine and L-aspartic acid. According to an elemental analysis 
(Table 2.23) of this product, the target complex [Ga(asp)(D-his)] was obtained. A 
subsequent crystallisation experiment with an aqueous solution of triethylamine and 
[Ga(asp)(D-his)] (pH 10.0) yielded a few crystals which were suitable for X-ray diffraction.  
Table 2.23: Interpretation of elemental analyses: [Ga(asp)(his)] complexes. The maximum difference (max. 
diff.) is given between the found and calculated percentages of the listed compositions. 
complex-salt contamination max. diff. 
[Ga(asp)(his)] 2.40 H2O + 0.05 HNEt3Cl  0.23 
[Ga(asp)(D-his)] 1.95 H2O  0.04 
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Figure 2.51: Plot of [{Ga(µ-asp)(D-his)}2] in crystals of 4b·1.61H2O. Space group: P41212. CShMOC-6: 0.449. 
The thermal ellipsoids are drawn at 50% probability (room temperature data collection). Interatomic distances 
(in Å) and angles (in °) with standard deviation of the last digit in parentheses: Ga1–N1 2.039(3), Ga1–N3 
2.044(2), Ga1–N4 2.048(3), Ga1–O1 2.045(2), Ga1–O3 1.945(2), Ga1–O5′ 1.958(2), N3–Ga1–N4 173.99(10), 
N1–Ga1–O3 170.53(10), O1–Ga1–O5′ 175.06(9), N1–Ga1–N4 97.52(11), N1–Ga1–N3 88.36(10), N1–Ga1–
O1 80.18(10), N3–Ga1–O1 89.25(10), N3–Ga1–O3 90.92(9), N3–Ga1–O5′ 91.93(9).  
 
Surprisingly, no mononuclear complex [Ga(asp)(D-his)] was crystallised. Instead, the 
binuclear complex [{Ga(µ-asp)(D-his)}2] (Figure 2.51) was obtained. The octahedral 
GaN3O3 coordination of the gallium(III) atoms is slightly distorted, and the interatomic 
distances and angles are in the expected range. The N- and O-atoms show a meridional 
arrangement, while the histidinato ligands are coordinated facially. Since this complex 
resembles the targeted mononuclear complex when it comes to its charge and 
composition, it is not distinguishable from the target complex by elemental analysis.  
Apparently, the crystallisation of a binuclear complex with two bridging aspartato ligands 
instead of the mononuclear complex is favoured. It might be possible that the formation of 
the mononuclear complex does not occur as it would require the formation of a second 
six-membered chelate ring which might, in turn, cause a higher distortion of the octahedral 
coordination sphere of gallium(III) in the complex. This would be averted by the formation 
of the binuclear complex. However, since the overall yield of crystals was very low and the 
crystals that feature this complex were the only ones that were obtained, it is not possible 
to determine if this complex was the only one that was formed. Hence, it cannot be ruled 
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out that the mononuclear complex exists in solution. In fact, molecular structures of 
gallium(III) complexes with tridentate N/O ligands that feature four six-membered chelate 
rings and two five-membered chelate rings have already been reported.[49] Therefore, the 
crystallisation or even the formation of a mononuclear complex might just not be favoured 
in this case. 
One striking difference when comparing [Ga(asp)(his)] with [{Ga(µ-asp)(D-his)}2] is the 
excellent solubility of [Ga(asp)(his)] in neutral aqueous solution. This might indicate that, 
at least in aqueous solution, the [Ga(asp)(his)] complex has a different structural 
configuration than [{Ga(µ-asp)(D-his)}2]. Hence, [Ga(asp)(his)] might actually be 
mononuclear and therefore resemble the targeted complex. On a side note, when racemic 
mixtures of both ligands were used for complex formation, the composition of the product 
remained unknown. However, it was soluble in water, hence the formation of the insoluble 
[{Ga(µ-asp)(D-his)}2] was not favoured.  
To further investigate the compositions of those complexes in solution, 13C{1H} and 
1H NMR spectroscopy in combination with 2D NMR techniques was used. Unfortunately, 
since [{Ga(µ-asp)(D-his)}2] is soluble only at basic pH level, a direct comparison of 
13C{1H} 
and 1H NMR spectra of this complex with spectra of [Ga(asp)(his)] solutions is not 
possible. In addition, the solubility of [{Ga(µ-asp)(D-his)}2] is very low even at higher pH 
levels, therefore the spectra are not interpretable and not displayed.  
 
Figure 2.52: 13C{1H} NMR spectrum of [Ga(asp)(his)] + 2.40 H2O + 0.05 HNEt3Cl in D2O* (c = 0.25 mol L−1). 
Cyan: signals of L-histidinato and L-aspartato ligands, red: signals of free AA, green: signals that are to be 
assigned to either bound or free AA, grey: HNEt3+, orange: MeOH. * One drop of MeOH was added for 
referencing.  
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The 13C{1H} NMR spectrum of [Ga(asp)(his)] + 2.40 H2O + 0.05 HNEt3Cl depicted in 
Figure 2.52 (pH 7.0) shows at least two signal sets of both amino acids. Since two different 
aa ligands were used in the synthesis, some of the signals in the spectra are found in close 
proximity. Therefore, the assignment of signals and a detailed evaluation of the spectrum 
is difficult without comparing it to spectra of similar compounds. Subsequently, two of the 
signal sets in the 13C{1H} NMR spectrum were assignable to free amino acid. The signals 
of the aa ligands are broadened and seem to be formed by overlapping signals in most 
cases. This indicates that different isomers of [Ga(asp)(his)] or maybe even overall 
different complexes are present in solution. Nevertheless, the intensities of the signal sets 
reveal that equal amounts of the two amino acids are bound to gallium(III). This indicates 
that the complexes in solution are, most likely, heteroleptic [Ga(asp)(his)] complexes of 
some sort, since it seems unlikely that two homoleptic complexes with different charges 
and quite different ligands are by chance equally stable in solution. Regrettably, it was not 
possible to conclude if mono- or binuclear complexes are present in solution with the 
available data. 
An important aspect which can be derived from this spectrum is that over 80% of amino 
acids in solution are bound to gallium(III) at neutral pH levels. However, ligand exchange 
reactions are still present, most likely by the incorporation of hydroxido ligands.  
This example shows that with the information gathered about complexes with aa ligands 
in solution, it is possible to draw conclusions about the stability and formation of unknown 
gallium(III) complexes with aa ligands, at least to some extent, without the absolute 
necessity of molecular structures. Previous investigations of aminecarboxylatogallium(III) 
complexes with 13C{1H} and 1H NMR spectroscopy shown in this work provide useful 
pointers for the investigation of other gallium(III) complexes with aa ligands. For example, 
the signal of the atom C2 of proteinogenic amino acids was—with only very few 
exceptions—shifted to high field when coordinated to a gallium(III) centre. In addition, the 
signals of the carboxylate functions were almost always shifted to low field when 
coordinated to gallium(III). Furthermore, the sharpness of the signals in the spectra can 
be used to gather information as well. If broadening of the signals occurs at neutral pH 
levels, these signals should, most likely, be assigned to a ligand, while the opposite is true 
for the signals of uncoordinated AA. By combining this knowledge with 2D NMR 
experiments, solid information about the composition in solution can be gained.  
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2.5 Gallium(III) complexes with tetradentate amine ligands 
 
The successful synthesis of gallium(III) complexes with aminecarboxylato ligands led to 
the conclusion that a combination of amine ligands with carboxylate ligands might be a 
feasible way of synthesising further gallium(III) complexes. With tris(2-aminoethyl)amine 
(tren) and triethylenetetramine (trien), two structural analogues of nta and edda are 
available. According to the experiences with aminecarboxylato ligands, trien and tren 
should, in combination with bidentate dicarboxylic or hydroxycarboxylic acids, allow the 
synthesis of heteroleptic complexes at neutral pH levels. The choice of bidentate ligands 
was based on the following considerations: first, only the formation of five- and six-
membered chelate rings should lead to complex formation. Therefore, the complexing 
oxygen atoms must be three atoms apart at most. Furthermore, the ligands should be 
simple, nontoxic and not sterically demanding. Apart from oxalic and malonic acid a few 
hydroxycarboxylic acids like L-malic acid were considered uitable ligands. Since tren itself 
is a toxic substance—which contradicts the purpose of finding substances suitable for 
pharmacological applications—experiments with this ligand should be seen as a proof of 
concept. While trien is considered toxic through contact with skin but not when 
administered orally[50] it is already used in pharmacological applications[51,52]. Hence, trien 
might be an appropriate ligand for the intended purpose.  
 
Figure 2.53: Chemical equation for the synthesis of [Ga(malo)(tren)]Cl. 
 
A few experiments with tren and different bidentate ligands were done, but only one 
experiment generated crystals suitable for X-ray diffraction. The synthetic approach of 
[Ga(malo)(tren)]Cl was slightly different when compared to every other compound in this 
work, as the synthesis was done in ethanol instead of water. While water also worked as 
a solvent of the reaction, the product was obtained with higher purity when ethanol was 
used. Another difference compared to the usual reaction conditions was the huge excess 
of triethylamine used as base. Apart from that, the other starting materials were used in 
stoichiometric ratios (Figure 2.53). The product precipitated over the course of the reaction 
and was separated by filtration. 
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According to elemental analysis of the crude product (Table 2.24), [Ga(malo)(tren)]Cl was 
synthesised. Crystallisation experiments with this raw product in methanolic solution 
yielded crystals of this complex (Figure 2.54).  
 
Table 2.24: Interpretation of elemental analyses: tren and trien compounds. The maximum difference (max. 
diff.) is given between the found and calculated percentages of the listed compositions. 
compounds contamination max. diff. 
[Ga(malo)(tren)]Cl 1.10 H2O + 0.05 EtOH 0.16 
[Ga(mal)(trien)] 0.85 EtOH + 0.30 H2O + 0.20 Ga(OH)3 0.07 
[Ga(malo)(trien)]Cl 1.65 H2O + 0.05 Ga(OH)3  0.20 
[Ga(ox)(trien)]Cl 2.75 H2O 0.12 
 
 
 
Figure 2.54: Plot of [Ga(malo)(tren)]+ in crystals of 5aCl·MeOH. Space group: P21/c. CShMOC-6: 0.378. The 
thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.0925(12), Ga1–N2 2.0450(12), Ga1–N3 2.0728(13), Ga1–
N4 2.0708(13), Ga1–O1 1.9844(10), Ga1–O3 1.9268(10), N3–Ga1–N4 164.81(5), N1–Ga1–O3 175.63(5), 
N2–Ga1–O1 174.75(5), N1–Ga1–N4 82.94(5), N1–Ga1–O1 89.56(4), N3–Ga1–O1 88.27(5), N3–Ga1–O3 
100.75(5), N4–Ga1–O1 85.64(5), O1–Ga1–O3 92.60(4). 
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This is proof that complexes with the tetradentate ligand tren and a bidentate dianionic 
ligand can be formed. The octahedral GaN4O2 coordination of gallium(III) in this complex 
is slightly distorted and the Ga–N/O distances and angles are in the expected range. The 
complex is therefore comparable with similar complexes which feature aminecarboxylato 
ligands. Unfortunately, the solubility of the compound is very low both in methanol and 
water. Therefore, an NMR-spectroscopic examination of the complex in solution was not 
feasible.  
In contrast to tren, the synthesis and the procedure to obtain trien complexes were done 
the usual way. Water was used as solvent and triethylamine as base. The synthesis of 
[Ga(ox)(trien)]Cl was done with stoichiometric ratios of the starting materials (Figure 2.55). 
Water had to be removed after the reaction to allow for the separation of the byproduct 
and the target complex with organic solvents.  
 
 
Figure 2.55: Chemical equation for the synthesis of [Ga(ox)(trien)]Cl. 
 
According to the elemental analysis of the obtained product, [Ga(ox)(trien)]Cl was 
contaminated only with residual water and, therefore, obtained with high purity (Table 
2.24). Since the compound is hygroscopic, a contamination with water was almost 
impossible to avoid under the conditions of the synthesis. 
Crystals of [Ga(ox)(trien)]Cl·2H2O (Figure 2.56) were obtained from aqueous solution. The 
solubility of the compound was increased by addition of a very small amount of 
triethylamine. This raised the pH of the solution to 7.0, which was only slightly acidic due 
to the high concentration of the solution. In contrast to the other crystallisations in this 
section, the yield of crystals was quite high with a recovery rate of 37.8%.  
The interatomic distances and angles between gallium(III) and the nitrogen and oxygen 
atoms of this complex are in the expected ranges. Gallium(III) features the expected 
GaN4O2 environment and with a CShMOC-6 value of 1.111, the distortion of the octahedral 
coordination sphere is more significant than in most other complexes of this work.  
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Figure 2.56: Plot of [Ga(ox)(trien)]+ (5b) in crystals of 5b·5c·2Cl·4H2O. Space group: Pn. CShMOC-6: 1.111. 
The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard 
deviation of the last digit in parentheses: Ga1–N1 2.056(3), Ga1–N2 2.068(3), Ga1–N3 2.082(3), Ga1–N4 
2.048(3), Ga1–O1 1.992(3), Ga1–O3 1.979(2), N1–Ga1–N3 164.79(10), N2–Ga1–O3 171.52(10), N4–Ga1–
O1 168.08(11), N2–Ga1–N4 100.00(12), N1–Ga1–O1 92.05(11), N2–Ga1–O1 89.56(11), N3–Ga1–O1 
90.67(9), O1–Ga1–O3 82.01(11). 
 
 
Figure 2.57: The four possible constitutional isomers of [Ga(ox)(trien)]+. 
 
The isomers found in crystals of this compound (isomer III and IV) are two of four different 
potential isomers (Figure 2.57). When compared, the C2-symmetric complex isomers I and 
II should allow for a less strained arrangement of the trien ligand, which would, in turn, 
lead to lesser distortion of the octahedral coordination sphere. These isomers would also 
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be similar to the isomers that were found in every crystal of edda complexes. Yet, these 
isomers of [Ga(ox)(trien)]+ are not observed in the crystal structure, a difference which is 
surprising since trien and edda are very similar ligands.  
13C{1H} and 1H NMR spectra of a solution of [Ga(ox)(trien)]Cl + 2.75 H2O in D2O (pH 7.0) 
were examined. The 13C{1H} NMR spectrum of this compound (Figure 2.58a) features 
three signals of oxalic acid, either of the oxalato ligand or uncoordinated oxalate and about 
a dozen signals of trien. The many signals of trien indicate the existence of different 
complexes or complex isomers in solution. This was expected due to the experiences with 
[Ga(aa)(edda)] complexes. Unfortunately, despite the overall high quality of the spectrum 
and significantly fewer signals and lesser signal overlap when compared to spectra of 
[Ga(aa)(edda)] complexes, it was not possible to determine if free oxalic acid was present 
in solution with the information of only this spectrum. In addition, 2D NMR experiments 
were of no use due to the lack of C–H bonds in oxalic acid. Consequently, it was not even 
possible to figure out if the oxalato ligand in one [Ga(ox)(trien)]+ complex isomer showed 
two different signals in the spectrum. While this is unlikely, it is possible since the chemical 
environments of the carboxylato functions do not necessarily have to be exactly similar. 
 
 
Figure 2.58: [Ga(ox)(trien)]Cl + 2.75 H2O in aqueous solution (c = 0.25 mol L−1). a: 13C{1H} NMR spectrum of 
[Ga(ox)(trien)]Cl + 2.75 H2O in D2O*, b: 13C{1H} NMR spectrum of [Ga(ox)(trien)]Cl + 2.75 H2O with 0.25 equ. 
of oxalic acid in D2O*. Cyan: oxalato in [Ga(ox)(trien)]+, blue: trien in [Ga(ox)(trien)]+, red: oxalate, orange: 
MeOH. * One drop of MeOH was added for referencing. 
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To at least determine if free oxalic acid is present, 0.25 equivalents (5 mg) of oxalic acid 
were added to the solution of [Ga(ox)(trien)]Cl + 2.75 H2O in D2O and the NMR spectra 
were re-measured.  
The amount of oxalic acid had to be chosen carefully. It had to be as low as possible to 
not change the pH of the solution too drastically while still allowing for a discernible signal. 
With these measures taken, the pH of the solution still changed, but dropped only from 7.0 
to 6.0. The 13C{1H} NMR spectrum of this experiment is displayed in Figure 2.58b. Indeed, 
with the addition of free oxalic acid, a fourth signal in close proximity to the already present 
signals of the oxalato ligands occurs. It is thereby proven that a solution of [Ga(ox)(trien)]Cl 
in D2O does not contain free oxalic acid. Hence, the complex seems to be stable against 
hydrolysis at physiological pH levels.  
Still, it must be mentioned that the signals of trien are not only affected by the addition of 
oxalic acid, but even the emergence of new signals can be observed. It seems that the 
change of the solution’s pH only has a significant effect on the trien ligand. A probable 
explanation for this might be found in the pKa values of the ligands. The pKa of the 
carboxylic functions is much lower than the pKa of the amine groups. Therefore, it seems 
plausible that partial protonation of the amine functions of trien and, therefore, changes in 
gallium(III) bonding occur while the oxalato ligand is unaffected. 
In conclusion, it seems that this is the first complex synthesised in this work which is stable 
against hydrolysis in aqueous solution at neutral pH levels. In addition—or as a result—
the complex is easy to synthesise and crystallise.  
It is possible to investigate this issue further with a very similar complex. 
[Ga(malo)(trien)]Cl should show the same characteristics as [Ga(ox)(trien)]Cl since the 
only difference between the two complexes can be found in the formation of one six-
membered chelate ring instead of a five-membered one. The synthesis and procedure to 
obtain this complex was the same as for [Ga(ox)(trien)]Cl, with the exception that the basic 
compound was used in excess (Figure 2.59, pH 9.0) and the product was precipitated 
directly by addition of organic solvents.  
 
 
Figure 2.59: Chemical equation for the synthesis of [Ga(malo)(trien)]. 
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According to the elemental analysis of the crude product obtained, [Ga(malo)(trien)]Cl was 
successfully synthesised. Unfortunately, no crystals of this compound were yielded in 
crystallisation experiments. Therefore, further analytical data was obtained only by NMR 
spectroscopy. The aqueous solutions of [Ga(malo)(trien)]Cl + 1.65 H2O + 0.05 Ga(OH)3 
and [Ga(ox)(trien)]Cl + 2.75 H2O both have a pH of 7.0 which enabled the comparison of 
their spectra. It should be noted that a saturated solution of [Ga(malo)(trien)]Cl was used 
as an NMR sample because of the low solubility of this compound in water. The 
13C{1H} NMR spectrum of the aqueous solution of [Ga(malo)(trien)]Cl + 1.65 H2O + 0.05 
Ga(OH)3 is shown in Figure 2.60. Just as in the spectrum of [Ga(ox)(trien)]Cl + 2.75 H2O, 
about a dozen signals of trien are visible. Therefore, different complex isomers or 
complexes must be present. In contrast to the spectrum of [Ga(ox)(trien)]Cl + 2.75 H2O, 
the signals of the malonato ligand are broadened clusters. This indicates the existence of 
different complex isomers, but does not enable their identification. However, no signal of 
free malonate is visible, hence it seems that the complex is stable against hydrolysis in 
aqueous solution, just as the [Ga(ox)(trien)]+ complex. Since this characteristic was found 
for two similar complexes, the conclusion concerning their stability could be reached with 
more confidence. 
 
 
Figure 2.60: 13C{1H} NMR spectrum of [Ga(malo)(trien)]Cl + 1.65 H2O + 0.05 Ga(OH)3 in D2O*. Cyan: 
malonato in [Ga(malo)(trien)]+, blue: trien in [Ga(malo)(trien)]+, orange: MeOH. * One drop of MeOH was added 
for referencing. 
As stated earlier, some experiments with a combination of hydroxycarboxylic acids—for 
example L-malic acid—and trien were performed. The synthesis of [Ga(Hmal)(trien)]Cl was 
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done by reacting stoichiometric ratios of starting materials (Figure 2.61), while the amount 
of triethylamine proved to be excessive for the obtained product. According to elemental 
analysis, [Ga(Hmal)(trien)]Cl was contaminated with water, ethanol and gallium(III) 
hydroxide and therefore by no means pure. 
 
Figure 2.61: Chemical equation for the synthesis of [Ga(Hmal)(trien)]Cl. 
 
 
Figure 2.62: Plot of [Ga(mal)(trien)] in crystals of 5d·3H2O. Space group: P21. CShMOC-6: 0.870. The thermal 
ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with standard deviation 
of the last digit in parentheses: Ga1–N1 2.068(6), Ga1–N2 2.109(5), Ga1–N3 2.090(5), Ga1–N4 2.054(4), 
Ga1–O1 2.002(3), Ga1–O3 1.907(5), N1–Ga1–N3 162.3(2), N2–Ga1–O3 170.3(2), N4–Ga1–O1 172.8(2), 
N2–Ga1–N3 81.1(2), N1–Ga1–O3 99.9(2), N3–Ga1–O3 97.7(2), N4–Ga1–O3 93.5(2), O1–Ga1–O3 84.7(2). 
Crystallisation experiments with this raw product in a mixture of methanol and water 
yielded crystals, but those were comprised of [Ga(mal)(trien)]. The molecular structure of 
this complex is very similar to the structure of [Ga(ox)(trien)]+. It features an isomer similar 
to isomer III of the oxalato complex (Figure 2.57). Hence, trien is, once again, not 
coordinated in a C2-symmetric fashion. The distortion of the octahedral GaN4O2 
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coordination is slightly lower than in [Ga(ox)(trien)]+ and the interatomic distances and 
angles of [Ga(mal)(trien)] are in the expected range. 
The difference between the crystalline compound and the crude product concerning its 
composition caused problems when it came to the reliable synthesis of a specific 
compound and a potential NMR-spectroscopic analysis, since differing protonation states 
of a functional group can cause chaotic spectra. In combination with the fact that the 
malato ligand can bind to gallium(III) in two different ways—resulting in the potential 
formation of twelve different isomers of [Ga(mal)(trien)]—the interpretation of spectra is 
not a feasible task.  
However, the compound is soluble at neutral pH levels and malic acid is non-hazardous[53], 
wherefore it might still be applicable as a pharmaceutical. In general, it seems that 
experiments with further hydroxycarboxyliato ligands in combination with tetradentate 
amine ligands might be a promising endeavour. 
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2.6 HDIPEA[Ga(edda)(malo)] 
 
The successful use of aminecarboxylato, amine and dicarboxylato ligands to form 
gallium(III) complexes pointed to even more possible ligand combinations. For example, 
the combination of the tetradentate ligand edda with a dicarboxylato ligand has not been 
tried yet. This mix of ligands should lead to the formation of a monoanionic octahedral 
complex which is, therefore, comparable to the [Ga(aa)(nta)]− complexes. As described 
before, the replacement of nta with edda while still obtaining a monoanionic complex is 
advantageous as edda—in contrast to nta[45]—is not classified as potentially carcinogenic. 
To obtain HDIPEA[Ga(edda)(malo)], the ligands and GaCl3 were used in stoichiometric 
ratios and the basic compound was used in excess (Figure 2.63, pH 8.0). 
 
Figure 2.63: Chemical equation for the synthesis of HDIPEA[Ga(edda)(malo)]. 
 
The procedure was done in the already established manner and the elemental analysis 
indicated that the target compound was obtained. According to this analysis, the target 
complex was formed with a small amount of residual water still present in the product: 
HDIPEA[Ga(edda)(malo)] + 0.95 H2O. The maximum difference between the found and 
calculated percentages of this composition is 0.10.  
To crystallise HDIPEA[Ga(edda)(malo)], an aqueous solution of the raw product was 
stored over dimethyl sulfoxide for one month. As can be seen in the plot of the complex 
salt (Figure 2.64), the octahedral GaN2O4 coordination is slightly distorted. This is backed 
by the distances and angles between gallium(III) and the nitrogen and oxygen atoms of 
the ligands, which are in the expected range. The complex isomer in the crystal structure 
is one of four possible isomers. Also, the binding pattern of edda is C2-symmetric and, 
therefore, equivalent to those found in molecular structures of [Ga(aa)(edda)] complexes.  
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Figure 2.64: Plot of HDIPEA[Ga(edda)(malo)] in crystals of (HDIPEA)3k·H2O. Space group: P?̅?. CShMOC-6: 
0.233. The thermal ellipsoids are drawn at 50% probability. Interatomic distances (in Å) and angles (in °) with 
standard deviation of the last digit in parentheses: Ga1–N1 2.0764(9), Ga1–N2 2.0933(9), Ga1–O1 1.9635(8), 
Ga1–O3 1.9855(8), Ga1–O5 1.9377(8), Ga1–O7 1.9231(8), N1–Ga1–O5 174.56(4), N2–Ga1–O7 172.10(4), 
O1–Ga1–O3 171.33(3), N2–Ga1–O3 82.15(4), N2–Ga1–O5 91.78(3), O1–Ga1–O5 92.23(3), O3–Ga1–O5 
93.62(3), O5–Ga1–O7 93.95(3), N3–O2 2.7643(13). 
 
The result of this experiment confirms that further combinations of ligands which were 
already used in this work are feasible to obtain new gallium(III) complexes.  
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3 Discussion 
 
3.1 Applicability and validity of analytical methods 
 
Different analytical methods were tried in the course of this work and most of them were 
dismissed as not expedient. As described in subsection 2.2.6, techniques like UV-Vis and 
IR spectroscopy as well as potentiometric titration were ruled out as sensible methods for 
the examination of gallium(III) complexes in solution.  
UV-Vis and IR spectroscopy were also not applicable for the analysis of solid compounds 
since the problems encountered in solution and in the solid state are identical. In addition, 
mass spectrometry was unsuccessfully tried with different compounds. This led to the use 
of elemental analysis as a first method for characterising product compositions, despite its 
obvious shortcomings. With the help of the online-program JASPER, even contaminated 
products—which was the usual case—were analysable. However, the interpretation of 
those product compositions would have remained dubious without X-ray diffraction 
experiments with single crystals.  
X-ray diffraction experiments were, to a large extent, only used to prove the existence of 
the respective compound as this was one of the main goals of this work. Since solution 
studies showed the presence of equilibria between different compounds in aqueous 
solution, the crystallisation of a specific compound is largely dependent on its solubility 
and not necessarily on its superior stability when compared to other compounds in 
solution. Hence, molecular structures of complexes are used only to discuss preferences 
in the formation of certain complex isomers if those are striking.  
The combination of these two analytical methods already led to quite accurate impressions 
about the composition of aqueous solutions of gallium(III) compounds. With the use of 
NMR spectroscopy, these assumptions were consolidated and enhanced. In general, most 
compounds were very soluble in water, a very positive aspect which allowed for a 
combination of elemental analysis, X-ray diffraction experiments and NMR spectroscopy. 
This was a reasonable mix of methods to obtain comprehensive information about most 
compounds. That being said, a more in-depth look into the NMR-spectroscopic analyses 
is appropriate due to some challenges that are faced when gallium(III) complexes are 
examined with this method. 
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3.2 Aqueous solutions of gallium(III) complexes: NMR studies  
 
NMR-spectroscopic analyses of gallium(III) complexes are challenging in general. One 
reason is found in the overall small CIS gallium(III) causes in the ligands. For that reason 
it is not easy to determine if a ligand is bound to gallium(III) or not and NMR spectra of 
gallium(III) complexes quickly become inconclusive without the possibility of exact 
referencing. If signals of free and bound ligand exist simultaneously, their signals are found 
in close proximity which impedes the interpretation of 2D NMR spectra to some extent. 
Still, the existence of both bound and free ligand is not only a disadvantage as described 
later on. 
Measuring different NMR-active nuclei was tried as an option to circumvent the problems 
caused by the low CIS. However, 14N NMR spectra proved to be inconclusive due to broad 
indistinguishable signals in the spectra. Without using 15N labelled ligands, nitrogen based 
NMR spectroscopy is not possible with these compounds. A further potential approach 
was to use 71Ga and 69Ga NMR spectroscopy. Unfortunately, these spectra proved to be 
inapplicable to characterise or even distinguish different octahedral complexes in solution. 
The signals in these spectra are broadened to such an extent that they are no longer 
visible. This problem was encountered with gallium(III) complexes before.[54]  
In this work, NMR-spectroscopic examinations were, therefore, done by measuring 13C{1H} 
and 1H NMR spectra in combination with DEPT135, 1H-1H-COSY, 1H-13C-HMQC and 1H-
13C-HMBC. The spectra of compounds in D2O were always referenced against methanol 
to provide precise absolute values of chemical shifts and enable their assignment.  
These efforts allowed a reasonable interpretation of most spectra. When it came to the 
analysis of their NMR spectra, one major advantage of most complexes in this work was 
their limited stability in aqueous solution. This seems counterintuitive at first, but it does 
eliminate the problems caused by the small CIS of gallium(III) to some extent. Due to the 
fact that ligands are present both in their free form and bound in a gallium(III) complex, 
discernible signals of both are visible in the spectra. Therefore, even tiny coordination-
induced shifts are identifiable and the formation of the complexes can be confirmed more 
easily. This would have not been possible by just comparing spectra of the complexes with 
those of free ligands, as in many cases the error would have been bigger than the CIS. To 
get the same effect in solutions of stable complexes, excess ligand would have to be 
added. 
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Different examples in this work have shown that the pH level of the solution has a 
significant effect on the signals and the chemical shifts in NMR spectra. The signal shifts 
are dependent on the pH level in solution, as is the position of the equilibrium. Therefore, 
spectra of different compounds are comparable only if the pH levels are approximately 
equal.  
The solvent in use also proved to have a major effect on the NMR spectra. A solution of 
[Ga(ala)(nta)]− in MeOD shows no equilibrium (Subsection 2.2.6). This is due to the 
absence of water/D2O which would act as both solvent and reactant in the equilibrium 
reaction. However, the position of the equilibrium is affected even by the small amounts of 
methanol which are added to aqueous solutions to allow for proper referencing. It seems 
that the change of the solutions’ polarity already has a significant effect on the equilibria. 
This has to be kept in mind when ratios of compounds in equilibria are discussed. Without 
the addition of methanol the equilibria are slightly shifted to the side of the hydroxido-
bridged complexes. It would have been possible to separate the sample and the reference 
by the use of methanol-filled capillaries, however this would have led to lower resolutions 
of the spectra.  
If the addition of triethylamine is necessary to obtain analysable solutions, the spectra are 
drastically altered as well. Not only does triethylamine raise the pH of solution, it also 
changes its polarity, both affecting the shift of signals as well as the equilibria.  
In summary, the use of NMR spectroscopy to gain information about the gallium(III) 
complexes of this work is feasible. However, a high level of accuracy is needed to reach 
reliable conclusions. In addition, the solvent in use and the pH of the solutions have huge 
impacts on the position of the equilibria and the quality of the analyses. 
  
3.3 Aminecarboxylato complexes 
 
3.3.1 Gallium(III) complexes with aa ligands 
 
The synthesis and characterisation of complexes with aa ligands was a major focus of this 
work. As mentioned in section 1.4, only two crystal structures with aa ligands coordinated 
to gallium(III) were available before.[36,37] Since those complexes were obtained under inert 
conditions and feature a tetrahedral coordination sphere, they are not equivalent to 
gallium(III) complexes with aa ligands synthesised under non-inert or aqueous conditions. 
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The latest publication on the topic of gallium(III) complexes with bidentate aa ligands 
suggested that octahedral [Ga(aa)3] complexes are formed.[34] However, no molecular 
structures of such compounds have yet confirmed this hypothesis.  
In order to change this, the synthesis and crystallisation of [Ga(gly)3] from aqueous solution 
was tried. While crystals of [Ga(gly)3] (1b) were obtained by chance, the direct synthesis 
of this complex by using stoichiometric amounts of starting material was not possible 
(Section 2.1) and, instead, resulted in the formation of [{Ga(gly)2(µ-OH)}2]—contaminated 
with unreacted glycine—which was subsequently crystallised (1a). Hence, the first 
molecular structures of octahedral complexes with Ga(aa)2+ fragments were obtained, but 
the synthesis of [Ga(aa)3] compounds proved to be not as straightforward as expected. 
This led to the utilisation of co-ligands in combination with aa ligands in order to generate 
more information about the chemistry of gallium(III) in combination with aa ligands.  
Complexes with a combination of bidentate aa ligands and tetradentate ligands—nta and 
edda—were synthesised, characterised and, in some cases, crystallised. Thereby, 
molecular structures of nine different [Ga(aa)(nta)]− and eight different [Ga(aa)(edda)] 
complexes and complex isomers were obtained by re-crystallising raw products of the 
respective complexes from aqueous or methanolic solutions or mixtures of methanol and 
water under non-inert conditions. However, not only the target complexes were obtained. 
Frequently only crystalline AA or hydroxido-bridged di- and hexanuclear complexes 
[{Ga(nta)(µ-OH)}2] and [{Ga(edda)(µ-OH)}n] were crystallised. In addition, the yields of 
target complexes by crystallisation were low in most cases. NMR-spectroscopic analyses 
of aqueous solutions of those compounds showed that equilibrium reactions between the 
target complexes, free AA and the hydroxido-bridged complexes exist. The equilibrium 
reaction explains the different compounds obtained in crystallisation experiments.  
In the equilibria, water is not only the solvent, but also a reactant. Hence, the concentration 
of [Ga(aa)(nta)]− and [Ga(aa)(edda)] solutions has a significant effect on the composition 
of such solutions. In hindsight, this explains why precipitating the target complexes by 
addition of organic solvents is, in most cases, an effective procedure only if done slowly. 
The addition of the solvent leads to a shift of the equilibrium to the side of the target 
complexes and, with rising concentration, to the precipitation of these compounds. The 
equilibrium reaction is also influenced by the pH of the solutions. A slight excess of basic 
compounds leads to higher yields since it results in a higher ratio of the target complex in 
solution.  
This might also explain why the complex formation with L-tyrosine as a ligand was not 
successful with the otherwise effective procedure. The solubility of this specific AA is very 
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low, even in water.[41] Presumably, the addition of organic solvent leads to precipitation of 
L-tyrosine and not the target complex, which, in turn, affects the equilibrium and results in 
the formation of more L-tyrosine. Eventually, no target complex is left in solution, and the 
precipitate contains mostly L-tyrosine. 
Since aqueous solutions of gallium(III) complexes with aa ligands were found to feature 
free AA and bound aa ligand, it is reasonable to assume that this happens in solutions with 
gallium(III) complexes which feature only aa ligands as well. Therefore, the attempt to 
synthesise [Ga(aa)3] from aqueous solution might result in the formation of product 
mixtures. In particular, the formation of a hydroxido-bridged dinuclear complex while free 
aa ligand remains might even be favoured. This was encountered when glycine was used. 
Hence, it seems reasonable to assume that homoleptic [Ga(aa)3] complexes are not stable 
against hydrolysis in aqueous solutions, which might cause the problems in the synthesis 
of well-defined products and with the crystallisation of target complexes.  
If the solubilities of starting materials allow for it, the synthesis of [Ga(aa)3] complexes as 
well as other complexes featuring aa ligands should be favoured in non-aqueous media 
like methanol or ethanol. This was discarded as a viable option at the beginning of this 
work, since first tests showed that the use of water as a solvent was more promising and 
practicable.  
All the data suggests that the formation of polynuclear species with hydroxido bridges 
between gallium(III) centres is a significant competing reaction in aqueous solutions at 
neutral pH levels when aa ligands are involved. If water is present, especially in excess, 
the chelating effect of bidentate and tridentate aa ligands cannot prevent the formation of 
such species. This phenomenon was not described before, and renders the applicability 
of such compounds as pharmaceuticals questionable. A more detailed discussion of this 
issue and a comparison with other ligands is found in section 3.6. 
Finally, it should be mentioned that the NMR-spectroscopic studies of gallium(III) 
complexes with aa ligands in aqueous solutions did show characteristics which are 
potentially useful for future investigations of such complexes. As discussed in subsection 
2.4.2, the signal of the C2 atom of an aa ligand in the 13C{1H} NMR spectrum is almost 
always shifted to high field when coordinated to gallium(III), while the signal of the 
carboxylato function is shifted to low field. In combination with the fact that the signals of 
bound aa ligands are less sharp than those of free aa ligand in most cases, even mixtures 
of different aa ligands in combination with gallium(III) might be interpretable by NMR 
spectroscopy. If this analytical approach is chosen, the purity of the tested samples is key 
and compositions need to be determined, for example, by using elemental analysis as a 
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second analytical method. 
 
3.3.2 Stability of aminecarboxylato complexes 
 
With the issues of bidentate aa ligands established, a closer look at the other 
aminecarboxylato ligands and their characteristics is necessary.  
The two tetradentate ligands nta and edda were, without exception, bound to gallium(III) 
(Sections 2.2 and 2.3). This stable bonding to gallium(III) can be explained by the chelating 
effect, but might also be due to the fact that it is not necessary to separate these ligands 
from the gallium(III) centre in order to form hydroxido-bridged gallium(III) complexes. Since 
the hydroxido ligands in such complexes are bound cis to each other, even if no 
tetradentate ligands are present (Section 2.1), four binding sites seem to be unaffected in 
general. Therefore, the only potential competing reactions with the binding of the utilised 
tetradentate ligands is the formation of gallium(III) hydroxide or the formation of complexes 
with the bidentate ligands instead, which is highly unlikely and indeed not observed. A 
further property which might factor into the bonding stability of the tetradentate ligands is 
the location of the amine function in the ligand. If the carboxylate functions are bound to 
the positively charged gallium(III) centre, the amine functions are forced to bind to 
gallium(III) as well due to their resulting close proximity to gallium(III). Simultaneously, the 
binding of another ligand in the specific position is prevented through steric hindrance.  
This might explain the issues encountered when the tridentate aa ligands asp and his are 
used in combination (Section 2.4). In case of the histidinato ligand, the amine functions 
are not necessarily forced to bind when the carboxylate function is bound to the gallium(III) 
centre. Also, the formation of dinuclear complexes with bridging asp ligands was observed 
when D-his and asp were used in combination. Therefore, the formation of dinuclear 
complexes is possible even without hydroxido-bridges. The bridging behaviour of the asp 
ligand may be favoured since only one instead of two six-membered chelate rings has to 
be formed this way.  
However, hydroxido-bridged complexes were also formed with this ligand combination 
since free aa ligands are present in aqueous solution according to NMR spectroscopy. As 
stated before, only four binding sites were shown to be unaffected when hydroxido ligands 
are bound to gallium(III). The chelating effect of tridentate ligands seems to not be strong 
enough to overcome the tendency of forming hydroxido-bridged complexes. At first, 
combinations of tridentate aminecarboxylato ligands were thought to be more stable than 
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combinations of tetra- and bidentate ligands. However, this is, at least, not the case when 
only tridentate aa ligands are used. In basic solutions of [Ga(his)(ida)], a comparable 
complex, no free ligand seems to be present. Unfortunately, it was not possible to obtain 
conclusive NMR-spectroscopic data of this complex, hence the bonding of the more 
symmetric tridentate ligand ida to gallium(III) cannot be further analysed. Subsequently, 
the assertion that the use of ida instead of asp is beneficial for complex formation cannot 
be made, especially since an examination at neutral pH levels was not possible. 
In conclusion, hydroxido-bridged gallium(III) complexes seem to form in aqueous solutions 
whenever bi-, tri- or tetradentate aminecarboxylato ligands are used. Ligand combinations, 
which are not solely comprised of aminecarboxylates, might not show this behaviour. The 
synthesis and crystallisation of HDIPEA[Ga(edda)(malo)] (Section 2.6) proved that such 
complexes are feasible. This issue was not further examined in this work, but might be an 
interesting topic for future investigations. 
 
3.3.3 Crystallisation of complexes: the influence of the counter-ion 
 
A peculiar characteristic of [Ga(aa)(nta)]− complexes was encountered when trying to 
replace the tertiary ammonium ions with alkali cations to potentially reduce disorder in 
crystal structures (Subsection 2.2.5). The elemental analyses showed that the target 
complexes were, indeed, formed after a simple cation exchange reaction with CsOH, 
however most of the products did also contain the dinuclear complex Cs2[{Ga(nta)(µ-
OH)}2], sometimes even as the main component. Re-crystallisation of such products did 
not yield Cs[Ga(aa)(nta)] compounds. Instead, only crystals of free aa ligands or 
Cs2[{Ga(nta)(µ-OH)}2] were obtained. Since tests with further alkali cations did not indicate 
a different outcome, the substitution of the tertiary ammonium ions was not pursued. 
However, these results were a main reason for in-depth solution studies by NMR 
spectroscopy of [Ga(aa)(nta)]− complexes. With the data gathered the appearance of 
[{Ga(nta)(µ-OH)}2]2− in experiments with caesium cations can be explained.  
An equilibrium between the targeted [Ga(aa)(nta)]− complexes and the dinuclear complex 
as well as free aa ligand is present in the reaction mixture. The target compounds as well 
as the dinuclear complex salt Cs2[{Ga(nta)(µ-OH)}2] are almost insoluble in organic 
solvents. Therefore, even slow addition of ethanol to such reaction mixtures leads to 
precipitation of both the target complexes and the dinuclear complex. If tertiary ammonium 
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cations are present instead of the alkali cations, the addition of organic solvent leads to a 
shift of the equilibrium to the target complex first, followed by the precipitation of these.  
Throughout this work, [{Ga(nta)(µ-OH)}2]2− compounds with tertiary ammonium cations 
were not crystallised. In contrast, Cs2[{Ga(nta)(µ-OH)}2] crystallised readily and apparently 
better than any Cs[Ga(aa)(nta)] compound. This may be due to the ionic bond network in 
crystals of Cs2[{Ga(nta)(µ-OH)}2] which cannot be formed with tertiary ammonium cations. 
Therefore, crystallisation experiments with the product mixtures yielded only crystals of 
the dinuclear complex while no target complexes were crystallised.  
 
3.4 Amine complexes 
 
As complex formation with aminecarboxylato ligands was possible, combinations of amine 
and carboxylato ligands were also examined. While experiments with tren as a ligand were 
done only as a proof of concept due to its toxicity, the ligand trien was seen as a viable 
option to meet every requirement set as a goal in this work. It is considered non-toxic when 
applied orally[50] and is already used as a chelating agent for copper(II) to treat Wilson’s 
disease[51,52]. In addition, it has been shown that trien can be used in the treatment of 
cancer[52].  
As shown in section 2.5, the synthesis and crystallisation of compounds like 
[Ga(malo)(tren)]Cl, [Ga(ox)(trien)]Cl and [Ga(mal)(trien)] is possible. Furthermore, 
according to NMR-spectroscopic studies, the complexes [Ga(ox)(trien)]Cl and 
[Ga(malo)(trien)]Cl were stable against hydrolysis at neutral pH levels, which is a decisive 
difference when compared to the aminecarboxylato complexes examined in this work. 
While only a few experiments with such ligand combinations were done, the results are 
intriguing and further investigation of such compounds seem promising, for example with 
combinations of amine and hydroxycarboxylato ligands. However, one shortcoming of trien 
as a ligand is the range of different complex isomers it can form. This limits the significance 
of NMR spectroscopy, and may cause problems concerning the formation of distinct 
complexes. If pharmacological applications of complexes are targeted, the toxicity of many 
amines does limit the variety of potential ligands. Hence, further experiments with trien 
may be advised despite potential analytical problems with this ligand. 
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3.5 Stability and binding patterns: GaNxOy 
 
The molecular structures of complexes presented feature different gallium(III) 
surroundings: GaNO5, GaN2O4, GaN3O3 and even GaN4O2. It would be advantageous for 
the future design of gallium(III) complexes if the stability of complexes were directly 
dependent on the respective gallium(III) environment.  
The quantity of each different gallium(III) surrounding in this work is not meaningful, as the 
complexes were obtained via the use of specific ligand combinations and, thereby, their 
formation was to some extent forced. However, the fact that different gallium(III) 
surroundings are possible already indicates that these may not influence the stability of 
complexes to such an extent that they are the only important factor. Direct evidence of this 
can be found in the equilibria in aqueous solutions: equilibria between [Ga(aa)(nta)]− 
complexes and [{Ga(nta)(µ-OH)}2] feature GaN2O4 and GaNO5 binding patterns. The ratio 
of these complexes in solution is influenced by different effects, for example the 
concentration or the pH level (Section 3.3). Due to the different influences, it is not possible 
to determine if the binding patterns have any impact in these cases. At least, no strong 
preference for one of the gallium(III) surroundings could be observed. The same reasoning 
can be applied to the equilibria between [Ga(aa)(edda)] and [{Ga(edda)(µ-OH)}n] 
complexes which feature GaN3O3 and GaN2O4 environments. If anything, the 
[Ga(aa)(edda)] complexes with GaN3O3 binding patterns seem to be less favoured in the 
equilibria. This might be due to the steric requirements of edda in addition to the 
aforementioned influences. The difference in ratios is also not prominent enough to allow 
for even a tentative hypothesis in this regard.  
In addition, NMR-spectroscopic analyses of the complexes [Ga(ox)(trien)]Cl and 
[Ga(malo)(trien)]Cl with GaN4O2 surroundings indicate that those are stable in aqueous 
solutions at neutral pH levels (Section 2.5) which would imply that more nitrogen in the 
vicinity of gallium(III) is beneficial for the stability of such complexes. This also matches a 
statement of Petrosyants[38] who mentions that gallium(III) has a tendency to form 
complexes with a GaN4O2 environment. However, it is not possible to say whether this 
statement is true under every circumstance. For example, the NMR spectra of 
[Ga(Hmal)(trien)]Cl (Section 2.5), a further complex featuring a GaN4O2 binding pattern, 
show the existence of so many different species that no sensible assignment of signals is 
possible. This is caused by the tridentate malic acid bound as a bidentate ligand. Hence, 
the potential formation of different complexes and many different complex isomers leads 
to insignificant data and prevents the determination whether a specific binding pattern is 
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preferred. The current state of research does not allow a definite hypothesis, but it may be 
possible that the double negative charge of the bidentate ligands ox, malo and mal in 
combination with a tetradentate neutral ligand is advantageous for the stability of these 
complexes.  
It should be mentioned that further experiments with different ligand combinations from 
those shown were done. In some of these attempts of synthesis—with procedures similar 
to those in this work—the target complexes would have carried a double negative charge. 
As those attempts were not successful and resulted in non-interpretable results, they are 
not displayed. A similar issue was encountered with acidic aa ligands in section 2.2. It 
seems that the resulting charge of the complex is an important factor when it comes to the 
formation of gallium(III) compounds, especially when the synthesis is done in aqueous 
media at close to neutral pH levels. Whenever possible, a charge higher than minus one 
seems to have been omitted by formation of different compounds. This is easy to achieve 
in aqueous solution, as hydroxido-bridging is possible. Also, the formation of five-
coordinated gallium(III) complexes is an option.  
While the results of this work are by no means extensive enough to allow for definite 
assertions, some tentative advice concerning the successful syntheses of gallium(III) 
complexes in aqueous solutions can be given. In approximately neutral solutions, charges 
of the target complexes should be neutral or +/− 1. Also, GaN4O2 binding patterns seem 
to be advantageous for the stability of the complexes in general. If amine functions are 
present, those should be part of the ligand with higher denticity to ensure that the bond 
formation is complete, as bidentate aminecarboxylato ligands are prone to ligand 
exchange reactions with hydroxido ligands. To ensure that a bidentate ligand is bound, 
two anionic functions seem to be beneficial. However, this is not always necessary. 
Literature about, for example, tris(maltolato)gallium(III) and tris(8-hydroxychinolinato)-
gallium(III) shows that these are, most likely, entirely stable in aqueous solution at neutral 
pH levels.[55] Finally, it seems that the formation of more than one six-membered chelate 
ring is avoided if possible. This should be kept in mind, especially when the reaction 
mixtures allow for various ligand combinations. 
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3.6 Applicability of synthesised compounds as pharmaceuticals 
 
Currently it is possible only to evaluate which compounds might feature the necessary 
characteristics to be applicable as therapeutic agents, since, so far, no pharmaceutical 
tests of the synthesised compounds have been carried out.  
The stability of compounds in aqueous solutions is important for therapeutic applicability. 
As already outlined in the introduction, complexes should be stable enough to keep 
gallium(III) in solution, hence the formation of gallium(III) hydroxide must be prevented. 
This can be phrased in another way: If gallium(III) hydroxide is formed instead of the target 
complex or as a sizeable concurring product, the combination of ligands in use is not 
suitable for the intended purpose. The persistent presence of solid during the synthesis 
was therefore avoided if possible to rule out the formation of gallium(III) hydroxide. 
However, sometimes gallium(III) hydroxide was found as a contaminant in raw products. 
This indicated that the reaction conditions for the synthesis of the target complexes were 
not optimised. If aqueous solutions of raw products did not show the formation of 
precipitate after the removal of gallium(III) hydroxide, the compounds are nevertheless 
stable enough to not degrade to gallium(III) hydroxide. In general, if aqueous solutions of 
gallium(III) compounds did not show the formation of precipitate over time at neutral pH 
levels, a first stability requirement was met. 
Most gallium(III) complexes shown in this work fulfil this demand. However, certain 
exceptions have to be mentioned. The solubility of some complexes at neutral pH levels 
was too low for a proper NMR-spectroscopic analysis. Thus, no assertions concerning 
their stability at neutral pH levels are possible. While the very low solubility of some 
complexes hinders meaningful solution studies, it is not necessarily a criterion which, in 
itself, renders such compounds inapplicable as pharmaceuticals. Tris(maltolato)-
gallium(III) and tris(8-hydroxyquinolinato)gallium(III) exhibit very low solubility in aqueous 
solutions, yet those are the gallium(III) complexes which are described as most promising 
in clinical trials.[24,55]  
Only one successfully synthesised complex shown in this work definitely does not fulfil the 
minimal stability criterion. As mentioned (Subsection 2.2.7), [Ga(cys)(nta)]− is not stable in 
aqueous solution due to the degradation of L-cysteine.  
Hence, with the exception of this compound, every other compound examined might be 
applicable as a therapeutic agent. However, there are further requirements which should 
be fulfilled. For example, to allow for oral application, it seems that the compounds should 
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be stable in aqueous solution. The biodistribution of tris(maltolato)gallium(III) and tris(8-
hydroxyquinolinato)gallium(III) is speculated to be rooted in their stability.[55] Whenever aa 
ligands are involved in complex formation (Section 3.3) the resulting complexes are not 
stable against hydrolysis. Only [Ga(ox)(trien)]Cl, [Ga(malo)(trien)]Cl and possibly the 
hydroxido-bridged species [{Ga(nta)(µ-OH)}2]2− and [{Ga(edda)(µ-OH)}n] might fulfil this 
requirement. The latter are, however, multinuclear species, a characteristic not shared 
with tris(maltolato)gallium(III) and tris(8-hydroxyquinolinato)gallium(III). Hence, out of all 
compounds examined, [Ga(ox)(trien)]Cl and [Ga(malo)(trien)]Cl might be the most 
promising options for pharmacological applications. 
In addition to oral administration, some tests regarding the antimicrobial use of gallium(III) 
compounds were done by releasing gallium(III) locally[56] or intravenously[25]. In both cases, 
the use of gallium(III) nitrate in such experiments has been reported. Since gallium(III) 
nitrate forms gallium(III) hydroxide in aqueous solutions[8,21], gallium(III) complexes which 
fulfil the minimal stability requirements might still be applicable and would keep gallium(III) 
in solution more efficiently when compared to those compounds. Hence, most complexes 
shown in this work might raise the bioavailability of gallium(III) when compared to more 
simple gallium(III) salts, presumably just not via oral administration.  
There are, of course, further characteristics of gallium(III) compounds which have an 
impact on their applicability as pharmaceuticals. Throughout chapter 2, the search for non-
hazardous compounds was outlined and described as an important matter. One of the 
main reasons to examine proteinogenic amino acids as ligands in detail is that they are 
endogenous. Hence, they are non-hazardous ligands, which would be a favourable 
characteristic for gallium(III) complexes used as pharmaceuticals. As described in section 
1.3, the therapeutic effect of gallium(III) compounds is based entirely on the reactions of 
gallium(III). The ligands are released in the process, therefore toxic or carcinogenic ligands 
are disadvantageous. This is also true for counter ions, if present. As mentioned before, 
nta is potentially carcinogenic and tren as well as the cations HNEt3+ and HDIPEA+ are 
hazardous.[43-45] The tetradentate ligands edda, which is not yet classified, and trien, which 
is considered non-toxic when applied orally and not classified as carcinogenic[50], might be 
applicable. Also, the bidentate ligands ox[57], malo[58] and mal[53] as well as all aa ligands 
are non-toxic and not carcinogenic. In the case of the tridentate ligand ida[59], just as with 
edda, no data to classify its toxicity is available. As mentioned, trien is already used 
pharmacologically as a chelating agent, therefore complexes containing this ligand might 
be the most promising option of the compounds examined.  
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3.7 Complex isomers 
 
In section 2.2, the two complex isomers I and II (Figure 2.6) were shown to exist and 
discussed to some extent. In isomer I, the nitrogen atom of the aa ligand and the nitrogen 
atom of nta are coordinated trans to each other, while the oxygen atom of the aa ligand is 
coordinated trans to the nitrogen atom of nta in isomer II. Only one crystal structure of 
[Ga(aa)(nta)]− complexes contained isomer II, while isomer I was found in 13 different 
crystal structures. Since only one molecular structure of isomer II is available, the 
informative value which can be obtained by comparison with isomer I is limited.  
 
As shown extensively in section 2.2, an equilibrium with free AA and [{Ga(nta)(µ-OH]}2]2− 
on one side and the target complexes on the other is present in aqueous solutions of the 
nitrilotriacetatogallium(III) complexes. Those solutions usually display only one signal set 
of the aa ligand. Though, in very few cases (Subsections 2.2.6 and 2.2.8), a second signal 
set of an aa ligand is visible. The intensity of this signals set is low, and it can be identified 
with certainty only in two NMR spectra of aqueous solutions (Figure 2.28 and Figure 2.29). 
Due to its rare occurrence—and the lack of a sensible different option—this signal set was 
assigned to isomer II, since this is the isomer which is the most uncommon in crystal 
structures. While this assumption seems reasonable, it is unfortunately not possible to 
prove its validity. However, this hypothesis would explain the low abundancy of isomer II 
in crystal structures, as it is already practically non-existent in solution.  
 
Regardless of signal assignment, one of the two isomers is formed in vastly superior 
amounts in every case. The investigations of solutions and crystalline compounds indicate 
that one isomer is formed to only very small, most of the time even undetectable, amounts. 
To reach such a high disparity, a substantial difference between the two isomers is 
expected. However, according to the characteristics of the crystal structures, the preferred 
occurrence of isomer I seems to not be rooted in the properties of the crystalline 
compounds. The molecular structures do not show significant steric hindrance in one of 
the two potential isomers. When comparing isomer I and II found in molecular structures 
of [Ga(met)(nta)]−, isomer II actually features a higher distortion of the octahedral 
coordination sphere of gallium(III), however the difference seems to be too small to have 
such a significant impact (Subsection 2.2.4). Subsequently, a calculation with ORCA* 
based on the molecular structure of [Ga(gly)(nta)]− was carried out to get information about 
the stability of both isomers. However, the difference between the isomers I and II was 
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found to be only 3 kJ/mol with isomer I being slightly more stable. This is not enough 
disparity to explain such a significant difference in complex formation.  
It seems that a mechanistic cause is the most reasonable explanation for the preferred 
formation of one isomer. However, no intermediates of the reaction were identifiable, 
neither by NMR spectroscopy nor by X-ray diffraction experiments, therefore it is 
impossible to propose a proper reaction mechanism. Since this issue is not important for 
the scope of this work, no further efforts were made to find an explanation. 
It should be noted that the occurrence of different isomers was not only a concern with nta 
but with edda and trien as well. As the latter two ligands enable the formation of many 
different isomers, no assignment of signals in NMR spectra to specific isomers was 
possible. In crystal structures, two different binding patterns of both ligands were found. 
While molecular structures of edda complexes featured only the C2-symmetric binding 
pattern (Section 2.3), trien was found only in the non-C2-symmetric binding pattern 
(Section 2.5). This is curious, since both ligands can potentially bind in the C2-symmetric 
pattern. However, this should just be noted, since trying to find an explanation for this issue 
is futile with the scarce information at hand. 
 
 
 
 
 
 
 
 
* The quantum-chemical calculations were done by Prof. Dr. Peter Klüfers with ORCA4 
(version 4.1.0) at DFT level. Initial geometries were taken from molecular structures 
obtained by X-ray diffraction experiments. Wave functions were calculated at the RI-DFT 
level using the functional BP86 and def2-TZVP basis set. Dispersion correction was 
applied by using Grimme’s D3-correction with Becke-Johnson-damping as implemented 
in ORCA4.[60]  
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4 Summary 
 
Past investigations have shown that both gallium(III) nitrate and gallium(III) citrate display 
antimicrobial activity[20,21], while gallium(III) compounds like tris(maltolato)gallium(III) and 
tris(8-hydroxy-quinolinato)gallium(III) were studied in clinical trials for their antineoplastic 
activity[24]. In another publication[34] on the subject of potential gallium(III)-based 
pharmaceuticals, [Ga(aa)3] complexes with bidentate proteinogenic aminecarboxylato (aa) 
ligands were described. Since no structural information on gallium(III) complexes with aa 
ligands at non-inert conditions has been available yet, a major goal of this work was the 
synthesis, crystallisation and characterisation of such complexes.  
The molecular structures of [{Ga(gly)2(µ-OH)}2] (1a) and [Ga(gly)3] (1b) are first examples 
of gallium(III) complexes with aa ligands which were obtained from aqueous solutions. 
However, the synthesis of such complexes was not as straightforward as anticipated, even 
though the formation of octahedral [Ga(aa)3] complexes with bidentate aa ligands has 
been described in the latest publication on this topic[34]. Acquiring further information on 
the formation of gallium(III) complexes with aa ligands was therefore advised. By utilising 
the two tetradentate ligands nta and edda as co-ligands in combination with aa ligands, 
nine [Ga(aa)(nta)]− (2a–2i) and eight [Ga(aa)(edda)] (3a–3h) complexes and complex 
isomers with bidentate aa ligands were crystallised and characterised by X-ray diffraction. 
According to elemental analyses, complexes of these kinds were obtained with each polar 
or nonpolar aa ligand except L-tyrosinate. The combination of acidic as well as basic aa 
ligands with nta or edda led to the formation of slightly different complexes. While 
octahedral complexes were synthesised, elemental analysis of the isolated products 
revealed that the basic and acid functions of the aa ligands’ side chains are protonated 
and adducts with the respective tertiary amine used as a basic compound were formed. 
This led to ill-defined products with the exception of [Ga(Harg)(edda)]Cl, 
[Ga(edda)(Hhis)]Cl and [Ga(edda)(Hlys)]Cl.  
NMR-spectroscopic analyses of the Ga(aa)-bearing compounds at neutral pH levels 
revealed an equilibrium between the target complex, free AA and hydroxido-bridged 
complexes—[{Ga(nta)(µ-OH)}2] and [{Ga(edda)(µ-OH)}n] (n = 2 or 6, 3i, 3j)—in aqueous 
solution. Hence, while the synthesis of gallium(III) complexes with aa ligands was feasible 
and the simultaneous existence of free AA and bound aa ligands simplified the assignment 
of signals in NMR spectra, those compounds are prone to ligand exchange reactions in 
aqueous solution. 
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The equilibria are influenced by the characteristics of the solvent in use, the pH value and 
the concentration of the solution as well as the respective aa ligand of the complexes. 
While a shift of the equilibrium position towards the target complexes was noticeable when 
L-threoninato and L-cysteinato were compared to other aa ligands, the pH of the solution 
has a much higher influence. For example, in acidic solutions the ratio of target complexes 
was significantly reduced. In case of [Ga(aa)(edda)] complexes, the influence of basic pH 
values was demonstrated: the ratio of the target complexes peaked at neutral and slightly 
basic pH levels. At higher pH levels (around 9.5 and above), no [Ga(aa)(edda)] complex 
was left. Since water is a reactant in the equilibrium reactions, the concentration of the 
aqueous solutions had a further major influence on the position of the equilibria. 
Furthermore, even the addition of small amounts of methanol to aqueous solutions led to 
a shift of the equilibrium positions, while the formation of hydroxido-bridged complexes 
and therefore an equilibrium reaction is not possible in dry organic solvents.  
The results of the NMR-spectroscopic studies can be used for the characterisation of 
further gallium(III) complexes with aa ligands in future experiments. For example, the 
signal of the C2 atom was, with only very few exceptions, shifted to high field when the aa 
ligand is bound to gallium(III). The opposite is true for the C1 atom in most cases. These 
characteristics, along with other features like the broadening of signals enhanced the 
assignability of signals in spectra.  
In addition to the use of bi- and tetradentate aminecarboxylato ligands, gallium(III) 
complexes with combinations of tridentate aminecarboxylato ligands were examined. 
[Ga(his)(ida)] (4a) was synthesised and crystallised, and the synthesis of [Ga(asp)(his)] 
was achieved according to elemental analysis and NMR spectroscopy. To get structural 
information on the latter complex, a combination of asp and D-his ligands was used. This 
resulted in the synthesis and crystallisation of [{Ga(µ-asp)(D-his)}2] (4b), a dinuclear 
complex. [Ga(asp)(his)] showed different characteristics than 4b, hence it is considered to 
be mononuclear. 
As the syntheses and characterisation of gallium(III) complexes with bi-, tri- and 
tetradentate aminecarboxylato ligands were successful—despite the reactivity of these 
complexes with water—complexes with combinations of amine and carboxylato ligands 
were synthesised. In this process, [Ga(malo)(tren)]Cl (5aCl), [Ga(ox)(trien)]Cl (5b·5c·2Cl) 
and [Ga(mal)(trien)] (5d) were crystallised and [Ga(malo)(trien)]Cl was characterised. 
NMR-spectroscopic analyses of [Ga(ox)(trien)]+ and [Ga(malo)(trien)]+ indicated that these 
two complexes are stable against hydrolysis at physiological pH levels, while the spectra 
of [Ga(mal)(trien)] remained inconclusive.  
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During the course of this work, reaction conditions and choice of basic compounds proved 
to be essential. Tertiary amines were used, since the separation of the respective 
hydrochlorides from the target complexes after the reaction proved to be efficient. While 
this in itself is a very convenient and important characteristic, it turned out that 
[Ga(aa)(nta)]− complexes were only crystallisable with triethylammonium and N,N-
diisopropylethylammonium ions. The presence of alkali cations M resulted in the 
crystallisation of the respective M2[{Ga(nta)(µ-OH)}2] instead. Consequently, without the 
use of the tertiary amines, a main source of information about the characteristics of aa 
ligands in gallium(III) complexes would not have been available. 
Due to the lack of tests regarding the applicability of the synthesised gallium(III) 
compounds as antimicrobial or antineoplastic agents, only the observed characteristics of 
the compounds can be used to consider their potential as such. Most compounds are 
stable enough to not precipitate gallium(III) hydroxide in aqueous solutions. This fulfils a 
first stability requirement in order to raise bioavailability, if administered locally or 
parenterally. Therefore, most compounds might be applicable as therapeutic agents. 
However, only two complexes—[Ga(ox)(trien)]+ and [Ga(malo)(trien)]+—seem to be stable 
against hydrolysis in aqueous solution at neutral pH levels. Since both share this 
characteristic with tris(maltolato)gallium(III) and tris(8-hydroxyquinolinato)gallium(III), 
those may be considered to be the most promising compounds when it comes to potential 
pharmaceutical use. In addition, none of the components of these compounds are 
considered hazardous, which is a further positive characteristic. Some of the examined 
gallium(III) compounds contain toxic or potentially carcinogenic ligands or cations. 
Consequently, those compounds might not be applicable as pharmaceuticals. In this work, 
only complexes which feature combinations of trien, edda, ida, ox, malo, mal or aa ligands 
could be considered as non-hazardous. 
If gallium(III) complexes should be synthesised at neutral pH levels in aqueous solution, a 
few tentative advices to raise their stability based on the experiences in this work can be 
given. The charge of the target complex should not exceed +/− 1. In addition, an octahedral 
GaN4O2 environment seems to be beneficial, as stated before[38]. Also, the formation of 
six-membered chelate ring is not guaranteed, while five-membered chelate rings are 
formed readily. As shown, the stability of the complexes is largely based on the kind of 
ligand in use, too. If amine functions are present, those should be incorporated in the ligand 
with higher denticity, while the ligand with lower denticity should carry the higher negative 
charge. Different ligand combinations can potentially form in the reaction mixture if those 
requirements are not met, and the resulting compounds are likely to differ from 
SUMMARY 
 119  
expectation. One general concern is the formation of hydroxido-bridged complexes by 
ligand exchange reactions with ligands of low denticity. 
Bearing that in mind, further use of tetradentate amine ligands like trien in combination 
with divalent bidentate ligands seems to be a reasonable endeavour. Additionally, 
combining those divalent bidentate ligands with tetradentate aminecarboxylato ligands like 
edda to form gallium(III) complexes is feasible. This was demonstrated by the synthesis 
and characterisation of [Ga(edda)(malo)]− (3k). 
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5 Experimental Part 
 
5.1 Common working techniques 
 
All reactions were carried out under air at room temperature. Methanol, ethanol and ethyl 
acetate were purified by rotary evaporation before use. Gallium(III) chloride was only 
added from aqueous stock solutions prepared of anhydrous gallium(III) chloride and 
deionised water. The concentration of the solutions ranged between 504 g L−1 and 
506 g L−1. Due to the minimal differences in volume the following procedures do not 
contain the added volume of gallium(III) chloride solution but the mass and the amount of 
added gallium(III) chloride salt.  
All products were analysed by elemental analysis. Crystallisation was attained by vapour 
diffusion of less polar solvents into aqueous or methanolic solutions of the raw products 
or by slow evaporation of these solutions.  
 
5.2 Analytical methods 
 
5.2.1 Elemental analysis 
 
CHNS analyses were done with an Elementar vario EL and an Elementar vario micro tube. 
The interpretation of the elemental analyses was done with JASPER[61]. 
 
5.2.2 X-ray diffraction 
  
Crystals were selected with a Leica MZ6 polarisation microscope. Suitable crystals were 
measured on a Bruker D8 Venture or an Oxford XCalibur 3 diffractometer using Mo-Kα 
irradiation (λ = 0.71073 Å). The structure solutions were done by direct methods using 
SHELXT[62] and the structures were refined by full-matrix least-squares calculations on F2 
using SHELXL-2016[63] and ShelXle[64]. For visualisation the programmes POV-Ray[65] and 
Mercury[66] were used. Further details and packing diagrams of every crystal structure are 
listed in the appendix (Section 6.2 and 6.3). 
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5.2.3 NMR spectroscopy 
 
NMR spectra were recorded on Bruker 400 and Bruker 400 TR spectrometers. All 
13C NMR spectra were recorded broad band proton decoupled (13C{1H} NMR). The 
chemical shift δ is given in ppm and refers to the signal of non-deuterated methanol which 
was added to every solution in D2O as a reference. An exception for this is only found 
when deuterated methanol was used as solvent, in that case the shift refers to the signal 
of deuterated methanol. 1H-1H-COSY, 1H-13C-HMQC, 1H-13C-HMBC and DEPT135 
experiments were used for signal-assignment if possible. Interpretation of the spectra was 
done with the software MestReNova[67].  
The NMR-spectroscopic analyses were done with solutions of obtained raw products—
their compositions are specified with the empirical formulas—with a concentration of 
0.25 mol L−1 whenever comparability regarding the ratios of compounds in solution is 
targeted. If no concentrations are specified below illustrations of NMR spectra, the 
examined solutions were almost saturated. This was done to enhance the examination by 
2D NMR methods. 
 
5.3 Signal shifts of recurring compounds in NMR spectra 
 
Due to the nature of this work almost every solution which was examined by 1H NMR and 
13C{1H} NMR contained recurring compounds. The chemical shifts of these compounds 
remained roughly the same in every experiment. For convenience and to emphasise this 
fact those signals are summarised here and not cited separately in each of the 
experiments.  
 
The signals of the triethylammonium (HNEt3+) and N,N-diisopropylethylammonium 
(HDIPEA+) cations are listed hereafter. Only the signals in 1H NMR spectra of 
[Ga(nta)(trp)]− and [Ga(nta)(phe)]− salts differ slightly when compared to every other 
spectrum and are therefore displayed separately.  
 
 
HNEt3+ 
1H NMR (400 MHz, D2O): δ = 3.19 (q, 6H, H1, 3J1,2 = 7.3 Hz), 1.26 or 1.27 (t, 9H, 
H2, 3J1,2 = 7.3–7.4 Hz) ppm. 
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HNEt3[Ga(nta)(phe)] 
1H NMR (400 MHz, D2O): δ = 3.16 (q, 6H, H1, 3J1,2 = 7.3 Hz), 1.25 
(t, 9H, H2, 3J1,2 = 7.3 Hz) ppm. 
HNEt3[Ga(nta)(trp)] 
1H NMR (400 MHz, D2O): δ = 3.03 (q, 6H, H1, 3J1,2 = 7.3 Hz), 1.17 (t, 
9H, H2, 3J1,2 = 7.3 Hz) ppm. 
HNEt3+ 
13C{1H} NMR (101 MHz, D2O): δ = 47.2 or 47.3 (C1), 8.9 (C2) ppm. 
 HDIPEA+ 1H NMR (400 MHz, D2O): δ = 3.64–3.74 (sp, 2H, H1), 3.18 or 3.19 (q, 2H, H4, 
3J4,5 = 7.4 Hz), 1.28–1.37 (sp, 15H, H2/H3/H5) ppm. 
HDIPEA[Ga(nta)(phe)] 1H NMR (400 MHz, D2O): δ = 3.61–3.71 (sp, 2H, H1), 3.15 (q, 2H, 
H4, 3J4,5 = 7.4 Hz), 1.25–1.34 (sp, 15H, H2/H3/H5) ppm. 
HDIPEA[Ga(nta)(trp)] 1H NMR (400 MHz, D2O): δ = 3.52–3.60 (sp, 2H, H1), 3.05 (q, 2H, 
H4, 3J4,5 = 7.4 Hz), 1.23–1.38 (sp, 15H, H2/H3/H5) ppm. 
HDIPEA+ 13C{1H} NMR (101 MHz, D2O): δ = 54.9 or 55.0 (C1), 43.1 or 43.2 (C4), 18.3 or 
18.4 (C2), 16.8 or 16.9 (C3), 12.7 or 12.8 (C5) ppm. 
 
1H NMR and 13C{1H} NMR spectroscopy revealed equilibria between different complexes 
as well as free ligand in aqueous solutions. In case of [Ga(aa)(nta)]−- and [Ga(aa)(edda)]-
complexes only the respective aa ligand was observed in its free form and with the state 
of protonation appropriate for the pH value of the individual solution. The signals of the 
free and bound proteinogenic amino acids of the solutions are listed in the individual 
experimental descriptions of the respective complexes.  
 
The tetradentate ligands were not observed in their uncoordinated form. As the chemical 
shifts of nta in [Ga(aa)(nta)]− complexes remained roughly the same in every experiment 
the corresponding signals are summarised in Table 5.1–Table 5.4. This is also true for the 
signals of nta in the [{Ga(nta)(µ-OH)}2]2− complex which are found in those aqueous 
solutions, therefore those signals are also given in Table 5.1–Table 5.4.  
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Table 5.1: δ in ppm of nta in 1H NMR spectra (400 MHz, D2O): compounds containing triethylamine and 
triethylammonium ions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
complex H2  complex H2 
[Ga(ala)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(Harg)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(asn)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(Hasp)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.77 (s, 6H) 
[Ga(cys-κ2S,X)(nta)]− 3.73 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.73 (s, 6H) 
[Ga(cys-κO,N)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.73 (s, 6H) 
[Ga(gln)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(Hglu)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.78 (s, 6H) 
[Ga(gly)(nta)]− 3.83 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(Hhis)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.76 (s, 6H) 
[Ga(ile)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(leu)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.70 (s, 6H) 
[Ga(Hlys)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(met)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(phe)]− 3.78 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.67 (s, 6H) 
[Ga(nta)(pro)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(ser)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(thr)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(trp)]− 3.68 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.54 (s, 6H) 
[Ga(nta)(val)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
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Table 5.2: δ in ppm of nta in 13C{1H} NMR spectra (101 MHz, D2O): compounds containing triethylamine and 
triethylammonium ions. The descriptors A and B are used in visual representations of spectra throughout this 
work to clarify signal assignments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
complex C1 (A) C2 (B) complex C1 (A) C2 (B) 
[Ga(ala)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(Harg)(nta)] 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.7 63.3 
[Ga(asn)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(Hasp)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(cys-κ2S,X)(nta)]− 176.0 63.4 [{Ga(nta)(µ-OH)}2]2− 175.6 63.4 
[Ga(cys-κO,N)(nta)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.4 
[Ga(gln)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(Hglu)(nta)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.4 
[Ga(gly)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(Hhis)(nta)] 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.7 63.3 
[Ga(ile)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(leu)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(Hlys)(nta)] 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.7 63.2 
[Ga(met)(nta)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(nta)(phe)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(nta)(pro)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(nta)(ser)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(nta)(thr)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(nta)(trp)]− 175.0 63.1 [{Ga(nta)(µ-OH)}2]2− 175.5 63.2 
[Ga(nta)(val)]− 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
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Table 5.3: δ in ppm of nta in 1H NMR spectra (400 MHz, D2O): compounds containing N,N-
diisopropylethylamine and N,N-diisopropylethylammonium ions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
complex H2  complex H2 
[Ga(ala)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(Harg)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(asn)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.74 (s, 6H) 
[Ga(Hasp)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.77 (s, 6H) 
[Ga(cys-κ2S,X)(nta)]− 3.72 (sp, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(cys-κO,N)(nta)]− 3.82 (sp, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(gln)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(Hglu)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.78 (s, 6H) 
[Ga(gly)(nta)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(Hhis)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.76 (s, 6H) 
[Ga(ile)(nta)]− 3.80 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.70 (s, 6H) 
[Ga(leu)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.70 (s, 6H) 
[Ga(Hlys)(nta)] 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(met)(nta)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(phe)]− 3.77 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.67 (s, 6H) 
[Ga(nta)(pro)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.72 (s, 6H) 
[Ga(nta)(ser)]− 3.82 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.71 (s, 6H) 
[Ga(nta)(thr)]− 3.81 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.70 (s, 6H) 
[Ga(nta)(trp)]− 3.71 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.58 (s, 6H) 
[Ga(nta)(val)]− 3.80 (s, 6H) [{Ga(nta)(µ-OH)}2]2− 3.70 (s, 6H) 
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Table 5.4: δ in ppm of nta in 13C{1H} NMR spectra (101 MHz, D2O): compounds containing N,N-
diisopropylethylamine and N,N-diisopropylethylammonium ions. The descriptors A and B are used in visual 
representations of spectra instead of numbers throughout this work to clarify signal assignments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
complex C1 (A) C2 (B) complex C1 (A) C2 (B) 
[Ga(ala)(nta)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.4 63.3 
[Ga(Harg)(nta)] 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.2 
[Ga(asn)(nta)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(Hasp)(nta)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.4 63.3 
[Ga(cys-κ2S,X)(nta)]− 176.0 63.4 [{Ga(nta)(µ-OH)}2]2− 175.6 63.4 
[Ga(cys-κO,N)(nta)]− 175.1 63.3 [{Ga(nta)(µ-OH)}2]2− 175.6 63.4 
[Ga(gln)(nta)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(Hglu)(nta)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.4 
[Ga(gly)(nta)]− 174.9 63.2 [{Ga(nta)(µ-OH)}2]2− 175.3 63.2 
[Ga(Hhis)(nta)] 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.3 
[Ga(ile)(nta)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(leu)(nta)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(Hlys)(nta)] 175.2 63.2 [{Ga(nta)(µ-OH)}2]2− 175.6 63.2 
[Ga(met)(nta)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(nta)(phe)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(nta)(pro)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(nta)(ser)]− 175.0 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(nta)(thr)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
[Ga(nta)(trp)]− 175.0 63.1 [{Ga(nta)(µ-OH)}2]2− 175.5 63.2 
[Ga(nta)(val)]− 175.1 63.2 [{Ga(nta)(µ-OH)}2]2− 175.5 63.3 
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Since the signals of edda in [{Ga(edda)(µ-OH)}n) are not distinguishable from those of 
edda in [Ga(aa)(edda)] complexes and furthermore resemble large signal clusters in 
13C{1H} NMR as well as 1H NMR spectra the signals of edda are listed as ranges without 
further distinction in Table 5.5 and Table 5.6. Note that significant differences of signal 
shifts are only found when pH-differences of the measured solutions are sizeable.  
 
Table 5.5: δ in ppm of edda in 1H NMR spectra (400 MHz, D2O). * only the [{Ga(edda)(µ-OH)}n] complex is 
present in the spectrum, the [Ga(aa)(edda)] complex is only given to state the origin of the solution. 
 
 
  
complexes H2–H5  
[Ga(ala)(edda)], [{Ga(edda)(µ-OH)}n] 3.51–4.25 (sp), 2.38–3.38 (sp). 
[Ga(Harg)(edda)]+, [{Ga(edda)(µ-OH)}n] 3.51–4.27 (sp), 2.38–3.38 (sp). 
[Ga(asn)(edda)], [{Ga(edda)(µ-OH)}n] 3.47–4.24 (sp), 2.39–3.40 (sp). 
[Ga(Hasp)(edda)], [{Ga(edda)(µ-OH)}n] 3.72–4.04 (sp), 2.81–3.30 (sp). 
[Ga(cys)(edda)], [{Ga(edda)(µ-OH)}n] - 
[Ga(edda)(gln)], [{Ga(edda)(µ-OH)}n] 3.64–4.02 (sp), 2.62–3.40 (sp). 
[Ga(edda)(Hglu)], [{Ga(edda)(µ-OH)}n] 3.66–4.07 (sp), 2.79–3.38 (sp). 
[Ga(edda)(gly)], [{Ga(edda)(µ-OH)}n] 3.61–4.25 (sp), 2.39–3.38 (sp). 
[Ga(edda)(Hhis)]+, [{Ga(edda)(µ-OH)}n] 3.51–4.24 (sp), 2.40–3.40 (m). 
[Ga(edda)(ile)], [{Ga(edda)(µ-OH)}n] 3.43–4.18 (m), 2.38–3.38 (m). 
[Ga(edda)(leu)], [{Ga(edda)(µ-OH)}n] 3.51–4.25 (sp), 2.38–3.38 (sp). 
[Ga(edda)(Hlys)]+, [{Ga(edda)(µ-OH)}n] 3.51–4.25 (sp), 2.38–3.38 (sp). 
[Ga(edda)(met)], [{Ga(edda)(µ-OH)}n] 3.51–4.25 (sp), 2.40–3.40 (m). 
[Ga(edda)(phe)], [{Ga(edda)(µ-OH)}n]* 3.67–3.95 (m), 2.52–3.30 (sp). 
[Ga(edda)(pro)], [{Ga(edda)(µ-OH)}n] 3.51–4.26 (sp), 2.40–3.40 (m). 
[Ga(edda)(ser)], [{Ga(edda)(µ-OH)}n] 3.51–4.26 (sp), 2.40–3.40 (m). 
[Ga(edda)(thr)], [{Ga(edda)(µ-OH)}n] 3.51–4.26 (sp), 2.40–3.40 (m). 
[Ga(edda)(trp)], [{Ga(edda)(µ-OH)}n]* 3.63–3.94 (sp), 2.46–3.46 (sp). 
[Ga(edda)(val)], [{Ga(edda)(µ-OH)}n] 3.51–4.25 (sp), 2.40–3.40 (m). 
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Table 5.6: δ in ppm of edda in 13C{1H} NMR spectra (101 MHz, D2O). The descriptors A and B are used in 
visual representations of spectra instead of numbers throughout this work to clarify signal assignments. * only 
the [{Ga(edda)(µ-OH)}n] complex is present in the spectrum, the [Ga(aa)(edda)] complex is only given to state 
the origin of the solution. 
 
 
 
 
  
complexes C1, C6 (A, ms) C2–C5 (B, ms) 
[Ga(ala)(edda)], [{Ga(edda)(µ-OH)}n] 177.1–178.4 50.0–52.9, 44.2–47.3. 
[Ga(Harg)(edda)]+, [{Ga(edda)(µ-OH)}n] 177.0–178.4 49.6–52.9, 44.2–47.3. 
[Ga(asn)(edda)], [{Ga(edda)(µ-OH)}n] 177.1–178.4 49.6–52.9, 44.2–47.3. 
[Ga(Hasp)(edda)], [{Ga(edda)(µ-OH)}n] - 50.8–51.4, 46.3. 
[Ga(cys)(edda)], [{Ga(edda)(µ-OH)}n] - - 
[Ga(edda)(gln)], [{Ga(edda)(µ-OH)}n] 177.0–179.0 50.8–51.9, 45.8–46.6. 
[Ga(edda)(Hglu)], [{Ga(edda)(µ-OH)}n] 177.1–178.0 50.9–51.4, 46.1–47.3. 
[Ga(edda)(gly)], [{Ga(edda)(µ-OH)}n] 177.1–178.4 46.9–52.9, 44.2–47.3. 
[Ga(edda)(Hhis)]+, [{Ga(edda)(µ-OH)}n] 177.0–178.5 50.0–52.9, 44.2–47.4. 
[Ga(edda)(ile)], [{Ga(edda)(µ-OH)}n] 177.0–178.5 50.0–52.9, 44.2–47.4. 
[Ga(edda)(leu)], [{Ga(edda)(µ-OH)}n] 177.0–178.4 50.1–52.9, 44.2–47.4. 
[Ga(edda)(Hlys)]+, [{Ga(edda)(µ-OH)}n] 177.0–178.5 50.1–52.9, 44.2–47.4. 
[Ga(edda)(met)], [{Ga(edda)(µ-OH)}n] 177.0–178.5 50.1–52.9, 44.2–47.4. 
[Ga(edda)(phe)], [{Ga(edda)(µ-OH)}n]* 178.1–179.0 51.2–52.3, 46.0–46.8. 
[Ga(edda)(pro)], [{Ga(edda)(µ-OH)}n] 176.9–178.4 50.0–52.9, 44.2–47.4. 
[Ga(edda)(ser)], [{Ga(edda)(µ-OH)}n] 176.9–178.4 50.0–52.9, 44.1–47.3. 
[Ga(edda)(thr)], [{Ga(edda)(µ-OH)}n] 177.1–178.4 50.0–52.9, 44.1–47.3. 
[Ga(edda)(trp)], [{Ga(edda)(µ-OH)}n]* 177.9–179.1 51.2–52.1, 45.9–46.8. 
[Ga(edda)(val)], [{Ga(edda)(µ-OH)}n] 177.1–178.4 49.7–52.9, 44.2–48.0. 
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5.4 Reagents and solvents 
 
  Name Purity [%] Distributor 
acetone 99.5 (technical grade) Bernd Kraft 
acetonitrile 99.99 VWR 
L-alanine 99 Acros Organics 
L-arginine ≥98 Sigma-Aldrich 
L-asparagine monohydrate 99 Acros Organics 
L-aspartic acid ≥98 Acros Organics 
caesium hydroxide monohydrate 99.95 Acros Organics 
choline hydroxide aqueous solution 48–50 TCI 
L-cysteine ≥99 Acros Organics 
deuterium oxide 99.9 Aldrich 
diethyl ether 99.7 (technical grade) Brenntag 
N,N-diisopropylethylamine 99 ABCR 
dimethyl sulfoxide 99.7 Acros Organics 
1,4-dioxane 99.9 (technical grade) Brenntag 
ethanol 99 (technical grade) BfB 
ethyl acetate 99.7 (technical grade) Staub 
ethylenediamine-N,N′-diacetic acid ≥98 TCI 
gallium(III) chloride 99.999 ABCR 
L-glutamic acid 99 Aldrich 
L-glutamine 98 Aldrich 
glycine 99 Acros Organics 
glycylglycylglycine 99 ABCR 
n-hexane 95 (technical grade) Grüssing 
D-histidine 99 Alfa Aesar 
L-histidine ≥99 Sigma-Aldrich 
iminodiacetic acid 98 Aldrich 
L-isoleucine 99 Acros Organics 
L-leucine ≥99.5 Fluka 
L-lysine hydrochloride ≥99 Acros Organics 
L-malic acid ≥99 Fluka 
malonic acid 99 Sigma-Aldrich 
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Name Purity [%] Distributor 
methanol 99.9 (technical grade) Staub 
methanol-d4 99.5 Eurisotop 
L-methionine ≥98 Sigma-Aldrich 
nitrilotriacetic acid ≥99 Fluka 
oxalic acid anhydrous ≥99 Fluka 
L-phenylalanine 98.5 Acros Organics 
L-proline 99 Acros Organics 
L-serine 99 Acros Organics 
L-threonine 98 Acros Organics 
toluene 99.5 (technical grade) Brenntag 
triethylamine 98 Acros Organics 
triethylenetetramine ≥97 Fluka 
tris(2-aminoethyl)amine ≥98 TCI 
L-tryptophan 99 Acros Organics 
L-tyrosine 99 Sigma-Aldrich 
L-valine ≥98 Aldrich 
water deionized house installation 
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5.5 Synthesis of gallium(III) complexes 
 
5.5.1 [{Ga(gly)2(µ-OH)}2] 
 
Starting material: Glycine, water, gallium(III) chloride, triethylamine, ethanol, diethyl 
ether, 1,4-dioxane. 
Procedure: 
Glycine (161 mg, 2.15 mmol) was dissolved in 1 mL of water. Gradual addition of 
gallium(III) chloride solution (126 mg, 0.71 mmol) and triethylamine (499 µL, 3.58 mmol) 
resulted in a colourless solution (pH 10.0). A colourless slurry was obtained after addition 
of ethanol (2 mL) and stirring at 0 °C for 30 min. The colourless amorphous solid was 
separated by filtration and washed with ethanol and diethyl ether. 
 Empirical formula:  C8H18Ga2N4O10 + 0.65 C2H5NO2 + 0.40 H2O + 0.10 C2H6O. 
 Yield:  189 mg (0.326 mmol, 91.1%). 
 Elemental analysis: 
 
 
Calcd. (%): C 21.52, H 4.31, N 12.28. 
Found (%): C 21.44, H 4.41, N 12.20. 
Calcd. C8H18Ga2N4O10 (%): C 20.46, H 3.86, N 11.93. 
 
Crystals of [{Ga(gly)2(µ-OH)}2] (1a) were obtained after six weeks by storing an aqueous 
solution (adjusted with triethylamine to pH 10.0) of the raw product over 1,4-dioxane. 
 Empirical formula:  C8H18Ga2N4O10, 469.70 g mol
−1. 
 Yield:  Few crystals. 
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5.5.2 [Ga(gly)3] 
 
Starting material: Gallium(III) chloride, glycylglycylglycine, glycine, choline hydroxide, 
water, ethanol. 
Procedure: Gallium(III) chloride solution (165 mg, 0.94 mmol) was added to a solution of 
glycylglycylglycine (178 mg, 0.94 mmol), glycine (71 mg, 0.94 mmol) and choline 
hydroxide (842 µL, 3.75 mmol, 50% solution in water) in water (1 mL). The yellow slurry 
(pH 9.0) was stirred for 16 h and after addition of ethanol (40 mL) the yellow solid was 
separated by filtration. Storing an aqueous solution of this product for one year while 
allowing for slow evaporation of the solvent yielded crystals of [Ga(gly)3]·H2O (1b·H2O). 
 Empirical formula:  C6H12GaN3O6·H2O, 291.92 g mol
−1. 
 Yield:  Few crystals. 
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5.5.3 HNEt3[Ga(ala)(nta)] 
 
Starting material: L-Alanine, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Alanine (89 mg, 1.0 mmol) was dissolved in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (10 mL). After filtration 
and washing with ethanol, ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C15H28GaN3O8 + 0.60 H2O. 
 Yield:  302 mg (0.658 mmol, 65.8%). 
 Elemental analysis: Calcd. (%): C 39.26, H 6.41, N 9.16. 
Found (%): C 39.35, H 6.50, N 9.16. 
Calcd. C15H28GaN3O8 (%): C 40.20, H 6.30, N 9.38. 
 
[Ga(ala)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.75–3.82 (sp, 1H, H2), 1.51 (d, 3H, H3, 3J2,3 = 7.3 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 180.0 (C1), 50.3 (C2), 18.0 (C3) ppm. 
L-Alanine: 
1H NMR (400 MHz, D2O): δ = 3.75–3.82 (sp, 1H, H2), 1.46 (d, 3H, H3, 3J2,3 = 7.3 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.3 (C1), 51.1 (C2), 16.8 (C3) ppm. 
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5.5.4 [Ga(Harg)(nta)]·0.10NEt3 
 
Starting material: L-Arginine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, diethyl ether. 
Procedure: L-Arginine (174 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.5) which was stirred for 16 h. The raw product was precipitated by addition of ethanol 
(30 mL). After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C12H20GaN5O8·0.10C6H15N + 1.55 H2O + 0.10 C2H6O.  
 Yield:  362 mg (0.763 mmol, 76.3%). 
 Elemental analysis: Calcd. (%): C 32.39, H 5.35, N 15.05. 
Found (%): C 32.41, H 5.42, N 15.02. 
Calcd. C12H20GaN5O8 (%): C 33.36, H 4.67, N 16.21. 
[Ga(Harg-κO,N)(nta)] (isomer I): 
1H NMR (400 MHz, D2O): δ = 3.74–3.80 (sp, 1H, H2), 3.21–3.26 (sp, 2H, H5), 1.97–2.11 
(m, 1H, H3), 1.78–1.87 (sp, 1H, H3), 1.69–1.86 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.6 (C1), 157.4 (C6), 54.1 (C2), 41.2 (C5), 29.3 (C3), 
25.3 (C4) ppm. 
[Ga(Harg-κO,N)(nta)] (isomer II):  
1H NMR (400 MHz, D2O): δ = - 
13C{1H} NMR (101 MHz, D2O): δ = 179.7 (C1), 53.6 (C2), 41.2 (C5), 29.7 (C3), 25.5 (C4) 
ppm. 
L-Arginine: 
1H NMR (400 MHz, D2O): δ = 3.74–3.80 (sp, 1H, H2), 3.21–3.26 (sp, 2H, H5), 1.83–1.94 
(sp, 2H, H3), 1.59–1.72 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.9 (C1), 157.4 (C6), 54.9 (C2), 41.1 (C5), 28.2 (C3), 
24.5 (C4) ppm.  
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5.5.5 HNEt3[Ga(asn)(nta)] 
 
Starting material: L-Asparagine monohydrate, water, gallium(III) chloride, nitrilotriacetic 
acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Asparagine monohydrate (150 mg, 1.00 mmol) was suspended in 1.0 mL of 
water. Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic 
acid (191 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (5 mL) and ethyl acetate (10 mL). 
The colourless solid was separated by filtration and suspended in ethanol (5 mL) and ethyl 
acetate (10 mL) again. After filtration and washing with ethyl acetate and diethyl ether the 
obtained colourless amorphous solid was first dried at 80 °C for 10 min and then under 
fine vacuum for 4 h.  
 Empirical formula:  C16H29GaN4O9 + 0.20 Ga(OH)3 + 0.15 C4H8O2. 
 Yield:  302 mg (0.576 mmol, 57.6%). 
 Elemental analysis: Calcd. (%): C 37.58, H 5.85, N 10.69. 
Found (%): C 37.70, H 5.96, N 10.56. 
Calcd. C16H29GaN4O9 (%): C 39.13, H 5.95, N 11.41. 
[Ga(asn)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97 (t, 1H, H2, 3J2,3 = 5.5 Hz), 2.95–2.97 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.6 (C1), 175.3 (C4), 51.4 (C2), 36.2 (C3) ppm. 
L-Asparagine: 
1H NMR (400 MHz, D2O): δ = 4.00–4.03 (m, 1H, H2), 2.82–2.96 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.9 (C4), 173.7 (C1), 51.8 (C2), 35.0 (C3) ppm. 
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5.5.6 HNEt3[Ga(Hasp)(nta)]·0.30NEt3 
 
Starting material: L-Aspartic acid, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, acetone, diethyl ether. 
Procedure: L-Aspartic acid (133 mg, 1.00 mmol) was suspended in 1.5 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and triethylamine (767 µL, 5.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (30 mL), ethyl acetate (250 mL) and acetone (100 mL). After filtration and 
washing with acetone and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C16H28GaN3O10·0.30C6H15N + 1.40 H2O. 
 Yield:  273 mg (0.498 mmol, 49.8%). 
 Elemental analysis: Calcd. (%): C 39.03, H 6.50, N 8.44. 
Found (%): C 39.04, H 6.72, N 8.43. 
Calcd. C16H28GaN3O10 (%): C 39.05, H 5.74, N 8.54. 
[Ga(Hasp)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.90–3.93 (m, 1H, H2), 2.79–2.93 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.9 (C1), 176.7 (C4), 51.8 (C2), 37.5 (C3) ppm. 
L-Aspartic acid: 
1H NMR (400 MHz, D2O): δ = 3.96–4.02 (m, 1H, H2), 2.79–2.93 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.7 (C1), 173.9 (C4), 52.1 (C2), 36.7 (C3) ppm. 
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5.5.7 HNEt3[Ga(cys)(nta)]  
 
Starting material: L-Cysteine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, acetone, diethyl ether. 
Procedure: L-Cysteine (121 mg, 1.00 mmol) was dissolved in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless slurry (pH 8.0) 
which was stirred for 16 h. The solvent was removed by rotary evaporation and the residue 
was suspended in ethanol (5 mL) and ethyl acetate (15 mL). After filtration and washing 
with acetone and diethyl ether the obtained colourless amorphous solid was first dried at 
80 °C for 10 min and then under fine vacuum for 5 h. 
 Empirical formula:  C15H28GaN3O8S + 1.25 H2O + 0.10 C3H7NO2S. 
 Yield:  264 mg (0.513 mmol, 51.3%). 
 Elemental analysis: Calcd. (%): C 35.70, H 6.11, N 8.43, S 6.85. 
Found (%): C 35.65, H 6.06, N 8.42, S 6.81. 
Calcd. C15H28GaN3O8S (%): C 37.52, H 5.88, N 8.75, S 6.68. 
 [Ga(cys-κ2S,X)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.5 (C1), 56.1 (C2), 24.6 (C3) ppm. 
[Ga(cys-κO,N)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 57.8 (C2) ppm. 
L-Cysteine: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.9 (C1), 56.4 (C2), 25.3 (C3) ppm. 
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5.5.8 HNEt3[Ga(gln)(nta)]  
 
Starting material: L-Glutamine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Glutamine (146 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.5) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL). After filtration and washing with ethanol, 
ethyl acetate and diethyl ether the obtained colourless amorphous solid was first dried at 
80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C17H31GaN4O9 + 0.75 H2O. 
 Yield:  405 mg (0.781 mmol, 78.1%). 
 Elemental analysis: Calcd. (%): C 39.37, H 6.32, N 10.80. 
Found (%): C 39.46, H 6.25, N 10.72. 
Calcd. C17H31GaN4O9 (%): C 40.42, H 6.19, N 11.09. 
[Ga(gln)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.71–3.82 (sp, 1H, H2), 2.48–2.52 (m, 2H, H4), 2.25–2.34 
(m, 1H, H3), 2.04–2.12 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.4 (C5), 178.1 (C1), 54.0 (C2), 32.1 (C4), 28.0 (C3) 
ppm. 
L-Glutamine: 
1H NMR (400 MHz, D2O): δ = 3.71–3.82 (sp, 1H, H2), 2.41–2.46 (m, 2H, H4), 2.08–2.15 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.1 (C5), 174.5 (C1), 54.7 (C2), 31.4 (C4), 26.8 (C3) 
ppm. 
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5.5.9 HNEt3[Ga(Hglu)(nta)]·0.10NEt3 
 
Starting material: L-Glutamic acid, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, acetone, diethyl ether. 
Procedure: L-Glutamic acid (147 mg, 1.00 mmol) was suspended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and triethylamine (767 µL, 5.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (20 mL), ethyl acetate (130 mL) and acetone (50 mL). After filtration and 
washing with acetone and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C17H30GaN3O10·0.10C6H15N + 0.55 H2O. 
 Yield:  352 mg (0.669 mmol, 66.9%). 
 Elemental analysis: Calcd. (%): C 40.17, H 6.25, N 8.25. 
Found (%): C 40.22, H 6.25, N 8.21. 
Calcd. C17H30GaN3O10 (%): C 40.34, H 5.97, N 8.30. 
[Ga(Hglu)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.57 (sp, 2H, H4), 1.98–2.18 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 54.1 (C2), 32.4 (C4), 28.1 (C3) ppm. 
L-Glutamic acid: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.57 (sp, 2H, H4), 1.98–2.18 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.5 (C5), 174.5 (C1), 54.7 (C2), 32.4 (C4), 26.9 (C3) 
ppm. 
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5.5.10 HNEt3[Ga(gly)(nta)] 
 
Starting material: Glycine, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, diethyl ether, acetone. 
Procedure: Glycine (75 mg, 1.0 mmol) was dissolved in 1 mL of water. Gradual addition 
of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition of 
ethanol. After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C14H26GaN3O8 + 0.20 H2O. 
 Yield:  353 mg (0.806 mmol, 80.6%). 
 Elemental analysis: Calcd. (%): C 38.42, H 6.08, N 9.60. 
Found (%): C 38.46, H 6.11, N 9.52. 
Calcd. C14H26GaN3O8 (%): C 38.74, H 6.04, N 9.68. 
[Ga(gly)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.55 (sp, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.1 (C1), 42.1 (C2) ppm. 
Glycine: 
1H NMR (400 MHz, D2O): δ = 3.55 (sp, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.9 (C1), 42.0 (C2) ppm. 
Crystals of HNEt3[Ga(gly)(nta)] ((HNEt3)2c) were obtained after two weeks by storing an 
aqueous solution (pH 6.5) of the raw product over acetone.    
 Empirical formula:  C14H26GaN3O8, 434.10 g mol
−1. 
 Yield:  263 mg (0.606 mmol, 60.6%). 
 Elemental analysis: Calcd. (%): C 38.74, H 6.04, N 9.68. 
Found (%): C 38.58, H 5.95, N 9.61. 
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5.5.11 [Ga(Hhis)(nta)]·0.30NEt3 
 
Starting material: L-Histidine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Histidine (155 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition of ethanol 
(55 mL) and ethyl acetate (20 mL). After filtration and washing with ethanol and diethyl 
ether the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then 
under fine vacuum for 3 h.  
 Empirical formula:  C12H15GaN4O8·0.30C6H15N + 1.60 H2O. 
 Yield:  243 mg (0.515 mmol, 51.5%). 
 Elemental analysis: Calcd. (%): C 35.10, H 4.85, N 12.76. 
Found (%): C 34.99, H 4.95, N 12.81. 
Calcd. C12H15GaN4O8 (%): C 34.90, H 3.66, N 13.57. 
[Ga(Hhis)(nta)]: 
1H NMR (400 MHz, D2O): δ = 8.34–8.44 (sp, 1H, H6), 7.15–7.31 (sp, 1H, H5), 4.01–4.07 
(sp, 1H, H2), 3.24–3.47 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.9 (C1), 133.2 (C6), 129.0 (C4), 116.5 (C5), 53.7 
(C2), 26.9 (C3) ppm. 
L-Histidine: 
1H NMR (400 MHz, D2O): δ = 8.34–8.44 (sp, 1H, H6), 7.15–7.31 (sp, 1H, H5), 4.01–4.07 
(sp, 1H, H2), 3.24–3.47 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.5 (C1), 136.2 (C6), 129.0 (C4), 118.2 (C5), 54.5 
(C2), 27.7 (C3) ppm. 
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5.5.12 HNEt3[Ga(ile)(nta)] 
 
Starting material: L-Isoleucine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Isoleucine (131 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (10 mL). After filtration 
and washing with ethanol, ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then on under fine vacuum for 3 h.  
 Empirical formula:  C18H34GaN3O8, 490.21 g mol−1. 
 Yield:  329 mg (0.671 mmol, 67.1%). 
 Elemental analysis: Calcd. (%): C 44.10, H 6.99, N 8.57. 
Found (%): C 44.06, H 6.92, N 8.53. 
[Ga(ile)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.66–3.68 (sp, 1H, H2), 2.17–2.26 (m, H1, H3), 1.25–1.33 
(sp, 2H, H4), 1.06 (d, 3H, H6, 3J3,6 = 7.0 Hz), 0.88–0.94 (sp, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.7 (C1), 59.5 (C2), 37.2 (C3), 24.1 (C4), 16.3 (C6), 
12.0 (C5) ppm. 
L-Isoleucine: 
1H NMR (400 MHz, D2O): δ = 3.66–3.68 (sp, 1H, H2), 1.92–2.01 (m, H1, H3), 1.41–1.51 
(m, 1H, H4), 1.19–1.26 (sp, 1H, H4), 0.99 (d, 3H, H6, 3J3,6 = 7.0 Hz), 0.88–0.94 (sp, 3H, 
H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.6 (C1), 60.1 (C2), 36.5 (C3), 25.1 (C4), 15.3 (C6), 
11.7 (C5) ppm. 
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5.5.13 HNEt3[Ga(leu)(nta)] 
 
Starting material: L-Leucine, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Leucine (131 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless slurry (pH 8.0) 
which was stirred for 16 h. The solvent was removed by rotary evaporation and the residue 
was dissolved in ethanol (5 mL). Colourless solid was precipitated by addition of ethyl 
acetate (20 mL) and separated by filtration. Afterwards, the solid was suspended in 
ethanol (5 mL) and ethyl acetate (10 mL) again. After filtration and washing with ethyl 
acetate and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C 
for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C18H34GaN3O8 + 0.05 Ga(OH)3. 
 Yield:  158 mg (0.318 mmol, 31.8%). 
 Elemental analysis: Calcd. (%): C 43.57, H 6.94, N 8.47. 
Found (%): C 43.54, H 6.80, N 8.37. 
Calcd. C18H34GaN3O8 (%): C 44.10, H 6.99, N 8.57. 
[Ga(leu)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.67–3.74 (sp, 1H, H2), 1.72–1.81 (sp, 2H, H3), 1.64-1.81 
(sp, 1H, H4), 0.93–0.97 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.7 (C1), 52.9 (C2), 41.4 (C3), 25.1 (C4), 23.1 (C5), 
20.7 (C6) ppm. 
L-Leucine: 
1H NMR (400 MHz, D2O): δ = 3.67–3.74 (sp, 1H, H2), 1.64–1.81 (sp, 1H, H4), 1.64–1.73 
(sp, 2H, H3), 0.93–0.97 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.0 (C1), 54.0 (C2), 40.4 (C3), 24.8 (C4), 22.7 (C5), 
21.6 (C6) ppm. 
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5.5.14 [Ga(Hlys)(nta)]·0.10NEt3 
 
Starting material: L-Lysine hydrochloride, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, diethyl ether. 
Procedure: L-Lysine hydrochloride (183 mg, 1.00 mmol) was dissolved in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and triethylamine (767 µL, 5.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (40 mL). After filtration and washing with ethanol and diethyl ether the obtained 
colourless amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum 
for 3 h.  
 Empirical formula:  C12H20GaN3O8·0.10C6H15N + 2.15 H2O. 
 Yield:  356 mg (0.786 mmol, 78.6%). 
 Elemental analysis: Calcd. (%): C 33.42, H 5.74, N 9.59. 
Found (%): C 33.62, H 5.79, N 9.78. 
Calcd. C12H20GaN3O8 (%): C 42.79, H 6.98, N 11.09. 
[Ga(Hlys-κO,N)(nta)] (isomer I): 
1H NMR (400 MHz, D2O): δ = 3.70–3.79 (sp, 1H, H2), 2.98–3.07 (sp, 2H, H6), 1.97–2.09 
(m, 2H, H3), 1.66–1.76 (sp, 2H, H5), 1.47–1.60 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.9 (C1), 54.2 (C2), 39.7 (C6), 31.6 (C3), 26.9 (C5), 
22.8 (C4) ppm. 
[Ga(Hlys-κO,N)(nta)] (isomer II): 
1H NMR (400 MHz, D2O): δ = - 
13C{1H} NMR (101 MHz, D2O): δ = 180.0 (C1), 53.7 (C2), 22.9 (C4) ppm. 
L-Lysine: 
1H NMR (400 MHz, D2O): δ = 3.70–3.79 (sp, 1H, H2), 2.98–3.07 (sp, 2H, H6), 1.80–1.93 
(m, 2H, H3), 1.66–1.76 (sp, 2H, H5), 1.37–1.54 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.1 (C1), 55.1 (C2), 39.7 (C6), 30.5 (C3), 27.0 (C5), 
22.0 (C4) ppm.  
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5.5.15 HNEt3[Ga(met)(nta)] 
 
Starting material: L-Methionine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether, acetone. 
Procedure: L-Methionine (149 mg, 1.00 mmol) was suspended in 3 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (40 mL). After filtration 
and washing with ethyl acetate and diethyl ether the obtained colourless amorphous solid 
was first dried at 80 °C for 10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C17H32GaN3O8S + 0.70 H2O. 
 Yield:  407 mg (0.781 mmol, 78.1%). 
 Elemental analysis: Calcd. (%): C 39.20, H 6.46, N 8.07, S 6.16. 
Found (%): C 39.13, H 6.33, N 8.02, S 6.20. 
Calcd. C17H32GaN3O8S (%): C 40.18, H 6.35, N 8.27, S 6.31. 
[Ga(met)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.84–3.89 (sp, 1H, H2), 2.66–2.78 (m, 2H, H4), 2.26–2.36 
(m, 1H, H3), 2.13 (s, 3H, H5), 2.02–2.11 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.5 (C1), 53.5 (C2), 31.2 (C3), 30.3 (C4), 14.6 (C5) 
ppm. 
L-Methionine: 
1H NMR (400 MHz, D2O): δ = 3.84–3.89 (sp, 1H, H2), 2.62 (t, 2H, H4, 3J3,4 = 7.6 Hz), 2.08–
2.23 (sp, 2H, H3), 2.11 (s, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.7 (C1), 54.5 (C2), 30.3 (C3), 29.4 (C4), 14.5 (C5) 
ppm. 
Crystals of HNEt3[Ga(met)(nta)] ((HNEt3)2f) were obtained after two weeks by an aqueous 
solution (pH 7.0) of the raw product over acetone.    
 Empirical formula:  C17H32GaN3O8S, 508.24 g mol
−1. 
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 Yield:  Few crystals. 
 
5.5.16 HNEt3[Ga(nta)(phe)] 
 
Starting material: L-Phenylalanine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Phenylalanine (165 mg, 1.00 mmol) was suspended in 2 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless slurry 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (40 mL). After filtration 
and washing with ethyl acetate and diethyl ether the obtained colourless amorphous solid 
was first dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C21H32GaN3O8 + 1.10 H2O. 
 Yield:  334 mg (0.614 mmol, 61.4%). 
 Elemental analysis: Calcd. (%): C 46.36, H 6.34, N 7.72. 
Found (%): C 46.37, H 6.27, N 7.74. 
Calcd. C21H32GaN3O8 (%): C 48.12, H 6.15, N 8.02. 
[Ga(nta)(phe)]−: 
1H NMR (400 MHz, D2O): δ = 7.40–7.45 (sp, 2H, H6), 7.34–7.39 (sp, 1H, H7), 7.32–7.38 
(sp, 2H, H5), 3.95–4.01 (sp, 1H, H2), 3.39–3.45 (m, 1H, H3), 3.00–3.08 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.9 (C1), 137.1 (C4), 129.8 (C5), 129.7 (C6), 128.0 
(C7), 55.8 (C2), 37.7 (C3) ppm. 
L-Phenylalanine: 
1H NMR (400 MHz, D2O): δ = 7.35–7.42 (sp, 2H, H6), 7.34–7.39 (sp, 1H, H7), 7.29–7.34 
(sp, 2H, H5), 3.95–4.01 (sp, 1H, H2), 3.23–3.29 (m, 1H, H3), 3.07–3.14 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.4 (C1), 135.7 (C4), 130.0 (C5), 129.7 (C6), 128.3 
(C7), 56.6 (C2), 37.0 (C3) ppm. 
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5.5.17 HNEt3[Ga(nta)(pro)] 
 
Starting material: L-Proline, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, ethyl acetate, diethyl ether, methanol, toluene. 
Procedure: L-Proline (115 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (30 mL). After filtration 
and washing with ethyl acetate and diethyl ether the obtained colourless amorphous solid 
was first dried at 80 °C for 10 min and then under fine vacuum for 2 h.  
 Empirical formula:  C17H30GaN3O8 + 0.75 H2O. 
 Yield:  199 mg (0.408 mmol, 40.8%). 
 Elemental analysis: Calcd. (%): C 41.87, H 6.51, N 8.62. 
Found (%): C 41.77, H 6.38, N 8.53. 
Calcd. C17H30GaN3O8 (%): C 43.06, H 6.38, N 8.86. 
[Ga(nta)(pro)]−: 
1H NMR (400 MHz, D2O): δ = 4.10–4.16 (sp, 1H, H2), 3.27–3.44 (sp, 2H, H5), 2.29–2.41 
(sp, 1H, H3), 1.95–2.10 (sp, 2H, H4), 1.87–1.98 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.2 (C1), 61.4 (C2), 48.7 (C5), 30.4 (C3), 26.8 (C4) 
ppm. 
L-Proline: 
1H NMR (400 MHz, D2O): δ = 4.10–4.16 (sp, 1H, H2), 3.27–3.44 (sp, 2H, H5), 2.29–2.41 
(sp, 1H, H3), 1.95–2.10 (sp, 2H, H4), 1.87–1.98 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.1 (C1), 61.8 (C2), 46.7 (C5), 29.6 (C3), 24.4 (C4) 
ppm. 
Crystals of HNEt3[Ga(nta)(pro)]·H2O ((HNEt3)2g·H2O) were obtained after ten months by 
storing a methanolic solution of the raw product over toluene.    
 Empirical formula:  C17H30GaN3O8·H2O, 492.18 g mol
−1. 
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 Yield:  Few crystals. 
 
5.5.18 HNEt3[Ga(nta)(ser)] 
 
Starting material: L-Serine, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, ethyl acetate, diethyl ether, methanol, n-hexane. 
Procedure: L-Serine (105 mg, 1.00 mmol) was suspended in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (5 mL). After filtration and 
washing with ethanol and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 2 h.  
 Empirical formula:  C15H28GaN3O9 + 0.15 Ga(OH)3 + 0.10 H2O. 
 Yield:  282 mg (0.583 mmol, 58.3%). 
 Elemental analysis: Calcd. (%): C 37.22, H 5.97, N 8.68. 
Found (%): C 37.19, H 5.91, N 8.64. 
Calcd. C15H28GaN3O9 (%): C 38.82, H 6.08, N 9.05. 
[Ga(nta)(ser)]−: 
1H NMR (400 MHz, D2O): δ = 3.91–4.04 (sp, 2H, H3), 3.81–3.88 (sp, 1H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.6 (C1), 61.4 (C3), 56.2 (C2) ppm. 
L-Serine: 
1H NMR (400 MHz, D2O): δ = 3.91–4.04 (sp, 2H, H3), 3.81–3.88 (sp, 1H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.8 (C1), 60.8 (C3), 57.0 (C2) ppm. 
Crystals of HNEt3[Ga(nta)(ser)]·0.14H2O ((HNEt3)2h·0.14H2O) were obtained after two 
weeks by storing a methanolic solution of the raw product over n-hexane.    
 Empirical formula:  C17H30GaN3O8·0.14H2O, 468.66 g mol
−1. 
 Yield:  Few crystals. 
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5.5.19 HNEt3[Ga(nta)(thr)] 
 
Starting material: L-Threonine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Threonine (119 mg, 1.00 mmol) was suspended in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition of ethanol 
(15 mL) and ethyl acetate (30 mL). After filtration and washing with ethanol, ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1.5 h. 
 Empirical formula:  C16H30GaN3O9 + 0.15 H2O. 
 Yield:  194 mg (0.403 mmol, 40.3%). 
 Elemental analysis: Calcd. (%): C 39.97, H 6.35, N 8.74. 
Found (%): C 40.03, H 6.33, N 8.66. 
Calcd. C16H30GaN3O9 (%): C 40.19, H 6.32, N 8.79. 
[Ga(nta)(thr)]−: 
1H NMR (400 MHz, D2O): δ = 4.53–4.59 (m, 1H, H3), 3.58–3.63 (sp, 1H, H2), 1.30–1.34 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.0 (C1), 66.4 (C3), 59.7 (C2), 20.1 (C4) ppm. 
L-Threonine: 
1H NMR (400 MHz, D2O): δ = 4.22–4.27 (m, 1H, H3), 3.58–3.62 (sp, 1H, H2), 1.30–1.34 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.3 (C1), 66.5 (C3), 61.0 (C2), 20.1 (C4) ppm. 
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5.5.20 HNEt3[Ga(nta)(trp)]/[Ga(nta)(Htrp)] 
 
Starting material: L-Tryptophan, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, ethyl acetate, acetone, diethyl ether. 
Procedure: L-Tryptophan (181 mg, 1.00 mmol) was suspended in 8.0 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless slurry 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (5 mL) and ethyl acetate (40 mL). After filtration and 
washing with acetone and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C23H33GaN4O8 + 0.10 C17H18GaN3O8 + 1.65 H2O. 
 Yield:  194 mg (0.334 mmol, 33.4%). 
 Elemental analysis: Calcd. (%): C 46.41, H 6.01, N 9.42. 
Found (%): C 46.41, H 5.97, N 9.46. 
Calcd. C23H33GaN4O8 (%): C 49.05, H 5.91, N 9.95. 
[Ga(nta)(trp)]−: 
1H NMR (400 MHz, D2O): δ = 7.64–7.68 (sp, 1H, H8), 7.47–7.50 (sp, 1H, H11), 7.29 (s, 
1H, H5), 7.21–7.25 (sp, 1H, H10), 7.12–7.16 (sp, 1H, H9), 4.00–4.04 (sp, 1H, H2), 3.44–
3.56 (sp, 1H, H3), 3.16–3.24 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.3 (C1), 137.0 (C6), 127.3 (C7), 125.4 (C5), 122.8 
(C10), 120.0 (C9), 119.0 (C8), 112.6 (C11), 109.2 (C4), 54.6 (C2), 27.9 (C3) ppm. 
L-Tryptophan: 
1H NMR (400 MHz, D2O): δ = 7.64–7.68 (sp, 1H, H8), 7.47–7.50 (sp, 1H, H11), 7.25 (s, 
1H, H5), 7.21–7.25 (sp, 1H, H10), 7.12–7.16 (sp, 1H, H9), 4.00–4.04 (sp, 1H, H2), 3.73–
3.45 (sp, 1H, H3), 3.22–3.28 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.8 (C1), 136.9 (C6), 127.3 (C7), 125.6 (C5), 122.7 
(C10), 120.1 (C9), 119.0 (C8), 112.6 (C11), 108.1 (C4), 55.5 (C2), 27.0 (C3) ppm. 
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5.5.21 Attempt of synthesis: HNEt3[Ga(nta)(tyr)] 
 
Starting material: L-Tyrosine, water, gallium(III) chloride, nitrilotriacetic acid, 
triethylamine, ethanol, diethyl ether. 
Procedure: L-Tyrosine (181 mg, 1.00 mmol) was suspended in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless slurry (pH 8.0) 
which was stirred for 16 h. The solvent was removed by rotary evaporation and the residue 
was suspended in ethanol (10 mL). After filtration and washing with ethanol and diethyl 
ether the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then 
under fine vacuum for 3 h.  
 Empirical formula:  C9H11NO3 + 1.15 H2O + 0.35 C24H46Ga2N4O14. 
 Yield:  380 mg.  
 Elemental analysis: Calcd. (%): C 44.86, H 6.36, N 7.22. 
Found (%): C 45.00, H 6.52, N 7.37. 
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5.5.22 HNEt3[Ga(nta)(val)] 
 
Starting material: L-Valine, water, gallium(III) chloride, nitrilotriacetic acid, triethylamine, 
ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Valine (117 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in a colourless solution 
(pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (15 mL) and ethyl acetate (5 mL). After filtration and 
washing with ethanol and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 2 h.  
 Empirical formula:  C17H32GaN3O8 + 0.15 H2O. 
 Yield:  221 mg (0.461 mmol, 46.1%). 
 Elemental analysis: Calcd. (%): C 42.64, H 6.80, N 8.77. 
Found (%): C 42.61, H 6.74, N 8.79. 
Calcd. C17H32GaN3O8 (%): C 42.88, H 6.77, N 8.82. 
[Ga(nta)(val)]−: 
1H NMR (400 MHz, D2O): δ = 3.66 (d, 1H, H2, 3J2,3 = 3.5 Hz), 2.46–2.53 (m, 1H, H3), 1.08 
(d, 3H, H4, 3J3,4 = 7.0 Hz), 0.91 (d, 3H, H5, 3J3,5 = 7.0 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.7 (C1), 59.8 (C2), 30.2 (C3), 19.2 (C4), 15.9 (C5) 
ppm. 
L-Valine: 
1H NMR (400 MHz, D2O): δ = 3.60 (d, 1H, H2, 3J2,3 = 4.3 Hz), 2.21–2.31 (m, 1H, H3), 1.03 
(d, 3H, H4, 3J3,4 = 7.0 Hz), 0.98 (d, 3H, H5, 3J3,5 = 7.0 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.7 (C1), 60.9 (C2), 29.7 (C3), 18.6 (C4), 17.3 (C5) 
ppm. 
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5.5.23 (HNEt3)2[{Ga(nta)(µ-OH)}2] 
 
Starting material: Nitrilotriacetic acid, water, gallium(III) chloride, triethylamine, ethanol, 
diethyl ether. 
Procedure: Nitrilotriacetic acid (191 mg, 1.00 mmol) was suspended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol) and triethylamine 
(627 µL, 4.50 mmol) resulted in a colourless solution (pH 8.0) which was stirred for 16 h. 
The raw product was precipitated by addition of ethanol (30 mL). After filtration and 
washing with ethanol and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then on a lyophilizer for 2 days.  
 Empirical formula:  C24H46Ga2N4O14 + 1.60 H2O. 
 Yield:  310 mg (0.396 mmol, 79.2%). 
 Elemental analysis: Calcd. (%): C 36.82, H 6.33, N 7.16. 
Found (%): C 36.80, H 6.32, N 7.15. 
Calcd. C24H46Ga2N4O14 (%): C 38.23, H 6.15, N 7.43. 
[{Ga(nta)(µ-OH)}2]2−: 
1H NMR (400 MHz, D2O): δ = 3.71 (s, 6H) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.5 (C1), 63.2 (C2) ppm. 
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5.5.24 HDIPEA[Ga(ala)(nta)] 
 
Starting material: L-Alanine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, dimethyl sulfoxide. 
Procedure: L-Alanine (89 mg, 1.0 mmol) was dissolved in 2 mL of water. Gradual addition 
of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The colourless solution was concentrated by 
rotary evaporation and the raw product was precipitated by addition of ethanol (10 mL) 
and ethyl acetate (30 mL). After filtration and washing with ethyl acetate and diethyl ether 
the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C17H32GaN3O8 + 0.85 H2O. 
 Yield:  358 mg (0.728 mmol, 72.8%). 
 Elemental analysis: Calcd. (%): C 41.54, H 6.91, N 8.55. 
Found (%): C 41.57, H 6.91, N 8.54. 
Calcd. C17H32GaN3O8 (%): C 42.88, H 6.77, N 8.82. 
[Ga(ala)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.76–3.82 (sp, 1H, H2), 1.51 (d, 3H, H3, 3J2,3 = 7.3 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.7 (C1), 50.3 (C2). 18.1 (C3) ppm. 
L-Alanine: 
1H NMR (400 MHz, D2O): δ = 3.76–3.82 (sp, 1H, H2), 1.46 (d, 3H, H3, 3J2,3 = 7.2 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.1 (C1), 51.1 (C2), 16.8 (C3) ppm. 
[Ga(ala-κO,N)(nta)]− (isomer I): 
1H NMR (400 MHz, MeOD): δ = 3.63–3.71 (sp, 1H, H2), 3.70 (s, 6H, nta), 1.53 (d, 3H, H3, 
3J2,3 = 7.3 Hz) ppm. 
13C{1H} NMR (101 MHz, MeOD): δ = 179.4 (C1), 175.0 (C1, A, nta), 64.7 (C2, B, nta), 51.5 
(C2). 19.0 (C3) ppm. 
 
EXPERIMENTAL PART 
 155  
[Ga(ala-κO,N)(nta)]− (isomer II): 
1H NMR (400 MHz, MeOD): δ = - 
13C{1H} NMR (101 MHz, MeOD): δ = 179.4 (C1), 51.6 (C2). 19.1 (C3) ppm. 
HDIPEA+:  
1H NMR (400 MHz, MeOD): δ = 3.69–3.79 (sp, 2H, H1), 3.24 (q, 2H, H4, 3J4,5 = 7.4 Hz), 
1.36–1.40 (sp, 15H, H2/H3/H5) ppm. 
13C{1H} NMR (101 MHz, MeOD): δ = 56.2 (C1), 44.2 (C4), 19.2 (C2), 17.8 (C3), 13.6 (C5) 
ppm. 
Crystals of HDIPEA[Ga(ala)(nta)]·2H2O ((HDIPEA)2a·2H2O) were obtained after one 
week by storing an aqueous solution (pH 7.0) of the raw product over dimethyl sulfoxide. 
   
 Empirical formula:  C16H30GaN3O8·2H2O, 512.22 g mol−1. 
 Yield:  189 mg (0.369 mmol, 36.9%). 
 Elemental analysis: Calcd. (%): C 39.86, H 7.08, N 8.20. 
Found (%): C 39.78, H 6.84, N 8.22. 
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5.5.25 [Ga(Harg)(nta)]·0.05DIPEA 
 
Starting material: L-Arginine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, diethyl ether. 
Procedure: L-Arginine (174 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 9.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (50 mL). After filtration and washing with ethanol and diethyl ether the obtained 
colourless amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum 
for 1.5 h.  
 Empirical formula:  C12H20GaN5O8·0.05C8H19N + 2.45 H2O. 
 Yield:  344 mg (0.713 mmol, 71.3%). 
 Elemental analysis: Calcd. (%): C 30.86, H 5.40, N 14.66. 
Found (%): C 30.94, H 5.30, N 14.57. 
Calcd. C12H20GaN5O8 (%): C 33.36, H 4.67, N 16.21. 
 [Ga(Harg-κO,N)(nta)] (isomer I): 
1H NMR (400 MHz, D2O): δ = 3.77–3.83 (sp, 1H, H2), 3.21–3.26 (sp, 2H, H5), 1.98–2.12 
(m, 1H, H3), 1.78–1.86 (sp, 1H, H3), 1.69–1.87 (sp, 2 H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.6 (C1), 157.3 (C6), 54.1 (C2), 41.2 (C5), 29.3 (C3), 
25.3 (C4) ppm. 
[Ga(Harg-κO,N)(nta)] (isomer II):  
1H NMR (400 MHz, D2O): δ = - 
13C{1H} NMR (101 MHz, D2O): δ = 179.6 (C1), 53.6 (C2), 41.2 (C5), 29.7 (C3), 25.5 (C4) 
ppm. 
L-Arginine: 
1H NMR (400 MHz, D2O): δ = 3.73–3.79 (sp, 1H, H2), 3.21–3.26 (sp, 2H, H5), 1.83–1.95 
(sp, 2H, H3), 1.58–1.74 (sp, 2 H, H4) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 174.9 (C1), 157.3 (C6), 54.9 (C2), 41.1 (C5), 28.2 (C3), 
24.5 (C4) ppm. 
 
5.5.26 HDIPEA[Ga(asn)(nta)] 
 
Starting material: L-Asparagine monohydrate, water, gallium(III) chloride, nitrilotriacetic 
acid, N,N-diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, methanol, acetone. 
Procedure: L-Asparagine monohydrate (150 mg, 1.00 mmol) was suspended in 7 mL of 
water. Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic 
acid (191 mg, 1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in 
a colourless suspension (pH 7.5) which was stirred for 16 h. The colourless slurry was 
concentrated by rotary evaporation and the obtained oil diluted with 1 mL of water. The 
raw product was precipitated by addition of ethanol (40 mL) and ethyl acetate (60 mL). 
After filtration and washing with ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C18H33GaN4O9 + 0.20 Ga(OH)3 + 0.05 C2H6O. 
 Yield:  322 mg (0.590 mmol, 59.0%). 
 Elemental analysis: Calcd. (%): C 39.84, H 6.26, N 10.27. 
Found (%): C 39.77, H 6.37, N 10.36. 
Calcd. C18H33GaN4O9 (%): C 41.64, H 6.41, N 10.79. 
[Ga(asn)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97 (t, 1H, H2, 3J2,3 = 5.5 Hz), 2.95–2.97 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.6 (C1), 175.2 (C4), 51.4 (C2), 36.2 (C3) ppm. 
L-Asparagine: 
1H NMR (400 MHz, D2O): δ = 4.03 (dd, 1H, H2), 2.82–2.95 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.8 (C4), 173.7 (C1), 51.8 (C2), 35.0 (C3) ppm. 
 
Crystals of HDIPEA[Ga(asn)(nta)] ((HDIPEA)2b) were obtained after one week by storing 
a methanolic solution of the raw product over acetone.    
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 Empirical formula:  C18H33GaN4O9, 519.20 g mol−1. 
 Yield:  Few crystals. 
  
5.5.27 HDIPEA[Ga(Hasp)(nta)]·0.10DIPEA 
 
Starting material: L-Aspartic acid, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Aspartic acid (133 mg, 1.00 mmol) was suspended in 2.5 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and N,N-diisopropylethylamine (909 µL, 5.50 mmol) resulted in a 
colourless solution (pH 8.0) which was stirred for 16 h. The colourless solution was 
concentrated by rotary evaporation and the raw product was precipitated by addition of 
ethanol (10 mL) and ethyl acetate (50 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 2 h.  
 Empirical formula:  C18H32GaN3O10·0.10C8H19N + 0.10 Ga(OH)3. 
 Yield:  470 mg (0.862 mmol, 86.2%). 
 Elemental analysis: Calcd. (%): C 41.42, H 6.32, N 7.96. 
Found (%): C 41.20, H 6.19, N 8.13. 
Calcd. C18H32GaN3O10 (%): C 41.56, H 6.20, N 8.08. 
[Ga(Hasp)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.93 (t, 1H, H2, 3J2,3 = 5.5 Hz), 2.83–2.96 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.7 (C1), 176.2 (C4), 51.7 (C2), 37.3 (C3) ppm. 
L-Aspartic acid: 
1H NMR (400 MHz, D2O): δ = 3.98–4.07 (m, 1H, H2), 2.83–2.96 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.2 (C1), 173.6 (C4), 51.9 (C2), 36.5 (C3) ppm. 
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5.5.28 HDIPEA[Ga(cys)(nta)] 
 
Starting material: L-Cysteine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, acetone, diethyl ether. 
Procedure: L-Cysteine (121 mg, 1.00 mmol) was dissolved in 3.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
slurry (pH 7.0) which was stirred for 16 h. The solvent was removed by rotary evaporation 
and the residue was suspended in ethanol (10 mL) and ethyl acetate (70 mL). After 
filtration and washing with acetone and diethyl ether the obtained colourless amorphous 
solid was first dried at 80 °C for 10 min and then under fine vacuum for 15 h.  
 Empirical formula:  C17H32GaN3O8S + 0.10 Ga(OH)3 + 0.10 H2O + 0.05 C2H6O. 
 Yield:  448 mg (0.854 mmol, 85.4%). 
 Elemental analysis: Calcd. (%): C 39.16, H 6.30, N 8.01, S 6.11. 
Found (%): C 39.17, H 6.33, N 8.08, S 6.05. 
Calcd. C17H32GaN3O8S (%): C 40.18, H 6.35, N 8.27, S 6.31. 
 [Ga(cys-κ2S,X)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.5 (C1), 56.1 (C2), 24.6 (C3) ppm. 
[Ga(cys-κO,N)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 57.8 (C2), 26.5 (C3) ppm. 
L-Cysteine: 
1H NMR (400 MHz, D2O): δ = 3.97–4.01 (sp, 1H, H2), 2.97–3.03 (sp, 1H, H3), 2.81–2.85 
(sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.8 (C1), 56.4 (C2), 25.3 (C3) ppm. 
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5.5.29 HDIPEA[Ga(gln)(nta)] 
 
Starting material: L-Glutamine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Glutamine (146 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 9.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (30 mL) and ethyl acetate (30 mL). After filtration and washing with ethanol and 
diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 10 min 
and then under fine vacuum for 1.5 h.  
 Empirical formula:  C19H35GaN4O9 + 0.2 H2O + 0.05 C2H6O. 
 Yield:  464 mg (0.861 mmol, 86.1%). 
 Elemental analysis: Calcd. (%): C 42.55, H 6.67, N 10.39. 
Found (%): C 42.51, H 6.61, N 10.34. 
Calcd. C19H35GaN4O9 (%): C 42.80, H 6.62, N 10.51. 
[Ga(gln)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.71–3.82 (sp, 1H, H2), 2.46–2.54 (m, 2H, H4), 2.24–2.35 
(m, 1H, H3), 2.02–2.12 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.3 (C5), 178.0 (C1), 54.0 (C2), 32.2 (C4), 28.1 (C3) 
ppm. 
L-Glutamine: 
1H NMR (400 MHz, D2O): δ = 3.71–3.82 (sp, 1H, H2), 2.41–2.46 (m, 2H, H4), 2.08–2.17 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.0 (C5), 174.4 (C1), 54.7 (C2), 31.4 (C4), 26.8 (C3) 
ppm. 
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5.5.30 HDIPEA[Ga(Hglu)(nta)]·0.05DIPEA 
 
Starting material: L-Glutamic acid, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Glutamic acid (147 mg, 1.00 mmol) was suspended in 2.5 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and N,N-diisopropylethylamine (909 µL, 5.50 mmol) resulted in a 
colourless solution (pH 8.0) which was stirred for 16 h. The colourless solution was 
concentrated by rotary evaporation and the raw product was precipitated by addition of 
ethanol (10 mL) and ethyl acetate (50 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 2 h.  
Empirical formula:  C19H34GaN3O10·0.05C8H19N + 0.30 H2O + 0.05 Ga(OH)3. 
 Yield:  524 mg (0.949 mmol, 94.9%). 
 Elemental analysis: Calcd. (%): C 42.20, H 6.52, N 7.74. 
Found (%): C 40.02, H 6.31, N 7.80. 
Calcd. C19H34GaN3O10 (%): C 42.72, H 6.42, N 7.87. 
[Ga(Hglu)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.57 (sp, 2H, H4), 1.98–2.18 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 54.0 (C2), 32.2 (C4), 28.0 (C3) ppm. 
L-Glutamic acid: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.57 (sp, 2H, H4), 1.98–2.18 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.9 (C5), 174.2 (C1), 54.6 (C2), 32.1 (C4), 26.8 (C3) 
ppm. 
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5.5.31 HDIPEA[Ga(gly)(nta)] 
 
Starting material: Glycine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, methanol, acetone, dimethyl 
sulfoxide. 
Procedure: Glycine (75 mg, 1.0 mmol) was dissolved in 1.0 mL of water. Gradual addition 
of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The colourless solution was concentrated by 
rotary evaporation and the raw product was precipitated by addition of ethanol (15 mL) 
and ethyl acetate (30 mL). After filtration and washing with ethyl acetate and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then under 
fine vacuum for 1.5 h.  
 Empirical formula:   C16H30GaN3O8 + 0.95 H2O. 
 Yield:  401 mg (0.837 mmol, 83.7%). 
 Elemental analysis: Calcd. (%): C 40.10, H 6.71, N 8.77. 
Found (%): C 40.02, H 6.58, N 8.86. 
Calcd. C16H30GaN3O8 (%): C 41.58, H 6.54, N 9.09. 
[Ga(gly)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.57 (s, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.7 (C1), 42.1 (C2) ppm. 
Glycine: 
1H NMR (400 MHz, D2O): δ = 3.55 (s, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.7 (C1), 42.0 (C2) ppm. 
 
Crystals of HDIPEA[Ga(gly)(nta)]·H2O ((HDIPEA)2c· H2O) were obtained after two weeks 
by storing a methanolic solution of the raw product over acetone.   
 Empirical formula:  C16H30GaN3O8·H2O, 480.17 g mol−1. 
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 Yield:  178 mg (0.371 mmol, 37.1%). 
 Elemental analysis: Calcd. (%):C 40.02, H 6.72, N 8.75. 
Found (%): C 39.97, H 6.70, N 8.65. 
 
Crystals of HDIPEA[Ga(gly)(nta)]·MeOH ((HDIPEA)2c·MeOH) were obtained after one 
week by storing a methanolic solution of the raw product over dimethyl sulfoxide. 
 Empirical formula:  C16H30GaN3O8·CH4O, 494.19 g mol−1. 
 Yield:  Few crystals. 
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5.5.32 [Ga(Hhis)(nta)]·0.25DIPEA 
 
Starting material: L-Histidine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, diethyl ether. 
Procedure: L-Histidine (155 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (20 mL). After filtration and 
washing with ethanol and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C12H15GaN4O8·0.25C8H19N + 2.10 H2O + 0.05 C2H6O. 
 Yield:  234 mg (0.482 mmol, 48.2%). 
 Elemental analysis: Calcd. (%): C 34.89, H 5.04, N 12.26. 
Found (%): C 34.76, H 5.13, N 12.43. 
Calcd. C12H15GaN4O8 (%): C 34.90, H 3.66, N 13.57. 
[Ga(Hhis)(nta)]: 
1H NMR (400 MHz, D2O): δ = 8.34–8.43 (sp, 1H, H6), 7.14–7.30 (sp, 1H, H5), 4.02–4.08 
(sp, 1H, H2), 3.24–3.47 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.9 (C1), 133.3 (C6), 129.6 (C4), 116.5 (C5), 53.7 
(C2), 26.8 (C3) ppm. 
L-Histidine: 
1H NMR (400 MHz, D2O): δ = 8.34–8.43 (sp, 1H, H6), 7.14–7.30 (sp, 1H, H5), 4.02–4.08 
(sp, 1H, H2), 3.24–3.47 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.5 (C1), 136.2 (C6), 129.6 (C4), 118.2 (C5), 54.4 
(C2), 27.7 (C3) ppm. 
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5.5.33 HDIPEA[Ga(ile)(nta)] 
 
Starting material: L-Isoleucine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Isoleucine (131 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (15 mL) and ethyl acetate (50 mL). 
After filtration and washing with ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C20H38GaN3O8 + 0.20 H2O. 
 Yield:  421 mg (0.807 mmol, 80.7%). 
 Elemental analysis: Calcd. (%): C 46.03, H 7.42, N 8.05. 
Found (%): C 46.05, H 7.36, N 7.98. 
Calcd. C20H38GaN3O8 (%): C 46.35, H 7.39, N 8.11. 
[Ga(ile)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.65–3.72 (sp, 1H, H2), 2.16–2.26 (m, H1, H3), 1.25–1.35 
(sp, 2H, H4), 1.06 (d, 3H, H6, 3J3,6 = 7.0 Hz), 0.88–0.95 (sp, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.5 (C1), 59.5 (C2), 37.2 (C3), 24.1 (C4), 16.3 (C6), 
12.0 (C5) ppm. 
L-Isoleucine: 
1H NMR (400 MHz, D2O): δ = 3.65–3.72 (sp, 1H, H2), 1.92–2.02 (m, H1, H3), 1.40–1.51 
(sp, 1H, H4), 1.20–1.31 (sp, 1H, H4), 0.99 (d, 3H, H6, 3J3,6 = 7.0 Hz), 0.88–0.95 (sp, 3H, 
H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.5 (C1), 60.1 (C2), 36.5 (C3), 25.1 (C4), 15.3 (C6), 
11.8 (C5) ppm. 
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5.5.34 HDIPEA[Ga(leu)(nta)] 
 
Starting material: L-Leucine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, methanol, acetone. 
Procedure: L-Leucine (131 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (20 mL) and ethyl acetate (40 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C20H38GaN3O8 + 0.15 H2O + 0.05 C4H8O2. 
 Yield:  356 mg (0.678 mmol, 67.8%). 
 Elemental analysis: Calcd. (%): C 46.18, H 7.43, N 8.00. 
Found (%): C 46.20, H 7.38, N 7.98. 
Calcd. C20H38GaN3O8 (%): C 46.35, H 7.39, N 8.11. 
[Ga(leu)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.65–3.74 (sp, 1H, H2), 1.72–1.80 (sp, 2H, H3), 1.64–1.80 
(sp, 1H, H4), 0.93–0.98 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.6 (C1), 52.9 (C2), 41.4 (C3), 25.1 (C4), 23.1 (C5), 
20.7 (C6) ppm. 
L-Leucine: 
1H NMR (400 MHz, D2O): δ = 3.65–3.74 (sp, 1H, H2), 1.64–1.80 (sp, 1H, H4), 1.64–1.72 
(sp, 2H, H3), 0.93–0.98 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.9 (C1), 54.0 (C2), 40.4 (C3), 24.8 (C4), 22.7 (C5), 
21.6 (C6) ppm. 
Crystals of HDIPEA[Ga(leu)(nta)] ((HDIPEA)2d) were obtained after 2 days by storing a 
methanolic solution of the raw product over acetone. 
 Empirical formula:  C20H38GaN3O8, 518.26 g mol
−1. 
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 Yield:  Few crystals.  
5.5.35 [Ga(Hlys)(nta)]·0.05DIPEA 
 
Starting material: L-Lysine hydrochloride, water, gallium(III) chloride, nitrilotriacetic acid, 
N,N-diisopropylethylamine, ethanol, diethyl ether. 
Procedure: L-Lysine hydrochloride (183 mg, 1.00 mmol) was dissolved in 1.5 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and N,N-diisopropylethylamine (909 µL, 5.50 mmol) resulted in a 
colourless solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (50 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then under 
fine vacuum for 1.5 h.  
 Empirical formula:  C12H20GaN3O8·0.05C8H19N + 2.25 H2O + 0.15 C2H6O. 
 Yield:  305 mg (0.666 mmol, 66.6%). 
 Elemental analysis: Calcd. (%): C 33.31, H 5.80, N 9.33. 
Found (%): C 33.16, H 5.87, N 9.50. 
Calcd. C12H20GaN3O8 (%): C 35.67, H 4.99, N 10.40. 
[Ga(Hlys-κO,N)(nta)] (isomer I): 
1H NMR (400 MHz, D2O): δ = 3.70–3.79 (sp, 1H, H2), 2.98–3.07 (sp, 2H, H6), 1.95–2.10 
(m, 2H, H3), 1.64–1.77 (sp, 2H, H5), 1.50–1.60 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.8 (C1), 54.2 (C2), 39.7 (C6), 31.6 (C3), 26.9 (C5), 
22.8 (C4) ppm. 
[Ga(Hlys-κO,N)(nta)] (isomer II): 
13C{1H} NMR (101 MHz, D2O): δ = 179.9 (C1), 53.7 (C2), 39.7 (C6), 31.9 (C3), 22.9 (C4) 
ppm. 
L-Lysine: 
1H NMR (400 MHz, D2O): δ = 3.70–3.79 (sp, 1H, H2), 2.98–3.07 (sp, 2H, H6), 1.80–1.95 
(m, 2H, H3), 1.64–1.77 (sp, 2H, H5), 1.37–1.54 (sp, 2H, H4) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 175.1 (C1), 55.0 (C2), 39.7 (C6), 30.5 (C3), 27.0 (C5), 
22.0 (C4) ppm. 
5.5.36 HDIPEA[Ga(met)(nta)] 
 
Starting material: L-Methionine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, diethyl ether, acetone. 
Procedure: L-Methionine (149 mg, 1.00 mmol) was suspended in 3 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8) which was stirred for 16 h. The solvent was removed by rotary evaporation 
and the residue was suspended in ethanol (10 mL). After filtration and washing with ethyl 
acetate and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 
10 min.  
 Empirical formula:  C19H36GaN3O8S + 0.05 H2O. 
 Yield:  505 mg (0.940 mmol, 94.0%). 
 Elemental analysis: Calcd. (%): C 42.48, H 6.77, N 7.82, S 5.97. 
Found (%): C 42.52, H 6.66, N 7.87, S 5.86. 
Calcd. C19H36GaN3O8S (%): C 42.55, H 6.77, N 7.84, S 5.98. 
[Ga(met)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.83–3.88 (sp, 1H, H2), 2.65–2.78 (m, 2H, H4), 2.25–2.36 
(m, 1H, H3), 2.13 (s, 3H, H5), 2.02–2.12 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.4 (C1), 53.5 (C2), 31.3 (C3), 30.3 (C4), 14.6 (C5) 
ppm. 
L-Methionine: 
1H NMR (400 MHz, D2O): δ = 3.83–3.88 (sp, 1H, H2), 2.62 (t, 2H, H4, 3J3,4 = 7.5 Hz), 2.09–
2.23 (sp, 2H, H3), 2.11 (s, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.6 (C1), 54.5 (C2), 30.3 (C3), 29.4 (C4), 14.5 (C5) 
ppm. 
Crystals of HDIPEA[Ga(met)(nta)] ((HDIPEA)2e) were obtained after two weeks by storing 
an aqueous solution (pH 7.0) of the raw product over acetone.    
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 Empirical formula:  C19H36GaN3O8S, 536.29 g mol−1. 
 Yield:  177 mg (0.330 mmol, 33.0%). 
 Elemental analysis: Calcd. (%): C 42.55, H 6.77, N 7.84, S 5.98. 
Found (%): C 42.49, H 6.47, N 7.89, S 6.00. 
 
5.5.37 HDIPEA[Ga(nta)(phe)] 
 
Starting material: L-Phenylalanine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Phenylalanine (165 mg, 1.00 mmol) was suspended in 2.0 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol) and N,N-diisopropylethylamine (774 µL, 4.50 mmol) resulted in a 
colourless solution (pH 8.5) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (13 mL) and ethyl acetate (70 mL). 
After filtration and washing with ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum for 3 h.  
 Empirical formula:  C23H36GaN3O8 + 0.90 H2O. 
 Yield:  375 mg (0.660 mmol, 66.0%). 
 Elemental analysis: Calcd. (%): C 48.59, H 6.70, N 7.39. 
Found (%): C 48.52, H 6.60, N 7.40. 
Calcd. C23H36GaN3O8 (%): C 50.02, H 6.57, N 7.61. 
[Ga(nta)(phe)]−: 
1H NMR (400 MHz, D2O): δ = 7.40–7.46 (sp, 2H, H6), 7.34–7.39 (sp, 1H, H7), 7.32–7.38 
(sp, 2H, H5), 3.95–4.01 (sp, 1H, H2), 3.39–3.46 (m, 1H, H3), 2.99–3.08 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.9 (C1), 137.1 (C4), 129.8 (C5), 129.7 (C6), 128.0 
(C7), 55.8 (C2), 37.8 (C3) ppm. 
L-Phenylalanine: 
1H NMR (400 MHz, D2O): δ = 7.35–7.42 (sp, 2H, H6), 7.34–7.39 (sp, 1H, H7), 7.29–7.34 
(sp, 2H, H5), 3.95–4.01 (sp, 1H, H2), 3.23–3.29 (m, 1H, H3), 3.07–3.14 (sp, 1H, H3) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 174.4 (C1), 135.7 (C4), 130.0 (C5), 129.7 (C6), 128.3 
(C7), 56.6 (C2), 37.0 (C3) ppm. 
 
5.5.38 HDIPEA[Ga(nta)(pro)] 
 
Starting material: L-Proline, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, methanol, dimethyl sulfoxide. 
Procedure: L-Proline (115 mg, 1.00 mmol) was suspended in 2.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (774 µL, 4.50 mmol) resulted in a colourless 
solution (pH 9.0) which was stirred for 16 h. The colourless solution was concentrated by 
rotary evaporation and the raw product was precipitated by addition of ethanol (3 mL) and 
ethyl acetate (50 mL). After filtration and washing with ethyl acetate and diethyl ether the 
obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C19H34GaN3O8 + 0.05 Ga(OH)3 + 0.05 H2O. 
 Yield:  478 mg (0.939 mmol, 93.9%). 
 Elemental analysis: Calcd. (%): C 44.82, H 6.78, N 8.25. 
Found (%): C 44.74, H 6.69, N 8.25. 
Calcd. C19H34GaN3O8 (%): C 45.44, H 6.82, N 8.37. 
[Ga(nta)(pro)]−: 
1H NMR (400 MHz, D2O): δ = 4.10–4.16 (sp, 1H, H2), 3.27–3.44 (sp, 2H, H5), 2.29–2.41 
(sp, 1H, H3), 1.95–2.10 (sp, 2H, H4), 1.87–1.98 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.1 (C1), 61.4 (C2), 48.7 (C5), 30.4 (C3), 26.7 (C4) 
ppm. 
L-Proline: 
1H NMR (400 MHz, D2O): δ = 4.10–4.16 (sp, 1H, H2), 3.27–3.44 (sp, 2H, H5), 2.29–2.41 
(sp, 1H, H3), 1.95–2.10 (sp, 2H, H4), 1.87–1.98 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.0 (C1), 61.8 (C2), 46.7 (C5), 29.6 (C3), 24.4 (C4) 
ppm. 
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Crystals of HDIPEA[Ga(nta)(pro)] ((HDIPEA)2g) were obtained after two days by storing 
a methanolic solution of the raw product over dimethyl sulfoxide.    
 Empirical formula:  C19H34GaN3O8, 502.22 g mol−1. 
 Yield:  Few crystals. 
  
5.5.39 HDIPEA[Ga(nta)(ser)] 
 
Starting material: L-Serine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Serine (105 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (774 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (20 mL) and ethyl acetate (70 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C17H32GaN3O9 + 0.80 H2O. 
 Yield:  420 mg (0.829 mmol, 82.9%). 
 Elemental analysis: Calcd. (%): C 40.31, H 6.69, N 8.29. 
Found (%): C 40.26, H 6.60, N 8.25. 
Calcd. C17H32GaN3O9 (%): C 41.49, H 6.55, N 8.54. 
[Ga(nta)(ser)]−: 
1H NMR (400 MHz, D2O): δ = 3.91–4.04 (sp, 2H, H3), 3.81–3.88 (sp, 1H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.4 (C1), 61.4 (C3), 56.2 (C2) ppm. 
L-Serine: 
1H NMR (400 MHz, D2O): δ = 3.91–4.04 (sp, 2H, H3), 3.81–3.88 (sp, 1H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 172.8 (C1), 60.8 (C3), 56.9 (C2) ppm. 
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5.5.40 HDIPEA[Ga(nta)(thr)] 
 
Starting material: L-Threonine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Threonine (165 mg, 1.00 mmol) was suspended in 1.0 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (774 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (20 mL) and ethyl acetate (40 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C18H34GaN3O9 + 0.50 H2O. 
 Yield:  291 mg (0.565 mmol, 56.5%). 
 Elemental analysis: Calcd. (%): C 41.96, H 6.85, N 8.16. 
Found (%): C 41.80, H 6.67, N 8.28. 
Calcd. C18H34GaN3O9 (%): C 42.71, H 6.77, N 8.30. 
[Ga(nta)(thr)]−:  
1H NMR (400 MHz, D2O): δ = 4.54–4.58 (m, 1H, H3), 3.57–3.63 (sp, 1H, 2H), 1.29–1.36 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.9 (C1), 66.4 (C3), 59.7 (C2), 20.1 (C4) ppm. 
L-Threonine: 
1H NMR (400 MHz, D2O): δ = 4.21–4.28 (m, 1H, H3), 3.57–3.63 (sp, 1H, 2H), 1.29–1.36 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.2 (C1), 66.5 (C3), 61.0 (C2), 20.1 (C4) ppm. 
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5.5.41  HDIPEA[Ga(nta)(trp)] 
 
Starting material: L-Tryptophan, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Tryptophan (204 mg, 1.00 mmol) was suspended in 16 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid 
(191 mg, 1.00 mmol), N,N-diisopropylethylamine (774 µL, 4.50 mmol) and ethanol 
(10 mL) resulted in a yellow solution (pH 7.0) which was stirred for 16 h. The solution was 
concentrated by rotary evaporation and the raw product was precipitated by addition of 
ethanol (10 mL) and ethyl acetate (60 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 2 h.  
 Empirical formula:  C25H37GaN4O8 + 0.25 H2O + 0.20 Ga(OH)3. 
 Yield:  343 mg (0.553 mmol, 55.3%). 
 Elemental analysis: Calcd. (%): C 48.43, H 6.19, N 9.04. 
Found (%): C 48.44, H 6.21, N 9.06. 
Calcd. C25H37GaN4O8 (%): C 50.78, H 6.31, N 9.48. 
[Ga(nta)(trp)]−: 
1H NMR (400 MHz, D2O): δ = 7.66–7.69 (sp, 1H, H8), 7.48–7.52 (sp, 1H, H11), 7.30 (s, 
1H, H5), 7.22–7.26 (sp, 1H, H10), 7.13–7.18 (sp, 1H, H9), 4.02–4.05 (sp, 1H, H2), 3.46–
3.54 (sp, 1H, H3), 3.16–3.24 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.4 (C1), 137.1 (C6), 127.3 (C7), 125.4 (C5), 122.8 
(C10), 120.1 (C9), 119.0 (C8), 112.6 (C11), 109.2 (C4), 54.6 (C2), 28.0 (C3) ppm. 
L-Tryptophan: 
1H NMR (400 MHz, D2O): δ = 7.66–7.69 (sp, 1H, H8), 7.48–7.52 (sp, 1H, H11), 7.26 (s, 
1H, H5), 7.22–7.26 (sp, 1H, H10), 7.13–7.18 (sp, 1H, H9), 4.02–4.05 (sp, 1H, H2), 3.39–
3.45 (m, 1H, H3), 3.22–3.29 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.9 (C1), 136.9 (C6), 127.3 (C7), 125.6 (C5), 122.7 
(C10), 120.1 (C9), 119.0 (C8), 112.6 (C11), 108.1 (C4), 55.5 (C2), 27.0 (C3) ppm. 
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5.5.42 Attempt of synthesis: HDIPEA[Ga(nta)(tyr)] 
 
Starting material: L-Tyrosine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Tyrosine (181 mg, 1.00 mmol) was suspended in 4.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (774 µL, 4.50 mmol) resulted in a colourless 
slurry (pH 8.0) which was stirred for 16 h. The solvent was removed by rotary evaporation 
and the residue was suspended in ethanol (10 mL) and ethyl acetate (30 mL). After 
filtration and washing with ethyl acetate and diethyl ether the obtained colourless 
amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C9H11NO3 + 0.05 C23H36GaN3O9 + 0.05 Ga(OH)3. 
 Yield:  135 mg.  
 Elemental analysis: Calcd. (%): C 56.53, H 6.05, N 7.47. 
Found (%): C 56.42, H 5.91, N 7.28. 
Calcd. C23H36GaN3O9 (%): C 48.61, H 6.39, N 7.39. 
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5.5.43 HDIPEA[Ga(nta)(val)] 
 
Starting material: L-Valine, water, gallium(III) chloride, nitrilotriacetic acid, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Valine (117 mg, 1.00 mmol) was suspended in 1.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), nitrilotriacetic acid (191 mg, 
1.00 mmol) and N,N-diisopropylethylamine (744 µL, 4.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (20 mL) and ethyl acetate (60 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1.5 h.  
 Empirical formula:  C19H36GaN3O8 + 0.15 H2O. 
 Yield:  312 mg (0.615 mmol, 61.5%). 
 Elemental analysis: Calcd. (%): C 45.02, H 7.22, N 8.29. 
Found (%): C 45.01, H 7.14, N 8.24. 
Calcd. C19H36GaN3O8 (%): C 45.26, H 7.20, N 8.33. 
[Ga(nta)(val)]−: 
1H NMR (400 MHz, D2O): δ = 3.65 (d, 1H, H2, 3J2,3 = 3.4 Hz), 2.46–2.54 (m, 1H, H3), 1.08 
(d, 3H, H4, 3J3,4 = 7.0 Hz), 0.91 (d, 3H, H5, 3J3,5 = 7.0 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.5 (C1), 59.8 (C2), 30.2 (C3), 19.2 (C4), 15.9 (C5) 
ppm. 
L-Valine: 
1H NMR (400 MHz, D2O): δ = 3.60 (d, 1H, H2, 3J2,3 = 4.3 Hz), 2.21–2.31 (m, 1H, H3), 1.03 
(d, 3H, H4, 3J3,4 = 7.0 Hz), 0.98 (d, 3H, H5, 3J3,5 = 7.0 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.6 (C1), 60.9 (C2), 29.7 (C3), 18.6 (C4), 17.3 (C5) 
ppm. 
Crystals of HDIPEA[Ga(nta)(val)]·H2O ((HDIPEA)2i·H2O) were obtained after one year by 
storing an aqueous solution (pH 7.0) of the raw product.    
 Empirical formula:  C19H36GaN3O8·H2O, 522.25 g mol−1. 
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 Yield:  Few crystals. 
  
5.5.44 HDIPEA2[{Ga(nta)(µ-OH)}2] 
 
Starting material: Nitrilotriacetic acid, water, gallium(III) chloride, N,N-
diisopropylethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: Nitrilotriacetic acid (191 mg, 1.00 mmol) was suspended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol) and N,N-diisopropyl-
ethylamine (744 µL, 4.50 mmol) resulted in a colourless solution (pH 8.0) which was stirred 
for 16 h. The raw product was precipitated by addition of ethanol (30 mL) and ethyl acetate 
(50 mL). After filtration and washing with ethyl acetate and diethyl ether the obtained 
colourless amorphous solid was first dried at 80 °C for 10 min and then under fine vacuum 
for 1.5 h.  
 Empirical formula:  C28H54Ga2N4O14 + 0.25 Ga(OH)3. 
 Yield:  271 mg (0.322 mmol, 64.5%). 
 Elemental analysis: Calcd. (%): C 40.02, H 6.57, N 6.67. 
Found (%): C 39.99, H 6.40, N 6.73. 
Calcd. C28H54Ga2N4O14 (%): C 41.54, H 6.72, N 6.92. 
[{Ga(nta)(µ-OH)}2]2−: 
1H NMR (400 MHz, D2O): δ = 3.72 (s, 6H) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.3 (C1), 63.2 (C2) ppm. 
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5.5.45 Cs[Ga(ala)(nta)]  
 
Starting material: HNEt3[Ga(ala)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether, methanol. 
Procedure: A solution of HNEt3[Ga(ala)(nta)] (0.65 mmol) and caesium hydroxide 
monohydrate (110 mg, 0.65 mmol) in 6 mL of water (pH 9.0) was stirred for 16 h. The 
solvent was removed by rotary evaporation and the residue was suspended in ethanol 
(30 mL). After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min. The product was dissolved in a 
water/methanol mixture and then dried on a lyophilizer for 4 days.  
 Empirical formula:  C9H12CsGaN2O8 + 0.25 C12H14Cs2Ga2N2O14 + 1.00 CH4O + 
1.00 H2O. 
 Yield:  167 mg (0.228 mmol, 35.1%). 
 Elemental analysis: Calcd. (%): C 21.31, H 2.96, N 4.78. 
Found (%): C 21.34, H 2.97, N 4.78. 
Calcd. C9H12CsGaN2O8 (%): C 22.58, H 2.53, N 5.85. 
 
[Ga(ala)(nta)]−: 
1H NMR (400 MHz, D2O): δ = 3.82 (s, 6H, H2, nta), 3.75–3.82 (sp, 1H, H2, ala), 1.51 (d, 
3H, H3, 3J2,3 = 7.4 Hz, ala) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 180.0 (C1, ala), 175.2 (C1, nta), 63.2 (C2, nta), 50.3 
(C2, ala), 18.0 (C3, ala) ppm. 
L-Alanine: 
1H NMR (400 MHz, D2O): δ = 3.75–3.82 (sp, 1H, H2), 1.46 (d, 3H, H3, 3J2,3 = 7.3 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.3 (C1), 51.1 (C2), 16.8 (C3) ppm. 
[{Ga(nta)(µ-OH)}2]2−: 
1H NMR (400 MHz, D2O): δ = 3.70 (s, 6H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.7 (C1), 63.2 (C2) ppm.  
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5.5.46 Cs[Ga(asn)(nta)]  
 
Starting material: HNEt3[Ga(asn)(nta)], caesium hydroxide monohydrate, triethylamine, 
water, ethanol, diethyl ether. 
Procedure: A solution of HNEt3[Ga(asn)(nta)] (0.32 mmol), caesium hydroxide (56 mg, 
0.34 mmol) and triethylamine (44 µL, 0.32 mmol) in 2 mL of water was stirred for 16 h. The 
solvent was removed by rotary evaporation and the residue was suspended in ethanol 
(10 mL). After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C10H13CsGaN3O9 + 2.35 H2O + 0.25 Ga(OH)3. 
 Yield:  133 mg (0.224 mmol, 70.0%). 
 Elemental analysis: Calcd. (%): C 20.21, H 3.13, N 7.07. 
Found (%): C 20.19, H 3.16, N 7.10. 
Calcd. C10H13CsGaN3O9 (%): C 23.02, H 2.51, N 8.05. 
 
5.5.47 Cs[Ga(gln)(nta)]  
 
Starting material: HNEt3[Ga(gln)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(gln)(nta)] (0.97 mmol) and caesium hydroxide 
monohydrate (171 mg, 1.02 mmol) in 2 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (20 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C11H15CsGaN3O9 + 0.25 C12H14Cs2Ga2N2O14 + 2.80 H2O. 
 Yield:  378 mg (0.478 mmol, 49.3%). 
 Elemental analysis: Calcd. (%): C 21.28, H 3.07, N 6.20. 
Found (%): C 21.38, H 3.13, N 6.09. 
Calcd. C11H15CsGaN3O9 (%): C 24.65, H 2.82, N 7.84. 
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5.5.48 Cs[Ga(gly)(nta)]  
 
Starting material: HNEt3[Ga(gly)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(gly)(nta)] (0.80 mmol) and caesium hydroxide 
monohydrate (141 mg, 0.84 mmol) in 1.5 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (15 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C8H10CsGaN2O8 + 0.35 C12H14Cs2Ga2N2O14 + 5.20 H2O. 
 Yield:  145 mg (0.172 mmol, 21.5%). 
 Elemental analysis: Calcd. (%): C 17.36, H 3.02, N 4.48. 
Found (%): C 17.21, H 2.88, N 4.64. 
Calcd. C8H10CsGaN2O8 (%): C 20.67, H 2.17, N 6.03. 
 
5.5.49 Cs[Ga(ile)(nta)]  
 
Starting material: HNEt3[Ga(ile)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(ile)(nta)] (0.42 mmol) and caesium hydroxide 
monohydrate (75 mg, 0.45 mmol) in 1.5 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C12H18CsGaN2O8 + 0.65 C12H14Cs2Ga2N2O14 + 3.15 H2O. 
 Yield:  118 mg (0.107 mmol, 25.5%). 
 Elemental analysis: Calcd. (%): C 21.47, H 3.04, N 4.17. 
Found (%): C 21.64, H 3.22, N 3.99. 
Calcd. C12H18CsGaN2O8 (%): C 27.67, H 3.48, N 5.38. 
 
EXPERIMENTAL PART 
 180  
5.5.50 Cs[Ga(leu)(nta)]  
 
Starting material: HNEt3[Ga(leu)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(leu)(nta)] (0.11 mmol) and caesium hydroxide 
monohydrate (19 mg, 0.11 mmol) in 0.5 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C12H18CsGaN2O8 + 3.4 H2O + 0.25 C2H6O. 
 Yield:  15 mg (0.025 mmol, 22.7%). 
 Elemental analysis: Calcd. (%): C 25.29, H 4.47, N 4.72. 
Found (%): C 25.28, H 4.44, N 4.71. 
Calcd. C12H18CsGaN2O8 (%): C 27.67, H 3.48, N 5.38. 
 
5.5.51 Cs[Ga(met)(nta)]  
 
Starting material: HNEt3[Ga(met)(nta)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(met)(nta)] (0.30 mmol) and caesium hydroxide 
monohydrate (52 mg, 0.31 mmol) in 1.5 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C11H16CsGaN2O8S + 0.15 C12H14Cs2Ga2N2O14 + 3.05 H2O. 
 Yield:  75 mg (0.105 mmol, 35.0%). 
 Elemental analysis: Calcd. (%): C 21.47, H 3.41, N 4.50, S 4.48. 
Found (%): C 21.48, H 3.29, N 4.38, S 4.58. 
Calcd. C11H16CsGaN2O8S (%): C 24.51, H 2.99, N 5.20, S 
5.95. 
EXPERIMENTAL PART 
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5.5.52 Cs[Ga(nta)(phe)]  
 
Starting material: HNEt3[Ga(nta)(phe)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(phe)] (0.44 mmol) and caesium hydroxide 
monohydrate (77 mg, 0.46 mmol) in 1 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C15H16CsGaN2O8 + 0.05 C12H14Cs2Ga2N2O14 + 3.25 H2O. 
 Yield:  59 mg (0.090 mmol, 20.5%). 
 Elemental analysis: Calcd. (%): C 28.64, H 3.57, N 4.50. 
Found (%): C 28.86, H 3.45, N 4.28. 
Calcd. C15H16CsGaN2O8 (%): C 32.47, H 2.91, N 5.05. 
 
5.5.53 Cs[Ga(nta)(pro)] 
 
Starting material: HNEt3[Ga(nta)(pro)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(pro)] (0.44 mmol) and caesium hydroxide 
monohydrate (77 mg, 0.46 mmol) in 0.5 mL of water was stirred for 16 h. The solvent was 
removed by rotary evaporation and the residue was suspended in ethanol (4 mL). After 
filtration and washing with ethanol and diethyl ether the obtained colourless amorphous 
solid was dried at 80 °C for 10 min.  
 Empirical formula:  C11H14CsGaN2O8 + 0.05 C12H14Cs2Ga2N2O14 + 1.60 H2O. 
 Yield:  45 mg (0.078 mmol, 17.7%). 
 Elemental analysis: Calcd. (%): C 24.25, H 3.14, N 5.12. 
Found (%): C 24.35, H 3.18, N 5.01. 
Calcd. C11H14CsGaN2O8 (%): C 26.17, H 2.80, N 5.55. 
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5.5.54 Cs[Ga(nta)(ser)] 
 
Starting material: HNEt3[Ga(nta)(ser)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(ser)] (0.28 mmol) and caesium hydroxide 
monohydrate (55 mg, 0.33 mmol) in 0.5 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C9H12CsGaN2O9 + 0.30 C12H14Cs2Ga2N2O14 + 3.10 H2O. 
 Yield:  110 mg (0.138 mmol, 49.3%). 
 Elemental analysis: Calcd. (%): C 19.03, H 2.84, N 4.58. 
Found (%): C 18.99, H 2.87, N 4.63. 
Calcd. C9H12CsGaN2O9 (%): C 21.85, H 2.44, N 5.66. 
 
5.5.55 Cs[Ga(nta)(thr)] 
 
Starting material: HNEt3[Ga(nta)(thr)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(thr)] (0.63 mmol) and caesium hydroxide 
monohydrate (110 mg, 0.66 mmol) in 1 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (20 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C10H14CsGaN2O9 + 0.15 C12H14Cs2Ga2N2O14 + 3.05 H2O. 
 Yield:  238 mg (0.347 mmol, 55.1%). 
 Elemental analysis: Calcd. (%): C 20.66, H 3.26, N 4.70. 
Found (%): C 20.61, H 3.33, N 4.77. 
Calcd. C10H14CsGaN2O9 (%): C 23.60, H 2.77, N 5.51. 
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5.5.56 Cs[Ga(nta)(trp)] 
 
Starting material: HNEt3[Ga(nta)(trp)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(trp)] (0.69 mmol) and caesium hydroxide 
monohydrate (121 mg, 0.72 mmol) in 2 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (20 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C17H17CsGaN3O8 + 1.65 C12H14Cs2Ga2N2O14 + 4.00 H2O. 
 Yield:  170 mg (0.085 mmol, 12.4%). 
 Elemental analysis: Calcd. (%): C 21.97, H 2.41, N 4.39. 
Found (%): C 22.20, H 2.63, N 4.15. 
Calcd. C17H17CsGaN3O8 (%): C 34.38, H 2.89, N 7.07. 
 
5.5.57 Cs[Ga(nta)(val)] 
 
Starting material: HNEt3[Ga(nta)(val)], caesium hydroxide monohydrate, water, ethanol, 
diethyl ether. 
Procedure: A solution of HNEt3[Ga(nta)(val)] (0.60 mmol) and caesium hydroxide 
monohydrate (105 mg, 0.63 mmol) in 1 mL of water was stirred for 16 h. The raw product 
was precipitated by addition of ethanol (10 mL). After filtration and washing with ethanol 
and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C11H16CsGaN2O8 + 0.35 C12H14Cs2Ga2N2O14 + 3.85 H2O. 
 Yield:  208 mg (0.241 mmol, 40.2%). 
 Elemental analysis: Calcd. (%): C 21.19, H 3.35, N 4.39. 
Found (%): C 21.24, H 3.32, N 4.32. 
Calcd. C11H16CsGaN2O8 (%): C 26.07, H 3.18, N 5.53. 
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5.5.58  [Ga(ala)(edda)] 
 
Starting material: L-Alanine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Alanine (89 mg, 1.0 mmol) was dissolved in 1 mL of water. Gradual addition 
of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-diacetic acid 
(176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a colourless 
solution (pH 8.0) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (30 mL) and ethyl acetate (10 mL). 
After filtration and washing with ethanol, ethyl acetate and diethyl ether the obtained 
colourless amorphous solid was dried at 80 °C for 10 min and then on a lyophilizer for 7 
days. 
 Empirical formula:  C9H16GaN3O6 + 0.20 H2O. 
 Yield:  318 mg (0.948 mmol, 94.8%). 
 Elemental analysis: Calcd. (%): C 32.21, H 4.93, N 12.52. 
Found (%): C 32.28, H 5.01, N 12.49. 
Calcd. C9H16GaN3O6 (%): C 32.56, H 4.86, N 12.66. 
[Ga(ala)(edda)]: 
1H NMR (400 MHz, D2O): δ = 3.74–3.81 (sp, 1H, H2), 1.45–1.50 (sp, 3H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 180.3–180.5 (2s, C1), 49.8–50.5 (2s, C2), 18.0–18.2 
(3s, C3) ppm. 
L-Alanine: 
1H NMR (400 MHz, D2O): δ = 3.77 (q, 1H, H2, 3J2,3 = 7.2 Hz), 1.47 (d, 3H, H3, 3J2,3 = 
7.2 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.3 (C1), 51.1 (C2), 16.8 (C3) ppm. 
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5.5.59 [Ga(Harg)(edda)]Cl 
 
Starting material: L-Arginine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Arginine (174 mg, 1.00 mmol) was dissolved in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 9.0) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (40 mL). After filtration the colourless amorphous solid was washed 
with ethanol and diethyl ether and dried at 80 °C for 10 min and then on a lyophilizer for 8 
days. 
 Empirical formula:  C12H24ClGaN6O6 + 2.00 H2O + 0.05 C6H16ClN. 
 Yield:  307 mg (0.618 mmol, 61.8%). 
 Elemental analysis: Calcd. (%): C 29.76, H 5.85, N 17.07. 
Found (%): C 29.83, H 5.86, N 16.98. 
Calcd. C12H24ClGaN6O6 (%): C 34.56, H 5.56, N 20.15. 
[Ga(Harg)(edda)]Cl: 
1H NMR (400 MHz, D2O): δ = 3.64–3.75 (sp, 1H, H2), 3.20–3.28 (sp, 2H, H5), 1.94–2.12 
(sp, 2H, H3), 1.71–1.90 (sp, 2 H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.9–179.1 (3s, C1), 157.3 (C6), 53.8–54.3 (3s, C2), 
41.2 (2s, C5), 29.3–29.4 (2s, C3), 25.3–25.6 (2s, C4) ppm. 
L-Arginine·HCl: 
1H NMR (400 MHz, D2O): δ = 3.77 (t, 1H, H2, 3J2,3 = 6.1 Hz), 3.24 (t, 2H, H5, 3J4,5 = 6.9 
Hz), 1.88–1.95 (sp, 2H, H3), 1.58–1.80 (sp, 2 H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.9 (C1), 157.3 (C6), 54.9 (C2), 41.1 (C5), 28.1 (C3), 
24.5 (C4) ppm. 
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5.5.60 [Ga(asn)(edda)] 
 
Starting material: L-Asparagine monohydrate, water, gallium(III) chloride, 
ethylenediamine-N,N′-diacetic, triethylamine, ethanol, diethyl ether, acetone. 
Procedure: L-Asparagine monohydrate (150 mg, 1.00 mmol) was suspended in 1 mL of 
water. Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), 
ethylenediamine-N,N′-diacetic (176 mg, 1.00 mmol) and triethylamine (488 µL, 
3.50 mmol) resulted in a colourless solution (pH 8.5) which was stirred for 16 h. The raw 
product was precipitated by addition of ethanol (30 mL). After filtration the colourless 
amorphous solid was washed with ethanol and diethyl ether and dried at 80 °C for 10 min.  
 Empirical formula:  C10H17GaN4O7 + 0.15 H2O. 
 Yield:  324 mg (0.858 mmol, 85.8%). 
 Elemental analysis: Calcd. (%): C 31.80, H 4.62, N 14.83. 
Found (%): C 31.96, H 4.64, N 14.67. 
Calcd. C10H17GaN4O7 (%): C 32.03, H 4.57, N 14.94. 
[Ga(asn)(edda)]: 
1H NMR (400 MHz, D2O): δ = 3.98–4.01 (sp, 1H, H2), 2.89–2.97 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.1–178.6 (2s, C1), 175.4–175.5 (3s, C4), 50.4–51.6 
(2s, C2), 36.2–36.4 (3s, C3) ppm. 
L-Asparagine: 
1H NMR (400 MHz, D2O): δ = 3.98–4.01 (sp, 1H, H2), 2.82–2.97 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.0 (C4), 173.8 (C1), 51.9 (C2), 35.1 (C3) ppm. 
 
Crystals of [Ga(asn)(edda)]·2H2O (3a·2H2O) were obtained after four weeks by storing an 
aqueous solution (pH 7.0) of the raw product over acetone.    
 Empirical formula:  C10H17GaN4O7·2H2O, 411.03 g mol−1. 
 Yield:  Few crystals. 
EXPERIMENTAL PART 
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5.5.61 [Ga(Hasp)(edda)]·0.30NEt3 
 
Starting material: L-Aspartic acid, water, gallium(III) chloride, ethylenediamine-N,N′-
diacetic acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Aspartic acid (133 mg, 1.00 mmol) was suspended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-
N,N′-diacetic acid (176 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in 
a colourless solution (pH 9.0) which was stirred for 16 h. The solvent was removed by 
rotary evaporation and the residue was suspended in ethanol (30 mL) and ethyl acetate 
(10 mL). After filtration and washing with ethanol, ethyl acetate and diethyl ether the 
obtained colourless amorphous solid was first dried at 80 °C for 10 min and then on a 
lyophilizer for 4 days.  
 Empirical formula:  C10H16GaN3O8·0.30C6H15N + 1.30 H2O. 
 Yield:  251 mg (0.584 mmol, 58.4%). 
 Elemental analysis: Calcd. (%): C 32.98, H 5.42, N 10.76. 
Found (%): C 32.95, H 5.35, N 10.82. 
Calcd. C10H16GaN3O8 (%): C 31.95, H 4.29, N 11.18. 
[Ga(Hasp)(edda)]: 
1H NMR (400 MHz, D2O): δ = 3.93–3.99 (sp, 1H, H2), 2.81–2.90 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 52.1 (1s, C2). 37.9 (1s, C3) ppm. 
L-Aspartic acid: 
1H NMR (400 MHz, D2O): δ = 3.93–3.99 (sp, 1H, H2), 2.81–2.90 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 52.2 (C2), 36.6 (C3) ppm. 
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5.5.62 [Ga(cys)(edda)] 
 
Starting material: L-Cysteine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Cysteine (146 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 7.0) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (50 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then on a 
lyophilizer for 3 days.  
 Empirical formula:  C9H16GaN3O6S + 1.05 H2O + 0.10 C6H16ClN. 
 Yield:  360 mg (0.907 mmol, 90.7%). 
 Elemental analysis: Calcd. (%): C 29.07, H 5.01, N 10.95, S 8.08. 
Found (%): C 29.03, H 4.91, N 11.06, S 7.98. 
Calcd. C9H16GaN3O6S (%): C 29.07, H 4.43, N 11.54, S 8.81. 
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5.5.63 [Ga(edda)(gln)] 
 
Starting material: L-Glutamine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Glutamine (146 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 8.0) which was stirred for 16 h. Ethanol (10 mL) was added to the 
obtained slurry. After filtration and washing with ethanol and diethyl ether the obtained 
colourless amorphous solid was first dried at 80 °C for 10 min and then on a lyophilizer for 
7 days.  
 Empirical formula:  C11H19GaN4O7 + 0.80 H2O + 0.05 C6H16ClN. 
 Yield:  269 mg (0.656 mmol, 65.6%). 
 Elemental analysis: Calcd. (%): C 33.08, H 5.26, N 13.83. 
Found (%): C 32.94, H 5.45, N 14.00. 
Calcd. C11H19GaN4O7 (%): C 33.96, H 4.92, N 14.40. 
[Ga(edda)(gln)]: 
1H NMR (400 MHz, D2O): δ = 3.59 (t, 1H, H2, 3J2,3 = 6.2 Hz), 2.33–2.44 (sp, 2H, H4), 1.96–
2.11 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.7 (C5), 177.4 (C1), 55.2 (C2), 31.8 (C4), 28.4 (C3) 
ppm. 
L-Glutamine: 
1H NMR (400 MHz, D2O): δ = 4.14–4.18 (m, 1H, H2), 2.41–2.53 (sp, 2H, H4), 1.99–2.43 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 182.3 (C5), 180.8 (C1), 59.0 (C2), 30.3 (C4), 26.0 (C3) 
ppm. 
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5.5.64 [Ga(edda)(Hglu)]·0.15NEt3 
 
Starting material: L-Glutamic acid, water, gallium(III) chloride, ethylenediamine-N,N′-
diacetic acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Glutamic acid (147 mg, 1.00 mmol) was suspended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-
N,N′-diacetic acid (176 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in 
a colourless solution (pH 9.0) which was stirred for 16 h. The solvent was removed by 
rotary evaporation and the residue was suspended in ethanol (30 mL) and ethyl acetate 
(10 mL). After filtration and washing with ethanol, ethyl acetate and diethyl ether the 
obtained colourless amorphous solid was first dried at 80 °C for 10 min and then on a 
lyophilizer for 4 days.  
 Empirical formula:  C11H18GaN3O8·0.15C6H15N + 1.25 H2O. 
 Yield:  215 mg (0.503 mmol, 50.3%). 
 Elemental analysis: Calcd. (%): C 33.42, H 5.36, N 10.32. 
Found (%): C 33.35, H 5.31, N 10.37. 
Calcd. C11H18GaN3O8 (%): C 33.88, H 4.65, N 10.77. 
[Ga(edda)(Hglu)]: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.48 (sp, 2H, H4), 1.98–2.20 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 54.6 (1s, C2), 32.9 (1s, C4). 28.1 (1s, C3) ppm. 
L-Glutamic acid: 
1H NMR (400 MHz, D2O): δ = 3.78–3.82 (sp, 1H, H2), 2.41–2.48 (sp, 2H, H4), 1.98–2.20 
(sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 180.0 (C5), 174.8 (C1), 54.9 (C2), 32.8 (C4), 26.9 (C3) 
ppm. 
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5.5.65 [Ga(edda)(gly)] 
 
Starting material: Glycine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether, acetone. 
Procedure: Glycine (75 mg, 1.0 mmol) was dissolved in 1 mL of water. Gradual addition 
of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-diacetic acid 
(176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a colourless 
solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated by addition 
of ethanol (30 mL). After filtration and washing with ethanol and diethyl ether the obtained 
colourless amorphous solid was first dried at 80 °C for 10 min, then under fine vacuum for 
2 h and finally on a lyophilizer for 3 days.  
 Empirical formula:  C8H14GaN3O6 + 1.40 H2O + 0.10 Ga(OH)3. 
 Yield:  287 mg (0.808 mmol, 80.8%). 
 Elemental analysis: Calcd. (%): C 27.05, H 4.85, N 11.83. 
Found (%): C 27.03, H 4.84, N 11.85. 
Calcd. C8H14GaN3O6 (%): C 30.22, H 4.44, N 13.22. 
[Ga(edda)(gly)]: 
1H NMR (400 MHz, D2O): δ = 3.45–3.57 (sp, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.0–177.1 (2s, C1), 41.7–42.4 (2s, C2) ppm. 
Glycine: 
1H NMR (400 MHz, D2O): δ = 3.55 (s, 2H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.0 (C1), 42.0 (C2) ppm. 
Crystals of [Ga(edda)(gly)]·2H2O (3b·2H2O) were obtained after one week by storing an 
aqueous solution (pH 7.0) of the raw product over acetone.    
 Empirical formula:  C8H14GaN3O6·2H2O, 353.97 g mol−1. 
 Yield:  277 mg (0.783 mmol, 78.3%). 
 Elemental analysis: Calcd. (%): C 27.15, H 5.13, N 11.87. 
Found (%): C 27.38, H 5.08, N 11.77. 
EXPERIMENTAL PART 
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5.5.66 [Ga(edda)(Hhis)]Cl 
 
Starting material: L-Histidine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, acetone, diethyl ether. 
Procedure: L-Histidine (155 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless slurry (pH 9.0) which was stirred for 16 h. The raw product was precipitated by 
addition of ethanol (30 mL) and acetone (80 mL). After filtration and washing with ethanol, 
acetone and diethyl ether the obtained colourless amorphous solid was dried at 80 °C for 
10 min and then on a lyophilizer for 4 days.  
Empirical formula:  C12H19ClGaN5O6 + 0.10 H2O + 0.05 C6H16ClN. 
 Yield:  217 mg (0.490 mmol, 49.0%). 
 Elemental analysis: Calcd. (%): C 33.34, H 4.55, N 15.96. 
Found (%): C 33.41, H 4.68, N 15.95. 
Calcd. C12H19ClGaN5O6 (%): C 33.17, H 4.41, N 16.12. 
[Ga(edda)(Hhis)]Cl: 
1H NMR (400 MHz, D2O): δ = 8.00–8.16 (m, 1H, H6), 7.06–7.19 (sp, 1H, H5), 3.88–3.99 
(sp, 1H, H2), 3.14–3.28 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.7–177.1 (2s, C1), 136.2–137.8 (2s, C6), 132.4–
133.2 (2s, C4), 117.4–124.0 (2s, C5), 54.3–54.4 (2s, C2), 26.5–28.8 (2s, C3) ppm. 
L-Histidine·HCl: 
1H NMR (400 MHz, D2O): δ = 7.95 (s, 1H, H6), 7.12 (s, 1H, H5), 3.88–3.99 (sp, 1H, H2), 
3.14–3.28 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.2 (C1), 136.5 (C6), 131.8 (C4), 117.7 (C5), 55.1 
(C2), 28.2 (C3) ppm. 
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5.5.67 [Ga(edda)(ile)] 
 
Starting material: L-Isoleucine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Isoleucine (131 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless slurry (pH 8.0) which was stirred for 16 h. The raw product was precipitated by 
addition of ethanol (30 mL) and ethyl acetate (20 mL). After filtration and washing with 
ethanol and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C 
for 10 min and then on a lyophilizer for 3 days.  
 Empirical formula:  C12H22GaN3O6 + 0.80 H2O + 0.05 C6H16ClN. 
 Yield:  333 mg (0.842 mmol, 84.2%). 
 Elemental analysis: Calcd. (%): C 37.37, H 6.22, N 10.81. 
Found (%): C 37.42, H 6.32, N 10.85. 
Calcd. C12H22GaN3O6 (%): C 38.53, H 5.93, N 11.23. 
[Ga(edda)(ile)]: 
1H NMR (400 MHz, D2O): δ = 3.58–3.68 (sp, 1H, H2), 2.11–2.26 (sp, H1, H3), 1.21–1.31 
(sp, 2H, H4), 1.00–1.04 (sp, 3H, H6), 0.86–0.95 (sp, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.2–179.3 (2s, C1), 59.2–59.8 (3s, C2), 37.2–37.5 
(2s, C3), 24.0–24.2 (2s, C4), 15.9–16.4 (3s, C6), 11.9–12.0 (2s, C5) ppm. 
L-Isoleucine: 
1H NMR (400 MHz, D2O): δ = 3.66 (d, 1H, H2, 3J2,3 = 4.0 Hz), 1.92–2.02 (m, H1, H3), 1.40–
1.51 (m, 1H, H4), 1.19–1.33 (sp, 1H, H4), 1.00 (d, 3H, H6, 3J3,6 = 7.0 Hz), 0.93 (t, 3H, H5, 
3J4,5 = 7.4 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.7 (C1), 60.2 (C2), 36.5 (C3), 25.1 (C4), 15.3 (C6), 
11.7 (C5) ppm. 
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5.5.68 [Ga(edda)(leu)] 
 
Starting material: L-Leucine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, acetone, diethyl ether, acetonitrile. 
Procedure: L-Leucine (131 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless slurry (pH 8.5) which was stirred for 16 h. The raw product was precipitated by 
addition of ethanol (30 mL) and acetone (30 mL). After filtration and washing with ethanol, 
acetone and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C 
for 10 min and then on a lyophilizer for 4 days.  
 Empirical formula:  C12H22GaN3O6 + 1.50 H2O. 
 Yield:  239 mg (0.596 mmol, 59.6%). 
 Elemental analysis: Calcd. (%): C 35.94, H 6.28, N 10.48. 
Found (%): C 35.94, H 6.24, N 10.43. 
Calcd. C12H22GaN3O6 (%): C 38.53, H 5.93, N 11.23. 
[Ga(edda)(leu)]: 
1H NMR (400 MHz, D2O): δ = 3.69–3.74 (sp, 1H, H2), 1.59–1.79 (sp, 3H, H3/H4), 0.91–
1.01 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 180.2–180.3 (2s, C1), 53.1–53.2 (2s, C2), 41.5 (1s, 
C3), 25.0–25.2 (3s, C4), 23.0–23.1 (3s, C5), 20.6–20.8 (3s, C6) ppm. 
L-Leucine: 
1H NMR (400 MHz, D2O): δ = 3.69–3.74 (sp, 1H, H2), 1.59–1.79 (sp, 3H, H3/H4), 0.91–
1.01 (sp, 6H, H5/H6) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 176.1 (C1), 54.0 (C2), 40.4 (C3), 24.8 (C4), 22.7 (C5), 
21.5 (C6) ppm. 
Crystals of [Ga(edda)(leu)]2·[{Ga(edda)(µ-OH)}2]·6H2O (3c·3d·3i·6H2O) were obtained 
after two months by storing an aqueous solution (pH 7.0) of the raw product over 
acetonitrile.    
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 Empirical formula:  2C12H22GaN3O6·C12H22Ga2N4O10·6H2O, 1377.96 g mol−1. 
 Yield:  Few crystals. 
  
5.5.69 [Ga(edda)(Hlys)]Cl 
 
Starting material: L-Lysine hydrochloride, water, gallium(III) chloride, ethylenediamine-
N,N′-diacetic acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Lysine hydrochloride (183 mg, 1.00 mmol) was dissolved in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-
N,N′-diacetic acid (176 mg, 1.00 mmol) and triethylamine (627 µL, 4.50 mmol) resulted in 
a colourless solution (pH 9.0) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (40 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then on a 
lyophilizer for 7 days. 
 Empirical formula:  C12H24ClGaN4O6 + 0.60 H2O. 
 Yield:  350 mg (0.802 mmol, 80.2%). 
 Elemental analysis: Calcd. (%): C 33.03, H 5.82, N 12.84. 
Found (%): C 33.07, H 5.73, N 12.74. 
Calcd. C12H24ClGaN4O6 (%): C 33.87, H 5.69, N 13.17. 
[Ga(edda)(lys)]Cl: 
1H NMR (400 MHz, D2O): δ = 3.63–3.76 (sp, 1H, H2), 2.94–3.07 (sp, 2H, H6), 1.89–2.10 
(sp, 2H, H3), 1.68–1.85 (sp, 2H, H5), 1.50–1.60 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.2–179.4 (3s, C1), 53.9–54.5 (3s, C2), 39.8 (C6), 
31.6–31.7 (3s, C3), 26.9 (2s, C5), 22.7–23.13 (2s, C4) ppm. 
L-Lysine·HCl: 
1H NMR (400 MHz, D2O): δ = 3.75 (t, 1H, H2, 3J2,3 = 6.1 Hz), 2.99–3.04 (sp, 2H, H6), 1.86–
1.93 (sp, 2H, H3), 1.68–1.76 (sp, 2H, H5), 1.37–1.59 (sp, 2H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.1 (C1), 55.1 (C2), 39.7 (C6), 30.5 (C3), 27.0 (C5), 
22.0 (C4) ppm. 
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5.5.70 [Ga(edda)(met)] 
 
Starting material: L-Methionine, water, gallium(III) chloride, ethylenediamine-N,N′-
diacetic acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Methionine (149 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 8.0) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (20 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was dried at 80 °C for 1 h.  
 Empirical formula:  C11H20GaN3O6S + 0.55 H2O + 0.15 Ga(OH)3. 
 Yield:  340 mg (0.809 mmol, 80.9%). 
 Elemental analysis: Calcd. (%): C 31.45, H 5.17, N 10.00, S 7.63. 
Found (%): C 31.42, H 5.13, N 10.08, S 7.65. 
Calcd. C11H20GaN3O6S (%): C 33.70, H 5.14, N 10.72, S 8.18. 
[Ga(edda)(met)]: 
1H NMR (400 MHz, D2O): δ = 3.75–3.87 (sp, 1H, H2), 2.63–2.78 (sp, 2H, H4), 2.17–2.33 
(sp, 1H, H3), 2.11–2.13 (sp, 3H, H5), 2.00–2.12 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.9–179.1 (3s, C1), 52.9–53.9 (3s, C2), 31.2–31.3 
(3s, C3), 30.2–30.4 (3s, C4), 14.5 (3s, C5) ppm. 
L-Methionine: 
1H NMR (400 MHz, D2O): δ = 3.83–3.87 (sp, 1H, H2), 2.62 (t, 2H, H4, 3J3,4 = 7.5 Hz), 2.08–
2.22 (sp, 2H, H3), 2.12 (s, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.8 (C1), 54.5 (C2), 30.3 (C3), 29.5 (C4), 14.6 (C5) 
ppm. 
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5.5.71 [Ga(edda)(phe)] 
 
Starting material: L-Phenylalanine, water, gallium(III) chloride, ethylenediamine-N,N′-
diacetic acid, triethylamine, ethanol, ethyl acetate, diethyl ether, acetone. 
Procedure: L-Phenylalanine (165 mg, 1.00 mmol) was dissolved in 11 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-
N,N′-diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in 
a colourless slurry (pH 8.5) which was stirred for 16 h. The colourless slurry was 
concentrated by rotary evaporation and the raw product was precipitated by addition of 
ethanol (10 mL) and ethyl acetate (30 mL). After filtration and washing with ethyl acetate 
and diethyl ether the obtained colourless amorphous solid was first dried at 80 °C for 
10 min and then under fine vacuum for 1 h.  
 Empirical formula:  C15H20GaN3O6 + 1.05 H2O. 
 Yield:  380 mg (0.890 mmol, 89.0%). 
 Elemental analysis: Calcd. (%): C 42.20, H 5.22, N 9.84. 
Found (%): C 42.21, H 5.21, N 9.88. 
Calcd. C15H20GaN3O6 (%): C 44.15, H 4.94, N 10.30. 
L-Phenylalanine: 
1H NMR (400 MHz, D2O): δ = 7.31–7.41 (sp, 2H, H6), 7.27–7.37 (sp, 1H, H7), 7.24–7.37 
(sp, 2H , H5), 3.54–3.59 (m, 1H, H2), 2.99–3.13 (sp, 1H, H3), 2.81–2.91 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 181.2 (C1), 138.4 (C4), 130.0 (C5), 129.3 (C6), 127.4 
(C7), 57.8 (C2), 40.6 (C3) ppm. 
Crystals of 2[Ga(edda)(phe)]·3H2O (3e·3f·3H2O) were obtained after one week by storing 
an aqueous solution of the raw product (360 mg) and 200 µL of triethylamine (pH 9.5) over 
acetone.  
 Empirical formula:  C15H20GaN3O6·1.5H2O, 435.09 g mol−1. 
 Yield:  191 mg (0.439 mmol, 43.9%). 
 Elemental analysis: Calcd. (%): C 41.41, H 5.33, N 9.66. 
Found (%): C 41.21, H 5.29, N 9.65. 
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5.5.72 [Ga(edda)(pro)] 
 
Starting material: L-Proline, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Proline (115 mg, 1.00 mmol) was dissolved in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 8.5) which was stirred for 16 h. The raw product was precipitated 
by addition of ethanol (50 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min, then under 
fine vacuum for 2 h and finally on a lyophilizer for 7 days. 
 Empirical formula:  C11H18GaN3O6 + 0.10 H2O. 
 Yield:  306 mg (0.850 mmol, 85.0%). 
 Elemental analysis: Calcd. (%): C 36.72, H 5.10, N 11.68. 
Found (%): C 36.78, H 5.00, N 11.57. 
Calcd. C11H18GaN3O6 (%): C 36.90, H 5.07, N 11.74. 
[Ga(edda)(pro)]: 
1H NMR (400 MHz, D2O): δ = 4.09–4.14 (sp, 1H, H2), 3.29–3.45 (sp, 2H, H5), 2.29–2.38 
(sp, 1H, H3), 1.97–2.10 (sp, 2H, H4), 1.92–2.03 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.7–179.9 (3s, C1), 60.9–62.1 (3s, C2), 47.8–48.5 
(3s, C5), 30.1–30.2 (2s, C3), 27.0–27.3 (3s, C4) ppm. 
L-Proline: 
1H NMR (400 MHz, D2O): δ = 4.09–4.14 (sp, 1H, H2), 3.29–3.45 (sp, 2H, H5), 2.29–2.38 
(sp, 1H, H3), 1.97–2.10 (sp, 2H, H4), 1.92–2.03 (sp, 1H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.2 (C1), 61.8 (C2), 46.7 (C5), 29.6 (C3), 24.4 (C4) 
ppm. 
Crystals of [Ga(edda)(pro)]·3H2O (3g·3H2O) were obtained after one week by storing an 
aqueous solution (pH 7.0) of the raw product over ethanol.    
 Empirical formula:  C11H18GaN3O6·3H2O, 412.05 g mol−1. 
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 Yield:  168 mg (0.408 mmol, 40.8%). 
 Elemental analysis: Calcd. (%): C 32.06, H 5.87, N 10.20. 
Found (%): C 31.83, H 5.62, N 10.21. 
 
5.5.73 [Ga(edda)(ser)] 
 
Starting material: L-Serine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether, acetone. 
Procedure: L-Serine (105 mg, 1.00 mmol) was dissolved in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 8.5) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the resulting amorphous solid was resolved in water (1 mL). A colourless 
precipitate was obtained by addition of ethanol (30 mL). After filtration and washing with 
ethanol and diethyl ether the obtained colourless amorphous solid was again dissolved in 
water (2 mL). The raw product was precipitated by addition of ethanol (50 mL) and ethyl 
acetone (20 mL). After filtration and washing with ethanol, acetone and diethyl ether the 
obtained colourless amorphous solid was dried on a lyophilizer for 1 day. 
 Empirical formula:  C9H16GaN3O7 + 1.55 H2O + 0.10 Ga(OH)3. 
 Yield:  242 mg (0.624 mmol, 62.4%). 
 Elemental analysis: Calcd. (%): C 27.86, H 5.04, N 10.83. 
Found (%): C 27.86, H 5.00, N 10.88. 
Calcd. C9H16GaN3O7 (%): C 31.07, H 4.63, N 12.08. 
[Ga(edda)(ser)]: 
1H NMR (400 MHz, D2O): δ = 3.91–4.01 (sp, 2H, H3), 3.80–3.87 (sp, 1H, H2) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.1–177.2 (2s, C1), 61.4–62.1 (3s, C3), 55.5–56.5 
(4s, C2) ppm. 
L-Serine: 
1H NMR (400 MHz, D2O): δ = 3.91–4.01 (sp, 2H, H3), 3.80–3.87 (sp, 1H, H2) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 172.9 (C1), 60.8 (C3), 57.0 (C2) ppm. 
 
5.5.74 [Ga(edda)(thr)] 
 
Starting material: L-Threonine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether, acetone. 
Procedure: L-Threonine (119 mg, 1.00 mmol) was suspendended in 1 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-
N,N′-diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in 
a colourless solution (pH 8.5) which was stirred for 16 h. The solvent was removed by 
rotary evaporation and the residue was suspended in water (1 mL) and ethanol (30 mL). 
After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was again dissolved in water (2 mL). The raw product was precipitated 
by addition of ethanol (50 mL). After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was dried on a lyophilizer for 1 day.  
 Empirical formula:  C10H18GaN3O7 + 1.75 H2O. 
 Yield:  280 mg (0.712 mmol, 71.2%). 
 Elemental analysis: Calcd. (%): C 30.52, H 5.51, N 10.68. 
Found (%): C 30.71, H 5.35, N 10.49. 
Calcd. C10H18GaN3O7 (%): C 33.18, H 5.01, N 11.61. 
[Ga(edda)(thr)]: 
1H NMR (400 MHz, D2O): δ = 4.51–4.60 (sp, 1H, H3), 3.53–3.63 (sp, 1H, 2H), 1.26–1.33 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.3–177.4 (2s, C1), 66.4–66.8 (3s, C3), 59.0–60.1 
(4s, C2), 20.0–20.2 (3s, C4) ppm. 
L-Threonine: 
1H NMR (400 MHz, D2O): δ = 4.21–4.28 (m, 1H, H3), 3.53–3.63 (sp, 1H, 2H), 1.26-1.33 
(sp, 3H, H4) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 173.4 (C1), 66.5 (C3), 61.0 (C2), 20.1 (C4) ppm. 
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Crystals of [Ga(edda)(thr)]·2H2O (3h·2H2O) were obtained after one month by storing an 
aqueous solution (pH 6.0) of the raw product over acetone.    
 Empirical formula:  C10H18GaN3O7·2H2O, 398.02 g mol−1. 
 Yield:  260 mg (0.653 mmol, 65.3%). 
 Elemental analysis: Calcd. (%): C 30.18, H 5.57, N 10.56. 
Found (%): C 30.15, H 5.47, N 10.54. 
 
5.5.75 [Ga(edda)(trp)] 
 
Starting material: L-Tryptophan, water, gallium(III) chloride, ethylenediamine-N,N′-
diacetic acid, triethylamine, ethanol, acetone, diethyl ether. 
Procedure: L-Tryptophan (204 mg, 1.00 mmol) was suspended in 3 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (432 µL, 3.10 mmol) resulted in a 
colourless solution (pH 8.0) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (60 mL). After filtration and 
washing with ethanol, acetone and diethyl ether the obtained colourless amorphous solid 
was first dried at 80 °C for 10 min and then on a lyophilizer for 1 day.  
 Empirical formula:  C17H21GaN4O6 + 1.50 H2O. 
 Yield:  385 mg (0.812 mmol, 81.2%). 
 Elemental analysis: Calcd. (%): C 43.07, H 5.10, N 11.82. 
Found (%): C 43.03, H 5.05, N 11.76. 
Calcd. C17H21GaN4O6 (%): C 45.67, H 4.73, N 12.53. 
L-Tryptophan: 
1H NMR (400 MHz, D2O): δ = 7.69–7.71 (m, 1H, H8), 7.46–7.50 (m, 1H , H11), 7.22 (s, 
1H, H5), 7.19–7.28 (sp, 1H, H10), 7.12–7.17 (m, 1H, H9), 3.67–3.71 (sp, 1H, H2), 3.22–
3.30 (sp, 2H, H3) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 180.2 (C1), 136.8 (C6), 127.7 (C7), 125.1 (C5), 122.5 
(C10), 119.8 (C9), 119.3 (C8), 112.4 (C11), 110.2 (C4), 56.6 (C2), 29.6 (C3) ppm. 
 
5.5.76 Attempt of synthesis: [Ga(edda)(tyr)] 
 
Starting material: L-Tyrosine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: L-Tyrosine (181 mg, 1.00 mmol) was suspended in 11 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless slurry (pH 8.0) which was stirred for 16 h. Ethanol (50 mL) and ethyl acetate 
(20 mL) were added to the slurry. After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C9H11NO3 + 0.05 H2O. 
 Yield:  147 mg. 
 Elemental analysis: Calcd. (%): C 59.37, H 6.14, N 7.69. 
Found (%): C 59.27, H 6.14, N 7.70. 
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5.5.77 [Ga(edda)(val)] 
 
Starting material: L-Valine, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, triethylamine, ethanol, diethyl ether. 
Procedure: L-Valine (117 mg, 1.00 mmol) was suspended in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N′-
diacetic acid (176 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a 
colourless solution (pH 8.5) which was stirred for 16 h. The solvent was removed by rotary 
evaporation and the residue was suspended in ethanol (40 mL). After filtration and 
washing with ethanol and diethyl ether the obtained colourless amorphous solid was first 
dried at 80 °C for 10 min, then under fine vacuum for 2 h and finally on a lyophilizer for 
7 days. 
 Empirical formula:  C11H20GaN3O6 + 0.50 H2O. 
 Yield:  181 mg (0.490 mmol, 49.0%). 
 Elemental analysis: Calcd. (%): C 35.80, H 5.74, N 11.39. 
Found (%): C 35.86, H 5.73, N 11.31. 
Calcd. C11H20GaN3O6 (%): C 36.70, H 5.60, N 11.67. 
[Ga(edda)(val)]: 
1H NMR (400 MHz, D2O): δ = 3.57–3.67 (sp, 1H, H2), 2.38–2.53 (sp, 1H, H3), 1.02–1.06 
(sp, 3H, H4), 0.85–0.92 (sp, 3H, H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.3–179.5 (3s, C1), 59.4–60.2 (3s, C2), 30.0–30.9 
(4s, C3), 19.0–19.2 (3s, C4), 15.7–15.9 (2s, C5) ppm. 
L-Valine: 
1H NMR (400 MHz, D2O): δ = 3.60 (d, 1H, H2, 3J2,3 = 4.4 Hz), 2.22–2.32 (m, 1H, H3), 1.03 
(d, 3H, H4, 3J3,4 = 7.0 Hz), 0.98 (d, 3H, H5, 3J3,5 = 7.0 Hz) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 174.8 (C1), 61.0 (C2), 29.7 (C3), 18.6 (C4), 17.3 (C5) 
ppm. 
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5.5.78 [{Ga(edda)(OH)}6] 
 
Starting material: Ethylenediamine-N,N′-diacetic acid, gallium(III) chloride, water, 
triethylamine, ethanol, ethyl acetate, diethyl ether, acetone. 
Procedure: Ethylenediamine-N,N′-diacetic acid (176 mg, 1.00 mmol) was dissolved in 
gallium(III) chloride solution (176 mg, 1.00 mmol), 0.5 mL of water and triethylamine 
(488 µL, 3.50 mmol). The colourless solution (pH 8.5) was stirred for 16 h. Ethanol (30 mL) 
and ethyl acetate (20 mL) were added. After filtration and washing with ethanol and diethyl 
ether the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then 
on a lyophilizer for 2 days. 
 Empirical formula:  C36H66Ga6N12O30 + 7.60 H2O. 
 Yield:  62 mg (0.036 mmol, 21.9%). 
 Elemental analysis: Calcd. (%): C 25.40, H 4.81, N 9.87. 
Found (%): C 25.41, H 4.74, N 9.80. 
Calcd. C36H66Ga6N12O30 (%): C 27.62, H 4.25, N 10.74. 
[{Ga(edda)(OH)}6]: 
1H NMR (400 MHz, D2O): δ = 3.51–4.25 (sp, 2H, H2–H5), 2.38–3.38 (sp, 6H, H2–H5) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 177.2–178.5 (ms, C1, C6), 49.6–52.9 (ms, C2–C5), 
44.2–47.0 (ms, C2–C5) ppm. 
 
Crystals of [{Ga(edda)(µ-OH)}6]·xH2O (3j·xH2O) were obtained after one week by storing 
an aqueous solution (pH 7.0) of the raw product over acetone.    
 Empirical formula:  C36H66Ga6N12O30·xH2O. 
 Yield:  Few crystals. 
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5.5.79 [Ga(his)(ida)] 
 
Starting material: Iminodiacetic acid, L-histidine, water, gallium(III) chloride, 
triethylamine, ethanol, diethyl ether. 
Procedure: Iminodiacetic acid (133 mg, 1.00 mmol) and L-histidine (155 mg, 1.00 mmol) 
were dissolved in 0.5 mL of water. Gradual addition of gallium(III) chloride solution 
(176 mg, 1.00 mmol) and triethylamine (418 µL, 3.00 mmol) resulted in a solution (pH 5.5) 
which was stirred for 16 h. The raw product was precipitated by addition of ethanol 
(50 mL). After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C10H13GaN4O6 + 0.40 H2O. 
 Yield:  305 mg (0.842 mmol, 84.2%). 
 Elemental analysis: Calcd. (%): C 33.16, H 3.84, N 15.47. 
Found (%): C 33.15, H 3.85, N 15.44. 
Calcd. C10H13GaN4O6 (%): C 33.84, H 3.69, N 15.78. 
 
Crystals of [Ga(his)(ida)] (4a) were obtained by storing a solution of the raw product in a 
water/triethylamine mixture (20:1, pH 8.5) in an open vessel for one week.  
 Empirical formula:  C10H13GaN4O6, 354.96 g mol−1. 
 Yield:  Few crystals. 
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5.5.80 [Ga(asp)(his)] 
 
Starting material: L-Aspartic acid, L-histidine, water, gallium(III) chloride, triethylamine, 
ethanol, diethyl ether. 
Procedure: L-Aspartic acid (134 mg, 1.01 mmol) and L-histidine (156 mg, 1.01 mmol) 
were suspended in 1.5 mL of water. Gradual addition of gallium(III) chloride solution 
(177 mg, 1.01 mmol) and triethylamine (561 µL, 4.02 mmol) resulted in a solution (pH 7.5) 
which was stirred for 16 h. The raw product was precipitated by addition of ethanol 
(50 mL). After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was first dried at 80 °C for 10 min and then on a lyophilizer for 1 day.  
 Empirical formula:  C10H13GaN4O6 + 2.40 H2O + 0.05 C6H16NCl. 
 Yield:  149 mg (0.368 mmol, 36.4%). 
 Elemental analysis: Calcd. (%): C 30.54, H 4.63, N 14.00. 
Found (%): C 30.38, H 4.61, N 14.23. 
Calcd. C10H13GaN4O6 (%): C 33.84, H 3.69, N 15.78. 
[Ga(asp)(his)]: 
1H NMR (400 MHz, D2O): δ = 7.72–8.16 (sp, 1H, H6, his), 7.07–7.19 (sp, 1H, H5, his), 
4.15–4.20 (sp, 1H, H2, his), 3.89–3.97 (sp, 1H, H2, asp), 3.24–3.36 (sp, 2H, H3, his), 2.84–
3.16 (sp, 2H, H3, asp) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 179.0–180.0 (sp, C1, asp/his), 177.3–177.9 (ms, C4, 
asp), 135.7–136.6 (ms, C6, his), 132.4–133.4 (ms, C4, his), 115.7–116.8 (ms, C5, his), 
52.8–54.0 (ms, C2, his), 50.9–51.9 (ms, C2, asp), 37.8–38.3 (ms, C3, asp), 27.5–28.3 
(ms, C3, his) ppm. 
L-Aspartic acid: 
1H NMR (400 MHz, D2O): δ = 3.87–3.90 (sp, 1H, H2), 2.63–2.81 (sp, 2H, H3) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 178.1 (C4), 174.7 (C1), 52.8 (C2), 37.1 (C3) ppm. 
L-Histidine: 
1H NMR (400 MHz, D2O): δ = 7.72–8.16 (sp, 1H, H6), 7.07–7.19 (sp, 1H, H5), 3.98–4.01 
(m, 1H, H2), 3.18–3.26 (sp, 2H, H3) ppm. 
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13C{1H} NMR (101 MHz, D2O): δ = 173.1 (C1), 135.7–136.6 (sp, C6), 132.7 (C4), 115.7–
116.8 (sp, C5), 54.8 (C2), 27.5 (C3) ppm. 
 
5.5.81 [{Ga(µ-asp)(D-his)}2] 
 
Starting material: L-Aspartic acid, D-histidine, water, gallium(III) chloride, triethylamine, 
ethanol, diethyl ether, acetone. 
Procedure: L-Aspartic acid (134 mg, 1.01 mmol) and D-histidine (156 mg, 1.01 mmol) 
were suspended in 1.5 mL of water. Gradual addition of gallium(III) chloride solution 
(177 mg, 1.01 mmol) and triethylamine (561 µL, 4.02 mmol) resulted in a slurry (pH 9.0) 
which was stirred for 16 h. Further solid was precipitated by addition of ethanol (20 mL). 
After filtration and washing with ethanol and diethyl ether the obtained colourless 
amorphous solid was dried at 80 °C for 10 min.  
 Empirical formula:  C10H13GaN4O6 + 1.95 H2O. 
 Yield:  335 mg (0.859 mmol, 85.9%). 
 Elemental analysis: Calcd. (%): C 30.79, H 4.37, N 14.36. 
Found (%): C 30.72, H 4.31, N 14.45. 
Calcd. C10H13GaN4O6 (%): C 33.84, H 3.69, N 15.78. 
 
Crystals of [{Ga(asp)(D-his)}2]·1.61H2O (4b·1.61H2O) were obtained by storing a solution 
of the raw product in a water-triethylamine-mixture (20:1, pH 10.0) over acetone for two 
month.  
 Empirical formula:  C20H26Ga2N8O12·1.61H2O, 738.92 g mol−1. 
 Yield:  Few crystals. 
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5.5.82 [Ga(malo)(tren)]Cl 
 
Starting material: Tris(2-aminoethyl)amine, gallium(III) chloride, malonic acid, 
triethylamine, ethanol, diethyl ether, methanol, n-hexane. 
Procedure: Tris(2-aminoethyl)amine (154 mg, 1.05 mmol) was added to a solution of 
gallium(III) chloride (185 mg, 1.05 mmol), malonic acid (109 mg, 1.05 mmol) and 
triethylamine (1025 µL, 7.35 mmol) in 7 mL of ethanol. The resulting suspension was 
stirred for 16 h. After filtration and washing with ethanol and diethyl ether the obtained 
colourless amorphous solid was dried under fine vacuum for 3 h.  
 Empirical formula:  C9H20ClGaN4O4 + 1.10 H2O + 0.05 C2H6O. 
 Yield:  160 mg (0.426 mmol, 42.6%). 
 Elemental analysis: Calcd. (%): C 29.10, H 6.04, N 14.92. 
Found (%): C 29.01, H 5.88, N 14.76.  
Calcd. C9H20ClGaN4O4 (%): C 30.58, H 5.70, N 15.85. 
 
Crystals of [Ga(malo)(tren)]Cl·MeOH (5aCl·MeOH) were obtained after four months by 
storing a methanolic solution of the raw product over n-hexane. 
 Empirical formula:  C9H20ClGaN4O4·CH4O, 385.50 g mol−1. 
 Yield:  Few crystals. 
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5.5.83 [Ga(ox)(trien)]Cl 
 
Starting material: Oxalic acid, water, gallium(III) chloride, triethylamine, 
triethylenetetramine, ethanol, ethyl acetate, diethyl ether, acetone. 
Procedure: Oxalic acid (90 mg, 1.0 mmol) was dissolved in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), triethylamine (279 µL, 
2.00 mmol) and triethylenetetramine (146 mg, 1.00 mmol) resulted in a yellowish solution 
(pH 8.5) which was stirred for 16 h. The solvent was removed by rotary evaporation and 
the residue was suspended in ethanol (10 mL) and ethyl acetate (30 mL). After filtration 
and washing with ethyl acetate and diethyl ether the obtained beige amorphous solid was 
first dried at 80 °C for 10 min and then under fine vacuum for 2 h. 
 Empirical formula:  C8H18ClGaN4O4 + 2.75 H2O. 
 Yield:  340 mg (0.874 mmol, 87.4%). 
 Elemental analysis: Calcd. (%): C 24.70, H 6.09, N 14.40. 
Found (%): C 24.61, H 5.97, N 14.51. 
Calcd. C8H18ClGaN4O4 (%): C 28.31, H 5.35, N 16.51. 
[Ga(ox)(trien)]+: 
1H NMR (400 MHz, D2O): δ = 2.53–3.55 (sp, 12H, H1–H6, trien) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 165.4–166.1 (3s, C1, ox), 44.5–46.7 (ms, C1–C6, 
trien), 37.8–39.4 (ms, C1–C6, trien), 35.0–35.8 (ms, C1–C6, trien) ppm. 
 
Crystals of [Ga(ox)(trien)]Cl·2H2O (5b·5c·2Cl·4H2O) were obtained after one week by 
storing an aqueous solution of the raw product (pH 7.0, adjusted with triethylamine) over 
acetone.    
 Empirical formula:  C8H18ClGaN4O4·2H2O, 375.46 g mol−1. 
 Yield:  142 mg (0.378 mmol, 37.8%). 
 Elemental analysis: Calcd. (%): C 25.59, H 5.91, N 14.92. 
Found (%): C 25.39, H 5.69, N 14.67. 
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5.5.84  [Ga(malo)(trien)]Cl 
 
Starting material: Malonic acid, water, gallium(III) chloride, triethylenetetramine, 
triethylamine, ethanol, ethyl acetate, diethyl ether. 
Procedure: Malonic acid (104 mg, 1.00 mmol) was suspended in 0.5 mL of water. 
Gradual addition of gallium(III) chloride solution (176 mg, 1.00 mmol), triethylenetetramine 
(146 mg, 1.00 mmol) and triethylamine (488 µL, 3.50 mmol) resulted in a yellowish 
solution (pH 9.0) which was stirred for 16 h. Addition of ethanol (30 mL) and ethyl acetate 
(30 mL) yielded a yellow slurry. After filtration and washing with ethyl acetate and diethyl 
ether the obtained beige amorphous solid was dried at 80 °C for 10 min. 
 Empirical formula:  C9H20ClGaN4O4 + 1.65 H2O + 0.05 Ga(OH)3. 
 Yield:  308 mg (0.791 mmol, 79.1%). 
 Elemental analysis: Calcd. (%): C 27.77, H 6.07, N 14.39. 
Found (%): C 27.94, H 5.98, N 14.19. 
Calcd. C9H20ClGaN4O4 (%): C 30.58, H 5.70, N 15.85. 
[Ga(malo)(trien)]+: 
1H NMR (400 MHz, D2O): δ = 3.15–3.25 (sp, 2H, H2, malo), 2.33–3.47 (sp, 12H, H1–H6, 
trien) ppm. 
13C{1H} NMR (101 MHz, D2O): δ = 175.0–176.1 (ms, C1, malo), 44.3–47.9 (ms, C1–C6, 
trien), 42.1–44.3 (ms, C2, malo), 36.8–39.4 (ms, C1–C6, trien), 34.9–35.9 (ms, C1–C6, 
trien) ppm. 
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5.5.85 [Ga(mal)(trien)] 
 
Starting material: L-malic acid, water, gallium(III) chloride, triethylamine, 
triethylenetetramine, ethanol, diethyl ether, methanol, acetonitrile. 
Procedure: L-Malic acid (134 mg, 1.00 mmol) was dissolved in 0.5 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), triethylamine (418 µL, 
3.00 mmol) and triethylenetetramine (146 mg, 1.00 mmol) resulted in a yellowish solution 
(pH 9.0) which was stirred for 16 h. A yellow slurry was obtained which was then diluted 
with ethanol (10 mL). After filtration and washing with ethanol and diethyl ether the 
obtained beige amorphous solid was dried at 80 °C for 10 min. 
 Empirical formula:  C10H22GaClN4O5 + 0.85 C2H6O + 0.30 H2O + 0.20 Ga(OH)3. 
 Yield:  311 mg (0.688 mmol, 68.8%). 
 Elemental analysis: Calcd. (%): C 31.08, H 6.31, N 12.39. 
Found (%): C 31.03, H 6.36, N 12.46. 
Calcd. C10H22GaClN4O5 (%): C 31.32, H 5.78, N 14.61. 
 
Crystals of [Ga(mal)(trien)]·3H2O (5d·3H2O) were obtained after one month by storing a 
solution of the raw product in a water/methanol mixture (1:1, pH 7.0) of the raw product 
over acetonitrile.    
 Empirical formula:  C10H21GaN4O5·3H2O, 401.08 g mol−1. 
 Yield:  Few crystals.  
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5.5.86 HDIPEA[Ga(edda)(malo)] 
 
Starting material: Malonic acid, water, gallium(III) chloride, ethylenediamine-N,N′-diacetic 
acid, N,N-diisopropylethylamine, ethanol, ethyl acetate, diethyl ether, dimethyl sulfoxide. 
Procedure: Malonic acid (104 mg, 1.00 mmol) was dissolved in 1 mL of water. Gradual 
addition of gallium(III) chloride solution (176 mg, 1.00 mmol), ethylenediamine-N,N`-
diacetic acid (176 mg, 1.00 mmol) and N,N-diisopropylethylamine (826 µL, 5.00 mmol) 
resulted in a colourless slurry (pH 8.0) which was stirred for 16 h. The solution was 
concentrated by rotary evaporation. Addition of ethanol (20 mL) and ethyl acetate (30 mL) 
yielded colourless precipitate. After filtration and washing with ethanol and diethyl ether 
the obtained colourless amorphous solid was first dried at 80 °C for 10 min and then under 
fine vacuum for 2 h.  
 Empirical formula:  C17H32GaN3O8 + 0.95 H2O. 
 Yield:  334 mg (0.677 mmol, 67.7%). 
 Elemental analysis: Calcd. (%): C 41.39, H 6.93, N 8.52. 
Found (%): C 41.30, H 6.83, N 8.48. 
Calcd. C17H32GaN3O8 (%): C 42.88, H 6.77, N 8.82. 
 
Crystals of HDIPEA[Ga(edda)(malo)]·H2O ((HDIPEA)3k·H2O) were obtained after one 
month by storing an aqueous solution of the raw product (pH 7.0) over dimethyl sulfoxide.
  
 Empirical formula:  C17H32GaN3O8·H2O, 494.19 g mol−1. 
 Yield:  Few crystals. 
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6 Appendix 
6.1 Illustrations of 13C{1H} NMR spectra  
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Figure 6.1: HDIPEA[Ga(asn)(nta)] + 0.20 Ga(OH)3 + 0.05 EtOH in aqueous solution. a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of HDIPEA[Ga(asn)(nta)] + 0.20 Ga(OH)3 + 0.05 EtOH in D2O*, c: 13C{1H} NMR 
spectrum of L-asparagine in D2O*. Red: L-asparagine, cyan: L-asparaginato in [Ga(asn)(nta)]−, blue: nta in 
[Ga(asn)(nta)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was 
added for referencing. 
 
Table 6.1: 13C{1H} NMR shifts (δ/ppm, D2O) of L-asparagine and the L-asparaginato ligand in [Ga(asn)(nta)]−. 
The relative shift is given in Δδ (CIS).  
   C1 C2 C3 C4 
HDIPEA+ [Ga(asn)(nta)]−  δ 177.6 51.4 36.2 175.2 
 L-Asparagine δ 174.8 51.8 35.0 173.7 
  Δδ 2.8 ˗0.4 1.2 1.5 
HNEt3+ [Ga(asn)(nta)]−  δ 177.6 51.4 36.2 175.3 
 L-Asparagine δ 174.9 51.8 35.0 173.7 
  Δδ 2.7 ˗0.4 1.2 1.6 
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Figure 6.2: HDIPEA[Ga(gln)(nta)] + 0.20 + 0.05 EtOH in aqueous solution. a: equilibrium reaction, b: 
13C{1H} NMR spectrum of HDIPEA[Ga(gln)(nta)] + 0.20 + 0.05 EtOH in D2O*, c: 13C{1H} NMR spectrum of 
L-glutamine in D2O*. Red: L-glutamine, cyan: L-glutaminato in [Ga(gln)(nta)]−, blue: nta in [Ga(gln)(nta)]−, green: 
nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
 
Table 6.2: 13C{1H} NMR shifts (δ/ppm, D2O) of L-glutamine and the L-glutaminato ligand in [Ga(gln)(nta)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 
HDIPEA+ [Ga(gln)(nta)]−  δ 178.0 54.0 28.1 32.2 178.3 
 L-Glutamine δ 174.4 54.7 26.8 31.4 178.0 
  Δδ 3.6 ˗0.7 1.3 0.8 0.3 
HNEt3+ [Ga(gln)(nta)]−  δ 178.1 54.0 28.0 32.1 178.4 
 L-Glutamine δ 174.5 54.7 26.8 31.4 178.1 
  Δδ 3.6 ˗0.7 1.2 0.7 0.3 
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Figure 6.3: HDIPEA[Ga(Hglu)(nta)]·0.05DIPEA + 0.30 H2O + 0.05 Ga(OH)3 in aqueous solution. a: equili-
brium reaction, b: 13C{1H} NMR spectrum of HDIPEA[Ga(Hglu)(nta)]·0.05DIPEA + 0.30 H2O + 0.05 Ga(OH)3 
in D2O*, c: 13C{1H} NMR spectrum of L-glutamic acid in D2O*. Red: L-glutamic acid, cyan: L-glutamato in 
[Ga(Hglu)(nta)]−, blue: nta in [Ga(Hglu)(nta)]−, green: nta in in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, yellow: 
residual EtOH, orange: MeOH. * One drop of MeOH was added for referencing. 
 
Table 6.3: 13C{1H} NMR shifts (δ/ppm, D2O) of L-glutamic acid and the L-glutamato ligand in [Ga(Hglu)(nta)]− 
complexes. The relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 
HDIPEA+ [Ga(Hglu)(nta)]−  δ - 54.0 28.0 32.2 - 
 L-Glutamic acid δ 174.2 54.6 26.8 32.1 178.9 
  Δδ - ˗0.6 1.2 0.1 - 
HNEt3+ [Ga(Hglu)(nta)]−  δ - 54.1 28.1 32.4 - 
 L-Glutamic acid δ 174.5 54.7 26.9 32.4 179.5 
  Δδ - ˗0.6 1.2 0.0 - 
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Figure 6.4: HDIPEA[Ga(gly)(nta)] + 0.95 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(gly)(nta)] + 0.95 H2O in D2O*, c: 13C{1H} NMR spectrum of HDIPEA[Ga(gly)(nta)] + 
0.95 H2O with 0.5 equ. of glycine in D2O*, d: 13C{1H} NMR spectrum of glycine in D2O*. Red: glycine, cyan: 
glycinato in [Ga(gly)(nta)]−, blue: nta in [Ga(gly)(nta)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, 
orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.4: 13C{1H} NMR shifts (δ/ppm, D2O) of glycine and the glycinato ligand in [Ga(gly)(nta)]−. The relative 
shift is given in Δδ (CIS). 
   C1 C2 
HDIPEA+ [Ga(gly)(nta)]−  δ 176.7 42.1 
 Glycine δ 172.7 42.0 
  Δδ 4.0 0.1 
HNEt3+ [Ga(gly)(nta)]−  δ 177.1 42.1 
 Glycine δ 172.9 42.0 
  Δδ 4.2 0.1 
 
 
 
 
Figure 6.5: HDIPEA[Ga(ile)(nta)] + 0.20 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(ile)(nta)] + 0.20 H2O in D2O*, c: 13C{1H} NMR spectrum of L-isoleucine in D2O*. Red: 
L-isoleucine, cyan: L-isoleucinato in [Ga(ile)(nta)]−, blue: nta in [Ga(ile)(nta)]−, green: nta in [{Ga(nta)(µ-
OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.5: 13C{1H} NMR shifts (δ/ppm, D2O) of L-isoleucine and the L-isoleucinato ligand in [Ga(ile)(nta)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 C6 
HDIPEA+ [Ga(ile)(nta)]−  δ 178.5 59.5 37.2 24.1 16.3 12.0 
 L-Isoleucine δ 174.5 60.1 36.5 25.1 15.3 11.8 
  Δδ 4.0 ˗0.6 0.7 ˗1.0 1.0 0.2 
HNEt3+ [Ga(ile)(nta)]−  δ 178.7 59.5 37.2 24.1 16.3 12.0 
 L-Isoleucine δ 174.6 60.1 36.5 25.1 15.3 11.7 
  Δδ 4.1 ˗0.6 0.7 ˗1.0 1.0 0.3 
 
 
 
 
Figure 6.6: HDIPEA[Ga(leu)(nta)] + 0.15 H2O + 0.05 EtOAc in aqueous solution. a: equilibrium reaction, b: 
13C{1H} NMR spectrum of HDIPEA[Ga(leu)(nta)] + 0.15 H2O + 0.05 EtOAc in D2O*, c: 13C{1H} NMR spectrum 
of L-leucine in D2O*. Red: L-leucine, cyan: L-leucinato in [Ga(leu)(nta)]−, blue: nta in [Ga(leu)(nta)]−, green: nta 
in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.6: 13C{1H} NMR shifts (δ/ppm, D2O) of L-leucine and the L-leucinato ligand in [Ga(leu)(nta)]−. The 
relative shift is given in Δδ (CIS).  
   C1 C2 C3 C4 C5 C6 
HDIPEA+ [Ga(leu)(nta)]−  δ 179.6 52.9 41.4 25.1 23.1 20.7 
 L-Leucine δ 175.9 54.0 40.4 24.8 22.7 21.6 
  Δδ 3.7 ˗1.1 1.0 0.3 0.4 ˗0.9 
HNEt3+ [Ga(leu)(nta)]−  δ 179.7 52.9 41.4 25.1 23.1 20.7 
 L-Leucine δ 176.0 54.0 40.4 24.8 22.7 21.6 
  Δδ 3.7 ˗1.1 1.0 0.3 0.4 ˗0.9 
 
 
 
 
Figure 6.7: HDIPEA[Ga(met)(nta)] + 0.05 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(met)(nta)] + 0.05 H2O in D2O*, c: 13C{1H} NMR spectrum of L-methionine in D2O*. 
Red: L-methionine, cyan: L-methioninato in [Ga(met)(nta)]−, blue: nta in [Ga(met)(nta)]−, green: nta in 
[{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.7: 13C{1H} NMR shifts (δ/ppm, D2O) of L-methionine and the L-methioninato ligand in [Ga(met)(nta)]−. 
The relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 
HDIPEA+ [Ga(met)(nta)]−  δ 178.4 53.5 31.3 30.3 14.6 
 L-Methionine δ 174.6 54.5 30.3 29.4 14.5 
  Δδ 3.8 ˗1.0 1.0 0.9 0.1 
HNEt3+ [Ga(met)(nta)]−  δ 178.5 53.5 31.2 30.3 14.6 
 L-Methionine δ 174.7 54.5 30.3 29.4 14.5 
  Δδ 3.8 ˗1.0 0.9 0.9 0.1 
 
 
 
Figure 6.8: HDIPEA[Ga(nta)(phe)] + 0.90 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(nta)(phe)] + 0.90 H2O in D2O*, c: 13C{1H} NMR spectrum of L-phenylalanine in D2O*. 
Red: L-phenylalanine, cyan: L-phenylalaninato in [Ga(nta)(phe)]−, blue: nta in [Ga(nta)(phe)]−, green: nta in 
[{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.8: 13C{1H} NMR shifts (δ/ppm, D2O) of L-phenylalanine and the L-phenylalaninato ligand in 
[Ga(nta)(phe)]−. The relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 C6 C7 
HDIPEA+ [Ga(nta)(phe)]−  δ 177.9 55.8 37.8 137.1 129.8 129.7 128.0 
 L-Phenylalanine δ 174.4 56.6 37.0 135.7 130.0 129.7 128.3 
  Δδ 3.5 ˗0.8 0.8 1.4 ˗0.2 0.0 ˗0.3 
HNEt3+ [Ga(nta)(phe)]−  δ 177.9 55.8 37.7 137.1 129.8 129.7 128.0 
 L-Phenylalanine δ 174.4 56.6 37.0 135.7 130.0 129.7 128.3 
  Δδ 3.5 ˗0.8 0.7 1.4 ˗0.2 0.0 ˗0.3 
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Figure 6.9: HDIPEA[Ga(nta)(pro)] + 0.05 Ga(OH)3 + 0.05 H2O in aqueous solution. a: equilibrium reaction, b: 
13C{1H} NMR spectrum of HDIPEA[Ga(nta)(pro)] + 0.05 Ga(OH)3 + 0.05 H2O in D2O*, c: 13C{1H} NMR 
spectrum of HDIPEA[Ga(nta)(pro)] + 0.05 Ga(OH)3 + 0.05 H2O with 0.5 equ. of L-proline in D2O*, d: 
13C{1H} NMR spectrum of L-proline in D2O*. Red: L-proline, cyan: L-prolinato in [Ga(nta)(pro)]−, blue: nta in 
[Ga(nta)(pro)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was 
added for referencing. 
 
 
 
APPENDIX 
 224  
Table 6.9: 13C{1H} NMR shifts (δ/ppm, D2O) of L-proline and the L-prolinato ligand in [Ga(nta)(pro)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 
HDIPEA+ [Ga(nta)(pro)]−  δ 179.1 61.4 30.4 26.7 48.7 
 L-Proline δ 175.0 61.8 29.6 24.4 46.7 
  Δδ 4.1 ˗0.4 0.8 2.3 2.0 
HNEt3+ [Ga(nta)(pro)]−  δ 179.2 61.4 30.4 26.8 48.7 
 L-Proline δ 175.1 61.8 29.6 24.4 46.7 
  Δδ 4.1 ˗0.4 0.8 2.4 2.0 
 
 
 
Table 6.10: 13C{1H} NMR shifts (δ/ppm, D2O) of L-serine and the L-serlinato ligand in [Ga(nta)(ser)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 
HDIPEA+ [Ga(nta)(ser)]−  δ 176.4 56.2 61.4 
 L-Serine δ 172.8 56.9 60.8 
  Δδ 3.6 ˗0.7 0.6 
HNEt3+ [Ga(nta)(ser)]−  δ 176.6 56.2 61.4 
 L-Serine δ 172.8 57.0 60.8 
  Δδ 3.8 ˗0.8 0.6 
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Figure 6.10: HDIPEA[Ga(nta)(ser)] + 0.80 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(nta)(ser)] + 0.80 H2O in D2O*, c: 13C{1H} NMR spectrum of HDIPEA[Ga(nta)(ser)] 
+ 0.80 H2O with 0.5 equ. of L-serine in D2O*, d: 13C{1H} NMR spectrum of L-serine in D2O*. Red: L-serine, cyan: 
L-serinato in [Ga(nta)(ser)]−, blue: nta in [Ga(nta)(ser)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, 
orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.11: HDIPEA[Ga(nta)(thr)] + 0.50 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(nta)(thr)] + 0.50 H2O in D2O*, c: 13C{1H} NMR spectrum of HDIPEA[Ga(nta)(thr)] 
+ 0.50 H2O with 0.5 equ. of L-threonine in D2O*, d: 13C{1H} NMR spectrum of L-threonine in D2O*. Red: L-
threonine, cyan: L-threoninato in [Ga(nta)(thr)]−, blue: nta in [Ga(nta)(thr)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, 
grey: HDIPEA+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Table 6.11: 13C{1H} NMR shifts (δ/ppm, D2O) of L-threonine and the L-threoninato ligand in [Ga(nta)(thr)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 
HDIPEA+ [Ga(nta)(thr)]−  δ 176.9 59.7 66.4 20.1 
 L-Threonine δ 173.2 61.0 66.5 20.1 
  Δδ 3.7 ˗1.3 ˗0.1 0.0 
HNEt3+ [Ga(nta)(thr)]−  δ 177.0 59.7 66.4 20.1 
 L-Threonine δ 173.3 61.0 66.5 20.1 
  Δδ 3.7 ˗1.3 ˗0.1 0.0 
 
 
 
Figure 6.12: HDIPEA[Ga(nta)(trp)] + 0.25 H2O + 0.20 Ga(OH)3 in aqueous solution. a: equilibrium reaction, b: 
13C{1H} NMR spectrum of HDIPEA[Ga(nta)(trp)] + 0.25 H2O + 0.20 Ga(OH)3 in D2O*, c: 13C{1H} NMR 
spectrum of L-tryptophan in D2O*. Red: L-tryptophan, cyan: L-tryptophanato in [Ga(nta)(trp)]−, blue: nta in 
[Ga(nta)(trp)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, orange: MeOH. * One drop of MeOH was 
added for referencing. 
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Table 6.12: 13C{1H} NMR shifts (δ/ppm, D2O) of L-tryptophan and the L-tryptophanato ligand in [Ga(nta)(trp)]−. 
The relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 
HDIPEA+ [Ga(nta)(trp)]− δ 178.4 54.6 28.0 109.2 125.4 137.1 127.3 119.0 120.1 122.8 112.6 
 L-Tryptophan δ 174.9 55.5 27.0 108.1 125.6 136.9 127.3 119.0 120.1 122.7 112.6 
  Δδ 3.5 ˗0.9 1.0 1.1 ˗0.2 0.2 0.0 0.0 0.0 0.1 0.0 
HNEt3+ [Ga(nta)(trp)]− δ 178.3 54.6 27.9 109.2 125.4 137.0 127.3 119.0 120.0 122.8 112.6 
 L-Tryptophan δ 174.8 55.5 27.0 108.1 125.6 136.9 127.3 119.0 120.1 122.7 112.6 
  Δδ 3.5 ˗0.9 0.9 1.1 ˗0.2 0.1 0.0 0.0 ˗0.1 0.1 0.0 
 
 
Table 6.13: 13C{1H} NMR shifts (δ/ppm, D2O) of L-valine and the L-valinato ligand in [Ga(nta)(val)]−. The 
relative shift is given in Δδ (CIS). 
   C1 C2 C3 C4 C5 
HDIPEA+ [Ga(nta)(val)]−  δ 178.5 59.8 30.2 19.2 15.9 
 L-Valine δ 174.6 60.9 29.7 18.6 17.3 
  Δδ 3.9 ˗1.1 0.5 0.6 ˗1.4 
HNEt3+ [Ga(nta)(val)]−  δ 178.7 59.8 30.2 19.2 15.9 
 L-Valine δ 174.7 60.9 29.7 18.6 17.3 
  Δδ 4.0 ˗1.1 0.5 0.6 ˗1.4 
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Figure 6.13: HDIPEA[Ga(nta)(val)] + 0.15 H2O in aqueous solution. a: equilibrium reaction, b: 13C{1H} NMR 
spectrum of HDIPEA[Ga(nta)(val)] + 0.15 H2O in D2O*, c: 13C{1H} NMR spectrum of HDIPEA[Ga(nta)(val)] 
+ 0.15 H2O with 0.5 equ. of L-valine in D2O*, d: 13C{1H} NMR spectrum of L-valine in D2O*. Red: L-valine, cyan: 
L-valinato in [Ga(nta)(val)]−, blue: nta in [Ga(nta)(val)]−, green: nta in [{Ga(nta)(µ-OH)}2]2−, grey: HDIPEA+, 
orange: MeOH. * One drop of MeOH was added for referencing. 
 
 
APPENDIX 
 230  
 
Figure 6.14: [Ga(ala)(edda)] + 0.20 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(ala)(edda)] + 0.20 H2O in D2O*, c: 13C{1H} NMR spectrum of L-alanine in D2O*. 
Red: L-alanine, cyan: L-alaninato in [Ga(ala)(edda)], blue (A and B): edda in [Ga(ala)(edda)] and [{Ga(edda)(µ-
OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.15: [Ga(asn)(edda)] + 0.15 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(asn)(edda)] + 0.15 H2O in D2O*, c: 13C{1H} NMR spectrum of L-asparagine in 
D2O*. Red: L-asparagine, cyan: L-asparaginato in [Ga(asn)(edda)], blue (A and B): edda in [Ga(asn)(edda)] 
and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.16: [Ga(edda)(Hglu)]·0.30NEt3 + 1.25 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium 
reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(Hglu)]·0.30NEt3 + 1.25 H2O in D2O*, c: 13C{1H} NMR 
spectrum of L-glutamic acid in D2O*. Red: L-glutamic acid, cyan: L-glutamato in [Ga(edda)(Hglu)], blue (A and 
B): edda in [Ga(edda)(Hglu)] and [{Ga(edda)(µ-OH)}n] complexes, grey: HNEt3+, orange: MeOH. * One drop 
of MeOH was added for referencing. 
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Figure 6.17: [Ga(edda)(gly)] + 1.40 H2O + 0.10 Ga(OH)3 in aqueous solution (c = 0.25 mol L−1). a: equilibrium 
reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(gly)] + 1.40 H2O + 0.10 Ga(OH)3 in D2O*, c: 13C{1H} NMR 
spectrum of [Ga(edda)(gly)] + 1.40 H2O + 0.10 Ga(OH)3 with 1.0 equ. of glycine in D2O*, d: 13C{1H} NMR 
spectrum of glycine in D2O*. Red: glycine, cyan: glycinato in [Ga(edda)(gly)], blue (A and B): edda in 
[Ga(edda)(gly)] and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for 
referencing. 
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Figure 6.18: [Ga(edda)(Hhis)]Cl + 0.10 H2O + 0.05 HNEt3Cl in aqueous solution (c = 0.25 mol L−1). a: 
equilibrium reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(Hhis)]Cl + 0.10 H2O + 0.05 HNEt3Cl in D2O*, c: 
13C{1H} NMR spectrum of L-histidine in D2O*. Red: L-histidine, cyan: L-histidinato in [Ga(edda)(Hhis)]+, blue (A 
and B): edda in [Ga(edda)(Hhis)]+ and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH 
was added for referencing. 
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Figure 6.19: [Ga(edda)(ile)] + 0.80 H2O + 0.05 HNEt3Cl in aqueous solution (c = 0.25 mol L−1). a: equilibrium 
reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(ile)] + 0.80 H2O + 0.05 HNEt3Cl in D2O*, c: 13C{1H} NMR 
spectrum of L-isoleucine in D2O*. Red: L-isoleucine, cyan: L-isoleucinato in [Ga(edda)(ile)], blue (A and B): 
edda in [Ga(edda)(ile)] and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added 
for referencing. 
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Figure 6.20: [Ga(edda)(leu)] + 1.50 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(edda)(leu)] + 1.50 H2O in D2O*, c: 13C{1H} NMR spectrum of L-leucine in D2O*. 
Red: L-leucine, cyan: L-leucinato in [Ga(edda)(leu)], blue (A and B): edda in [Ga(edda)(leu)] and [{Ga(edda)(µ-
OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.21: [Ga(edda)(Hlys)]Cl + 0.60 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(edda)(Hlys)]Cl + 0.60 H2O in D2O*, c: 13C{1H} NMR spectrum of L-lysine 
hydrochloride in D2O*. Red: L-lysine, cyan: L-lysinato in [Ga(edda)(Hlys)]+, blue (A and B): edda in 
[Ga(edda)(Hlys)]+ and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for 
referencing. 
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Figure 6.22: [Ga(edda)(met)] + 0.55 H2O + 0.10 Ga(OH)3 in aqueous solution (c = 0.25 mol L−1). a: equilibri-
um reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(met)] + 0.55 H2O + 0.10 Ga(OH)3 in D2O*, c: 
13C{1H} NMR spectrum of L-methionine in D2O*. Red: L-methionine, cyan: L-methioninato in [Ga(edda)(met)], 
blue (A and B): edda in [Ga(edda)(met)] and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of 
MeOH was added for referencing. 
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Figure 6.23: [Ga(edda)(pro) + 0.10 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(edda)(pro)] + 0.10 H2O in D2O*, c: 13C{1H} NMR spectrum of [Ga(edda)(pro)] 
+ 0.10 H2O with 1.0 equ. of L-proline in D2O*, d: 13C{1H} NMR spectrum of L-proline in D2O*. Red: L-proline, 
cyan: L-prolinato in [Ga(edda)(pro)], blue (A and B): edda in [Ga(edda)(pro)] and [{Ga(edda)(µ-OH)}n] 
complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.24: [Ga(edda)(ser)] + 1.55 H2O + 0.10 Ga(OH)3 in aqueous solution (c = 0.25 mol L−1). a: equilibrium 
reaction, b: 13C{1H} NMR spectrum of [Ga(edda)(ser)] + 1.55 H2O + 0.10 Ga(OH)3 in D2O*, c: 13C{1H} NMR 
spectrum of L-serine in D2O*. Red: L-serine, cyan: L-serinato in [Ga(edda)(ser)], blue (A and B): edda in 
[Ga(edda)(ser)] and [{Ga(edda)(µ-OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for 
referencing. 
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Figure 6.25: [Ga(edda)(trp)] + 1.50 H2O in basic aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, 
b: 13C{1H} NMR spectrum of [Ga(edda)(trp)] + 1.50 H2O in D2O and triethylamine*, c: 13C{1H} NMR spectrum 
of L-tryptophan in D2O and triethylamine*. Red: L-tryptophanate, blue (A and B): edda in [{Ga(edda)(µ-OH)}n] 
complexes, grey: HNEt3+, orange: MeOH. * One drop of MeOH was added for referencing. 
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Figure 6.26: [Ga(edda)(val)] + 0.50 H2O in aqueous solution (c = 0.25 mol L−1). a: equilibrium reaction, b: 
13C{1H} NMR spectrum of [Ga(edda)(val)] + 0.50 H2O in D2O*, c: 13C{1H} NMR spectrum of L-valine in D2O*. 
Red: L-valine, cyan: L-valinato in [Ga(edda)(val)], blue (A and B): edda in [Ga(edda)(val)] and [{Ga(edda)(µ-
OH)}n] complexes, orange: MeOH. * One drop of MeOH was added for referencing. 
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6.2 Packing diagrams of crystal structures 
 
 
Figure 6.27: Packing diagram of 1a (uv174) in the monoclinic space group P21/n with view along [100]. The 
symmetry elements of the space group P21/n are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce).  
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Figure 6.28: Packing diagram of 1b·H2O (wv552) in the monoclinic space group P21/c with view along [100]. 
The symmetry elements of the space group P21/c are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.29: Packing diagram of (HNEt3)2c (uo063) in the monoclinic space group P21/c with view along [100]. 
The symmetry elements of the space group P21/c are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce).  
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Figure 6.30: Packing diagram of (HNEt3)2f (uv281) in the monoclinic space group P21 with view along [001]. 
The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red), gallium (puce) and sulphur (yellow).  
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Figure 6.31: Packing diagram of (HNEt3)2g·H2O (vv202) in the orthorhombic space group P212121 with view 
along [010]. The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.32: Packing diagram of (HNEt3)2h·0.14H2O (uv170) in the triclinic space group P1 with view along 
[100]. Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.33: Packing diagram of (HDIPEA)2a·2H2O (vv373) in the monoclinic space group P21 with view along 
[010]. The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.34: Packing diagram of (HDIPEA)2b (vv753) in the monoclinic space group P21 with view along 
[010]. The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.35: Packing diagram of (HDIPEA)2c·MeOH (uv716) in the orthorhombic space group Pna21 with 
view along [001]. The symmetry elements of the space group Pna21 are overlaid. Atoms: carbon (grey), 
hydrogen (white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.36: Packing diagram of (HDIPEA)2c·H2O (wv334) in the monoclinic space group P21/n with view 
along [100]. The symmetry elements of the space group P21/n are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.37: Packing diagram of (HDIPEA)2d (wo068) in the orthorhombic space group P212121 with view 
along [010]. The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.38: Packing diagram of (HDIPEA)2e (vv362) in the orthorhombic space group P212121 with view 
along [010]. The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red), gallium (puce) and sulphur (yellow). 
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Figure 6.39: Packing diagram of (HDIPEA)2g (vv128) in the monoclinic space group P21 with view along 
[100]. The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce).  
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Figure 6.40: Packing diagram of (HDIPEA)2i·H2O (wv547) in the orthorhombic space group P212121 with view 
along [100]. The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.41: Packing diagram of 3a·2H2O (wv356) in the monoclinic space group P21 with view along [001]. 
The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce). 
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Figure 6.42: Packing diagram of 3b·2H2O (uv502) in the monoclinic space group P21/c with view along [100]. 
The symmetry elements of the space group P21/c are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.43: Packing diagram of 3c·3d·3i·6H2O (vv062) in the triclinic space group P1 with view along [100]. 
Atoms: carbon (grey), hydrogen (white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.44: Packing diagram of 3e·3f·3H2O (uv537) in the monoclinic space group P21 with view along [100]. 
The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce). 
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Figure 6.45: Packing diagram of 3g·3H2O (uo103) in the orthorhombic space group P212121 with view along 
[100]. The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen 
(white), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.46: Packing diagram of 3h·2H2O (uv699) in the monoclinic space group P21 with view along [100]. 
The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce). 
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Figure 6.47: Packing diagram of 3j·xH2O (vv074) in the tetragonal space group I41/a with view along [001]. 
The symmetry elements of the space group I41/a are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce). 
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Figure 6.48: Packing diagram of 4a (vv161) in the orthorhombic space group P212121 with view along [100]. 
The symmetry elements of the space group P212121 are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.49: Packing diagram of 4b·1.61H2O (vv351) in the tetragonal space group P41212 with view along 
[001]. The symmetry elements of the space group P41212 are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.50: Packing diagram of 5aCl·MeOH (uv087) in the monoclinic space group P21/c with view along 
[010]. The symmetry elements of the space group P21/c are overlaid. Atoms: carbon (grey), hydrogen (white), 
chlorine (green), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.51: Packing diagram of 5b·5c·2Cl·4H2O (uv732) in the monoclinic space group Pn with view along 
[001]. The symmetry elements of the space group Pn are overlaid. Atoms: carbon (grey), hydrogen (white), 
chlorine (green), nitrogen (blue), oxygen (red) and gallium (puce). 
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Figure 6.52: Packing diagram of 5d·3H2O (vv079) in the monoclinic space group P21 with view along [001]. 
The symmetry elements of the space group P21 are overlaid. Atoms: carbon (grey), hydrogen (white), nitrogen 
(blue), oxygen (red) and gallium (puce). 
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Figure 6.53: Packing diagram of (HDIPEA)3k·H2O (wv137) in the triclinic space group P?̅? with view along 
[010]. The symmetry elements of the space group P?̅? are overlaid. Atoms: carbon (grey), hydrogen (white), 
nitrogen (blue), oxygen (red) and gallium (puce). 
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6.3 Crystallographic tables 
Table 6.14: Crystallographic data of [{Ga(gly)2(µ-OH)}2] (1a), [Ga(gly)3]·H2O (1b·H2O) and HNEt3[Ga(gly)(nta)] 
((HNEt3)2c). 
a C- and N-bonded H: constr., b O-bonded H: constr., c O-bonded H: O–H fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 1a 1b·H2O (HNEt3)2c 
empirical formula C8H18Ga2N4O10 C6H14GaN3O7 C14H26GaN3O8 
Mr/g mol−1 469.70 309.92 434.10 
crystal system monoclinic monoclinic monoclinic 
space group P21/n P21/c P21/c 
a/Å 5.7023(2) 6.1913(2) 10.7329(3) 
b/Å 16.8012(5) 14.5830(4) 14.3878(4) 
c/Å 7.8405(2) 12.2156(4) 12.0805(4) 
α/° 90 90 90 
β/° 100.2090(10) 100.8500(10) 105.736(4) 
γ/° 90 90 90 
V/Å3 739.27(4) 1083.20(6) 1795.59(10) 
Z 2 4 4 
ρcalc/g cm−3 2.110 1.900 1.606 
μ/mm−1 3.708 2.572 1.581 
crystal size/mm 0.110 × 0.040 × 0.030 0.100 × 0.030 × 0.010 0.177 × 0.165 × 0.084 
T/K 100(2) 107(2) 123(2) 
diffractometer Bruker D8Venture Bruker D8Venture Oxford XCalibur 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode fine-focus sealed tube 
rated input/kW 2.5 2.5 2.00 
θ-range/° 3.585–27.12 3.269–25.69 4.192–28.842 
reflexes for metric 9990 9900 3780 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6482–0.7455 0.6901–0.7453 0.89111–1.00000 
reflexes measured 29889 20716 10402 
independent reflexes 1632 2067 4120 
Rint 0.0377 0.0310 0.0329 
mean σ(I)/I 0.0185 0.0203 0.0425 
reflexes with I ≥ 2σ(I) 1515 1964 3396 
x,y (weighting scheme) 0.0106, 0.8587 0.0174, 0.9322 0.0300, 1.3611 
hydrogen refinement a,b a,c a 
Flack parameter - - - 
parameters 110 162 238 
restraints 0 3 0 
R(Fobs) 0.0173 0.0180 0.0335 
Rw(F2) 0.0435 0.0465 0.0807 
S 1.129 1.069 1.046 
shift/errormax 0.002 0.001 0.001 
max. electron density/e Å−3 0.388 0.357 0.916 
min. electron density/e Å−3 −0.269 −0.282 −0.604 
measurement code uv174 wv552 uo063 
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Table 6.15: Crystallographic data of HNEt3[Ga(met)(nta)] ((HNEt3)2f), HNEt3[Ga(nta)(pro)]·H2O 
((HNEt3)2g·H2O) and HNEt3[Ga(nta)(ser)]·0.14H2O ((HNEt3)2h·0.14H2O). 
a C-bonded H: constr., b N-bonded H: constr., c N-bonded H: mixed constr. and refall, d O-bonded H: O–H fixed 
to 0.83 Å, H...H fixed to 1.31 Å, e ISOR was used for eight atoms. 
 (HNEt3)2f (HNEt3)2g·H2O (HNEt3)2h·0.14H2O 
empirical formula C17H32GaN3O8S C17H32GaN3O9 C15H28.28GaN3O9.14 
Mr/g mol−1 508.23 492.17 466.64 
crystal system monoclinic orthorhombic triclinic 
space group P21 P212121 P1 
a/Å 10.4808(7) 9.4523(3) 10.5532(4) 
b/Å 21.4486(15) 10.0306(4) 10.6604(3) 
c/Å 11.0268(6) 22.8924(7) 10.8684(4) 
α/° 90 90 107.6010(10) 
β/° 115.749(2) 90 117.8210(10) 
γ/° 90 90 97.2030(10) 
V/Å3 2232.7(3) 2170.48(13) 977.88(6) 
Z 4 4 2 
ρcalc/g cm−3 1.512 1.506 1.585 
μ/mm−1 1.373 1.321 1.462 
crystal size/mm 0.090 × 0.060 × 0.030 0.100 × 0.080 × 0.050 0.130 × 0.100 × 0.060 
T/K 100(2) 100(2) 100(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 2.795–25.37 2.961–25.70 3.731–27.13 
reflexes for metric 9988 9898 9871 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6361–0.7452 0.6931–0.7453 0.6740–0.7455 
reflexes measured 53576 37690 25503 
independent reflexes 8043 4109 6954 
Rint 0.0583 0.0433 0.0195 
mean σ(I)/I 0.0430 0.0370 0.0490 
reflexes with I ≥ 2σ(I) 7217 3886 6746 
x,y (weighting scheme) 0.0527, 3.7250 0.0261, 0.5307 0.0026, 0.4765 
hydrogen refinement a,b a,c,d a,c,d 
Flack parameter 0.053(9) 0.000(4) 0.027(5) 
parameters 549 285 548 
restraints 49 e 3 7 
R(Fobs) 0.0414 0.0238 0.0267 
Rw(F2) 0.1113 0.0556 0.0628 
S 1.088 1.036 1.054 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 1.471 0.675 1.110 
min. electron density/e Å−3 −0.751 −0.379 −0.538 
measurement code uv281 vv202 uv170 
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Table 6.16: Crystallographic data of HDIPEA[Ga(ala)(nta)]·2H2O ((HDIPEA)2a·2H2O), HDIPEA[Ga(asn)(nta)] 
((HDIPEA)2b) and HDIPEA[Ga(gly)(nta)]·MeOH ((HDIPEA)2c·MeOH). 
a C- and N-bonded H: constr., b O-bonded H: constr., c O-bonded H: O–H fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 (HDIPEA)2a·2H2O (HDIPEA)2b (HDIPEA)2c·MeOH 
empirical formula C17H36GaN3O10 C18H33GaN4O9 C17H34GaN3O9 
Mr/g mol−1 512.21 519.20 494.19 
crystal system monoclinic monoclinic orthorhombic 
space group P21 P21 Pna21 
a/Å 10.6793(5) 9.8125(4) 10.0228(2) 
b/Å 8.5181(4) 9.1108(3) 25.0997(5) 
c/Å 13.0630(7) 13.7554(4) 8.8022(2) 
α/° 90 90 90 
β/° 102.427(2) 110.881(2) 90 
γ/° 90 90 90 
V/Å3 1160.47(10) 1148.96(7) 2214.36(8) 
Z 2 2 4 
ρcalc/g cm−3 1.466 1.501 1.482 
μ/mm−1 1.241 1.253 1.295 
crystal size/mm 0.060 × 0.030 × 0.010 0.100 × 0.080 × 0.010 0.100 × 0.080 × 0.020 
T/K 100(2) 103(2) 100(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 3.194–25.68 3.152–28.77 3.247–28.30 
reflexes for metric 4846 9890 9966 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6741–0.7453 0.6773–0.7458 0.6831–0.7457 
reflexes measured 19254 24556 38669 
independent reflexes 4354 5884 5466 
Rint 0.0505 0.0299 0.0332 
mean σ(I)/I 0.0740 0.0446 0.0414 
reflexes with I ≥ 2σ(I) 3879 5464 4860 
x,y (weighting scheme) -, - 0.0223, 0.0054 -, 0.6689 
hydrogen refinement a,c a a,b 
Flack parameter 0.025(9) 0.024(4) 0.018(5) 
parameters 302 294 279 
restraints 7 1 1 
R(Fobs) 0.0376 0.0252 0.0264 
Rw(F2) 0.0639 0.0586 0.0558 
S 1.013 1.040 1.053 
shift/errormax 0.001 0.001 0.002 
max. electron density/e Å−3 0.379 0.427 0.293 
min. electron density/e Å−3 −0.429 −0.284 −0.263 
measurement code vv373 vv753 uv716 
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Table 6.17: Crystallographic data of HDIPEA[Ga(gly)(nta)]·H2O ((HDIPEA)2c·H2O), HDIPEA[Ga(leu)(nta)] 
((HDIPEA)2d) and HDIPEA[Ga(met)(nta)] ((HDIPEA)2e). 
a C- and N-bonded H: constr., b O-bonded H: O–H fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 
 (HDIPEA)2c·H2O (HDIPEA)2d (HDIPEA)2e 
empirical formula C16H32GaN3O9 C20H38GaN3O8 C19H36GaN3O8S 
Mr/g mol−1 480.16 518.25 536.29 
crystal system monoclinic orthorhombic orthorhombic 
space group P21/n P212121 P212121 
a/Å 13.1944(4) 9.2378(6) 8.8393(4) 
b/Å 8.7962(3) 10.1131(5) 9.8826(4) 
c/Å 19.0764(7) 25.4953(16) 27.5357(13) 
α/° 90 90 90 
β/° 94.1170(10) 90 90 
γ/° 90 90 90 
V/Å3 2208.30(13) 2381.8(2) 2405.39(18) 
Z 4 4 4 
ρcalc/g cm−3 1.444 1.445 1.481 
μ/mm−1 1.296 1.205 1.279 
crystal size/mm 0.090 × 0.080 × 0.040 0.239 × 0.135 × 0.112 0.100 × 0.080 × 0.010 
T/K 299(2) 143(2) 100(2) 
diffractometer Bruker D8Venture Oxford XCalibur Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode fine-focus sealed tube rotating anode 
rated input/kW 2.5 2.00 2.5 
θ-range/° 3.154–27.14 4.336–28.275 3.179–26.36 
reflexes for metric 9620 3041 9349 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.8195–0.8620 0.90988–1.00000 0.6379–0.7454 
reflexes measured 54559 14182 35820 
independent reflexes 4856 5455 4883 
Rint 0.0317 0.0591 0.0517 
mean σ(I)/I 0.0189 0.0778 0.0599 
reflexes with I ≥ 2σ(I) 4161 4364 4191 
x,y (weighting scheme) 0.0302, 0.9324 0.0479, 0.2105 0.0156, 6.8760 
hydrogen refinement a,b a a 
Flack parameter - −0.015(11) 0.039(7) 
parameters 275 296 295 
restraints 3 0 0 
R(Fobs) 0.0246 0.0489 0.0485 
Rw(F2) 0.0671 0.1180 0.0970 
S 1.053 1.042 1.061 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 0.305 0.775 0.645 
min. electron density/e Å−3 −0.232 −0.728 −0.710 
measurement code wv334 wo068 vv362 
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Table 6.18: Crystallographic data of HDIPEA[Ga(nta)(pro)] ((HDIPEA)2g), HDIPEA[Ga(nta)(val)]·H2O 
((HDIPEA)2i·H2O) and [Ga(asn)(edda)]·2H2O (3a·2H2O). 
a C- and N-bonded H: constr., b O-bonded H: O–H fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 
 (HDIPEA)2g (HDIPEA)2i·H2O 3a·2H2O 
empirical formula C19H34GaN3O8 C19H38GaN3O9 C10H21GaN4O9 
Mr/g mol−1 502.21 522.24 411.03 
crystal system monoclinic orthorhombic monoclinic 
space group P21 P212121 P21 
a/Å 10.5247(4) 8.7517(3) 9.5516(17) 
b/Å 8.9515(3) 10.6239(3) 8.0803(14) 
c/Å 24.2972(8) 25.7782(8) 10.3637(17) 
α/° 90 90 90 
β/° 96.2220(10) 90 91.898(6) 
γ/° 90 90 90 
V/Å3 2275.60(14) 2396.78(13) 799.4(2) 
Z 4 4 2 
ρcalc/g cm−3 1.466 1.447 1.708 
μ/mm−1 1.258 1.201 1.776 
crystal size/mm 0.080 × 0.070 × 0.010 0.090 × 0.080 × 0.070 0.100 × 0.030 × 0.020 
T/K 100(2) 108(2) 299(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 3.021–25.71 3.118–25.68 3.198–27.48 
reflexes for metric 9978 9970 9246 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6842–0.7453 0.6926–0.7453 0.6553–0.7456 
reflexes measured 41874 46559 20605 
independent reflexes 8525 4530 3672 
Rint 0.0449 0.0617 0.0382 
mean σ(I)/I 0.0563 0.0422 0.0414 
reflexes with I ≥ 2σ(I) 7490 4084 3404 
x,y (weighting scheme) 0.0377, 2.0279 0.0205, 0.5109 0.0253, 0.0797 
hydrogen refinement a a,b a,b 
Flack parameter 0.015(5) 0.003(6) 0.015(6) 
parameters 569 304 225 
restraints 1 3 8 
R(Fobs) 0.0395 0.0273 0.0276 
Rw(F2) 0.0931 0.0582 0.0633 
S 1.049 1.054 1.066 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 0.735 0.278 0.441 
min. electron density/e Å−3 −0.682 −0.288 −0.335 
measurement code vv128 wv547 wv356 
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Table 6.19: Crystallographic data of [Ga(edda)(gly)]·2H2O (3b·2H2O), 2[Ga(edda)(leu)]·[{Ga(edda)(µ-
OH)}2]·6H2O (3c·3d·3i·6H2O) and [Ga(edda)(phe)]·3H2O (3e·3f·3H2O). 
a C- and N-bonded H: constr., b O-bonded H: refall, c O-bonded H: O–H of water molecules fixed to 0.83 Å, 
H...H fixed to 1.31 Å, d ISOR was used for 16 atoms, e ISOR was used for two atoms. 
 3b·2H2O 3c·3d·3i·6H2O 3e·3f·3H2O 
empirical formula C8H18GaN3O8 C36H78Ga4N10O28 C30H46Ga2N6O15 
Mr/g mol−1 353.97 1377.96 870.17 
crystal system monoclinic triclinic monoclinic 
space group P21/c P1 P21 
a/Å 8.7524(4) 5.8411(3) 8.0741(10) 
b/Å 10.1518(5) 14.7435(7) 21.902(3) 
c/Å 15.1341(7) 15.4884(8) 10.6153(15) 
α/° 90 80.585(2) 90 
β/° 102.723(2) 83.636(2) 106.024(4) 
γ/° 90 88.522(2) 90 
V/Å3 1311.69(11) 1307.72(11) 1804.3(4) 
Z 4 1 2 
ρcalc/g cm−3 1.792 1.750 1.602 
μ/mm−1 2.141 2.139 1.572 
crystal size/mm 0.100 × 0.050 × 0.020 0.500 × 0.040 × 0.020 0.500 × 0.500 × 0.200 
T/K 100(2) 100(2) 100(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 3.118–27.13 3.220–25.65 2.825–25.79 
reflexes for metric 6985 8879 7836 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6559–0.7455 0.6690–0.7453 0.5201–0.7453 
reflexes measured 21581 27257 26047 
independent reflexes 2879 9630 6761 
Rint 0.0378 0.0428 0.0861 
mean σ(I)/I 0.0308 0.0706 0.1025 
reflexes with I ≥ 2σ(I) 2316 7952 5647 
x,y (weighting scheme) 0.0232, 1.2552 0.0352, 0.8506 0.0532, - 
hydrogen refinement a,c a,b,c a,c 
Flack parameter - 0.076(16) 0.058(12) 
parameters 197 749 502 
restraints 6 188 d 22 e 
R(Fobs) 0.0245 0.0422 0.0536 
Rw(F2) 0.0638 0.0916 0.1240 
S 1.051 1.024 1.013 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 0.353 1.012 0.917 
min. electron density/e Å−3 −0.370 −0.593 −1.140 
measurement code uv502 vv062 uv537 
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Table 6.20: Crystallographic data of [Ga(edda)(pro)]·3H2O (3g·3H2O), [Ga(edda)(thr)]·2H2O (3h·2H2O) and 
[{Ga(edda)(µ-OH)}6]·xH2O (3j·xH2O). 
a C-bonded H: constr., b N-bonded H: constr., c N-bonded H: refall., d O-bonded H: refall., e O-bonded H: O–H 
fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 3g·3H2O 3h·2H2O 3j·xH2O 
empirical formula C11H24GaN3O9 C10H22GaN3O9 C36H66Ga6N12O30 
Mr/g mol−1 412.05 398.02 1498.80 
crystal system orthorhombic monoclinic tetragonal 
space group P212121 P21 I41/a 
a/Å 5.3979(2) 5.5295(2) 31.0336(4) 
b/Å 14.3225(6) 14.4347(5) 31.0336 
c/Å 21.5455(8) 9.5439(3) 14.9558(4) 
α/° 90 90 90 
β/° 90 92.4630(10) 90 
γ/° 90 90 90 
V/Å3 1665.71(11) 761.06(5) 14403.7(5) 
Z 4 2 8 
ρcalc/g cm−3 1.643 1.737 1.382 
μ/mm−1 1.703 1.861 2.290 
crystal size/mm 0.500 × 0.183 × 0.066 0.100 × 0.030 × 0.010 0.100 × 0.080 × 0.050 
T/K 173(2) 100(2) 100(2) 
diffractometer Oxford XCalibur Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode fine-focus sealed tube rotating anode rotating anode 
rated input/kW 2.00 2.5 2.5 
θ-range/° 4.223–27.484 3.540–27.14 2.935–28.31 
reflexes for metric 3937 9904 9966 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.79233–1.00000 0.6602–0.7455 0.6644–0.7457 
reflexes measured 11126 21775 123508 
independent reflexes 3796 3343 8928 
Rint 0.0306 0.0317 0.0392 
mean σ(I)/I 0.0341 0.0332 0.0214 
reflexes with I ≥ 2σ(I) 3616 3265 7761 
x,y (weighting scheme) 0.0276, 0.1571 0.0166, 0.0306 0.0443, 99.4994 
hydrogen refinement a,b,e a,b,e a,c,d 
Flack parameter −0.008(6) 0.027(4) - 
parameters 241 225 536 
restraints 9 7 0 
R(Fobs) 0.0251 0.0167 0.0430 
Rw(F2) 0.0577 0.0424 0.1144 
S 1.056 1.021 1.078 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 0.461 0.294 2.268 
min. electron density/e Å−3 −0.453 −0.228 −0.998 
measurement code uo103 uv699 vv074 
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Table 6.21: Crystallographic data of [Ga(his)(ida)] (4a), [{Ga(µ-asp)(D-his)}2]·1.61H2O (4b·1.61H2O) and 
[Ga(malo)(tren)]Cl·MeOH (5aCl·MeOH). 
a C-bonded H: constr., b N-bonded H: constr., c N-bonded H: refall, d O-bonded H: refall, e O-bonded H: O–H 
fixed to 0.83 Å, H...H fixed to 1.31 Å. 
 4a 4b·1.61H2O 5aCl·MeOH 
empirical formula C10H13GaN4O6 C20H29.23Ga2N8O13.61 C10H24ClGaN4O5 
Mr/g mol−1 354.96 739.01 385.50 
crystal system orthorhombic tetragonal monoclinic 
space group P212121 P41212 P21/c 
a/Å 9.3204(2) 7.8793(3) 13.1283(4) 
b/Å 10.9873(3) 7.8793 8.9147(3) 
c/Å 12.0573(3) 42.747(3) 14.4947(4) 
α/° 90 90 90 
β/° 90 90 112.1890(10) 
γ/° 90 90 90 
V/Å3 1234.74(5) 2653.9(3) 1570.76(8) 
Z 4 4 4 
ρcalc/g cm−3 1.909 1.850 1.630 
μ/mm−1 2.267 2.117 1.948 
crystal size/mm 0.100 × 0.050 × 0.010 0.100 × 0.040 × 0.030 0.120 × 0.040 × 0.020 
T/K 100(2) 297(2) 100(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 2.508–26.07 2.954–26.38 3.352–27.16 
reflexes for metric 9811 9779 9836 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6798–0.7453 0.6819–0.7454 0.6844–0.7455 
reflexes measured 45516 68815 62749 
independent reflexes 2443 2709 3471 
Rint 0.0351 0.0282 0.0389 
mean σ(I)/I 0.0184 0.0137 0.0199 
reflexes with I ≥ 2σ(I) 2357 2680 3152 
x,y (weighting scheme) 0.0120, 0.5924 0.0223, 1.3967 0.0178, 1.1091 
hydrogen refinement a,b a,c,e a,c,d 
Flack parameter 0.006(3) 0.017(3) - 
parameters 190 226 219 
restraints 0 6 0 
R(Fobs) 0.0154 0.0206 0.0197 
Rw(F2) 0.0366 0.0522 0.0477 
S 1.106 1.166 1.048 
shift/errormax 0.001 0.002 0.001 
max. electron density/e Å−3 0.230 0.191 0.345 
min. electron density/e Å−3 −0.235 −0.242 −0.288 
measurement code vv161 vv351 uv087 
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Table 6.22: Crystallographic data of [Ga(ox)(trien)]Cl·2H2O (5b·5c·2Cl·4H2O), [Ga(mal)(trien)]·3H2O 
(5d·3H2O) and HDIPEA[Ga(edda)(malo)]·H2O ((HDIPEA)3k·H2O). 
a C-bonded H: constr., b N-bonded H: constr., c N-bonded H: refall, d O-bonded H: O–H fixed to 0.83 Å, H...H 
fixed to 1.31 Å. 
 5b·5c·2Cl·4H2O 5d·3H2O (HDIPEA)3k·H2O 
empirical formula C8H22ClGaN4O6 C10H27GaN4O8 C17H34GaN3O9 
Mr/g mol−1 375.46 401.07 494.19 
crystal system monoclinic monoclinic triclinic 
space group Pn P21 P1̅ 
a/Å 7.1651(2) 7.2277(5) 9.3499(3) 
b/Å 9.0775(3) 15.8606(11) 10.4273(3) 
c/Å 11.3216(4) 7.5211(5) 11.7875(4) 
α/° 90 90 83.2630(10) 
β/° 100.8160(10) 109.684(2) 89.9540(10) 
γ/° 90 90 71.1570(10) 
V/Å3 723.29(4) 811.80(10) 1079.27(6) 
Z 2 2 2 
ρcalc/g cm−3 1.724 1.641 1.521 
μ/mm−1 2.117 1.742 1.328 
crystal size/mm 0.100 × 0.030 × 0.030 0.050 × 0.030 × 0.010 0.100 × 0.100 × 0.080 
T/K 100(2) 100(2) 100(2) 
diffractometer Bruker D8Venture Bruker D8Venture Bruker D8Venture 
radiation MoKα MoKα MoKα 
anode rotating anode rotating anode rotating anode 
rated input/kW 2.5 2.5 2.5 
θ-range/° 3.663–25.71 3.150–25.68 2.553–33.13 
reflexes for metric 7959 5443 9957 
absorption correction multi-scan multi-scan multi-scan 
transmission factors 0.6537–0.7453 0.5998–0.7453 0.7124–0.7465 
reflexes measured 11066 12419 37876 
independent reflexes 2507 3093 8242 
Rint 0.0296 0.0586 0.0302 
mean σ(I)/I 0.0438 0.0637 0.0364 
reflexes with I ≥ 2σ(I) 2440 2756 7209 
x,y (weighting scheme) -, 0.0040 0.0335, - 0.0181, 0.4798 
hydrogen refinement a,b,d a,b,d a,c,d 
Flack parameter 0.030(6) 0.025(9) - 
parameters 197 232 314 
restraints 8 10 6 
R(Fobs) 0.0185 0.0352 0.0272 
Rw(F2) 0.0443 0.0753 0.0615 
S 1.046 1.035 1.032 
shift/errormax 0.001 0.001 0.001 
max. electron density/e Å−3 0.456 0.648 0.478 
min. electron density/e Å−3 −0.294 −0.387 −0.451 
measurement code uv732 vv079 wv137 
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